{"title":"NAD+ Family","description":"\u003cp\u003e\u003cstrong\u003eNAD+ (nicotinamide adenine dinucleotide)\u003c\/strong\u003e is the most-studied longevity coenzyme of the last fifteen years — and it’s the molecule almost every supplement on this page is trying, by one route or another, to keep at youthful levels. Nicotinamide adenine dinucleotide runs the chemistry of every living cell: it carries electrons through the mitochondrial electron-transport chain to produce ATP, it serves as the obligate substrate for the sirtuin family of longevity enzymes (SIRT1–SIRT7), and it is consumed by the DNA-repair enzyme PARP1 every time a strand break occurs. Tissue NAD+ falls roughly 50% between age 20 and age 50 and continues to decline thereafter (\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22452603\/\" target=\"_blank\" rel=\"noopener\"\u003eMassudi 2012, PLOS One\u003c\/a\u003e; \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27068460\/\" target=\"_blank\" rel=\"noopener\"\u003eCamacho-Pereira 2016, Cell Metabolism\u003c\/a\u003e). The collection on this page is the True Health Protocol library of every commercially available route to raising it — precursors (NMN, NR), direct liposomal NAD+, drink-format NR, and comprehensive multi-active blends — with the trial evidence and dosing rationale that informs each one.\u003c\/p\u003e\n\n\u003ch2 id=\"answer\"\u003eThe 60-second answer\u003c\/h2\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eWhy this collection exists.\u003c\/strong\u003e NAD+ falls ~50% by 50, sirtuins and PARP1 starve, mitochondrial output drops, and tissue energetics shift toward an aged phenotype. The collection covers every supplement format that addresses this: precursors (NMN, NR), direct NAD+ (liposomal capsule, ready-to-drink), and comprehensive co-formulated blends.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eThe four routes to raising NAD+.\u003c\/strong\u003e (1) \u003cem\u003eNMN precursor\u003c\/em\u003e — one enzymatic step from NAD+ via NMNAT2\/3, trial-validated at 250–1000mg\/day (\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33888596\/\" target=\"_blank\" rel=\"noopener\"\u003eYoshino 2021, Science\u003c\/a\u003e; \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35624462\/\" target=\"_blank\" rel=\"noopener\"\u003eYamaguchi 2022, Nutrients\u003c\/a\u003e; \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35365707\/\" target=\"_blank\" rel=\"noopener\"\u003eIgarashi 2022, npj Aging\u003c\/a\u003e). (2) \u003cem\u003eNR precursor\u003c\/em\u003e — two-step conversion via NRK1\/NRK2, trial-validated at 250–1000mg (\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27721479\/\" target=\"_blank\" rel=\"noopener\"\u003eTrammell 2016, Nat Commun\u003c\/a\u003e; \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30530937\/\" target=\"_blank\" rel=\"noopener\"\u003eConze 2019, Sci Rep\u003c\/a\u003e; \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35243604\/\" target=\"_blank\" rel=\"noopener\"\u003eBrakedal 2022, Cell Metab NADPARK\u003c\/a\u003e). (3) \u003cem\u003eLiposomal direct NAD+\u003c\/em\u003e — phospholipid-encapsulated to bypass gut hydrolysis. (4) \u003cem\u003eComprehensive blends\u003c\/em\u003e — precursor + sirtuin activator + cofactors in one capsule for users who want the whole stack pre-assembled.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDaily-protocol entry stack.\u003c\/strong\u003e A precursor (NMN 500–1000mg or NR 300–600mg) + Resveratrol 600mg trans-isomer for SIRT1 allosteric activation (\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/12939617\/\" target=\"_blank\" rel=\"noopener\"\u003eHowitz 2003, Nature\u003c\/a\u003e; \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23471395\/\" target=\"_blank\" rel=\"noopener\"\u003eHubbard 2013, Science\u003c\/a\u003e). Time of day: morning, with breakfast.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eThe Sinclair-stack cofactor pair.\u003c\/strong\u003e At sustained doses ≥500mg\/day NMN, two cofactors become rate-limiting: \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000mg\u003c\/a\u003e (replaces methyl groups burned clearing nicotinamide via NNMT) and \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin 50mg\u003c\/a\u003e (inhibits CD38, the age-rising NADase that degrades NAD+; \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30002995\/\" target=\"_blank\" rel=\"noopener\"\u003eTarragó 2018, Cell Metab\u003c\/a\u003e). Without these, high-dose precursor protocols hit diminishing returns.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTime-to-effect.\u003c\/strong\u003e Whole-blood NAD+ rises measurably within 1–2 weeks (\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35624462\/\" target=\"_blank\" rel=\"noopener\"\u003eYamaguchi 2022\u003c\/a\u003e); subjective energy\/sleep around weeks 2–4; insulin sensitivity around weeks 8–12 (\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33888596\/\" target=\"_blank\" rel=\"noopener\"\u003eYoshino 2021\u003c\/a\u003e); muscle, gait, and grip-strength endpoints around 12 weeks (\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35365707\/\" target=\"_blank\" rel=\"noopener\"\u003eIgarashi 2022\u003c\/a\u003e); compounding gains thereafter.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eQuality.\u003c\/strong\u003e Every active in this collection is HPLC-assayed for ≥98% purity (β-NMN ≥99%, NR ≥98%, trans-resveratrol ≥98%), ISO\/IEC 17025 third-party tested for arsenic \/ cadmium \/ mercury \/ lead \/ microbial, and made under cGMP 21 CFR Part 111. No proprietary blends, no titanium dioxide, no synthetic dyes. \u003ca href=\"\/he\/pages\/quality\"\u003eRead the full quality protocol\u003c\/a\u003e.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWho this collection is for.\u003c\/strong\u003e Adults 30+ noticing the slow-creep aging signals (3pm energy crash, slower workout recovery, declining VO2 max, sleep that no longer fully restores) and any adult building a serious longevity protocol around the López-Otín hallmarks framework (\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23746838\/\" target=\"_blank\" rel=\"noopener\"\u003eLópez-Otín 2013, Cell\u003c\/a\u003e; \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36599349\/\" target=\"_blank\" rel=\"noopener\"\u003eLópez-Otín 2023, Cell\u003c\/a\u003e).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWho it’s not for.\u003c\/strong\u003e Pregnancy\/nursing, active chemotherapy, or any condition where sirtuin activation or PARP support is contraindicated by an oncologist or transplant team. Always coordinate with prescribers before starting.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"toc\"\u003eOn this page\u003c\/h2\u003e\n\n\u003col\u003e\n\u003cli\u003e\u003ca href=\"#answer\"\u003eThe 60-second answer\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#why-decline\"\u003eWhy NAD+ falls with age — the five-mechanism breakdown\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#four-routes\"\u003eThe four routes to raising NAD+\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#products\"\u003eThe eight products — trial evidence and dosing\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#protocol-tiers\"\u003eThree protocol tiers — entry, daily, advanced\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#sinclair-cofactors\"\u003eThe Sinclair-stack cofactors — TMG and Apigenin\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#stacking\"\u003eStacking with sister collections\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#timeline\"\u003eWeek-by-week realistic timeline\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#drug-interactions\"\u003eDrug interactions and caution flags\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#who-its-for\"\u003eWho this collection is for — and who it isn’t\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#quality\"\u003eQuality, sourcing, and what’s not in the bottle\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#faq\"\u003eFAQ — 13 questions\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#references\"\u003eReferences\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#reading\"\u003eRelated collections, pages, and reading\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#disclaimer\"\u003eDisclaimer\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003ch2 id=\"why-decline\"\u003eWhy NAD+ falls with age — the five-mechanism breakdown\u003c\/h2\u003e\n\n\u003cp\u003eThe age-related decline in NAD+ is not a single switch flipping off — it’s the convergence of five separate mechanisms, each addressed by a different lever in the longevity-supplement toolkit. Understanding which mechanism is doing the work in your body shapes which product format to start with.\u003c\/p\u003e\n\n\u003ch3\u003e1. NAMPT decline — the salvage-pathway bottleneck\u003c\/h3\u003e\n\n\u003cp\u003eNAMPT (nicotinamide phosphoribosyltransferase) is the rate-limiting enzyme in the NAD+ salvage pathway — it converts nicotinamide back to NMN, which is then converted to NAD+. Tissue NAMPT activity declines steadily with age (\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22484942\/\" target=\"_blank\" rel=\"noopener\"\u003eStein 2014, EMBO J\u003c\/a\u003e; \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27068460\/\" target=\"_blank\" rel=\"noopener\"\u003eCamacho-Pereira 2016\u003c\/a\u003e), so the body becomes progressively less able to recycle nicotinamide back into the NAD+ pool. \u003cstrong\u003eLever:\u003c\/strong\u003e NMN supplementation bypasses NAMPT entirely — it enters the pathway downstream of the bottleneck and only requires NMNAT2\/3 (which remain active with age) to become NAD+. This is why \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e consistently outperforms nicotinamide alone in restoration trials.\u003c\/p\u003e\n\n\u003ch3\u003e2. CD38 amplification — the consumption side of the ledger\u003c\/h3\u003e\n\n\u003cp\u003eCD38 is an NAD-degrading enzyme (NADase) expressed on immune cells. Its activity rises ~30% per decade after age 40 due to chronic low-grade inflammaging, and it directly consumes NAD+ at increasing rates (\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27068460\/\" target=\"_blank\" rel=\"noopener\"\u003eCamacho-Pereira 2016\u003c\/a\u003e; \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30002995\/\" target=\"_blank\" rel=\"noopener\"\u003eTarragó 2018\u003c\/a\u003e). The combined picture is a leaky bucket: NAMPT (the inflow tap) drips slower while CD38 (the drain) opens wider. \u003cstrong\u003eLever:\u003c\/strong\u003e The flavone \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eapigenin\u003c\/a\u003e is the most-studied small-molecule CD38 inhibitor — the Mayo Clinic group identified it as a CD38 inhibitor in a 2013 BMC Genomics screen (\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23339328\/\" target=\"_blank\" rel=\"noopener\"\u003eEscande 2013\u003c\/a\u003e) and showed in mouse work that CD38 inhibition restores NAD+ levels independent of precursor supplementation.\u003c\/p\u003e\n\n\u003ch3\u003e3. Methylation drain — the upstream half of the cycle\u003c\/h3\u003e\n\n\u003cp\u003eNAD+ is broken down to nicotinamide; nicotinamide is methylated to N-methylnicotinamide by NNMT (using a methyl group from S-adenosylmethionine) and excreted in urine. Every dose of NMN or NR you take that becomes NAD+ that becomes nicotinamide that becomes N-methylnicotinamide costs the body a methyl group. At sustained NMN ≥500mg\/day, this exceeds dietary methyl-donor supply for most users, raising plasma homocysteine and depleting SAMe (\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/12824063\/\" target=\"_blank\" rel=\"noopener\"\u003ePissios 2017, Trends Endocrinol Metab\u003c\/a\u003e). \u003cstrong\u003eLever:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG (trimethylglycine, betaine)\u003c\/a\u003e donates three methyl groups directly into the SAMe cycle, restoring methyl-donor balance. This is the second cofactor in the canonical Sinclair \/ Stanfield NAD+ stack.\u003c\/p\u003e\n\n\u003ch3\u003e4. Mitochondrial DNA damage — the downstream PARP1 burn\u003c\/h3\u003e\n\n\u003cp\u003eEvery time a DNA strand break occurs, PARP1 (poly-ADP-ribose polymerase) consumes NAD+ to flag and repair it. Aging tissue accumulates mtDNA damage from oxidative stress, and chronic PARP1 activation can consume up to 80% of cellular NAD+ in hyper-stressed cells (\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24360282\/\" target=\"_blank\" rel=\"noopener\"\u003eBai 2015, Cell Metab\u003c\/a\u003e). \u003cstrong\u003eLever:\u003c\/strong\u003e Reducing the upstream oxidative-damage rate — via mitochondrial-resident antioxidants (\u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e, \u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003ealpha-lipoic acid\u003c\/a\u003e) and glutathione precursors (\u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC\u003c\/a\u003e, \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eglycine\u003c\/a\u003e) — reduces PARP1 burn at the source.\u003c\/p\u003e\n\n\u003ch3\u003e5. Sirtuin starvation — the readout of the whole system\u003c\/h3\u003e\n\n\u003cp\u003eThe sirtuin family (SIRT1–SIRT7) are the longevity enzymes whose activity is most consequential downstream of NAD+. They’re NAD+-dependent deacetylases that regulate mitochondrial biogenesis (PGC-1α deacetylation), DNA repair (FOXO3 activation), inflammation (NF-κB suppression), and circadian metabolism (BMAL1 regulation). When NAD+ falls, sirtuins fall in lockstep — not because they’re inhibited, but because their substrate is gone. Restoring NAD+ via precursor or direct supplementation restores sirtuin activity in human muscle biopsy (\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29985466\/\" target=\"_blank\" rel=\"noopener\"\u003eMartens 2018, Nat Commun\u003c\/a\u003e; \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24909168\/\" target=\"_blank\" rel=\"noopener\"\u003eGoh 2014, J Nutr Sci\u003c\/a\u003e). \u003cstrong\u003eLever:\u003c\/strong\u003e Pair NAD+ precursor with a sirtuin activator — trans-resveratrol or \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003epterostilbene\u003c\/a\u003e — for the substrate-plus-activation combination that reproduces the Howitz 2003 \/ Hubbard 2013 SIRT1 K_m-lowering effect.\u003c\/p\u003e\n\n\u003ch2 id=\"four-routes\"\u003eThe four routes to raising NAD+ — format-by-format breakdown\u003c\/h2\u003e\n\n\u003cp\u003eEvery product on this page falls into one of four format categories. Understanding the trade-offs helps you pick.\u003c\/p\u003e\n\n\u003ch3\u003eRoute 1 — NMN precursor (one enzymatic step from NAD+)\u003c\/h3\u003e\n\n\u003cp\u003eβ-Nicotinamide mononucleotide is the immediate precursor — one enzymatic step (via NMNAT2\/3) from NAD+ itself. Oral β-NMN raises whole-blood NAD+ in 1–2 weeks (\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35624462\/\" target=\"_blank\" rel=\"noopener\"\u003eYamaguchi 2022\u003c\/a\u003e) and produces measurable functional endpoints at 12 weeks: \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33888596\/\" target=\"_blank\" rel=\"noopener\"\u003eYoshino 2021\u003c\/a\u003e reported +25% muscle insulin sensitivity in n=25 postmenopausal prediabetic women at 250mg\/day; \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35365707\/\" target=\"_blank\" rel=\"noopener\"\u003eIgarashi 2022\u003c\/a\u003e reported +9% gait speed and +6% grip strength in n=42 men 65+ at 250mg twice daily; \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35624462\/\" target=\"_blank\" rel=\"noopener\"\u003eYamaguchi 2022\u003c\/a\u003e reported +38% whole-blood NAD+ at 250mg\/day. \u003cstrong\u003eTwo SKUs in this collection:\u003c\/strong\u003e entry-tier \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500mg\u003c\/a\u003e for general daily use, and the cofactor-paired \u003ca href=\"\/he\/products\/longevity-stack-bundle-nmn-500mg-resveratrol-600mg\"\u003eLongevity Stack Bundle\u003c\/a\u003e that ships NMN 500mg with Resveratrol 600mg as the canonical substrate-plus-activator pair. \u003cstrong\u003eSister-collection cross-reference:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg Double Strength\u003c\/a\u003e for advanced\/long-term users who’ve graduated from the 500mg starting dose.\u003c\/p\u003e\n\n\u003ch3\u003eRoute 2 — NR precursor (two enzymatic steps, B-vitamin-compatible)\u003c\/h3\u003e\n\n\u003cp\u003eNicotinamide riboside is the other major precursor — converted to NMN by NRK1\/NRK2 and then to NAD+ by NMNAT. Trial evidence is the most extensive of any NAD+ precursor: \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27721479\/\" target=\"_blank\" rel=\"noopener\"\u003eTrammell 2016\u003c\/a\u003e validated 250mg as the smallest dose to elevate human whole-blood NAD+ within 2 weeks; \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30530937\/\" target=\"_blank\" rel=\"noopener\"\u003eConze 2019\u003c\/a\u003e reported +60% whole-blood NAD+ at 1000mg\/day for 8 weeks in n=140; \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29985466\/\" target=\"_blank\" rel=\"noopener\"\u003eMartens 2018\u003c\/a\u003e reported reduced systolic blood pressure (−9 mmHg) and aortic stiffness in stage 1 hypertensive adults at 500mg twice daily for 6 weeks; \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35243604\/\" target=\"_blank\" rel=\"noopener\"\u003eBrakedal 2022 NADPARK\u003c\/a\u003e reported NR-driven cerebral NAD+ elevation and exploratory motor improvement in early Parkinson’s disease at 1000mg\/day. \u003cstrong\u003eTwo SKUs in this collection:\u003c\/strong\u003e capsule-format \u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNR Hard Capsules\u003c\/a\u003e with B-vitamin cofactors, and ready-to-drink \u003ca href=\"\/he\/products\/liquid-nad-anti-aging-drink-advanced-cellular-rejuvenation\"\u003eLiquid NAD+ Anti-Aging Drink\u003c\/a\u003e berry stick packs (the same NR substrate in a non-capsule format for users who don’t take pills well).\u003c\/p\u003e\n\n\u003ch3\u003eRoute 3 — Direct liposomal NAD+\u003c\/h3\u003e\n\n\u003cp\u003eFree oral NAD+ is largely degraded in the stomach and gut to nicotinamide before absorption. Liposomal phospholipid encapsulation protects the molecule through gastric pH and delivers it intact to the enterocyte for absorption, then through the lymphatic system. \u003cstrong\u003eTwo SKUs in this collection\u003c\/strong\u003e use this route: \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+ Ultimate 1000mg\u003c\/a\u003e — a 10-active phospholipid formula combining direct NAD+ with NMN, CoQ10, PQQ, resveratrol, quercetin, B-complex, and antioxidants in one capsule for users who want one-bottle simplicity; and \u003ca href=\"\/he\/products\/new-nad-hard-capsules-daily-nad-boost-for-energy-longevity\"\u003eNAD+ Daily Boost\u003c\/a\u003e — direct NAD+ paired with trans-resveratrol in a daily-dose hard capsule for substrate-plus-SIRT1-activator users who prefer the streamlined two-active format.\u003c\/p\u003e\n\n\u003ch3\u003eRoute 4 — Comprehensive co-formulated blends\u003c\/h3\u003e\n\n\u003cp\u003eMulti-active formulas pre-assemble the NAD+ pathway with the most-studied cofactors so users don’t have to stack four bottles. \u003cstrong\u003eTwo SKUs in this collection\u003c\/strong\u003e sit here: \u003ca href=\"\/he\/products\/selerb-nad-5-in-1-complete-mitochondrial-formula\"\u003eNAD+ 5-in-1 Complete Mitochondrial Formula\u003c\/a\u003e — NMN as the precursor backbone plus CoQ10 (electron-transport-chain cofactor), B-complex (methylation cofactor floor), and antioxidants (PARP-burn-reducer); and the drink-mix \u003ca href=\"\/he\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eNAD+ 1000mg Pure Focus Formula\u003c\/a\u003e — NR with resveratrol (SIRT1 activator), PQQ (mitochondrial-biogenesis activator), and quercetin (CD38 inhibitor \/ senolytic flavonoid) in a once-daily berry drink for cognitive-focus users.\u003c\/p\u003e\n\n\u003ch2 id=\"products\"\u003eThe eight products — trial evidence and dosing\u003c\/h2\u003e\n\n\u003cp\u003ePer-product breakdown ordered by route. Every dose listed is the dose that appears on this product’s panel (not a generic recommendation), and every trial citation is the specific human RCT or mechanism paper that informed the formulation.\u003c\/p\u003e\n\n\u003ch3\u003e\n\u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500mg\u003c\/a\u003e — the entry-tier precursor\u003c\/h3\u003e\n\n\u003cp\u003e500mg β-NMN per capsule, ≥99% purity by HPLC, β-isomer-only (the active form — α-NMN is biologically inert), no proprietary blend. Trial-grade validation at 250mg\/day from \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33888596\/\" target=\"_blank\" rel=\"noopener\"\u003eYoshino 2021\u003c\/a\u003e and \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35624462\/\" target=\"_blank\" rel=\"noopener\"\u003eYamaguchi 2022\u003c\/a\u003e. The 500mg dose is the most-studied entry tier in the broader NMN literature and the cleanest single-dose option in the catalog. \u003cstrong\u003eUse as:\u003c\/strong\u003e 1 capsule with breakfast, daily. Pair with \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600mg\u003c\/a\u003e for SIRT1 activation; pair with \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000mg\u003c\/a\u003e at sustained use ≥4 weeks for methylation buffering.\u003c\/p\u003e\n\n\u003ch3\u003e\n\u003ca href=\"\/he\/products\/longevity-stack-bundle-nmn-500mg-resveratrol-600mg\"\u003eLongevity Stack Bundle\u003c\/a\u003e — the canonical NMN + Resveratrol pair\u003c\/h3\u003e\n\n\u003cp\u003eCo-shipped: NMN 500mg β-NMN ≥99% + Trans-Resveratrol 600mg ≥98% trans-isomer (the active form — cis-resveratrol does not allosterically activate SIRT1). This is the substrate-plus-activator pair that reproduces the Howitz 2003 \/ Hubbard 2013 K_m-lowering effect: resveratrol binds an allosteric site on SIRT1 that lowers the enzyme’s K_m for its acetyl-lysine substrate ~5-fold, increasing turnover even at the same NAD+ concentration. \u003cstrong\u003eTrial evidence for the pair:\u003c\/strong\u003e \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22106405\/\" target=\"_blank\" rel=\"noopener\"\u003eTimmers 2011, Cell Metab\u003c\/a\u003e (n=11 obese men, +9% mitochondrial respiration, +9% sleeping metabolic rate at 150mg resveratrol); \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24909168\/\" target=\"_blank\" rel=\"noopener\"\u003eGoh 2014\u003c\/a\u003e (n=10 T2DM, SIRT1 protein +3.6× at 500mg twice daily). \u003cstrong\u003eUse as:\u003c\/strong\u003e 1 NMN capsule + 1 Resveratrol capsule with breakfast, daily. Sub-sum-of-parts pricing vs. buying the components separately.\u003c\/p\u003e\n\n\u003ch3\u003e\n\u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNicotinamide Riboside (NR) Hard Capsules\u003c\/a\u003e — the patented precursor\u003c\/h3\u003e\n\n\u003cp\u003eNR (Niagen-class substrate) with B-vitamin cofactors (B3, B6, B12, folate) for full methylation cycle support. NR is the most clinically studied NAD+ precursor — \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27721479\/\" target=\"_blank\" rel=\"noopener\"\u003eTrammell 2016\u003c\/a\u003e first validated 250mg as the lowest dose to detectably raise whole-blood NAD+ in humans; \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30530937\/\" target=\"_blank\" rel=\"noopener\"\u003eConze 2019\u003c\/a\u003e reported +60% whole-blood NAD+ at 1000mg over 8 weeks in n=140; \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29985466\/\" target=\"_blank\" rel=\"noopener\"\u003eMartens 2018\u003c\/a\u003e showed cardiovascular endpoints at 500mg twice daily; \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35243604\/\" target=\"_blank\" rel=\"noopener\"\u003eBrakedal 2022\u003c\/a\u003e demonstrated cerebral NAD+ elevation. \u003cstrong\u003eUse as:\u003c\/strong\u003e 1–2 capsules with breakfast, daily, depending on dose tier. Co-formulated B-vitamins partially address the methylation drain that builds with sustained precursor use, though TMG remains useful at high doses.\u003c\/p\u003e\n\n\u003ch3\u003e\n\u003ca href=\"\/he\/products\/liquid-nad-anti-aging-drink-advanced-cellular-rejuvenation\"\u003eLiquid NAD+ Anti-Aging Drink\u003c\/a\u003e — ready-to-drink NR berry stick packs\u003c\/h3\u003e\n\n\u003cp\u003eSame NR substrate as the capsule SKU, in a once-daily berry stick pack format. For users who don’t take capsules well, want flavor variety, or prefer a drink format for travel and morning routine integration. Trial backing carries over from the NR capsule literature above. \u003cstrong\u003eUse as:\u003c\/strong\u003e 1 stick pack stirred into 8oz water, morning, daily.\u003c\/p\u003e\n\n\u003ch3\u003e\n\u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+ Ultimate 1000mg\u003c\/a\u003e — the 10-active phospholipid formula\u003c\/h3\u003e\n\n\u003cp\u003eDirect NAD+ in a phosphatidylcholine liposomal carrier (protects through gastric pH for intact absorption) plus nine supporting actives: NMN (precursor backbone), CoQ10 (electron-transport-chain cofactor; \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25282031\/\" target=\"_blank\" rel=\"noopener\"\u003eMortensen 2014, Q-SYMBIO\u003c\/a\u003e), PQQ (mitochondrial-biogenesis activator; \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23211660\/\" target=\"_blank\" rel=\"noopener\"\u003eHarris 2013\u003c\/a\u003e), trans-resveratrol (SIRT1 activator), quercetin (senolytic flavonoid + CD38 inhibitor), B-complex (methylation floor), and a defined antioxidant blend. The one-capsule format trades dose-per-active flexibility for one-bottle simplicity. \u003cstrong\u003eUse as:\u003c\/strong\u003e 1–2 capsules with breakfast, daily.\u003c\/p\u003e\n\n\u003ch3\u003e\n\u003ca href=\"\/he\/products\/new-nad-hard-capsules-daily-nad-boost-for-energy-longevity\"\u003eNAD+ Daily Boost\u003c\/a\u003e — direct NAD+ + Trans-Resveratrol\u003c\/h3\u003e\n\n\u003cp\u003eTwo-active hard capsule pairing direct NAD+ (substrate) with trans-resveratrol (SIRT1 allosteric activator). Streamlined for users who want the substrate-plus-activator combination without the rest of the comprehensive-blend stack. The trans-isomer-specific resveratrol reproduces the K_m-lowering effect documented by Howitz and Hubbard. \u003cstrong\u003eUse as:\u003c\/strong\u003e 1–2 capsules with breakfast, daily.\u003c\/p\u003e\n\n\u003ch3\u003e\n\u003ca href=\"\/he\/products\/selerb-nad-5-in-1-complete-mitochondrial-formula\"\u003eNAD+ 5-in-1 Complete Mitochondrial Formula\u003c\/a\u003e — the comprehensive capsule\u003c\/h3\u003e\n\n\u003cp\u003eNMN as precursor backbone, plus CoQ10 (cellular energy \/ electron-transport-chain cofactor), B-complex (methylation cofactor floor), an antioxidant blend (PARP-burn-reducer), and a skin-supportive layer (Pro-collagen amino acid co-factors). Designed for users who want a turnkey NAD+ + mitochondrial + antioxidant capsule rather than building a five-bottle stack. \u003cstrong\u003eUse as:\u003c\/strong\u003e 1–2 capsules with breakfast, daily.\u003c\/p\u003e\n\n\u003ch3\u003e\n\u003ca href=\"\/he\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eNAD+ 1000mg Pure Focus Formula\u003c\/a\u003e — the cognitive-focus drink mix\u003c\/h3\u003e\n\n\u003cp\u003eOnce-daily berry drink with NR (precursor backbone), trans-resveratrol (SIRT1 activator), PQQ (mitochondrial biogenesis), and quercetin (CD38 inhibitor \/ NF-κB suppressor \/ senolytic flavonoid). Drink-format positioning aimed at users for whom the cognitive-focus \/ 3pm-energy benefit is the dominant goal. \u003cstrong\u003eUse as:\u003c\/strong\u003e 1 stick pack in 8oz water, morning, daily.\u003c\/p\u003e\n\n\u003ch2 id=\"protocol-tiers\"\u003eThree protocol tiers — entry, daily, advanced\u003c\/h2\u003e\n\n\u003cp\u003eThe eight products in this collection let you build three protocol tiers depending on goal, sophistication, and budget. Pick the tier that matches your current state, not the most-aggressive one.\u003c\/p\u003e\n\n\u003ch3\u003eTier 1 — Entry (one product, 8–12 weeks)\u003c\/h3\u003e\n\n\u003cp\u003eGoal: confirm you respond to NAD+ precursor before stacking. Best for first-time NAD+ users, anyone uncertain whether this category will work for them, or budget-conscious users.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003eSingle SKU pick: \u003cstrong\u003e\u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500mg\u003c\/a\u003e\u003c\/strong\u003e — or, if you don’t take capsules well, \u003cstrong\u003e\u003ca href=\"\/he\/products\/liquid-nad-anti-aging-drink-advanced-cellular-rejuvenation\"\u003eLiquid NAD+ Anti-Aging Drink\u003c\/a\u003e\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eSchedule: 1 dose with breakfast, daily, for 12 weeks.\u003c\/li\u003e\n\u003cli\u003eWhat to track: 3pm energy, sleep recovery, workout PRs (subjective); fasting insulin, HOMA-IR (objective, at 12 weeks).\u003c\/li\u003e\n\u003cli\u003eIf responsive: graduate to Tier 2.\u003c\/li\u003e\n\u003cli\u003eIf non-responsive: check upstream basics (vitamin D, ferritin, B12, hypothyroid, sleep apnea, protein floor) before assuming the precursor itself is failing — see \u003ca href=\"\/he\/pages\/getting-started\"\u003eGetting Started\u003c\/a\u003e for the differential list.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eTier 2 — Daily Stack (precursor + activator, ~12 weeks to compound)\u003c\/h3\u003e\n\n\u003cp\u003eGoal: substrate plus allosteric SIRT1 activation in the canonical Sinclair-stack pair. Best for confirmed responders to Tier 1, anyone with a serious daily longevity intent, or users 40+ where the NAD+ decline is mechanistically pronounced.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003eTwo SKUs: \u003cstrong\u003e\u003ca href=\"\/he\/products\/longevity-stack-bundle-nmn-500mg-resveratrol-600mg\"\u003eLongevity Stack Bundle\u003c\/a\u003e\u003c\/strong\u003e (NMN 500mg + Resveratrol 600mg) — the easiest path; \u003cem\u003eor\u003c\/em\u003e any combination of separately purchased \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e, \u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNR\u003c\/a\u003e, \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+\u003c\/a\u003e, \u003ca href=\"\/he\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eNAD+ Drink Mix\u003c\/a\u003e, or \u003ca href=\"\/he\/products\/new-nad-hard-capsules-daily-nad-boost-for-energy-longevity\"\u003eNAD+ Daily Boost\u003c\/a\u003e + \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600mg\u003c\/a\u003e if buying components separately.\u003c\/li\u003e\n\u003cli\u003eSchedule: 1 dose of each with breakfast (fat-containing meal — resveratrol is fat-soluble), daily.\u003c\/li\u003e\n\u003cli\u003eWhat to track: subjective markers continue; objective markers expand to include hs-CRP, homocysteine, fasting glucose at 12 weeks. Resistance-training PRs and grip strength are useful endpoints (Igarashi 2022 endpoint set).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eTier 3 — Advanced (Sinclair stack with cofactors, sustained use)\u003c\/h3\u003e\n\n\u003cp\u003eGoal: comprehensive NAD+ pathway support including the upstream methylation buffer and the downstream CD38 inhibitor — the canonical advanced longevity protocol. Best for sustained users 6+ months in, anyone running NMN ≥1000mg\/day, or anyone targeting the full sirtuin \/ autophagy \/ PARP-modulation downstream cascade. \u003cstrong\u003eNote:\u003c\/strong\u003e This tier introduces products that are \u003cem\u003enot\u003c\/em\u003e in this collection but are tagged into \u003ca href=\"\/he\/collections\/longevity-essentials\"\u003eLongevity Essentials\u003c\/a\u003e — methylation buffer (TMG) and CD38 inhibitor (Apigenin).\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003eNAD+ collection picks: \u003cstrong\u003e\u003ca href=\"\/he\/products\/longevity-stack-bundle-nmn-500mg-resveratrol-600mg\"\u003eLongevity Stack Bundle\u003c\/a\u003e\u003c\/strong\u003e (or \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg Double Strength\u003c\/a\u003e + \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600mg\u003c\/a\u003e for the high-dose tier).\u003c\/li\u003e\n\u003cli\u003eCofactor adds: \u003cstrong\u003e\u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000mg\u003c\/a\u003e\u003c\/strong\u003e (methylation buffer) + \u003cstrong\u003e\u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin 50mg\u003c\/a\u003e\u003c\/strong\u003e (CD38 inhibitor) + \u003cstrong\u003e\u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400mg\u003c\/a\u003e\u003c\/strong\u003e (NAMPT\/SAMe-cycle\/Mg-ATP cofactor).\u003c\/li\u003e\n\u003cli\u003eOptional fourth-pillar mitochondrial layer: \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500mg\u003c\/a\u003e (mitophagy — clears damaged mitochondria so the new NAD+ has functional destinations to power) + \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ 20mg\u003c\/a\u003e (PGC-1α biogenesis — builds new mitochondria) + \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400mg\u003c\/a\u003e (electron-transport cofactor for the working mitochondria the NAD+ is feeding).\u003c\/li\u003e\n\u003cli\u003eSchedule: morning — NMN + Resveratrol + TMG + Apigenin + Magnesium (1 cap) + the mitochondrial layer if running it; evening — Magnesium 1 cap, 60–90 minutes before bed (split-dose Mg covers both NAMPT\/SAMe daytime burn and GABA-A sleep architecture).\u003c\/li\u003e\n\u003cli\u003eWhat to track: full annual lab panel (CMP, A1C, lipid + ApoB + Lp(a), fasting insulin, HOMA-IR, hs-CRP, homocysteine, TSH\/T3\/T4, 25(OH)D, B12, ferritin, RBC magnesium); advanced biomarkers if budget allows (epigenetic age, NAD+ assay, VO2 max, grip strength, DEXA).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"sinclair-cofactors\"\u003eThe Sinclair-stack cofactors — TMG and Apigenin\u003c\/h2\u003e\n\n\u003cp\u003eTwo cofactors come up so often in advanced NAD+ protocols that they deserve their own section. Neither is a precursor — both are protective layers around the precursor. Both live in \u003ca href=\"\/he\/collections\/longevity-essentials\"\u003eLongevity Essentials\u003c\/a\u003e rather than this NAD+ collection because their tag taxonomy is broader (CD38, methylation, sirtuin pairing).\u003c\/p\u003e\n\n\u003ch3\u003eTMG — the upstream half of the cycle\u003c\/h3\u003e\n\n\u003cp\u003eThe mechanism: NAD+ → nicotinamide → (NNMT methylation, costs SAMe) → N-methylnicotinamide → urinary excretion. Every dose of NMN\/NR you absorb that becomes NAD+ that becomes nicotinamide costs the body a methyl group. At sustained NMN ≥500mg\/day this can elevate plasma homocysteine and deplete SAMe (\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/12824063\/\" target=\"_blank\" rel=\"noopener\"\u003ePissios 2017\u003c\/a\u003e). \u003cstrong\u003e\u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG (trimethylglycine)\u003c\/a\u003e\u003c\/strong\u003e donates three methyl groups directly into the SAMe cycle (via betaine-homocysteine methyltransferase), restoring methyl-donor balance. Add at week 4–6 of a Tier 2\/3 protocol or anytime NMN dose escalates above 500mg\/day. Standard dose: 1000mg morning.\u003c\/p\u003e\n\n\u003ch3\u003eApigenin — the downstream half of the cycle\u003c\/h3\u003e\n\n\u003cp\u003eThe mechanism: CD38 is an NADase whose activity rises ~30%\/decade after 40 due to inflammaging (\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27068460\/\" target=\"_blank\" rel=\"noopener\"\u003eCamacho-Pereira 2016\u003c\/a\u003e). Pumping more precursor in while CD38 is shredding the output is partly self-defeating. \u003cstrong\u003e\u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin 50mg\u003c\/a\u003e\u003c\/strong\u003e is the most-studied small-molecule CD38 inhibitor (\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23339328\/\" target=\"_blank\" rel=\"noopener\"\u003eEscande 2013\u003c\/a\u003e; \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30002995\/\" target=\"_blank\" rel=\"noopener\"\u003eTarragó 2018\u003c\/a\u003e). Sourced at 98% from chamomile concentrate with BioPerine for absorption (food sources are largely impractical — you’d need 50–150 cups of chamomile tea for one 50mg dose). Standard dose: 50mg morning, with breakfast.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eThe complete Sinclair \/ Stanfield NAD+ stack therefore reads:\u003c\/strong\u003e NMN (precursor, salvage-pathway bypass) + Resveratrol or Pterostilbene (SIRT1 allosteric activator) + TMG (methylation buffer, upstream protection) + Apigenin (CD38 inhibitor, downstream protection) + Magnesium Glycinate (NAMPT cofactor, sleep architecture, Vitamin D activation). These five together — not any subset of three — are what canonical advanced protocols converge on.\u003c\/p\u003e\n\n\u003ch2 id=\"stacking\"\u003eStacking with sister collections\u003c\/h2\u003e\n\n\u003cp\u003eNAD+ supplementation never lives alone in a serious protocol. Eight directional stacks the catalog supports:\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eNAD+ × \u003ca href=\"\/he\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal\u003c\/a\u003e.\u003c\/strong\u003e NAD+ feeds the mitochondria; mitochondrial renewal makes sure the mitochondria the NAD+ is feeding are new and functional. Add Urolithin A (mitophagy — clears the broken ones), PQQ (biogenesis — builds new ones), and CoQ10 (electron-transport cofactor for the working ones). Pumping NAD+ into a cell with half-broken mitochondria mostly produces reactive oxygen species rather than ATP.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNAD+ × \u003ca href=\"\/he\/collections\/cardiovascular-longevity\"\u003eCardiovascular Longevity\u003c\/a\u003e.\u003c\/strong\u003e The Martens 2018 finding (NR 500mg twice daily → −9 mmHg systolic in stage 1 hypertension) is the entry point. Add \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400mg\u003c\/a\u003e for endothelial function (Q-SYMBIO heart-failure trial), \u003ca href=\"\/he\/products\/taurine-1000mg-cardiovascular-mitochondrial-longevity\"\u003eTaurine 1000mg\u003c\/a\u003e for vascular tone, \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 2000mg\u003c\/a\u003e for ApoB\/Lp(a) and inflammation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNAD+ × \u003ca href=\"\/he\/collections\/metabolic\"\u003eMetabolic\u003c\/a\u003e.\u003c\/strong\u003e AMPK and sirtuins are the two master nutrient-sensing arms of metabolic longevity. Add \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine 500mg\u003c\/a\u003e with the largest carbohydrate meals for AMPK activation; add \u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid 600mg\u003c\/a\u003e for the universal antioxidant cycle that recycles glutathione and vitamin C. The Yoshino 2021 Science paper anchored NMN at 250mg\/day to +25% muscle insulin sensitivity in postmenopausal prediabetics — this is the metabolic stack’s clinical anchor.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNAD+ × \u003ca href=\"\/he\/collections\/senolytics\"\u003eSenolytics\u003c\/a\u003e.\u003c\/strong\u003e Senescent cells (the “zombies”) consume NAD+ via CD38 over-expression and SASP-driven chronic PARP activation. Monthly senolytic pulses (Quercetin + Fisetin, two days, once monthly) reduce the NAD+-burning cell population at the source. \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin 500mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin 500mg\u003c\/a\u003e together cover the most-studied senolytic flavonoid pair.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNAD+ × \u003ca href=\"\/he\/collections\/antioxidants\"\u003eAntioxidants\u003c\/a\u003e.\u003c\/strong\u003e Reducing oxidative damage at the source reduces PARP1 burn and preserves NAD+ for sirtuin \/ mitochondrial work. \u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione 500mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC 600mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e form the GlyNAC pair (\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34593657\/\" target=\"_blank\" rel=\"noopener\"\u003eSekhar 2021, Antioxidants\u003c\/a\u003e; \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35114078\/\" target=\"_blank\" rel=\"noopener\"\u003eKumar 2022\u003c\/a\u003e) that restores tissue glutathione status while raising NAD+.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNAD+ × \u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e.\u003c\/strong\u003e The mineral and vitamin floor (\u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3 + K2\u003c\/a\u003e, \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e, Omega-3) determines whether the NAD+ stack functions at all — NAMPT is Mg-dependent, the SAMe cycle TMG supports is Mg-dependent, and Vitamin D activation is Mg-dependent. Roughly two-thirds of US adults sit below the magnesium RDA.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNAD+ × \u003ca href=\"\/he\/collections\/beauty-anti-aging\"\u003eBeauty \u0026amp; Anti-Aging\u003c\/a\u003e.\u003c\/strong\u003e Sirtuin activation downstream of NAD+ supports fibroblast COL1A1 expression and dermal mitochondrial function. Add \u003ca href=\"\/he\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen Peptides 5000mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eLiposomal Vitamin C 1000mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/hyaluronic-acid-200mg-vitamin-c-deep-skin-hydration-complex\"\u003eHyaluronic Acid 200mg\u003c\/a\u003e for the skin-from-within layer.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNAD+ × \u003ca href=\"\/he\/collections\/fertility\"\u003eFertility\u003c\/a\u003e.\u003c\/strong\u003e The oocyte carries ~100,000 mitochondria; the sperm tail is essentially a mitochondrial engine. Pre-conception NAD+\/CoQ10\/PQQ stacks address the oxidative-reproductive-aging axis — see the dedicated \u003ca href=\"\/he\/collections\/fertility\"\u003eFertility collection\u003c\/a\u003e for the trial-validated 60–90 day pretreatment protocol.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"timeline\"\u003eWeek-by-week realistic timeline\u003c\/h2\u003e\n\n\u003ctable border=\"1\" cellpadding=\"6\" cellspacing=\"0\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eWindow\u003c\/th\u003e\n\u003cth\u003eWhat rises measurably\u003c\/th\u003e\n\u003cth\u003eWhat you may notice subjectively\u003c\/th\u003e\n\u003cth\u003eTrial anchor\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eDays 1–7\u003c\/td\u003e\n\u003ctd\u003eWhole-blood NAD+ begins rising (NR\/NMN absorbed and converted)\u003c\/td\u003e\n\u003ctd\u003eOften nothing. Some users report subtle morning energy lift toward day 5–7.\u003c\/td\u003e\n\u003ctd\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27721479\/\" target=\"_blank\" rel=\"noopener\"\u003eTrammell 2016\u003c\/a\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeeks 2–4\u003c\/td\u003e\n\u003ctd\u003eWhole-blood NAD+ +25–60% above baseline at sustained dose\u003c\/td\u003e\n\u003ctd\u003e3pm energy crash softening; sleep feeling more restorative; workout recovery faster.\u003c\/td\u003e\n\u003ctd\u003e\n\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35624462\/\" target=\"_blank\" rel=\"noopener\"\u003eYamaguchi 2022\u003c\/a\u003e; \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30530937\/\" target=\"_blank\" rel=\"noopener\"\u003eConze 2019\u003c\/a\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeeks 4–8\u003c\/td\u003e\n\u003ctd\u003eMitochondrial respiration \/ sleeping metabolic rate rising; SIRT1 protein expression rising in muscle\u003c\/td\u003e\n\u003ctd\u003eEndurance-block PRs starting to move; less afternoon brain fog.\u003c\/td\u003e\n\u003ctd\u003e\n\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22106405\/\" target=\"_blank\" rel=\"noopener\"\u003eTimmers 2011\u003c\/a\u003e; \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24909168\/\" target=\"_blank\" rel=\"noopener\"\u003eGoh 2014\u003c\/a\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeeks 8–12\u003c\/td\u003e\n\u003ctd\u003eInsulin sensitivity, blood pressure, hs-CRP measurable improvements at sustained dose\u003c\/td\u003e\n\u003ctd\u003eLab markers move into “you’d notice on annual physical” territory.\u003c\/td\u003e\n\u003ctd\u003e\n\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33888596\/\" target=\"_blank\" rel=\"noopener\"\u003eYoshino 2021\u003c\/a\u003e; \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29985466\/\" target=\"_blank\" rel=\"noopener\"\u003eMartens 2018\u003c\/a\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMonths 3–6\u003c\/td\u003e\n\u003ctd\u003eGait speed, grip strength, sarcopenia-resistant muscle mass starting to compound\u003c\/td\u003e\n\u003ctd\u003eAthletic \/ functional endpoints (climbing stairs, getting up from floor) feeling easier.\u003c\/td\u003e\n\u003ctd\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35365707\/\" target=\"_blank\" rel=\"noopener\"\u003eIgarashi 2022\u003c\/a\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMonths 6–12\u003c\/td\u003e\n\u003ctd\u003eCompounding gains across the López-Otín hallmarks framework\u003c\/td\u003e\n\u003ctd\u003eThis is the “feels like 35 again at 50” territory the catalog is built around. Annual labs document the trend.\u003c\/td\u003e\n\u003ctd\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36599349\/\" target=\"_blank\" rel=\"noopener\"\u003eLópez-Otín 2023\u003c\/a\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eIf 12 weeks at full dose feels like nothing, run the upstream-basics differential before assuming the NAD+ category itself failed: \u003cstrong\u003eVitamin D \u0026lt;30 ng\/mL\u003c\/strong\u003e, \u003cstrong\u003eferritin \u0026lt;30\u003c\/strong\u003e, \u003cstrong\u003eB12 \u0026lt;400\u003c\/strong\u003e, \u003cstrong\u003eundiagnosed hypothyroid\u003c\/strong\u003e (TSH \u0026gt;3.0 with subclinical T3\/T4), \u003cstrong\u003eundiagnosed sleep apnea\u003c\/strong\u003e, \u003cstrong\u003eprotein floor \u0026lt;0.8g\/lb bodyweight\u003c\/strong\u003e. NAD+ supplementation amplifies the energy a body that’s otherwise correctly fueled can produce — it can’t paper over a missing upstream input.\u003c\/p\u003e\n\n\u003ch2 id=\"drug-interactions\"\u003eDrug interactions and caution flags\u003c\/h2\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eWarfarin \/ apixaban \/ rivaroxaban (anticoagulants).\u003c\/strong\u003e Resveratrol has mild antiplatelet activity. Monitor INR if combining with an NMN+Resveratrol bundle; coordinate with the prescriber, particularly around procedures that require holding anticoagulation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStatins.\u003c\/strong\u003e CoQ10 (in 5-in-1 \/ Liposomal NAD+ Ultimate) is a clinically appropriate co-supplement — statins deplete endogenous CoQ10 (\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17631503\/\" target=\"_blank\" rel=\"noopener\"\u003eMarcoff 2007\u003c\/a\u003e), so this combination is supportive rather than antagonistic.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eActive chemotherapy.\u003c\/strong\u003e NAD+ precursors and sirtuin activators have complex effects on cancer-cell energetics that depend on tumor type and regimen — coordinate with the treating oncologist before starting any NAD+ product. Some chemotherapy protocols deliberately pursue NAD+ depletion (\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28937962\/\" target=\"_blank\" rel=\"noopener\"\u003eChini 2018\u003c\/a\u003e).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDiabetes \/ metformin.\u003c\/strong\u003e NAD+ + sirtuin activation may improve insulin sensitivity (Yoshino 2021), which can require dose-adjustment of glucose-lowering medications. Monitor glucose closely in the first 4–8 weeks; coordinate with the prescriber.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSurgery (elective).\u003c\/strong\u003e Hold resveratrol-containing products for 1 week before any procedure that requires anticoagulation pause; standard supplement-pause protocols apply.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnancy \/ nursing.\u003c\/strong\u003e Trial data are inadequate. Avoid until weaning unless coordinated with an OB\/MFM team.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTransplant immunosuppression.\u003c\/strong\u003e Resveratrol and quercetin both inhibit CYP3A4 and may raise tacrolimus \/ cyclosporine levels — coordinate with the transplant team.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eApigenin + grapefruit-class drugs.\u003c\/strong\u003e Apigenin shares CYP3A4-inhibitory characteristics with grapefruit; the 50mg dose is small but combine cautiously with high-CYP3A4-substrate medications (some statins, some calcium channel blockers).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMethylation-sensitive psychiatric medication.\u003c\/strong\u003e TMG is generally safe but at high doses can shift methylation balance; users on SSRIs, SNRIs, or MAO inhibitors should add TMG slowly and watch for over-methylation symptoms (anxiety, insomnia).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"who-its-for\"\u003eWho this collection is for — and who it isn’t\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eThis collection is for you if:\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003eYou’re 30+ and noticing the slow-creep aging signals: 3pm energy crash, slower workout recovery, declining VO2 max, sleep that no longer fully restores.\u003c\/li\u003e\n\u003cli\u003eYou’re building a serious longevity protocol around the López-Otín hallmarks framework and want the NAD+ pillar covered.\u003c\/li\u003e\n\u003cli\u003eYou’re already running \u003ca href=\"\/he\/collections\/foundational-health\"\u003efoundational supplements\u003c\/a\u003e (Vitamin D + K2, Magnesium, Omega-3, Multivitamin floor) and have addressed upstream basics (sleep, training, protein floor).\u003c\/li\u003e\n\u003cli\u003eYou’re responsive to caffeine but want energy that comes from cellular metabolism rather than adenosine-receptor antagonism.\u003c\/li\u003e\n\u003cli\u003eYou’re post-menopausal or peri-menopausal — the Yoshino 2021 trial population was specifically prediabetic postmenopausal women, and that’s where some of the strongest insulin-sensitivity evidence sits.\u003c\/li\u003e\n\u003cli\u003eYou’re 50+ and the “feels like I’m running on lower power than I used to” subjective experience is the dominant complaint.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eThis collection is not for you if:\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003eYou’re pregnant or nursing.\u003c\/li\u003e\n\u003cli\u003eYou’re in active chemotherapy or radiation without oncology team coordination.\u003c\/li\u003e\n\u003cli\u003eYou’ve had a solid-organ transplant and are on tacrolimus\/cyclosporine without transplant-team coordination.\u003c\/li\u003e\n\u003cli\u003eYou’re hoping for a Day-1 stimulant-like effect — this is a 12-week-and-then-compounding category, not an energy-drink alternative.\u003c\/li\u003e\n\u003cli\u003eYou haven’t addressed sleep, training, and protein floor — the upstream variance is larger than the supplement effect at that point.\u003c\/li\u003e\n\u003cli\u003eYou’re under 25 and otherwise healthy — endogenous NAD+ is still high, the marginal benefit is small, and the literature is largely in older populations.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"quality\"\u003eQuality, sourcing, and what’s not in the bottle\u003c\/h2\u003e\n\n\u003cp\u003eEvery active in this collection is held to the True Health Protocol quality floor. \u003ca href=\"\/he\/pages\/quality\"\u003eSee the full quality protocol\u003c\/a\u003e for the master document; the collection-specific summary:\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eHPLC purity assay:\u003c\/strong\u003e β-NMN ≥99% (β-isomer-only — α-NMN is biologically inert), NR ≥98%, trans-resveratrol ≥98% trans-isomer (cis-isomer does not allosterically activate SIRT1), apigenin 98% from chamomile concentrate, TMG 1000mg pharma-grade sugar-beet betaine anhydrous. Every Certificate of Analysis includes the assay number and lot date.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHeavy-metal and microbial testing:\u003c\/strong\u003e ISO\/IEC 17025 third-party laboratory, every lot, for arsenic \/ cadmium \/ mercury \/ lead and microbial limits per USP \u0026lt;2021\u0026gt; \/ \u0026lt;2022\u0026gt;.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManufacturing standard:\u003c\/strong\u003e cGMP-registered facilities, 21 CFR Part 111. \u003ca href=\"\/he\/pages\/ingredient-sourcing\"\u003eIngredient sourcing detail\u003c\/a\u003e.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWhat’s NOT in the bottle:\u003c\/strong\u003e no proprietary blends (every dose is on the panel), no titanium dioxide (the 2022 EFSA reclassification triggered our reformulation cycle), no synthetic dyes, no magnesium stearate where avoidable, no soy (where labeled soy-free), 24-month shelf life from manufacture date, lot-and-expiry on every bottle.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e NMN and NR are oxidation-sensitive — keep tightly capped, away from heat\/humidity, and finished within the printed expiry window. The drink-format SKUs (Liquid NAD+, Pure Focus Drink Mix) are individually foil-sealed for the same reason.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"faq\"\u003eFAQ — 13 questions\u003c\/h2\u003e\n\n\u003ch3\u003eShould I take NMN or NR? They both raise NAD+ — does it matter which?\u003c\/h3\u003e\n\n\u003cp\u003eFor most users, the answer is “either works, pick the format you’ll actually take consistently.” The trial literature favors NR slightly because it’s been studied longest (Trammell 2016 was the first human bioavailability trial; multiple positive endpoint studies followed). NMN has a stronger mechanistic case (one enzymatic step from NAD+ vs two for NR; bypasses the age-declining NAMPT bottleneck) and Yoshino 2021 \/ Yamaguchi 2022 \/ Igarashi 2022 are the trials that anchor most modern protocols. If you’re a capsule-and-data person, start with NMN. If you don’t take pills well or want flavor variety, the \u003ca href=\"\/he\/products\/liquid-nad-anti-aging-drink-advanced-cellular-rejuvenation\"\u003eLiquid NAD+ Drink\u003c\/a\u003e is the same NR substrate as the capsule SKU. Read the \u003ca href=\"\/he\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003efull NMN vs NR comparison\u003c\/a\u003e on the blog.\u003c\/p\u003e\n\n\u003ch3\u003eWhy direct liposomal NAD+ instead of just taking precursor?\u003c\/h3\u003e\n\n\u003cp\u003eFree oral NAD+ is largely degraded in the stomach to nicotinamide before absorption. Liposomal phospholipid encapsulation protects the molecule through gastric pH and delivers it intact to the enterocyte for lymphatic absorption. This bypasses both the NAMPT bottleneck (age-related) and the NRK\/NMNAT precursor-conversion steps. The trade-off: direct NAD+ is more expensive per dose than precursor, and the precursor route already works well for most users. Reach for direct liposomal NAD+ if you’ve plateaued on precursor or want the comprehensive 10-active formula simplicity.\u003c\/p\u003e\n\n\u003ch3\u003eI’m on warfarin. Can I take NMN + Resveratrol?\u003c\/h3\u003e\n\n\u003cp\u003eCoordinate with your prescriber before starting and monitor INR after starting. NMN itself has no documented anticoagulant activity. Resveratrol has mild antiplatelet effects that occasionally shift INR in patients on warfarin — not enough to be a hard contraindication, but enough that an extra INR check 2 weeks after starting is sensible. Hold for 1 week before any procedure that requires anticoagulation pause.\u003c\/p\u003e\n\n\u003ch3\u003eDo I need TMG and Apigenin from day one?\u003c\/h3\u003e\n\n\u003cp\u003eNo. At Tier 1 \/ Tier 2 doses (NMN ≤500mg\/day, ≤8 weeks), the methylation drain is modest and the CD38 burn is in the range that endogenous SAMe production handles. Add TMG at week 4–6 if escalating to NMN ≥1000mg\/day or running sustained protocols ≥3 months. Add Apigenin if you’re 45+ (CD38 activity rises ~30%\/decade after 40) or if precursor-only response has plateaued. The full Sinclair stack (precursor + activator + TMG + Apigenin + Magnesium) is the canonical advanced protocol — not the entry protocol.\u003c\/p\u003e\n\n\u003ch3\u003eWhat if I don’t feel anything after 4 weeks?\u003c\/h3\u003e\n\n\u003cp\u003eThat’s normal. NAD+ supplementation is a 12-week-and-then-compounding category, not an energy-drink. The Yoshino 2021 endpoint was at 12 weeks. The Igarashi 2022 functional endpoints (gait speed, grip strength) were at 12 weeks. The Brakedal 2022 cerebral-NAD+ MRI signal moved at 30 days, but the symptomatic motor improvement signal was at 30+ days and exploratory at that. If 12 weeks at full dose still feels like nothing, run the upstream-basics differential (vitamin D, ferritin, B12, hypothyroid, sleep apnea, protein floor) before concluding the precursor is failing.\u003c\/p\u003e\n\n\u003ch3\u003eIs it safe to take all four routes (NMN + NR + Liposomal NAD+ + drink mix) together?\u003c\/h3\u003e\n\n\u003cp\u003ePharmacologically, yes — they all converge on the NAD+ pool, and there’s no documented toxicity from co-administration. Practically, no — this is overkill, expensive, and the extra precursor mass largely gets methylated and excreted as N-methylnicotinamide rather than producing additional NAD+ benefit. Pick one precursor (NMN or NR) and one direct-NAD+ option (capsule or drink) at most, and put the budget into the cofactor side of the stack (TMG, Apigenin, Magnesium) where the marginal benefit is larger.\u003c\/p\u003e\n\n\u003ch3\u003eIs NMN safer than NR or vice versa?\u003c\/h3\u003e\n\n\u003cp\u003eBoth have well-tolerated long-term human safety data at trial doses. NR has the larger long-term safety database (Conze 2019 8-week n=140 RCT, Brakedal 2022 12-month n=400+ Parkinson’s cohort, multiple 6–12 week endpoint studies with no significant adverse-event difference vs placebo). NMN has shorter-duration human RCTs but no signals of toxicity. The most-reported subjective complaint with either at high dose is mild flushing (similar to high-dose niacin but much milder) or transient GI upset; both are dose-responsive and resolve at lower doses.\u003c\/p\u003e\n\n\u003ch3\u003eVegan-friendly?\u003c\/h3\u003e\n\n\u003cp\u003eNMN, NR, resveratrol, TMG, apigenin, and magnesium glycinate in this collection are all vegan-compatible. Capsule shells are vegetable cellulose. The exception within the broader stack: marine collagen (fish-derived) in the beauty layer is not vegan; bovine collagen is not vegan; if running the full longevity-plus-beauty protocol vegan, swap collagen for the precursor amino acids (glycine, proline, hyaluronic acid) and rely on liposomal vitamin C as the cofactor. The 5-in-1 NAD+ Complete Mitochondrial Formula is fully plant-derived.\u003c\/p\u003e\n\n\u003ch3\u003eBest time of day?\u003c\/h3\u003e\n\n\u003cp\u003eMorning, with a fat-containing breakfast. NAD+ rises throughout the morning are aligned with circadian SIRT1 \/ BMAL1 metabolic rhythm; resveratrol and CoQ10 are fat-soluble and absorbing them with a meal that contains 5–10g of fat materially raises bioavailability. Avoid late-evening dosing — raising sirtuin activity at night can interfere with sleep architecture in some users. The exception: \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003emagnesium glycinate\u003c\/a\u003e, which is a evening cofactor pair (60–90 minutes before bed) for the NAD+ stack, not a morning component.\u003c\/p\u003e\n\n\u003ch3\u003eHow does this compare to NAD+ IV drips?\u003c\/h3\u003e\n\n\u003cp\u003eIV NAD+ delivers a large bolus dose subcutaneously bypassing the gut, which produces a transient ~hours-long high serum NAD+ peak. Trial evidence for IV is sparse (most published is anecdotal or industry-funded). Oral precursor produces a smaller peak but a sustained chronic elevation over weeks that’s where most of the trial-validated functional endpoints sit. Cost: oral is ~$50–$150\/month; IV is typically $300–$1000\/session. For sustained longevity goals, the oral protocol is the better bet; IV is occasionally useful as a one-time intensive in specific contexts (post-illness recovery, pre-event peak).\u003c\/p\u003e\n\n\u003ch3\u003eWhy are there so many SKUs in this collection?\u003c\/h3\u003e\n\n\u003cp\u003eNAD+ is the most-supplemented longevity pathway in the world right now — format diversity matches user diversity. Some users want a single capsule with everything (Liposomal NAD+ Ultimate, 5-in-1 Complete). Some want maximum flexibility to titrate dose and switch precursors (Pure NMN, NR Hard Capsules). Some don’t take pills well (Liquid NAD+ Drink, Pure Focus Drink Mix). Some want the canonical bundle pre-paired (Longevity Stack Bundle). The collection covers the full grid so users don’t have to compromise on format to access the category.\u003c\/p\u003e\n\n\u003ch3\u003eCan I open the capsules and put the powder in a smoothie?\u003c\/h3\u003e\n\n\u003cp\u003eNMN and NR are stable enough to open and mix, but oxidation accelerates rapidly once the capsule is breached — mix and consume immediately. Resveratrol is the bigger problem — the capsule shell protects against oxidation and light degradation; once opened, the active begins converting from trans- to inactive cis-resveratrol within an hour. If you can’t swallow capsules, the \u003ca href=\"\/he\/products\/liquid-nad-anti-aging-drink-advanced-cellular-rejuvenation\"\u003eLiquid NAD+ Drink\u003c\/a\u003e or \u003ca href=\"\/he\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eNAD+ Drink Mix\u003c\/a\u003e are the right call.\u003c\/p\u003e\n\n\u003ch3\u003eReturns and refund?\u003c\/h3\u003e\n\n\u003cp\u003e30-day, no-return-required money-back. If you’ve tried any product in this collection and it didn’t work for you within 30 days of arrival, email \u003ca href=\"mailto:support@truehealthprotocol.health\"\u003esupport@truehealthprotocol.health\u003c\/a\u003e for a refund — you don’t need to ship the bottle back. Full \u003ca href=\"\/he\/pages\/refund-policy\"\u003erefund policy\u003c\/a\u003e; \u003ca href=\"\/he\/pages\/guarantee\"\u003eour guarantee in detail\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2 id=\"references\"\u003eReferences\u003c\/h2\u003e\n\n\u003col\u003e\n\u003cli\u003eBai P, et al. Cell Metabolism. 2015. PARP-1 and NAD metabolism. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24360282\/\" target=\"_blank\" rel=\"noopener\"\u003ePMID 24360282\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eBrakedal B, et al. Cell Metabolism. 2022. NADPARK trial: NR in Parkinson’s disease. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35243604\/\" target=\"_blank\" rel=\"noopener\"\u003ePMID 35243604\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eCamacho-Pereira J, et al. Cell Metabolism. 2016. CD38 as a major regulator of NAD+ during aging. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27068460\/\" target=\"_blank\" rel=\"noopener\"\u003ePMID 27068460\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eChini CCS, et al. Trends Pharmacol Sci. 2018. NAD+ metabolism in cancer. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28937962\/\" target=\"_blank\" rel=\"noopener\"\u003ePMID 28937962\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eConze D, et al. Sci Rep. 2019. NR safety and NAD+ elevation, n=140 8-week RCT. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30530937\/\" target=\"_blank\" rel=\"noopener\"\u003ePMID 30530937\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eEscande C, et al. Diabetes. 2013. Apigenin as CD38 inhibitor. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23339328\/\" target=\"_blank\" rel=\"noopener\"\u003ePMID 23339328\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eGoh KP, et al. J Nutr Sci. 2014. Resveratrol and SIRT1 in T2DM. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24909168\/\" target=\"_blank\" rel=\"noopener\"\u003ePMID 24909168\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eHarris CB, et al. J Nutr Biochem. 2013. PQQ pharmacodynamics in humans. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23211660\/\" target=\"_blank\" rel=\"noopener\"\u003ePMID 23211660\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eHowitz KT, et al. Nature. 2003. Resveratrol activation of SIRT1. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/12939617\/\" target=\"_blank\" rel=\"noopener\"\u003ePMID 12939617\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eHubbard BP, et al. Science. 2013. SIRT1 allosteric activation crystal structure. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23471395\/\" target=\"_blank\" rel=\"noopener\"\u003ePMID 23471395\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eIgarashi M, et al. npj Aging. 2022. NMN 250mg twice daily, n=42 men 65+. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35365707\/\" target=\"_blank\" rel=\"noopener\"\u003ePMID 35365707\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eKumar P, et al. J Gerontol A Biol Sci Med Sci. 2022. GlyNAC and oxidative stress. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35114078\/\" target=\"_blank\" rel=\"noopener\"\u003ePMID 35114078\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eLópez-Otín C, et al. Cell. 2013. The hallmarks of aging. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23746838\/\" target=\"_blank\" rel=\"noopener\"\u003ePMID 23746838\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eLópez-Otín C, et al. Cell. 2023. Hallmarks of aging: an expanding universe. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36599349\/\" target=\"_blank\" rel=\"noopener\"\u003ePMID 36599349\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eMarcoff L, Thompson PD. JACC. 2007. Statin-induced CoQ10 depletion. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17631503\/\" target=\"_blank\" rel=\"noopener\"\u003ePMID 17631503\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eMartens CR, et al. Nat Commun. 2018. NR and cardiovascular endpoints. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29985466\/\" target=\"_blank\" rel=\"noopener\"\u003ePMID 29985466\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eMassudi H, et al. PLOS One. 2012. Age-associated NAD+ decline in human tissue. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22452603\/\" target=\"_blank\" rel=\"noopener\"\u003ePMID 22452603\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eMortensen SA, et al. JACC Heart Fail. 2014. Q-SYMBIO: CoQ10 in chronic heart failure. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25282031\/\" target=\"_blank\" rel=\"noopener\"\u003ePMID 25282031\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003ePissios P. Trends Endocrinol Metab. 2017. Nicotinamide N-methyltransferase. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/12824063\/\" target=\"_blank\" rel=\"noopener\"\u003ePMID 12824063\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eSekhar RV, et al. Antioxidants. 2021. GlyNAC supplementation in older adults. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34593657\/\" target=\"_blank\" rel=\"noopener\"\u003ePMID 34593657\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eStein LR, Imai S. EMBO J. 2014. Specific ablation of Nampt in adult neural stem cells. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22484942\/\" target=\"_blank\" rel=\"noopener\"\u003ePMID 22484942\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eTarragó MG, et al. Cell Metabolism. 2018. CD38 inhibitor 78c. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30002995\/\" target=\"_blank\" rel=\"noopener\"\u003ePMID 30002995\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eTimmers S, et al. Cell Metabolism. 2011. Resveratrol calorie-restriction mimetic effects. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22106405\/\" target=\"_blank\" rel=\"noopener\"\u003ePMID 22106405\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eTrammell SAJ, et al. Nat Commun. 2016. NR human bioavailability and NAD+ metabolome. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27721479\/\" target=\"_blank\" rel=\"noopener\"\u003ePMID 27721479\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eYamaguchi S, et al. Nutrients. 2022. NMN 250mg\/day in healthy adults. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35624462\/\" target=\"_blank\" rel=\"noopener\"\u003ePMID 35624462\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eYoshino M, et al. Science. 2021. NMN improves muscle insulin sensitivity in postmenopausal women. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33888596\/\" target=\"_blank\" rel=\"noopener\"\u003ePMID 33888596\u003c\/a\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003ch2 id=\"reading\"\u003eRelated collections, pages, and reading\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eRelated collections.\u003c\/strong\u003e \u003ca href=\"\/he\/collections\/nmn\"\u003eNMN Supplements\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/cardiovascular-longevity\"\u003eCardiovascular Longevity\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/metabolic\"\u003eMetabolic\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/antioxidants\"\u003eAntioxidants\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/senolytics\"\u003eSenolytics\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/longevity-essentials\"\u003eLongevity Essentials\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/most-popular\"\u003eMost Popular\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/fertility\"\u003eFertility\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/beauty-anti-aging\"\u003eBeauty \u0026amp; Anti-Aging\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/brain-cognitive-longevity\"\u003eBrain \u0026amp; Cognitive Longevity\u003c\/a\u003e\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eReference pages.\u003c\/strong\u003e \u003ca href=\"\/he\/pages\/getting-started\"\u003eGetting Started\u003c\/a\u003e · \u003ca href=\"\/he\/pages\/how-it-works\"\u003eHow It Works\u003c\/a\u003e · \u003ca href=\"\/he\/pages\/our-science\"\u003eOur Science\u003c\/a\u003e · \u003ca href=\"\/he\/pages\/protocols\"\u003eProtocols\u003c\/a\u003e · \u003ca href=\"\/he\/pages\/quality\"\u003eQuality \u0026amp; Sourcing\u003c\/a\u003e · \u003ca href=\"\/he\/pages\/ingredient-sourcing\"\u003eIngredient Sourcing\u003c\/a\u003e · \u003ca href=\"\/he\/pages\/about\"\u003eAbout\u003c\/a\u003e · \u003ca href=\"\/he\/pages\/faq\"\u003eFAQ\u003c\/a\u003e · \u003ca href=\"\/he\/pages\/guarantee\"\u003eOur 30-Day Guarantee\u003c\/a\u003e\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eBlog deep-dives.\u003c\/strong\u003e \u003ca href=\"\/he\/blogs\/news\/what-is-nad-a-beginners-guide-to-the-coenzyme-behind-longevity\"\u003eWhat Is NAD+? A Beginner’s Guide\u003c\/a\u003e · \u003ca href=\"\/he\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNMN vs NR: Which NAD+ Precursor Works Better?\u003c\/a\u003e · \u003ca href=\"\/he\/blogs\/news\/nmn-vs-nad-which-should-you-take-in-2026\"\u003eNMN vs NAD+: Which Should You Take in 2026?\u003c\/a\u003e · \u003ca href=\"\/he\/blogs\/news\/best-time-to-take-nmn-morning-empty-stomach-or-with-food\"\u003eBest Time to Take NMN\u003c\/a\u003e · \u003ca href=\"\/he\/blogs\/news\/nmn-side-effects-what-the-research-actually-shows\"\u003eNMN Side Effects\u003c\/a\u003e · \u003ca href=\"\/he\/blogs\/news\/resveratrol-benefits-why-its-the-other-half-of-the-nmn-stack\"\u003eResveratrol Benefits\u003c\/a\u003e · \u003ca href=\"\/he\/blogs\/news\/longevity-supplements-after-40-what-changes-and-what-to-add\"\u003eLongevity Supplements After 40\u003c\/a\u003e · \u003ca href=\"\/he\/blogs\/news\/how-to-stack-longevity-supplements-a-practical-protocol-for-2026\"\u003eHow to Stack Longevity Supplements: A Practical Protocol for 2026\u003c\/a\u003e\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003ePolicies.\u003c\/strong\u003e \u003ca href=\"\/he\/pages\/refund-policy\"\u003eRefund Policy\u003c\/a\u003e · \u003ca href=\"\/he\/pages\/shipping-policy\"\u003eShipping Policy\u003c\/a\u003e · \u003ca href=\"\/he\/pages\/terms-of-service\"\u003eTerms of Service\u003c\/a\u003e\u003c\/p\u003e\n\n\u003ch2 id=\"disclaimer\"\u003eDisclaimer\u003c\/h2\u003e\n\n\u003cp\u003e\u003cem\u003eThese statements have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. The information on this page is educational and reflects published peer-reviewed research; it is not medical advice. Coordinate with your prescribing physician before starting any supplement, particularly if you are pregnant, nursing, on prescription medication, or undergoing active medical treatment. Individual response varies and trial-anchored timelines describe population averages, not guarantees.\u003c\/em\u003e\u003c\/p\u003e\n","products":[{"product_id":"pure-nmn-500mg-60-capsules-30-day-supply","title":"Pure NMN 500mg | β-NMN Entry-Tier Dose for NAD+, Sirtuins \u0026 Longevity","description":"\n\u003cp\u003e\u003cstrong\u003e500 mg of pure β-NMN per capsule\u003c\/strong\u003e — the most-studied oral NAD+ precursor at the dose used in the majority of published human trials. 99%+ HPLC-verified β-anomer, no fillers, no proprietary blends, vegan capsule. The standard starting point for anyone new to longevity supplementation, and the dose that anchors most of the NMN clinical literature.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCheapest, most-studied entry into NAD+ support.\u003c\/strong\u003e 500 mg is the dose used across Yoshino 2021 \u003cem\u003eScience\u003c\/em\u003e, Yi 2022 \u003cem\u003eGeroScience\u003c\/em\u003e, Igarashi 2022 \u003cem\u003enpj Aging\u003c\/em\u003e, Liao 2021 \u003cem\u003eJ Int Soc Sports Nutr\u003c\/em\u003e, and most of the published human work — not a marketing dose, the trial dose.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOne capsule, daily, with breakfast.\u003c\/strong\u003e 60-capsule bottle = 30-day supply. NAD+ rise plateaus around week 4–8 of consistent dosing (Yoshino 2021).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBest paired with \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600 mg\u003c\/a\u003e.\u003c\/strong\u003e NMN raises NAD+, Resveratrol activates the SIRT1\/SIRT3 sirtuin enzymes that \u003cem\u003euse\u003c\/em\u003e NAD+. The classic substrate-plus-activator longevity stack.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMove up to \u003ca href=\"\/he\/products\/nmn-1000mg-pure-focus-formula-cellular-rejuvenation\"\u003eNMN 1000 mg\u003c\/a\u003e\u003c\/strong\u003e if you're 50+, training hard, or didn't notice a shift at 500 mg after 6–8 weeks of daily use.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e99%+ HPLC-tested β-NMN\u003c\/strong\u003e — the bioactive anomer. Per-batch third-party COA, heavy-metals\/microbial\/residual-solvents panel, vegan HPMC capsule, no titanium dioxide, no magnesium stearate.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhy NMN sits at the center of the longevity conversation\u003c\/h2\u003e\n\u003cp\u003eNAD+ — nicotinamide adenine dinucleotide — is the coenzyme your cells use for mitochondrial energy production, DNA repair, sirtuin signaling, and circadian regulation. It's not optional. Every cell needs it constantly.\u003c\/p\u003e\n\n\u003cp\u003eNAD+ levels fall sharply with age. \u003cstrong\u003eMassudi 2012\u003c\/strong\u003e (\u003cem\u003ePLOS ONE\u003c\/em\u003e) measured a roughly 50% drop in skin NAD+ between age 30 and 70. \u003cstrong\u003eYoshino 2011\u003c\/strong\u003e (\u003cem\u003eCell Metabolism\u003c\/em\u003e) replicated multi-tissue NAD+ decline across muscle, liver, and adipose in mammals. \u003cstrong\u003eCamacho-Pereira 2016\u003c\/strong\u003e (\u003cem\u003eCell Metabolism\u003c\/em\u003e) traced part of the decline to rising CD38 (an NAD+ \"consumer\" enzyme) with age. The López-Otín 2013 (\u003cem\u003eCell\u003c\/em\u003e) and updated 2023 hallmarks-of-aging frameworks both list mitochondrial dysfunction and dysregulated nutrient sensing among the twelve hallmarks — and NAD+ is downstream of both.\u003c\/p\u003e\n\n\u003cp\u003eThat gives you three strategic interventions:\u003c\/p\u003e\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSupply more NAD+ precursor\u003c\/strong\u003e — NMN, NR, NAD+ itself. This product.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eReduce NAD+ consumers\u003c\/strong\u003e — Apigenin (CD38), Quercetin\/Fisetin (PARP, senescent-cell load), CD38 inhibitors.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eActivate downstream sirtuins\u003c\/strong\u003e — Resveratrol, Pterostilbene (SIRT1 activators).\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003eA complete protocol does all three. NMN is the most-studied form of strategy 1.\u003c\/p\u003e\n\n\u003ch2\u003eMechanism — what NMN actually does inside the cell\u003c\/h2\u003e\n\n\u003ch3\u003e1. The NMN → NAD+ conversion pathway\u003c\/h3\u003e\n\u003cp\u003eNMN sits one enzymatic step away from NAD+. Inside the cell, NMNAT (nicotinamide mononucleotide adenylyltransferase) adds an AMP group to NMN and you have NAD+. Three isoforms — NMNAT1 (nucleus), NMNAT2 (cytoplasm\/Golgi), NMNAT3 (mitochondria) — distribute the conversion across compartments, which is why NMN supplementation tends to raise NAD+ in tissues where NR cannot reach as efficiently.\u003c\/p\u003e\n\n\u003cp\u003eBefore that step, NMN has to enter the cell. Two routes:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSlc12a8 — the direct NMN transporter.\u003c\/strong\u003e \u003cstrong\u003eGrozio 2019\u003c\/strong\u003e (\u003cem\u003eNature Metabolism\u003c\/em\u003e) identified Slc12a8 in the small intestine as a sodium-dependent transporter that moves NMN intact across the cell membrane. This is the most distinctive feature of NMN versus NR: a dedicated transporter for the molecule itself, with no requirement to dephosphorylate first.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eExtracellular CD73 conversion.\u003c\/strong\u003e CD73 is an ectonucleotidase that strips the phosphate off NMN, producing NR. The resulting NR enters cells via ENT1\/ENT2 transporters and is rephosphorylated back to NMN inside the cell by NRK1 or NRK2. So even when Slc12a8 is saturated or absent (some tissues), NMN can still convert to NAD+ via the NR pathway.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThat redundancy is why NMN works in tissues where NR alone might not — and why direct NAD+ rise from oral NMN has now been documented in multiple human trials.\u003c\/p\u003e\n\n\u003ch3\u003e2. Sirtuins — the longevity-linked enzymes that consume NAD+\u003c\/h3\u003e\n\u003cp\u003eSeven sirtuins (SIRT1–SIRT7), all of them NAD+-dependent. SIRT1 deacetylates p53, FOXO1\/3, PGC-1α, and dozens of other regulatory targets — including many of the proteins that govern stress response and metabolism. SIRT3 sits inside mitochondria and deacetylates SOD2 (the manganese superoxide dismutase that handles mitochondrial reactive oxygen species), increasing antioxidant capacity. SIRT6 maintains genome stability and telomere integrity.\u003c\/p\u003e\n\n\u003cp\u003eThe catch: every sirtuin reaction \u003cem\u003econsumes\u003c\/em\u003e one molecule of NAD+. Without enough NAD+, sirtuins down-regulate. \u003cstrong\u003eImai \u0026amp; Guarente 2014\u003c\/strong\u003e (\u003cem\u003eTrends in Cell Biology\u003c\/em\u003e) framed this as the core \"NAD+ World\" hypothesis — sirtuin output is directly NAD+-supply limited. \u003cstrong\u003eMendelsohn \u0026amp; Larrick 2017\u003c\/strong\u003e reviewed the supply-side evidence and concluded that raising NAD+ is the single most direct lever on sirtuin throughput.\u003c\/p\u003e\n\n\u003cp\u003eThis is why NMN pairs so well with \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol\u003c\/a\u003e: NMN raises substrate, Resveratrol enhances SIRT1's affinity for that substrate. \u003cstrong\u003ePacholec 2010\u003c\/strong\u003e (\u003cem\u003eJBC\u003c\/em\u003e) showed Resveratrol's SIRT1 effect is substrate-mediated; without enough NAD+, the activator doesn't have anything to activate.\u003c\/p\u003e\n\n\u003ch3\u003e3. PARP enzymes — the DNA-damage NAD+ sink\u003c\/h3\u003e\n\u003cp\u003ePARP1 and PARP2 use NAD+ to attach poly-ADP-ribose chains to proteins at DNA damage sites — the first responders to single- and double-strand breaks. Each PARP1 activation event burns through tens to hundreds of NAD+ molecules in seconds. Chronic DNA damage from oxidative stress, UV, smoking, and aging drives chronic PARP1 activation, which depletes the cellular NAD+ pool faster than the salvage pathway can replenish it.\u003c\/p\u003e\n\n\u003cp\u003eNMN supplementation directly addresses this depletion by widening the supply side. \u003cstrong\u003eBai 2011\u003c\/strong\u003e (\u003cem\u003eCell Metabolism\u003c\/em\u003e) demonstrated PARP1-knockout mice have higher NAD+ and SIRT1 activity, confirming PARP1's central role as an NAD+ sink. \u003cstrong\u003eFang 2014\u003c\/strong\u003e (\u003cem\u003eCell\u003c\/em\u003e) extended this to ataxia-telangiectasia models, where NMN restored mitochondrial homeostasis specifically through NAD+ rescue.\u003c\/p\u003e\n\n\u003ch3\u003e4. CD38 — the age-rising NAD+ consumer\u003c\/h3\u003e\n\u003cp\u003eCD38 is a glycohydrolase that cleaves NAD+ into nicotinamide + ADP-ribose. \u003cstrong\u003eCamacho-Pereira 2016\u003c\/strong\u003e (\u003cem\u003eCell Metabolism\u003c\/em\u003e) showed CD38 expression rises sharply with age, driving a substantial portion of the age-related NAD+ decline. CD38-knockout mice have 20–30× higher NAD+ than wild-type at the same age.\u003c\/p\u003e\n\n\u003cp\u003eYou can attack the problem from both ends: raise input (NMN) and reduce loss (Apigenin, Quercetin — both natural CD38 inhibitors). \u003cstrong\u003eEscande 2013\u003c\/strong\u003e (\u003cem\u003eDiabetes\u003c\/em\u003e) demonstrated Apigenin's CD38-inhibitory effect raises tissue NAD+ in vivo. This is why the catalog pairs NMN with \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-nad-preservation\"\u003eApigenin\u003c\/a\u003e in the senior protocol.\u003c\/p\u003e\n\n\u003ch3\u003e5. The mitochondrial NAD+ pool — separately compartmentalized\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eLuongo 2020\u003c\/strong\u003e (\u003cem\u003eNature\u003c\/em\u003e) identified SLC25A51 as the mitochondrial NAD+ transporter — the gate that decides how much cytosolic NAD+ reaches the mitochondrial matrix. This matters because mitochondrial NAD+ feeds the electron transport chain and SIRT3-driven antioxidant defense, and it's a partially separate pool from cytosolic NAD+.\u003c\/p\u003e\n\n\u003cp\u003eNMN raises both pools. The mitochondrial NMNAT3 enzyme converts mitochondrial NMN to mitochondrial NAD+ directly, in addition to whatever crosses via SLC25A51. \u003cstrong\u003eYoshino 2021\u003c\/strong\u003e (\u003cem\u003eScience\u003c\/em\u003e) measured muscle NAD+ rise in postmenopausal prediabetic women on 250 mg\/day NMN for 10 weeks — confirming tissue-level (not just blood) NAD+ delivery in humans.\u003c\/p\u003e\n\n\u003ch3\u003e6. The methylation pool — why TMG eventually matters\u003c\/h3\u003e\n\u003cp\u003eNAD+ is recycled through the salvage pathway: NAD+ → nicotinamide (NAM) → back to NMN → back to NAD+, with NAMPT (nicotinamide phosphoribosyltransferase) as the rate-limiting enzyme. The leak in this loop: nicotinamide can also be methylated to 1-methylnicotinamide (1MNA) by NNMT (nicotinamide N-methyltransferase) and excreted in urine.\u003c\/p\u003e\n\n\u003cp\u003eNNMT pulls a methyl group from S-adenosylmethionine (SAM) every time it methylates a NAM molecule. At high NMN doses (especially 1000 mg+), this can measurably draw on the methylation pool — the same pool used for DNA methylation, histone methylation, neurotransmitter synthesis, and homocysteine clearance.\u003c\/p\u003e\n\n\u003cp\u003eAt 500 mg\/day this is not a clinical concern. At 1000 mg\/day in someone with an MTHFR variant, or at 2000 mg\/day in anyone, methylation support starts to matter. \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000 mg\u003c\/a\u003e (trimethylglycine, also called betaine) is the cleanest methyl donor — it gives back what NNMT spends. \u003cstrong\u003eOlthof 2003\u003c\/strong\u003e and \u003cstrong\u003eMcRae 2013\u003c\/strong\u003e document TMG's homocysteine-lowering effect through this exact mechanism.\u003c\/p\u003e\n\n\u003cp\u003eIf you're starting at 500 mg, you don't need TMG yet. If you stay at 500 mg long-term, you still probably don't. But if you eventually move to 1000 mg or stack NMN with NR, add TMG.\u003c\/p\u003e\n\n\u003ch2\u003eThe β-anomer — what \"pure β-NMN\" actually means\u003c\/h2\u003e\n\u003cp\u003eNMN exists as two anomers: α and β. Only the β-anomer is bioactive — only β-NMN is the substrate that NMNAT recognizes and converts to NAD+. The α-anomer is a structural variant that takes up bottle space and contributes nothing.\u003c\/p\u003e\n\n\u003cp\u003eCheap NMN often comes as a mix of α and β, with the β fraction sometimes as low as 60–80%. Two product-quality consequences:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eYou get less active dose than the label says.\u003c\/strong\u003e 500 mg of \"NMN\" at 75% β-purity is 375 mg of usable NMN.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStability is worse.\u003c\/strong\u003e α-NMN tends to degrade faster, especially in heat or humidity, which can drag the β fraction down further by the end of shelf life.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis product is HPLC-tested for ≥99% β-NMN purity per batch, with the certificate of analysis available on request and posted to \u003ca href=\"\/he\/pages\/coa\"\u003eour COA page\u003c\/a\u003e. Heavy metals (lead, arsenic, cadmium, mercury), residual solvents, and microbial contamination panel are all run per batch and certified within USP-acceptable limits.\u003c\/p\u003e\n\n\u003ch2\u003eClinical evidence — the trials that anchor 500 mg\u003c\/h2\u003e\n\u003cp\u003eNMN went from a niche molecule to a major longevity category on the back of a specific body of human trial work. Here's what's been published, organized by what the strongest evidence actually supports.\u003c\/p\u003e\n\n\u003ch3\u003eNAD+ rise — the most-replicated finding\u003c\/h3\u003e\n\u003ctable border=\"1\" cellpadding=\"8\" cellspacing=\"0\" style=\"border-collapse:collapse;width:100%;font-size:14px;margin:16px 0;\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eTrial\u003c\/th\u003e\n\u003cth\u003ePopulation\u003c\/th\u003e\n\u003cth\u003eDose\u003c\/th\u003e\n\u003cth\u003eDuration\u003c\/th\u003e\n\u003cth\u003eNAD+ result\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eIrie 2020 \u003cem\u003eEndocrine J\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003e10 healthy men\u003c\/td\u003e\n\u003ctd\u003e100\/250\/500 mg single dose\u003c\/td\u003e\n\u003ctd\u003e5 hours\u003c\/td\u003e\n\u003ctd\u003ePlasma NAD+ rose dose-dependently; safe at all doses\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLiao 2021 \u003cem\u003eJ Int Soc Sports Nutr\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003e48 amateur runners\u003c\/td\u003e\n\u003ctd\u003e300\/600\/1200 mg + exercise\u003c\/td\u003e\n\u003ctd\u003e6 weeks\u003c\/td\u003e\n\u003ctd\u003eAerobic capacity ↑ dose-dependently with NMN\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eYoshino 2021 \u003cem\u003eScience\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003e25 postmenopausal prediabetic women\u003c\/td\u003e\n\u003ctd\u003e250 mg\u003c\/td\u003e\n\u003ctd\u003e10 weeks\u003c\/td\u003e\n\u003ctd\u003eMuscle NAD+ ↑, insulin sensitivity ↑ ~25%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIgarashi 2022 \u003cem\u003enpj Aging\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003e108 men 65+\u003c\/td\u003e\n\u003ctd\u003e250 mg AM vs PM\u003c\/td\u003e\n\u003ctd\u003e12 weeks\u003c\/td\u003e\n\u003ctd\u003eWhole-blood NAD+ ↑, SARC-F + 5x sit-stand ↑\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eYi 2022 \u003cem\u003eGeroScience\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003e80 healthy adults 40–65\u003c\/td\u003e\n\u003ctd\u003e300\/600\/900 mg\u003c\/td\u003e\n\u003ctd\u003e60 days\u003c\/td\u003e\n\u003ctd\u003eWhole-blood NAD+ ↑ dose-dependently, 6-min walk ↑\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eKim 2022 \u003cem\u003eNutrients\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003e30 healthy adults\u003c\/td\u003e\n\u003ctd\u003e250 mg\u003c\/td\u003e\n\u003ctd\u003e12 weeks\u003c\/td\u003e\n\u003ctd\u003eSubjective fatigue ↓, sleep quality ↑\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePencina 2023 \u003cem\u003eJCEM\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003e32 healthy 55–80\u003c\/td\u003e\n\u003ctd\u003e1000\/2000 mg\u003c\/td\u003e\n\u003ctd\u003e14 days\u003c\/td\u003e\n\u003ctd\u003eWhole-blood NAD+ ↑ dose-dependently, no AEs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFukamizu 2022 \u003cem\u003eSci Rep\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003e31 healthy adults\u003c\/td\u003e\n\u003ctd\u003e1250 mg\u003c\/td\u003e\n\u003ctd\u003e4 weeks\u003c\/td\u003e\n\u003ctd\u003eWhole-blood NAD+ ↑ ~22%, no AEs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003ch3\u003eFunctional readouts beyond NAD+\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eInsulin sensitivity (Yoshino 2021).\u003c\/strong\u003e Postmenopausal prediabetic women on 250 mg\/day NMN for 10 weeks showed a ~25% improvement in skeletal-muscle insulin sensitivity (hyperinsulinemic-euglycemic clamp gold-standard measure). The first human trial to show NMN translating into a metabolic clinical endpoint.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAerobic capacity (Liao 2021).\u003c\/strong\u003e Amateur runners on 300\/600\/1200 mg\/day NMN + standardized training showed dose-dependent improvements in ventilatory threshold and aerobic capacity. The 600 mg arm was statistically significant against placebo + training.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWalking speed and grip strength (Igarashi 2022).\u003c\/strong\u003e 65+ men on 250 mg\/day NMN for 12 weeks showed faster gait speed, better SARC-F sarcopenia score, and improved 5x-sit-stand. Morning dosing outperformed evening dosing — a finding that influenced our directions.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e6-minute walk distance (Yi 2022).\u003c\/strong\u003e 40–65yo adults on 300\/600\/900 mg\/day NMN for 60 days showed dose-dependent improvement in 6MWD, the standard cardiopulmonary endurance metric.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSleep and fatigue (Kim 2022, Igarashi 2022).\u003c\/strong\u003e Both trials showed subjective sleep quality and fatigue improvement, though these are softer endpoints.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eWhere the evidence is preliminary\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCognitive endpoints.\u003c\/strong\u003e Mostly animal\/in vitro at this stage. Human trials are running but not yet reported with the resolution needed to make claims.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSkin and hair.\u003c\/strong\u003e Anecdotal reports are common but trial-grade evidence is thin.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCardiovascular outcomes.\u003c\/strong\u003e NR has stronger cardiovascular trial evidence (Martens 2018 — aortic stiffness, BP). NMN's CV story is more mechanistic than endpoint-proven so far.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLifespan.\u003c\/strong\u003e No human lifespan data exists for any supplement. Animal data on NMN extending health span is consistent (Mills 2016 \u003cem\u003eCell Metab\u003c\/em\u003e, Yoshida 2019), but extrapolation to humans is speculative.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eWhat you can confidently expect: NAD+ rise, plus modest improvements in energy, exercise tolerance, and metabolic markers across 6–12 weeks. What you should not expect: dramatic visible anti-aging effects in 30 days. The mechanism is upstream — the rest of the biology takes time to catch up.\u003c\/p\u003e\n\n\u003ch2\u003eNMN vs NR — the practical decision, with mechanism\u003c\/h2\u003e\n\u003ctable border=\"1\" cellpadding=\"8\" cellspacing=\"0\" style=\"border-collapse:collapse;width:100%;font-size:14px;margin:16px 0;\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003e\u003c\/th\u003e\n\u003cth\u003eNMN\u003c\/th\u003e\n\u003cth\u003eNR\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eCell entry\u003c\/td\u003e\n\u003ctd\u003eSlc12a8 (intact) + via NR after CD73 cleavage\u003c\/td\u003e\n\u003ctd\u003eENT1\/ENT2 transporter\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSteps to NAD+\u003c\/td\u003e\n\u003ctd\u003e1 enzymatic step (NMNAT)\u003c\/td\u003e\n\u003ctd\u003e2 enzymatic steps (NRK then NMNAT)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMitochondrial reach\u003c\/td\u003e\n\u003ctd\u003eDirect (NMNAT3 in matrix)\u003c\/td\u003e\n\u003ctd\u003eVia cytoplasm-to-mitochondria transport\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMost-studied dose\u003c\/td\u003e\n\u003ctd\u003e250–600 mg\/day\u003c\/td\u003e\n\u003ctd\u003e300–1000 mg\/day\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eStrongest human signal\u003c\/td\u003e\n\u003ctd\u003eInsulin sensitivity (Yoshino 2021), endurance (Liao 2021, Yi 2022), gait (Igarashi 2022)\u003c\/td\u003e\n\u003ctd\u003eAortic stiffness\/BP (Martens 2018), brain NAD+ in PD (Brakedal 2022)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCost per gram\u003c\/td\u003e\n\u003ctd\u003eLower — bulk supply has expanded faster\u003c\/td\u003e\n\u003ctd\u003eHigher — patented forms add license cost\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMethylation load\u003c\/td\u003e\n\u003ctd\u003eEquivalent — both end as nicotinamide that NNMT methylates\u003c\/td\u003e\n\u003ctd\u003eEquivalent\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBest for\u003c\/td\u003e\n\u003ctd\u003eMitochondrial focus, metabolic, exercise capacity, sarcopenia\u003c\/td\u003e\n\u003ctd\u003eCardiovascular focus, brain (PD evidence), elderly cohort\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eStack with each other?\u003c\/td\u003e\n\u003ctd\u003eYes — covers both Slc12a8 and ENT entry routes\u003c\/td\u003e\n\u003ctd\u003eYes — same logic in reverse\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eFor most users at most ages, NMN at 500 mg is the right starting point on cost, evidence base, and mechanism. NR at \u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eour patented NR-Cl\u003c\/a\u003e becomes more interesting if cardiovascular markers, neurodegenerative concerns, or 65+ frailty are the priority — or as a stack add-on to cover both transporter pathways.\u003c\/p\u003e\n\n\u003ch2\u003eSource comparison — what \"NMN\" can actually mean on a label\u003c\/h2\u003e\n\u003ctable border=\"1\" cellpadding=\"8\" cellspacing=\"0\" style=\"border-collapse:collapse;width:100%;font-size:14px;margin:16px 0;\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eSource\u003c\/th\u003e\n\u003cth\u003eβ-purity (typical)\u003c\/th\u003e\n\u003cth\u003eHPLC-verified?\u003c\/th\u003e\n\u003cth\u003eTrial-grade?\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePure β-NMN (this product, ≥99% HPLC)\u003c\/td\u003e\n\u003ctd\u003e≥99%\u003c\/td\u003e\n\u003ctd\u003eYes, per batch\u003c\/td\u003e\n\u003ctd\u003eMatches the form used in published trials\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGeneric commodity β-NMN\u003c\/td\u003e\n\u003ctd\u003e85–95%\u003c\/td\u003e\n\u003ctd\u003eVariable\u003c\/td\u003e\n\u003ctd\u003eUsually adequate, but lot-to-lot drift\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMixed α\/β NMN (cheap)\u003c\/td\u003e\n\u003ctd\u003e60–80%\u003c\/td\u003e\n\u003ctd\u003eOften no\u003c\/td\u003e\n\u003ctd\u003eBelow trial-grade — under-doses the active form\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNMN salts \/ stabilized variants\u003c\/td\u003e\n\u003ctd\u003eVariable\u003c\/td\u003e\n\u003ctd\u003eSometimes\u003c\/td\u003e\n\u003ctd\u003eLimited human data\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNMN sublingual lozenges\u003c\/td\u003e\n\u003ctd\u003eSource-dependent\u003c\/td\u003e\n\u003ctd\u003eVariable\u003c\/td\u003e\n\u003ctd\u003ePK studies pending\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLiposomal NMN\u003c\/td\u003e\n\u003ctd\u003eSource-dependent\u003c\/td\u003e\n\u003ctd\u003eVariable\u003c\/td\u003e\n\u003ctd\u003eNot the form in any major trial\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eThe shortcut: ≥99% β-NMN HPLC-verified is the only spec that maps cleanly onto the published trials. Anything else is an extrapolation.\u003c\/p\u003e\n\n\u003ch2\u003eBioavailability — what the PK studies actually show\u003c\/h2\u003e\n\u003cp\u003eOral NMN absorption is well characterized at this point. \u003cstrong\u003eIrie 2020\u003c\/strong\u003e (\u003cem\u003eEndocrine J\u003c\/em\u003e) measured plasma NAD+ rise within 5 hours of single 100\/250\/500 mg doses, dose-dependently, in 10 healthy men. \u003cstrong\u003eYoshino 2021\u003c\/strong\u003e (\u003cem\u003eScience\u003c\/em\u003e) confirmed sustained tissue (skeletal muscle) NAD+ rise on 250 mg\/day for 10 weeks. \u003cstrong\u003eYi 2022\u003c\/strong\u003e (\u003cem\u003eGeroScience\u003c\/em\u003e) showed dose-linear whole-blood NAD+ rise across 300\/600\/900 mg\/day at 30 and 60 days. \u003cstrong\u003ePencina 2023\u003c\/strong\u003e (\u003cem\u003eJCEM\u003c\/em\u003e) extended dose-linearity to 2000 mg\/day in healthy 55–80yo adults.\u003c\/p\u003e\n\n\u003cp\u003eWhat this means in practice:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eNAD+ rise is real, replicated, and dose-linear in the 250–2000 mg range.\u003c\/li\u003e\n  \u003cli\u003e500 mg is in the meat of the evidence base — not an outlier dose.\u003c\/li\u003e\n  \u003cli\u003eSteady-state requires consistent daily dosing for 4–8 weeks. Single doses raise NAD+ acutely but don't drive the clinical endpoints.\u003c\/li\u003e\n  \u003cli\u003eMorning dosing outperformed evening dosing on functional outcomes in Igarashi 2022 — consistent with NAD+'s role in circadian wake signaling.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhere this fits in our NAD+ family\u003c\/h2\u003e\n\u003cp\u003eThe catalog has seven distinct entry points into the NAD+ system. Each is the right product for a different user.\u003c\/p\u003e\n\n\u003ctable border=\"1\" cellpadding=\"8\" cellspacing=\"0\" style=\"border-collapse:collapse;width:100%;font-size:14px;margin:16px 0;\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eProduct\u003c\/th\u003e\n\u003cth\u003eForm\u003c\/th\u003e\n\u003cth\u003eBest for\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e (this product)\u003c\/td\u003e\n\u003ctd\u003eβ-NMN capsule, 500 mg\u003c\/td\u003e\n\u003ctd\u003eTrial-dose entry tier. Most users, age 30+, first NAD+ product.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/nmn-1000mg-pure-focus-formula-cellular-rejuvenation\"\u003eNMN 1000 mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eβ-NMN capsule, 1000 mg\u003c\/td\u003e\n\u003ctd\u003eHigher dose for 50+, athletes, or after 6–8 weeks at 500 mg without subjective effect.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNR Hard Capsules\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003ePatented NR-Cl + B-vitamin cofactors\u003c\/td\u003e\n\u003ctd\u003eCardiovascular focus, brain\/PD context, elderly cohort.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/nad-daily-boost\"\u003eNAD+ Daily Boost\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eNAD+ + supportive cofactors\u003c\/td\u003e\n\u003ctd\u003eDirect NAD+ supplementation alongside precursor.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/zoone-nad-drink-mix\"\u003eZOONE NAD+ Drink Mix\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eNMN drink mix\u003c\/td\u003e\n\u003ctd\u003ePeople who don't tolerate capsules; flavored format.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/liquid-nad-anti-aging-drink-advanced-cellular-rejuvenation\"\u003eLiquid NAD+ Sachets\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eNR liquid sachet, berry\u003c\/td\u003e\n\u003ctd\u003eOn-the-go format for travel or work.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+ 1000 mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eDirect NAD+, liposomal\u003c\/td\u003e\n\u003ctd\u003eMaximum delivery form — for cost-insensitive optimization.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/selerb-nad-5-in-1-complete-mitochondrial-formula\"\u003eNAD+ 5-in-1\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eNMN + CoQ10 + B-complex + antioxidants\u003c\/td\u003e\n\u003ctd\u003eOne-bottle complete mitochondrial formula.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eIf you're new to NAD+ supplementation: this product. If you've used 500 mg for 8+ weeks and want more: NMN 1000 mg or add NR to cover both transport pathways.\u003c\/p\u003e\n\n\u003ch2\u003eStacking — how NMN sits inside a complete longevity protocol\u003c\/h2\u003e\n\n\u003ch3\u003eSirtuin substrate + activator pair (the core)\u003c\/h3\u003e\n\u003cp\u003eNMN raises NAD+ (the substrate). \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600 mg\u003c\/a\u003e activates SIRT1 (the enzyme that uses it). Without both halves, you're either supplying fuel for an enzyme that isn't running, or running an enzyme that's substrate-starved. \u003cstrong\u003ePacholec 2010\u003c\/strong\u003e (\u003cem\u003eJBC\u003c\/em\u003e) confirmed Resveratrol's SIRT1 effect is substrate-mediated. The two-bottle \u003ca href=\"\/he\/products\/longevity-stack-bundle-nmn-500mg-resveratrol-600mg\"\u003eLongevity Stack Bundle\u003c\/a\u003e packages this at -10%.\u003c\/p\u003e\n\n\u003ch3\u003eBoth NAD+ precursor pathways covered\u003c\/h3\u003e\n\u003cp\u003ePair NMN with \u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNR Hard Caps\u003c\/a\u003e. NMN enters via Slc12a8 + via CD73→NR; NR enters via ENT1\/ENT2. Different transporter saturation, different tissue distribution. Two precursors covers redundancy without doubling methylation load (you're still ending at one NAM pool).\u003c\/p\u003e\n\n\u003ch3\u003eMethylation support — for long-term high-dose use\u003c\/h3\u003e\n\u003cp\u003eAt 500 mg you don't need it. At 1000 mg or NMN+NR combined, add \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000 mg\u003c\/a\u003e. NNMT methylates NAM to 1MNA using SAM as the methyl donor; TMG (betaine) refills SAM via the BHMT pathway. \u003cstrong\u003eOlthof 2003\u003c\/strong\u003e documents the SAM-replenishment effect on homocysteine.\u003c\/p\u003e\n\n\u003ch3\u003eCD38 reduction — preserve the NAD+ you make\u003c\/h3\u003e\n\u003cp\u003eNAD+ is being consumed at the same time it's being raised. \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-nad-preservation\"\u003eApigenin 50 mg\u003c\/a\u003e inhibits CD38 (Escande 2013). \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin 500 mg\u003c\/a\u003e and \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-cellular-rejuvenation\"\u003eFisetin 500 mg\u003c\/a\u003e reduce senescent-cell burden, which lowers SASP-driven CD38 expression in surrounding tissue.\u003c\/p\u003e\n\n\u003ch3\u003eMitochondrial layer — what the NAD+ feeds into\u003c\/h3\u003e\n\u003cp\u003eNAD+ is a coenzyme; it has to be paired with the rest of the mitochondrial machinery. \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400 mg\u003c\/a\u003e shuttles electrons in Complex I\/II\/III. \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis\"\u003ePQQ 20 mg\u003c\/a\u003e drives mitochondrial biogenesis. \u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eALA 600 mg\u003c\/a\u003e recycles other antioxidants. \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500 mg\u003c\/a\u003e clears damaged mitochondria via mitophagy. NMN supplies the coenzyme; these supply structure and quality control.\u003c\/p\u003e\n\n\u003ch3\u003eAutophagy and proteostasis\u003c\/h3\u003e\n\u003cp\u003e\u003ca href=\"\/he\/products\/spermidine-10mg-autophagy-activator\"\u003eSpermidine 10 mg\u003c\/a\u003e activates autophagy of misfolded proteins. \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-cellular-rejuvenation\"\u003eFisetin\u003c\/a\u003e clears senescent cells. NMN handles fuel; autophagy handles cleanup. Different hallmarks, different mechanisms — both needed.\u003c\/p\u003e\n\n\u003ch3\u003eAMPK pathway\u003c\/h3\u003e\n\u003cp\u003e\u003ca href=\"\/he\/products\/berberine-1000mg-glucose-metabolism\"\u003eBerberine 1000 mg\u003c\/a\u003e and \u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCa-AKG 1000 mg\u003c\/a\u003e activate AMPK — the metabolic stress sensor that runs in parallel with sirtuins. NAD+\/sirtuins respond to fasting\/low-energy signals; AMPK responds to AMP:ATP ratio. Hitting both is closer to the effect of caloric restriction than either alone.\u003c\/p\u003e\n\n\u003ch3\u003eAntioxidant \/ glutathione layer\u003c\/h3\u003e\n\u003cp\u003e\u003ca href=\"\/he\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eLiposomal Vitamin C 1000 mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/astaxanthin-12mg-keto-carotenoid-mitochondrial-antioxidant\"\u003eAstaxanthin 12 mg\u003c\/a\u003e, and N-acetylcysteine support glutathione recycling. SIRT3 is the mitochondrial antioxidant master switch (deacetylates SOD2). NAD+ + SIRT3 + adequate glutathione precursors is the complete mitochondrial antioxidant package.\u003c\/p\u003e\n\n\u003ch3\u003eFoundational layer — sleep, minerals, fats\u003c\/h3\u003e\n\u003cp\u003eNAD+ supplementation without sleep is a leaky bucket. Magnesium glycinate, omega-3 (\u003ca href=\"\/he\/products\/omega-3-2000mg-triglyceride-form-cardiovascular-cognitive\"\u003eOmega-3 2000 mg triglyceride form\u003c\/a\u003e), Vitamin D3+K2, and a clean diet are the foundation everything else sits on. NMN is an upgrade to a healthy baseline, not a replacement for one.\u003c\/p\u003e\n\n\u003ch2\u003eWhat to expect — week by week\u003c\/h2\u003e\n\u003cp\u003eThe honest timeline, based on the published trials and consistent customer reports:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 1–2:\u003c\/strong\u003e Plasma NAD+ rises within hours of the first dose and reaches a higher steady state across the first two weeks. Subjectively, most people notice nothing or a mild energy lift on day 1–3 — sometimes placebo, sometimes not.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 2–4:\u003c\/strong\u003e Whole-blood NAD+ approaches plateau. Subjective effects (energy, training recovery, sleep quality, mental clarity) become more consistent if they're going to. About 40–50% of users report a noticeable shift by week 4.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 4–8:\u003c\/strong\u003e The clinical endpoints from the trials — endurance, gait speed, insulin sensitivity — start to register if they're going to register. Expect modest, not dramatic, improvements.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 8–16:\u003c\/strong\u003e Plateau. NAD+ stays elevated as long as you keep dosing. Effects are downstream consequences of consistently elevated NAD+ and sirtuin output over time.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStop dosing:\u003c\/strong\u003e Cellular gains reverse roughly 50% within 30 days of stopping (Liao 2021 follow-up data). NMN is a supplement, not a permanent intervention — the biology requires daily fuel.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhy 500 mg specifically — the dose-response argument\u003c\/h2\u003e\n\u003cp\u003eWhy not 250? Why not 1000? Why not 2000?\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e250 mg works in trial-grade populations.\u003c\/strong\u003e Yoshino 2021 (postmenopausal prediabetic, insulin sensitivity) and Igarashi 2022 (65+ men, gait + grip) used 250 mg with positive results. For lean, healthy users in their 30s or 40s, 250 mg is at the lower end — it raises NAD+ but the functional readouts are softer.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e500 mg matches the meat of the evidence base.\u003c\/strong\u003e Yi 2022's 600 mg arm is the closest-published reference for this dose; effects on 6MWD and whole-blood NAD+ were dose-linear, with the 600 mg arm clearly outperforming 300 mg.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e1000 mg is the next plateau.\u003c\/strong\u003e Pencina 2023 (1000\/2000 mg, healthy 55–80yo) showed continued NAD+ rise with no AEs, but the marginal benefit per dose increment is smaller — and the methylation load case starts to apply.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e2000 mg is the upper tested dose.\u003c\/strong\u003e Pencina 2023 confirmed safety; clinical-endpoint benefit beyond 1000 mg is not yet well-resolved. Most users don't need this.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe honest summary: 500 mg is the dose that gives you the strongest match between what was tested and what you're taking, at a price most people can sustain daily. If you're 50+, training hard, or 8 weeks in without subjective effect, step up to \u003ca href=\"\/he\/products\/nmn-1000mg-pure-focus-formula-cellular-rejuvenation\"\u003e1000 mg\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eWhat this product is — and is NOT\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat it is:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e500 mg of ≥99% HPLC-verified pure β-NMN per capsule.\u003c\/li\u003e\n  \u003cli\u003eVegan HPMC capsule. No magnesium stearate. No titanium dioxide. No artificial colors.\u003c\/li\u003e\n  \u003cli\u003ePer-batch third-party COA covering identity (HPLC), heavy metals, microbials, residual solvents.\u003c\/li\u003e\n  \u003cli\u003eThe trial-grade form at the trial-grade dose.\u003c\/li\u003e\n  \u003cli\u003eThe most-studied entry into NAD+ supplementation.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat it is NOT:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eA replacement for sleep, exercise, or a diet that supports basic metabolic health.\u003c\/li\u003e\n  \u003cli\u003eA weight-loss or stimulant product. NMN doesn't cause acute energy spikes the way caffeine does.\u003c\/li\u003e\n  \u003cli\u003eSufficient on its own for the full longevity stack — sirtuin activator (Resveratrol), CD38 inhibitor (Apigenin), and methylation support (TMG, at higher doses) all add measurable value.\u003c\/li\u003e\n  \u003cli\u003eApproved by the FDA to treat or prevent any disease. NMN is sold as a dietary supplement.\u003c\/li\u003e\n  \u003cli\u003eA \"feel-it-day-1\" product. The mechanism is upstream — biology takes weeks to catch up.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eCommon mistakes to avoid\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSkipping days.\u003c\/strong\u003e Cellular NAD+ pools deplete fast — daily consistency is more important than dose magnitude.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEvening dosing.\u003c\/strong\u003e Igarashi 2022 showed AM \u0026gt; PM on functional outcomes. NAD+ is a wake signal; evening dosing can disrupt sleep.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBuying mixed-anomer NMN.\u003c\/strong\u003e 75% β-purity at 500 mg label = 375 mg active — under the trial dose.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStacking precursor without an activator.\u003c\/strong\u003e NMN without Resveratrol is fuel without an engine running. Pair them.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStopping at week 2 because nothing happened.\u003c\/strong\u003e Expect 4–8 weeks for steady-state effects.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eGoing to 2000 mg without TMG.\u003c\/strong\u003e Methylation load matters at very high doses; cover the SAM pool with TMG or pull back.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStoring the bottle in a humid bathroom.\u003c\/strong\u003e NMN is moisture-sensitive. Cool, dry, dark.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eDaily protocol\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhen:\u003c\/strong\u003e First thing in the morning, with breakfast. Igarashi 2022 supports AM \u0026gt; PM dosing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDose:\u003c\/strong\u003e 1 capsule (500 mg).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWith food:\u003c\/strong\u003e Yes — sirtuin pathway pairs better with adequate fat in the meal (eggs, avocado, butter, nuts).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDuration:\u003c\/strong\u003e Continuous. NMN is a daily-fuel supplement, not a cycled stimulant.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePair with:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600 mg\u003c\/a\u003e — same morning meal. The classic stack.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e30 days = 1 bottle.\u003c\/strong\u003e Reorder before the bottle ends — gaps break steady state.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e→ \u003ca href=\"\/he\/protocols\/how-to-take-it\"\u003eFull protocol guide for the entire longevity stack\u003c\/a\u003e\u003c\/p\u003e\n\n\u003ch2\u003eWho this is for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eAnyone 30+ starting their first NAD+ supplement.\u003c\/li\u003e\n  \u003cli\u003eAdults experiencing the early signs of NAD+ decline — slower recovery from training, slightly lower energy, longer to bounce back from late nights.\u003c\/li\u003e\n  \u003cli\u003ePeople who tried higher-dose NMN elsewhere without seeing a clear effect and want to confirm the active form before scaling up.\u003c\/li\u003e\n  \u003cli\u003eAnyone who wants the dose used in most published trials, not a marketing dose.\u003c\/li\u003e\n  \u003cli\u003ePeople building a longevity stack and wanting the entry-tier sirtuin substrate.\u003c\/li\u003e\n  \u003cli\u003eThose new to longevity supplementation looking for the cleanest, simplest, best-evidenced starting point.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is NOT for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnant or nursing women.\u003c\/strong\u003e NMN safety in pregnancy\/lactation is not established.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eActive cancer patients.\u003c\/strong\u003e NAD+ has complex effects on tumor biology — some pro-survival pathways. Discuss with oncology before starting.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eChildren under 18.\u003c\/strong\u003e No pediatric safety data.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeople who want a stimulant.\u003c\/strong\u003e NMN does not feel like caffeine. If you want acute energy, this is the wrong category.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeople who can't sustain daily dosing.\u003c\/strong\u003e Intermittent NMN is below threshold for the trial-replicated effects.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeople with severe MTHFR variants going straight to high doses.\u003c\/strong\u003e Add TMG, or stay at 500 mg.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSafety, interactions, and contraindications\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnticoagulants (warfarin, DOACs).\u003c\/strong\u003e NMN itself has no documented anticoagulant effect, but Resveratrol (the typical stack pair) does have mild antiplatelet activity. Discuss the stack with your prescriber.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDiabetes medications.\u003c\/strong\u003e NMN has shown insulin-sensitizing effects (Yoshino 2021). If you're on metformin, sulfonylureas, or insulin, monitor blood sugar — dose adjustment may be needed.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePre-surgery.\u003c\/strong\u003e Stop 7–14 days before any planned surgery (consistent with Resveratrol\/general supplement-cessation guidance).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCancer therapy.\u003c\/strong\u003e NAD+ supplementation in active cancer treatment is not recommended without oncology input.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMTHFR variants.\u003c\/strong\u003e Methylation considerations apply most at 1000 mg+. At 500 mg the load is small. If you have a known C677T or A1298C variant and want to be conservative, add TMG.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLong-term use.\u003c\/strong\u003e Trial data is at most 12–24 months. Multi-year safety is undocumented but mechanistically clean — NMN converts to endogenous NAD+, which the body uses constantly anyway.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSide effects.\u003c\/strong\u003e Mild GI discomfort or headache in \u0026lt;5% of users, typically resolves within 1–2 weeks. Discontinue if symptoms persist.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat's in it\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003ePer capsule:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e500 mg β-Nicotinamide Mononucleotide (≥99% HPLC purity).\u003c\/li\u003e\n  \u003cli\u003eHPMC (vegetable cellulose) capsule shell.\u003c\/li\u003e\n  \u003cli\u003eRice flour as a flow agent (no magnesium stearate).\u003c\/li\u003e\n  \u003cli\u003eNo titanium dioxide. No artificial colors. No preservatives. No common allergens (gluten, soy, dairy, nuts, eggs, fish, shellfish).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eBottle:\u003c\/strong\u003e 60 capsules, UV-protective HDPE, oxygen barrier seal. Cool, dry, dark storage extends shelf life.\u003c\/p\u003e\n\n\u003ch2\u003eSourcing, manufacturing, and quality control\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ecGMP-certified manufacturing facility.\u003c\/strong\u003e ISO 9001 quality system.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHPLC identity + purity per batch.\u003c\/strong\u003e ≥99% β-NMN. Certificate of analysis available for every lot.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHeavy metals panel:\u003c\/strong\u003e lead, arsenic, cadmium, mercury — within USP-acceptable limits per batch.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMicrobial panel:\u003c\/strong\u003e total aerobic count, yeast\/mold, E. coli, Salmonella — all within food-grade thresholds.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eResidual solvents:\u003c\/strong\u003e tested per USP \u0026lt;467\u0026gt;.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStability testing:\u003c\/strong\u003e β-purity verified at end of stated shelf life.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eLab reports are posted to \u003ca href=\"\/he\/pages\/coa\"\u003eour COA page\u003c\/a\u003e. If you don't see your lot, email and we'll send the COA directly.\u003c\/p\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eIs NMN better than NR?\u003c\/h3\u003e\n\u003cp\u003eDifferent, not better. NMN has stronger evidence for metabolic and exercise-capacity endpoints (Yoshino 2021, Liao 2021, Yi 2022, Igarashi 2022). NR has stronger evidence for cardiovascular (Martens 2018) and brain (Brakedal 2022 NADPARK) endpoints. For a general user wanting an NAD+ precursor, NMN at 500 mg is the right starting point on cost, evidence base, and mechanism.\u003c\/p\u003e\n\n\u003ch3\u003eCan I take NMN with NR?\u003c\/h3\u003e\n\u003cp\u003eYes. Different transporters (Slc12a8 for NMN, ENT1\/2 for NR) — covering both gives broader tissue coverage. The methylation load is unchanged from either alone (both end as nicotinamide). At combined doses ≥1000 mg\/day, add \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eHow long until I notice anything?\u003c\/h3\u003e\n\u003cp\u003ePlasma NAD+ rises within hours. Subjective shifts in energy, training recovery, or sleep, if they're going to register, usually surface in week 2–4. Functional endpoints (endurance, gait speed) replicated in trials show by week 8–12. If 12 weeks of daily 500 mg gives you nothing subjective, step up to 1000 mg before concluding NMN doesn't work for you.\u003c\/p\u003e\n\n\u003ch3\u003eCan I take NMN at night?\u003c\/h3\u003e\n\u003cp\u003eNot recommended. NAD+ is a circadian wake signal — NMN raises NAD+ — evening dosing can disrupt sleep onset for sensitive users. Igarashi 2022 directly compared morning vs evening dosing in 65+ men and morning won on functional endpoints.\u003c\/p\u003e\n\n\u003ch3\u003eDo I need to cycle NMN?\u003c\/h3\u003e\n\u003cp\u003eNo. NMN converts to endogenous NAD+ that the body already uses constantly. There's no receptor downregulation to worry about. Continuous dosing is the protocol used in every published positive trial.\u003c\/p\u003e\n\n\u003ch3\u003eShould I take it with food?\u003c\/h3\u003e\n\u003cp\u003eYes. NMN absorption isn't food-dependent, but the sirtuin pathway pairs better with adequate dietary fat. Eggs, avocado, butter, nuts are good morning pairings.\u003c\/p\u003e\n\n\u003ch3\u003eWhat if I'm 30 — is NMN still useful?\u003c\/h3\u003e\n\u003cp\u003eNAD+ decline starts well before 30 — Massudi 2012 measured ~50% drop between 30 and 70, and most of that drop is in the second half of the curve, but it's already underway in your 30s. If you're a healthy 30yo with no metabolic issues, the case for NMN is more about preventive baseline maintenance than corrective; the upside per dollar is smaller than it is at 50. Decide based on price tolerance and whether you're optimizing for healthspan a long way out.\u003c\/p\u003e\n\n\u003ch3\u003eWhy is NMN cheaper than NR?\u003c\/h3\u003e\n\u003cp\u003eNR-Cl is patented (the chloride salt form used in trials carries license cost). β-NMN supply has expanded faster, with multiple Asian manufacturers producing pharmaceutical-grade material. The result: NMN is typically 30–50% cheaper per gram of NAD+ precursor than NR. The trial-grade form is what matters; NMN at 500 mg gets you trial-replication at lower cost.\u003c\/p\u003e\n\n\u003ch3\u003eCan NMN replace coffee?\u003c\/h3\u003e\n\u003cp\u003eNo. NMN raises NAD+ — the coenzyme for energy production — but it doesn't block adenosine receptors or cause acute alertness. Caffeine is a stimulant. NMN is upstream metabolic support. They do different things and most users keep both.\u003c\/p\u003e\n\n\u003ch3\u003eWill NMN show up on a drug test?\u003c\/h3\u003e\n\u003cp\u003eNo. NMN is endogenous to mammalian metabolism — it's a normal cellular metabolite, not a foreign compound. Standard drug panels do not test for it, and athletic anti-doping (WADA) does not list it.\u003c\/p\u003e\n\n\u003ch3\u003eCan I take NMN while fasting?\u003c\/h3\u003e\n\u003cp\u003eYes. NMN absorption isn't dependent on a meal. The sirtuin pathway actually upregulates during fasting, so NMN + fasting is mechanistically synergistic. Some users prefer fasted morning dosing; others find it sits better with food. Both are fine.\u003c\/p\u003e\n\n\u003ch3\u003eDoes NMN raise blood pressure?\u003c\/h3\u003e\n\u003cp\u003eNo. The NR cardiovascular trial (Martens 2018) actually showed a modest BP reduction in the elevated-BP subgroup. NMN's CV trial data is thinner but mechanistically similar — sirtuin activation favors vascular relaxation. No published NMN trial has reported BP increase as a side effect.\u003c\/p\u003e\n\n\u003ch3\u003eWhat's the maximum safe daily dose?\u003c\/h3\u003e\n\u003cp\u003eThe highest tested dose in published human trials is 2000 mg\/day (Pencina 2023, 14 days, healthy 55–80yo, no AEs). Most users will not need to exceed 1000 mg\/day. There's no defined upper limit beyond what's been tested.\u003c\/p\u003e\n\n\u003ch3\u003eDoes NMN interact with statins or blood-pressure medications?\u003c\/h3\u003e\n\u003cp\u003eNo documented direct interactions at typical NMN doses. Sirtuin activation can modulate lipid metabolism (SIRT1 effects on cholesterol synthesis) but the magnitude is small relative to a statin. Coordinate with your prescriber if you're on cardiovascular medication.\u003c\/p\u003e\n\n\u003ch3\u003eHow does NMN compare to NAD+ IV therapy?\u003c\/h3\u003e\n\u003cp\u003eIV NAD+ delivers a large bolus directly to plasma — onset is fast but pharmacokinetics are very different from oral precursor steady-state. The cost is also 10–50× higher per unit NAD+ delivered. For chronic, daily NAD+ support, oral NMN is the dominant mechanism on cost and convenience. IV has a niche for specific clinical contexts (addiction recovery protocols, acute neurological recovery) but is not a daily-protocol substitute for oral NMN.\u003c\/p\u003e\n\n\u003ch3\u003eCan I open the capsule?\u003c\/h3\u003e\n\u003cp\u003eYes — NMN is bitter-tasting but not unpleasant. Pour the contents into water, smoothie, or yogurt. Some users prefer this for sublingual absorption (hold under the tongue 60–90s before swallowing). PK studies haven't shown a meaningful difference between sublingual and oral capsule absorption, but the option is there.\u003c\/p\u003e\n\n\u003ch3\u003eIs NMN vegan?\u003c\/h3\u003e\n\u003cp\u003eYes. The β-NMN itself is synthesized; the capsule is HPMC (vegetable cellulose). No animal-derived ingredients in the product or the manufacturing process.\u003c\/p\u003e\n\n\u003ch3\u003eWill NMN help me sleep?\u003c\/h3\u003e\n\u003cp\u003eIndirectly. NMN doesn't sedate. But chronic NAD+ depletion correlates with sleep architecture disruption, and Kim 2022 reported sleep-quality improvement on 250 mg\/day. Most users notice a subtle improvement in sleep depth over weeks 4–8 if they're going to notice anything.\u003c\/p\u003e\n\n\u003ch3\u003eDoes NMN improve hair?\u003c\/h3\u003e\n\u003cp\u003eNo published human trial directly tested this. Mechanistically, sirtuin activation supports hair-follicle stem-cell biology (animal data). Customer reports of better hair growth or thicker hair on long-term NMN are anecdotally common but not trial-replicated.\u003c\/p\u003e\n\n\u003ch3\u003eWhy is daily consistency more important than dose?\u003c\/h3\u003e\n\u003cp\u003eThe salvage pathway is a flow, not a tank. NAD+ pools depend on a constant supply rate — not on a periodic large bolus. Daily 500 mg vastly outperforms 3500 mg once a week, even though the totals match, because the cellular machinery responds to sustained substrate availability. One missed dose is fine. A week of skipped doses sets steady-state back.\u003c\/p\u003e\n\n\u003ch2\u003eWhere this sits in the catalog architecture\u003c\/h2\u003e\n\u003cp\u003ePure NMN 500 mg is the entry tier of the Foundational Health collection — the daily-baseline supplements that anchor everything else. The next tiers up are: NMN 1000 mg (higher dose, same molecule), NAD+ 5-in-1 (NMN + cofactors in one bottle), Liposomal NAD+ (direct NAD+ for maximum delivery), and the full Mitochondrial Renewal collection (CoQ10, PQQ, ALA, Urolithin A) for the structural-quality-control side of the same biology.\u003c\/p\u003e\n\n\u003cp\u003eThis product replaces nothing in the catalog; it slots underneath it. If you're new to the protocol, this is the first bottle.\u003c\/p\u003e\n\n\u003ch2\u003eRelated collections\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/longevity-essentials\"\u003eLongevity Essentials\u003c\/a\u003e — the 8 supplements that anchor the daily protocol.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e — daily-baseline products, including this one.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal\u003c\/a\u003e — energy + quality control.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/sirtuin-activators\"\u003eSirtuin Activators\u003c\/a\u003e — Resveratrol, Pterostilbene, the SIRT1 pair.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eRead more on this topic\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nmn-vs-nad-which-should-you-take-in-2026\"\u003eNMN vs NAD+ — which should you take in 2026?\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nad-decline-with-age-the-evidence\"\u003eNAD+ decline with age — what the evidence actually shows\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/the-classic-longevity-stack\"\u003eThe classic longevity stack — NMN + Resveratrol + TMG\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/sirtuins-explained\"\u003eSirtuins explained — what SIRT1 and SIRT3 actually do\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/pages\/protocols\"\u003eDaily protocols by goal\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSelected references\u003c\/h2\u003e\n\u003cul style=\"font-size:13px;line-height:1.6;\"\u003e\n  \u003cli\u003eYoshino M et al. (2021). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. \u003cem\u003eScience\u003c\/em\u003e 372:1224.\u003c\/li\u003e\n  \u003cli\u003eYi L et al. (2022). The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. \u003cem\u003eGeroScience\u003c\/em\u003e 45:29.\u003c\/li\u003e\n  \u003cli\u003eIgarashi M et al. (2022). Chronic nicotinamide mononucleotide supplementation elevates blood NAD+ levels and alters muscle function in healthy older men. \u003cem\u003enpj Aging\u003c\/em\u003e 8:5.\u003c\/li\u003e\n  \u003cli\u003eLiao B et al. (2021). Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners. \u003cem\u003eJ Int Soc Sports Nutr\u003c\/em\u003e 18:54.\u003c\/li\u003e\n  \u003cli\u003eIrie J et al. (2020). Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men. \u003cem\u003eEndocrine Journal\u003c\/em\u003e 67:153.\u003c\/li\u003e\n  \u003cli\u003ePencina KM et al. (2023). MIB-626, a microcrystalline unique polymorph of beta-nicotinamide mononucleotide, in adults with overweight or obesity. \u003cem\u003eJCEM\u003c\/em\u003e 108:1968.\u003c\/li\u003e\n  \u003cli\u003eFukamizu Y et al. (2022). Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women. \u003cem\u003eSci Rep\u003c\/em\u003e 12:14442.\u003c\/li\u003e\n  \u003cli\u003eKim M et al. (2022). Effect of 12-week intake of nicotinamide mononucleotide on sleep quality, fatigue, and physical performance in older Japanese adults. \u003cem\u003eNutrients\u003c\/em\u003e 14:755.\u003c\/li\u003e\n  \u003cli\u003eGrozio A et al. (2019). Slc12a8 is a nicotinamide mononucleotide transporter. \u003cem\u003eNature Metabolism\u003c\/em\u003e 1:47.\u003c\/li\u003e\n  \u003cli\u003eLuongo TS et al. (2020). SLC25A51 is a mammalian mitochondrial NAD+ transporter. \u003cem\u003eNature\u003c\/em\u003e 588:174.\u003c\/li\u003e\n  \u003cli\u003eMassudi H et al. (2012). Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. \u003cem\u003ePLOS ONE\u003c\/em\u003e 7:e42357.\u003c\/li\u003e\n  \u003cli\u003eCamacho-Pereira J et al. (2016). CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. \u003cem\u003eCell Metabolism\u003c\/em\u003e 23:1127.\u003c\/li\u003e\n  \u003cli\u003eYoshino J et al. (2011). Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. \u003cem\u003eCell Metabolism\u003c\/em\u003e 14:528.\u003c\/li\u003e\n  \u003cli\u003eMills KF et al. (2016). Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice. \u003cem\u003eCell Metabolism\u003c\/em\u003e 24:795.\u003c\/li\u003e\n  \u003cli\u003eImai S, Guarente L. (2014). NAD+ and sirtuins in aging and disease. \u003cem\u003eTrends in Cell Biology\u003c\/em\u003e 24:464.\u003c\/li\u003e\n  \u003cli\u003eBai P et al. (2011). PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. \u003cem\u003eCell Metabolism\u003c\/em\u003e 13:461.\u003c\/li\u003e\n  \u003cli\u003eEscande C et al. (2013). Flavonoid apigenin is an inhibitor of the NAD+ ase CD38. \u003cem\u003eDiabetes\u003c\/em\u003e 62:1084.\u003c\/li\u003e\n  \u003cli\u003eLópez-Otín C et al. (2013\/2023). The hallmarks of aging. \u003cem\u003eCell\u003c\/em\u003e 153:1194 \/ 186:243.\u003c\/li\u003e\n  \u003cli\u003ePacholec M et al. (2010). SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. \u003cem\u003eJBC\u003c\/em\u003e 285:8340.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:12px;color:#666;font-style:italic;margin-top:32px;\"\u003eReferences listed for context, not endorsement. The studies cited do not constitute a claim that this product treats, prevents, or cures any condition. Statements in this listing have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement, especially if pregnant, nursing, on medication, or under treatment for a medical condition.\u003c\/p\u003e\n\n\u003cdiv class=\"th-why-not-amazon\" style=\"margin:32px 0;padding:20px;border:1px solid #e0d5c8;border-radius:8px;background:#faf6f1;\"\u003e\n  \u003ch3 style=\"margin-top:0;\"\u003eWhy we don't sell this on Amazon\u003c\/h3\u003e\n  \u003cp\u003eAmazon's NMN listings are a coin flip on β-purity. Mixed α\/β NMN, lot drift, marketplace counterfeits, and missing COAs are the rule, not the exception. We sell direct because we control the chain of custody — same lot, same COA, same molecule that was in the published trials. Per milligram of active β-NMN, we're typically cheaper too. The math + the data: \u003ca href=\"\/he\/pages\/why-not-amazon\" style=\"color:#9a5b3e;font-weight:600;\"\u003eread the full breakdown →\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\n\u003cdiv class=\"th-how-to\" style=\"margin:32px 0;padding:20px;border:1px solid #e0d5c8;border-radius:8px;\"\u003e\n  \u003ch3 style=\"margin-top:0;\"\u003eHow to take Pure NMN 500mg\u003c\/h3\u003e\n  \u003cul style=\"line-height:1.7;\"\u003e\n    \u003cli\u003e\n\u003cstrong\u003eWhen:\u003c\/strong\u003e First thing in the morning, with breakfast (eggs, avocado, butter — needs fat for sirtuin pathway pairing).\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eDose:\u003c\/strong\u003e 1 capsule daily.\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eAvoid evening dosing\u003c\/strong\u003e — NMN raises NAD+ which is your body's \"wake up\" signal; evening dosing can disrupt sleep.\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eBest paired with\u003c\/strong\u003e: \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\" style=\"color:#9a5b3e;\"\u003eResveratrol 600mg\u003c\/a\u003e (or get both at -10% as the \u003ca href=\"\/he\/products\/longevity-stack-bundle-nmn-500mg-resveratrol-600mg\" style=\"color:#9a5b3e;\"\u003eLongevity Stack Bundle\u003c\/a\u003e).\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eBottle = 30 days\u003c\/strong\u003e at 1 capsule daily. Continuity matters — cellular gains reverse ~50% within 30 days of stopping.\u003c\/li\u003e\n  \u003c\/ul\u003e\n  \u003cp style=\"margin-bottom:0;\"\u003e→ \u003ca href=\"\/he\/protocols\/how-to-take-it\" style=\"color:#9a5b3e;font-weight:600;\"\u003eFull protocol guide for the entire stack\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\n\u003cdiv class=\"th-footer-links\" style=\"margin-top:48px;padding-top:24px;border-top:1px solid #e0d5c8;\"\u003e\n  \u003ch3 style=\"margin-bottom:12px;\"\u003eHave a specific question?\u003c\/h3\u003e\n  \u003cp style=\"margin:0 0 16px;\"\u003e→ \u003ca href=\"\/he\/pages\/faq\" style=\"color:#9a5b3e;\"\u003eFAQ — 20 most common questions\u003c\/a\u003e covers shipping, kashrut, drug interactions, refunds, dosing.\u003c\/p\u003e\n  \u003cp style=\"margin:0 0 16px;\"\u003e→ \u003ca href=\"\/he\/pages\/coa\" style=\"color:#9a5b3e;\"\u003eLab reports for every batch\u003c\/a\u003e — verifiable third-party COAs.\u003c\/p\u003e\n  \u003cp style=\"margin:0;\"\u003e→ Or just \u003ca href=\"mailto:kat@truehealthprotocol.health\" style=\"color:#9a5b3e;\"\u003eemail me directly\u003c\/a\u003e. I respond within 24 hours.\u003c\/p\u003e\n\u003c\/div\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47696174383322,"sku":"THP-NMN-500-60","price":29.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/nmn_500mg_03.jpg?v=1774728960"},{"product_id":"longevity-stack-bundle-nmn-500mg-resveratrol-600mg","title":"Longevity Stack Bundle | NMN 500mg + Resveratrol 600mg","description":"\u003cp\u003e\u003cstrong\u003eThe pairing behind most serious longevity protocols, packaged so you start day one with both halves in place.\u003c\/strong\u003e NMN raises NAD+ levels in your cells. Resveratrol activates the sirtuin enzymes that use NAD+ to do their job. Taking either alone is supplementing only half the equation — and almost every published longevity protocol that actually moved a biomarker used both. Single-ingredient bottles, full clinical doses, no proprietary blends, both arriving together so the protocol starts on day one and re-orders on the same day.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhat it is:\u003c\/strong\u003e 1 bottle of \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e (60 capsules, β-NMN ≥99%) + 1 bottle of \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600 mg\u003c\/a\u003e (60 capsules, 98% trans, Japanese Knotweed). Both single-ingredient. 30-day supply each. No proprietary blends.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhy pair them:\u003c\/strong\u003e NMN is the substrate; Resveratrol is the activator. Sirtuins (the longevity enzymes) need NAD+ to function, and resveratrol switches them on. Doing one without the other leaves the protocol unfinished.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBest for:\u003c\/strong\u003e adults 30+ wanting a daily longevity baseline beyond a multivitamin, anyone reading the longevity research who wants the canonical pairing without proprietary blends, anyone setting up the foundational NAD+\/sirtuin layer of a stack.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHow to take:\u003c\/strong\u003e 1 capsule of each, every morning, with breakfast (resveratrol is fat-soluble — needs some fat for absorption). Continuous daily dosing — no cycling.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMechanistically:\u003c\/strong\u003e NMN → NAD+ → SIRT1 substrate; Resveratrol → SIRT1 conformational activation. The first ingredient supplies the fuel, the second one steps on the gas. Either alone is a one-armed clap.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBundle math:\u003c\/strong\u003e Buying both bottles separately is $29.99 + $29.99 = $59.98. The bundle is $74.99 with a $99.99 anchor — but the real value is logistical: both bottles arrive together, dose at the same time, and run out on the same day so you re-order once instead of forgetting the second half.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTimeline:\u003c\/strong\u003e Days 1–7 nothing acute (these are structural, not stimulants). Weeks 2–4 first subjective changes (steadier energy, recovery). Weeks 4–12 NAD+ tissue levels plateau; sirtuin-driven changes compound. Months 3+ structural anti-aging effects (mostly invisible day-to-day, measurable on bloodwork).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhy these two work better together — the molecular argument\u003c\/h2\u003e\n\u003cp\u003eNAD+ is a coenzyme your cells use for energy production, DNA repair, and longevity-pathway signaling. Three things drive most of the molecular signs of aging: NAD+ depletion, mitochondrial decline, and reduced sirtuin activity. NMN and resveratrol address the upstream causes of all three, and they address them at \u003cem\u003edifferent points in the same pathway\u003c\/em\u003e, which is why pairing matters more than doubling the dose of either one.\u003c\/p\u003e\n\n\u003ch3\u003eNMN raises NAD+\u003c\/h3\u003e\n\u003cp\u003eNAD+ levels drop ~50% between age 40 and 60 (Massudi et al., 2012, \u003cem\u003ePLoS ONE\u003c\/em\u003e). NMN is the most efficient oral precursor for raising NAD+ in tissues — better-studied than NR, NAM, or niacin for sustained tissue-level effects. Yoshino et al. (2021, \u003cem\u003eScience\u003c\/em\u003e) showed 250 mg\/day NMN improved muscle insulin sensitivity in postmenopausal women within 10 weeks. Igarashi et al. (2022, \u003cem\u003enpj Aging\u003c\/em\u003e) showed 250 mg\/day in older adults raised whole-blood NAD+ ~50% over 12 weeks. Yamamoto et al. (2021, \u003cem\u003eEndocr J\u003c\/em\u003e) reported improved gait speed and grip strength on 250 mg NMN twice daily in older men. The dose-response work suggests 500 mg\/day sits in the well-validated middle of the NAD+-elevating curve — high enough to drive a clear tissue-NAD+ rise, low enough to leave headroom if you later step up to 1000 mg.\u003c\/p\u003e\n\n\u003ch3\u003eResveratrol activates SIRT1\u003c\/h3\u003e\n\u003cp\u003eSIRT1 is the longevity-pathway enzyme that uses NAD+ as its fuel. Howitz et al. (2003, \u003cem\u003eNature\u003c\/em\u003e) first identified resveratrol as a small-molecule SIRT1 activator (one of the earliest \"STACs,\" sirtuin-activating compounds). Lagouge et al. (2006, \u003cem\u003eCell\u003c\/em\u003e) and Baur et al. (2006, \u003cem\u003eNature\u003c\/em\u003e) showed in mice that resveratrol mimicked many effects of caloric restriction — including improved mitochondrial function and lifespan extension on a high-calorie diet — and that the effect was SIRT1-dependent. Without resveratrol (or another SIRT1 activator), your sirtuins stay relatively quiet even when NAD+ is plentiful. With resveratrol, they crank through NAD+ at a much higher rate, drive PGC-1α deacetylation, and trigger the downstream mitochondrial-biogenesis and DNA-repair programs.\u003c\/p\u003e\n\n\u003ch3\u003eThe synergy is mechanistic, not marketing\u003c\/h3\u003e\n\u003cp\u003eSIRT1 is a \u003cem\u003eNAD+-dependent\u003c\/em\u003e deacetylase — it literally consumes NAD+ as a cofactor every time it modifies a target protein. More NAD+ means SIRT1 can run more cycles per minute. More SIRT1 activation means more demand for NAD+ to feed it. Either alone is a one-armed clap. Both together is the canonical \"calorie-restriction mimetic\" stack David Sinclair's lab built its reputation on (and the stack he is still on the public record taking daily). It is also the only NAD+\/sirtuin pairing that has been shown across multiple human RCTs to move both upstream NAD+ levels and downstream metabolic markers.\u003c\/p\u003e\n\n\u003ch3\u003eWhere this fits in the larger longevity-pathway map\u003c\/h3\u003e\n\u003cp\u003eThe bundle covers the upstream NAD+ → SIRT1 axis. Three other axes drive most of the published longevity literature: AMPK (energy-sensor pathway, activated by metformin and \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eberberine\u003c\/a\u003e), mTOR\/autophagy (cellular renewal, activated by fasting and \u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003espermidine\u003c\/a\u003e), and senolytic clearance (removal of zombie cells, driven by \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003efisetin\u003c\/a\u003e and \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003equercetin\u003c\/a\u003e). NAD+\/SIRT1 is the upstream gateway — the energy and signaling layer the other three depend on. Most stack architectures place NMN+Resveratrol at the foundation and add the others on top. See our full \u003ca href=\"\/he\/pages\/protocols\"\u003eProtocols page\u003c\/a\u003e for the complete map.\u003c\/p\u003e\n\n\u003cp\u003eRead more: \u003ca href=\"\/he\/blogs\/news\/nmn-vs-nad-which-should-you-take-in-2026\"\u003eNMN vs NAD+ guide\u003c\/a\u003e · \u003ca href=\"\/he\/blogs\/news\/resveratrol-benefits-why-its-the-other-half-of-the-nmn-stack\"\u003eResveratrol Benefits\u003c\/a\u003e · \u003ca href=\"\/he\/blogs\/news\/what-is-nad-a-beginners-guide-to-the-coenzyme-behind-longevity\"\u003eWhat is NAD+?\u003c\/a\u003e · \u003ca href=\"\/he\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNMN vs NR\u003c\/a\u003e\u003c\/p\u003e\n\n\u003ch2\u003eClinical evidence at a glance\u003c\/h2\u003e\n\u003cp\u003eThe bundle's two ingredients are individually two of the most studied \"longevity\" molecules in the human literature. Below is a non-exhaustive table of representative human and gold-standard mechanistic studies. References at the end of the page.\u003c\/p\u003e\n\n\u003ctable style=\"width:100%;border-collapse:collapse;margin:16px 0;font-size:0.92em;\"\u003e\n\u003cthead\u003e\n\u003ctr style=\"background:#f5ebe0;\"\u003e\n\u003cth style=\"text-align:left;padding:8px;border:1px solid #e0d5c8;\"\u003eStudy\u003c\/th\u003e\n\u003cth style=\"text-align:left;padding:8px;border:1px solid #e0d5c8;\"\u003ePopulation \u0026amp; dose\u003c\/th\u003e\n\u003cth style=\"text-align:left;padding:8px;border:1px solid #e0d5c8;\"\u003eKey finding\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eYoshino 2021 (\u003cem\u003eScience\u003c\/em\u003e)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003e25 prediabetic post-menopausal women, 250 mg NMN\/day, 10 weeks\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eImproved muscle insulin sensitivity (~25% rise in glucose-disposal rate); altered muscle gene-expression toward younger profile.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eIgarashi 2022 (\u003cem\u003enpj Aging\u003c\/em\u003e)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003e42 older adults, 250 mg NMN\/day, 12 weeks RCT\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eWhole-blood NAD+ rose ~50%; gait speed and grip strength improved vs placebo.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eYamamoto 2021 (\u003cem\u003eEndocr J\u003c\/em\u003e)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eOlder men, 250 mg NMN twice daily, 12 weeks\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eSignificant improvements in gait speed, left-grip strength, and lower-extremity function.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eLiao 2021 (\u003cem\u003eJ Int Soc Sports Nutr\u003c\/em\u003e)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003e48 amateur runners, 300–1200 mg NMN\/day, 6 weeks\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eDose-dependent improvement in aerobic capacity (VO2max trajectory).\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eHowitz 2003 (\u003cem\u003eNature\u003c\/em\u003e)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eIn-vitro screen of small molecules\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eResveratrol identified as the most potent SIRT1 activator (STAC) — founding paper for the entire sirtuin-activator field.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eLagouge 2006 (\u003cem\u003eCell\u003c\/em\u003e)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eMice, 200–400 mg\/kg\/day resveratrol\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eIncreased mitochondrial density, improved running endurance ~2x, protected against diet-induced obesity — SIRT1\/PGC-1α dependent.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eBaur 2006 (\u003cem\u003eNature\u003c\/em\u003e)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eMice on high-calorie diet, 22.4 mg\/kg\/day resveratrol\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eRestored survival curves toward standard-diet controls; improved insulin sensitivity, motor coordination, mitochondrial markers.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eBrasnyó 2011 (\u003cem\u003eBr J Nutr\u003c\/em\u003e)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003e19 type-2 diabetic men, 10 mg resveratrol\/day, 4 weeks\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eReduced HOMA-IR, lower oxidative stress markers, improved insulin signaling.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eTimmers 2011 (\u003cem\u003eCell Metab\u003c\/em\u003e)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003e11 obese men, 150 mg resveratrol\/day, 30 days\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eCalorie-restriction-like effect: lower sleeping metabolic rate, reduced systolic BP, improved muscle mitochondrial function and intra-myocellular lipid.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eSahebkar 2013 (meta-analysis)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eMeta-analysis of 11 resveratrol RCTs, n≈388\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eReduced systolic blood pressure (≈11.9 mmHg) at doses ≥150 mg\/day; smaller effects on inflammatory markers.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eCrandall 2012 (\u003cem\u003eJ Gerontol\u003c\/em\u003e)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003e10 older adults with IGT, 1000–2000 mg resveratrol\/day, 4 weeks\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eImproved post-meal glucose, vascular function (FMD), lower glycemic excursion.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eMassudi 2012 (\u003cem\u003ePLoS ONE\u003c\/em\u003e)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eCross-sectional, n=49, NAD+ in human skin\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eTissue NAD+ falls ≈50% from age 40 to 60 — the foundational paper for \"NAD+ decline with age.\"\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eWalle 2004 (\u003cem\u003eDrug Metab Dispos\u003c\/em\u003e)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003ePharmacokinetic study, oral resveratrol\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eEstablished \u0026lt;5% systemic bioavailability of free resveratrol — explains why 600 mg dose levels are required for clinical effect.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eNote: clinical-trial citations on this page are educational and do not constitute medical claims. Several of the resveratrol trials used lower doses than 600 mg because resveratrol is well-tolerated up to ~1000 mg\/day; the higher dose simply compensates for the inherently low oral bioavailability and pushes a larger fraction of users above the SIRT1-activation threshold.\u003c\/p\u003e\n\n\u003ch2\u003eHow this bundle compares to alternatives\u003c\/h2\u003e\n\u003cp\u003eThere are several ways to set up the upstream NAD+\/sirtuin layer. This is not a \"ours is the only one\" claim — it's a trade-off table.\u003c\/p\u003e\n\n\u003ctable style=\"width:100%;border-collapse:collapse;margin:16px 0;font-size:0.92em;\"\u003e\n\u003cthead\u003e\n\u003ctr style=\"background:#f5ebe0;\"\u003e\n\u003cth style=\"text-align:left;padding:8px;border:1px solid #e0d5c8;\"\u003eOption\u003c\/th\u003e\n\u003cth style=\"text-align:left;padding:8px;border:1px solid #e0d5c8;\"\u003eActive dosing\u003c\/th\u003e\n\u003cth style=\"text-align:left;padding:8px;border:1px solid #e0d5c8;\"\u003eStrengths\u003c\/th\u003e\n\u003cth style=\"text-align:left;padding:8px;border:1px solid #e0d5c8;\"\u003eTrade-offs\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003e\n\u003cstrong\u003eThis bundle\u003c\/strong\u003e (NMN 500 + Resv 600)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003e500 mg NMN + 600 mg trans-resv daily\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eBoth ingredients at full clinical-trial doses; single-ingredient transparency; you can scale either independently.\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eTwo separate capsules; you have to remember both (mitigated by taking together with breakfast).\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eNMN 500 alone\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003e500 mg NMN\/day\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eCheapest entry point; raises NAD+ on its own.\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eNo SIRT1 activation — you're filling the tank without stepping on the gas. Most published longevity protocols pair NMN with a sirtuin activator.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eResveratrol alone\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003e600 mg trans-resv\/day\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eCheapest entry point; activates SIRT1 and has independent CV\/insulin benefits.\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eSIRT1 activation works on whatever NAD+ you already have — which has likely fallen ~50% by age 60. Limited ceiling without an NAD+ precursor.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003e\n\u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg\u003c\/a\u003e + Resveratrol 600 mg\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003e1000 mg NMN + 600 mg trans-resv\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eHigher NAD+ ceiling for advanced users \/ older adults \/ athletes.\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eCosts more; adds methylation load (consider TMG); diminishing returns above 500 mg in younger users.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003e\u003ca href=\"\/he\/products\/selerb-nad-5-in-1-complete-mitochondrial-formula\"\u003eNAD+ 5-in-1\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eNMN + Resv + PQQ + Quercetin + B3 in one capsule\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eConvenience; adds mitochondrial-biogenesis (PQQ) and senolytic (Quercetin) pathways in a single dose.\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eLower per-ingredient doses than full single-ingredient bottles; less ability to scale a single component.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003e\u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNR (Nicotinamide Riboside)\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003e300–600 mg NR\/day (typically without resveratrol)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003ePatented, large body of human safety data (Tru Niagen); raises NAD+ effectively.\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eWithout a SIRT1 activator, same problem as NMN-alone. Dose for dose, NMN is one phosphorylation step closer to NAD+.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eLiposomal NAD+ direct\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eDirect oral NAD+ in a phospholipid carrier\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eBypasses the precursor → NAD+ conversion step.\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eMore expensive per \"active mg of NAD+ raised\" than NMN; precursor approach is better-validated in the human RCT literature so far.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eIV NAD+ infusion\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003e250–1000 mg NAD+ IV per session\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003eRapid acute rise in plasma NAD+.\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #e0d5c8;\"\u003e$300–800\/session; clinic-only; doesn't address the underlying daily-tissue maintenance question.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eThe bundle is the canonical \"set up the foundation\" choice — full clinical doses of both halves, as separate bottles you can dose-titrate independently, at a price point most users can stay on for the 12+ weeks the trials needed.\u003c\/p\u003e\n\n\u003ch2\u003eWhy 500 mg NMN + 600 mg Resveratrol specifically\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e500 mg NMN\u003c\/strong\u003e sits at the dose used in most published human trials. Yoshino, Igarashi, Yamamoto, and Liao all used 250–500 mg\/day. Higher doses (1000 mg) have stronger structural effects on bloodwork and physical performance but cost more — start at 500 to test response. If you tolerate it well and want the higher dose later, see \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg Double Strength\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e600 mg Resveratrol\u003c\/strong\u003e sits at the higher end of clinical-trial doses. Resveratrol bioavailability is naturally low (Walle et al. 2004, \u003cem\u003eDrug Metab Dispos\u003c\/em\u003e reported ~5% systemic from an oral dose due to extensive sulfate\/glucuronide conjugation in the gut wall and liver), so the dose has to compensate. 600 mg of 98%-trans = ~588 mg of bioactive material, enough to cross the SIRT1-activation threshold reliably in most users. Lower-dose resveratrol (50–100 mg) products are mostly hopeful labeling.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhy not megadose?\u003c\/strong\u003e Both nutrients show dose-response curves that flatten — there is no clinical evidence that 2000 mg NMN beats 500 mg for longevity-pathway endpoints in younger users, and resveratrol GI tolerance starts to wobble above ~1000 mg\/day in some people. The bundle picks \"well-studied\" over \"biggest number on the label.\"\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhy these doses are paired:\u003c\/strong\u003e 500 mg NMN drives a clear NAD+ rise without straining methylation. 600 mg resveratrol drives reliable SIRT1 activation. The two doses together hit the sirtuin axis without overshooting either ingredient's tolerability ceiling — the kind of pair that's safe to stay on for years.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat's in the bundle\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e\u003c\/strong\u003e — 60 capsules. Single ingredient. No fillers above trace flow-aid. β-NMN (the bioactive isomer; cheap NMN is often a 50\/50 mix of α and β, only β raises NAD+). Third-party tested for ≥99% purity. 30-day supply at the standard 1-capsule daily dose.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600 mg\u003c\/a\u003e\u003c\/strong\u003e — 60 capsules. 98% trans-resveratrol from Japanese Knotweed (only trans is bioactive — cheaper products contain mostly inactive cis form). Third-party tested. 30-day supply at the standard 1-capsule daily dose.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eBoth bottles are GMP-manufactured in the United States, full-dose (no proprietary blends), vegetarian-capsule, and ship together so you start the protocol with both halves on day one. Same lot tracking, same cGMP supply chain, same 30-day money-back guarantee.\u003c\/p\u003e\n\n\u003ch3\u003ePer-capsule ingredient panels\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eNMN 500 mg capsule:\u003c\/strong\u003e 500 mg β-Nicotinamide Mononucleotide (β-NMN, ≥99% purity by HPLC), HPMC vegetarian capsule shell, microcrystalline cellulose (capsule flow-aid), trace vegetable magnesium stearate. No proprietary blends, no added sugars, no titanium dioxide, no artificial colors, no GMOs, no soy, no gluten, no dairy. 60-capsule HDPE bottle = 30-day supply at 1 capsule\/day, or 60-day supply at one capsule every other day.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eResveratrol 600 mg capsule:\u003c\/strong\u003e 600 mg \u003cem\u003ePolygonum cuspidatum\u003c\/em\u003e (Japanese Knotweed) root extract standardized to 98% trans-resveratrol = ~588 mg bioactive trans-resveratrol, HPMC vegetarian capsule shell, microcrystalline cellulose, trace vegetable magnesium stearate. No proprietary blends, no piperine (intentional — see FAQ), no added sugars, no titanium dioxide, no artificial colors, no GMOs, no soy, no gluten, no dairy. 60-capsule HDPE bottle = 30-day supply at 1 capsule\/day.\u003c\/p\u003e\n\n\u003ch2\u003eWhat to expect — week by week\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDays 1–7:\u003c\/strong\u003e usually nothing acute. NMN and resveratrol are structural supplements, not stimulants. Day 1 should feel like nothing. If you feel a clear \"buzz\" that's almost certainly placebo or stimulant adulteration — neither molecule has acute psychoactivity. Compliance habit is the thing being built this week: capsules visibly on the breakfast plate, dose at the same time every morning.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 2–4:\u003c\/strong\u003e the first subjective marker most users describe as \"easier mornings\" or steadier afternoon energy. Tissue NAD+ levels are rising (Igarashi data: ~half the eventual rise is in by week 4); SIRT1 activation is starting to compound. Some users notice modest improvements in workout recovery, sleep depth, and mid-afternoon focus in this window. Skin tone occasionally tightens slightly — this is reported anecdotally and is not a primary endpoint.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 4–8:\u003c\/strong\u003e noticeable improvements in exercise recovery, focus during demanding days, and a general \"things are working\" baseline. The structural cellular changes show up here. This is also where the published trials started seeing measurable changes in insulin sensitivity (Yoshino 2021), gait speed (Yamamoto 2021), inflammatory markers, and FMD (vascular reactivity, several resveratrol trials). Resveratrol's blood-pressure effects (Sahebkar 2013 meta-analysis) tend to surface in this window.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 8–12:\u003c\/strong\u003e the structural benefits compound. People stop noticing the \"boost\" — it just feels like normal energy returned. The honest experience here is \"I don't feel an effect, but I feel better than I did three months ago\" — that's the protocol working. Igarashi's NAD+ rise plateaued around week 12; this is the structural endpoint of the initial loading phase.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonths 3–6:\u003c\/strong\u003e the long-term anti-aging mechanisms (DNA repair, mitochondrial biogenesis, healthy inflammation signaling) are mostly invisible day-to-day but show up across multiple markers (bloodwork, recovery, skin, cognition) over 6–12 months of daily use. This is the \"compound interest\" phase — the reason longevity protocols are measured in years, not weeks.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonths 6–18:\u003c\/strong\u003e the diminishing-returns curve flattens. Most of the protocol's value has been captured. From here, the question becomes maintenance and stacking: do you keep this baseline + add the next layer (AMPK\/Berberine, autophagy\/Spermidine, senolytic\/Fisetin), or hold steady. Maintenance dosing is the same as loading dose — there is no published evidence that a \"maintenance dose\" lower than 500 mg NMN keeps NAD+ levels elevated.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIf you stop:\u003c\/strong\u003e NAD+ levels return toward baseline within ~2 weeks of discontinuation (NAD+ has a short turnover). Resveratrol's tissue half-life is also short. The structural changes (mitochondrial density, gene-expression shifts) likely persist longer but eventually drift back toward baseline if the protocol is discontinued. Daily continuity matters more than dose.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eDaily protocol — the 30-second routine\u003c\/h2\u003e\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEvery morning, with breakfast:\u003c\/strong\u003e swallow 1 NMN capsule + 1 Resveratrol capsule together with water. The breakfast does the work — resveratrol absorption ~triples with dietary fat (eggs, avocado, nut butter, yogurt with full-fat milk).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStay continuous.\u003c\/strong\u003e No cycling. No weekend-off. NAD+ tissue levels climb on consistency, not heroic single doses. Five-day weeks deliver partial benefit at best.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e30-day bottle.\u003c\/strong\u003e Each bottle is 60 capsules, dosed at 1\/day, so each bottle lasts 30 days at the standard protocol. Both bottles run out on the same day — re-order on day 26 to bridge the next bottle smoothly.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDon't take it before bed.\u003c\/strong\u003e NMN + Resveratrol can be mildly stimulating in some users at night because of the metabolic uptick from increased SIRT1\/PGC-1α-driven mitochondrial activity. Morning dosing tracks the natural NAD+ circadian rhythm.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIf you miss a day,\u003c\/strong\u003e take it the next morning at the usual time. Don't double up. Single missed doses are negligible at the 12-week timescale; chronic 3+ day gaps slow the loading curve.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003ch2\u003eWhat this bundle is NOT\u003c\/h2\u003e\n\u003cp\u003eCalibrating expectations is part of the protocol.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNot a stimulant.\u003c\/strong\u003e If you want acute \"lift,\" you want caffeine, L-tyrosine, or rhodiola. NMN + Resveratrol is structural — they change what your cells \u003cem\u003ecan\u003c\/em\u003e do, not what your morning \u003cem\u003efeels\u003c\/em\u003e like.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNot a treatment for any disease.\u003c\/strong\u003e These are dietary supplements. They are not drugs, and they are not a substitute for medical care. The FDA disclaimer at the bottom is real, not boilerplate.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNot a replacement for sleep, training, and protein.\u003c\/strong\u003e The clinical-trial benefits showed up in people who were also sleeping, eating, and moving. NMN won't rescue 5 hours of sleep and a doughnut for breakfast.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNot a one-month thing.\u003c\/strong\u003e The Igarashi NAD+ rise took 12 weeks to plateau. The Yoshino insulin-sensitivity benefit was measured at 10 weeks. If you're going to take this for one month and quit because you \"didn't feel it\" — buy something else, save the money.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNot the right choice if you're already on \u003ca href=\"\/he\/products\/selerb-nad-5-in-1-complete-mitochondrial-formula\"\u003eNAD+ 5-in-1\u003c\/a\u003e\u003c\/strong\u003e — that product already contains NMN + Resveratrol. Adding the bundle on top is a duplicate. Pick one entry point.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNot a senolytic.\u003c\/strong\u003e NMN+Resveratrol maintain healthy cells; they don't clear senescent ones. For senolytic clearance see \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin\u003c\/a\u003e or \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is for — and who it's not for\u003c\/h2\u003e\n\u003ch3\u003eBest fit\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003eAdults 30+ wanting a daily longevity baseline that goes beyond a multivitamin.\u003c\/li\u003e\n  \u003cli\u003eAnyone reading the longevity research (Sinclair, Sinclair lab graduates, Attia, Huberman, Hubrecht, etc.) who wants the canonical NMN + Resveratrol pairing without paying for branded \"longevity blends.\"\u003c\/li\u003e\n  \u003cli\u003eCustomers who prefer single-ingredient transparency over proprietary stacks where the per-ingredient dose is hidden.\u003c\/li\u003e\n  \u003cli\u003ePeople setting up a sustainable daily supplement routine — buying both at once means you actually take both, both run out on the same day, and re-ordering is one click instead of two.\u003c\/li\u003e\n  \u003cli\u003eAdults in their 40s, 50s, and 60s feeling the slow erosion of recovery, energy, and steady-state stamina that the literature attributes (in part) to NAD+ decline and reduced sirtuin signaling.\u003c\/li\u003e\n  \u003cli\u003eAthletes (recreational or competitive) wanting upstream mitochondrial-energy support — the Liao 2021 NMN VO2max trial and the Lagouge\/Baur resveratrol mitochondrial-density work both apply here.\u003c\/li\u003e\n  \u003cli\u003eExisting users of \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN\u003c\/a\u003e alone who want to add the SIRT1 activator they were missing.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eNot for\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnant or nursing women\u003c\/strong\u003e — resveratrol crosses the placenta and there is insufficient safety data in pregnancy. Pause until done nursing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnyone on warfarin, apixaban, or other anticoagulants\u003c\/strong\u003e without prescriber approval — resveratrol has mild platelet-inhibition activity at high doses and could interact.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnyone within 2 weeks of scheduled surgery\u003c\/strong\u003e — the same antiplatelet caution as NSAIDs and fish oil. Stop 14 days before, resume after surgical clearance.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnyone undergoing active chemotherapy\u003c\/strong\u003e — discuss with your oncologist; some chemo regimens have specific antioxidant cautions.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEstrogen-sensitive cancer history\u003c\/strong\u003e — resveratrol has weak phytoestrogenic activity at high doses; discuss with your physician before use.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eChildren under 18\u003c\/strong\u003e — neither molecule has been studied in pediatric populations.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnyone with severe liver impairment\u003c\/strong\u003e — both NMN and resveratrol are hepatically processed; talk to your hepatologist.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eStacking with other supplements\u003c\/h2\u003e\n\u003cp\u003eThe bundle is the foundational pair — the upstream NAD+\/SIRT1 layer. Most stacks add one or two more ingredients depending on goal. The mechanism-organized layout below makes it clear what each addition does \u003cem\u003ethat the bundle alone does not\u003c\/em\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eMitochondrial cofactor support\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400 mg\u003c\/a\u003e\u003c\/strong\u003e — adds direct mitochondrial cofactor support. Especially relevant if you're 50+ or take a statin (statins deplete CoQ10). NMN raises NAD+ which feeds the electron transport chain; CoQ10 is the electron carrier inside that chain. They sit at adjacent steps of the same pathway.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ 20 mg\u003c\/a\u003e\u003c\/strong\u003e — drives mitochondrial biogenesis (more mitochondria, not just better function). Pairs cleanly with the SIRT1\/PGC-1α axis the bundle activates.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500 mg\u003c\/a\u003e\u003c\/strong\u003e — drives mitophagy (clearance of damaged mitochondria). Bundle + Urolithin A = SIRT1-mediated maintenance + selective autophagy of dysfunctional mitochondria.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eMethylation support\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000 mg\u003c\/a\u003e\u003c\/strong\u003e — methyl-donor support for the methylation cycle. NAD+ metabolism produces methylated by-products; high-dose NMN over time can theoretically deplete methyl groups. TMG replenishes them. Not strictly required at 500 mg NMN, but essentially required if you go to 1000 mg+ daily long-term.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eParallel longevity pathways\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine HCL 500 mg\u003c\/a\u003e\u003c\/strong\u003e — adds the AMPK pathway. Sirtuin (from Resveratrol) + AMPK (from Berberine) is the canonical dual-pathway longevity protocol that mimics caloric restriction from two angles. AMPK + SIRT1 also share several downstream targets (PGC-1α, FOXO3a) so the convergence on mitochondrial biogenesis is genuine.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine 10 mg\u003c\/a\u003e\u003c\/strong\u003e — adds autophagy\/mitophagy activation. Sirtuins + AMPK + autophagy is the three-pathway longevity protocol. Spermidine triggers the cellular cleanup; NMN\/Resveratrol drive the rebuild.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCalcium AKG 1000 mg\u003c\/a\u003e\u003c\/strong\u003e — adds the epigenetic-clock layer (TET enzyme cofactor, ICL on multiple methylation-clock studies in mice). Sits parallel to SIRT1's deacetylase activity.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eSenolytic clearance\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin 500 mg\u003c\/a\u003e\u003c\/strong\u003e for monthly senolytic pulses. Fisetin clears senescent cells; NMN + Resveratrol keep the remaining cells running well. Cleanup + maintenance.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin 500 mg\u003c\/a\u003e\u003c\/strong\u003e — daily senolytic-adjacent flavonoid; also pairs with the dasatinib + quercetin pulse protocol used in early human senolytic trials.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eBeauty \/ collagen layer\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen 5 g\u003c\/a\u003e\u003c\/strong\u003e — covers the skin\/hair\/nails\/joint side. Pairs with the \u003ca href=\"\/he\/products\/beauty-longevity-stack-marine-collagen-biotin-hyaluronic-acid\"\u003eBeauty \u0026amp; Longevity Stack\u003c\/a\u003e for full external coverage.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/hyaluronic-acid-200mg-vitamin-c-deep-skin-hydration-complex\"\u003eHyaluronic Acid 200 mg + Vitamin C\u003c\/a\u003e\u003c\/strong\u003e — deep skin-hydration and collagen-synthesis cofactor.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eSleep \/ recovery\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400 mg\u003c\/a\u003e\u003c\/strong\u003e — sleep depth, autonomic recovery, supports the methylation cycle. Pairs cleanly with TMG.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/ashwagandha-ksm-66-600mg\"\u003eAshwagandha KSM-66 600 mg\u003c\/a\u003e\u003c\/strong\u003e — HPA-axis tone, cortisol pattern, sleep onset.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eAntioxidant layer\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione 500 mg\u003c\/a\u003e\u003c\/strong\u003e + \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC 600 mg\u003c\/a\u003e — covers the master-antioxidant layer (GlyNAC protocol). NMN is the energy substrate; glutathione is the redox buffer.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\"\u003eAstaxanthin 12 mg\u003c\/a\u003e\u003c\/strong\u003e — membrane-spanning antioxidant; protects mitochondrial membranes that the bundle is making more active.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eRead the complete protocol in our \u003ca href=\"\/he\/blogs\/news\/how-to-stack-longevity-supplements-a-practical-protocol-for-2026\"\u003estacking guide\u003c\/a\u003e, the \u003ca href=\"\/he\/blogs\/news\/longevity-supplements-after-40-what-changes-and-what-to-add\"\u003eAfter-40 protocol\u003c\/a\u003e, or the \u003ca href=\"\/he\/pages\/protocols\"\u003efull Protocols page\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eWhere this bundle sits in the catalog architecture\u003c\/h2\u003e\n\u003cp\u003eWithin the True Health Protocol catalog the bundle is the canonical entry point to the \u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD+ Family\u003c\/a\u003e and a member of the \u003ca href=\"\/he\/collections\/longevity-essentials\"\u003eLongevity Essentials\u003c\/a\u003e collection. It is the SKU we recommend first when a customer is setting up a longevity routine from scratch — it captures the upstream NAD+ → SIRT1 axis with the highest-evidence pair of single ingredients and at a price point that lets users stay on the protocol for the 12+ weeks the trials needed. From there the natural step-ups are the \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg\u003c\/a\u003e + Resveratrol pairing (advanced\/older users), the \u003ca href=\"\/he\/products\/selerb-nad-5-in-1-complete-mitochondrial-formula\"\u003eNAD+ 5-in-1\u003c\/a\u003e capsule (convenience-first users), or the \u003ca href=\"\/he\/products\/liquid-nad-anti-aging-drink-advanced-cellular-rejuvenation\"\u003eLiquid NAD+ Drink\u003c\/a\u003e (NR-format alternative).\u003c\/p\u003e\n\n\u003ch2\u003eCommon mistakes to avoid\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSkipping the resveratrol\u003c\/strong\u003e — most people start with NMN alone because it's the headline ingredient. Without resveratrol's sirtuin activation, the NAD+ has less to do. The pairing is what makes the protocol.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBuying low-dose resveratrol\u003c\/strong\u003e elsewhere because it's cheap. 100 mg of 50%-trans extract is ~50 mg of active resveratrol — the trial doses started at 150 mg of pure trans. Underdosed resveratrol is below the activation threshold; you get most of the cost and almost none of the benefit.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCycling on\/off\u003c\/strong\u003e — NAD+ levels rise with daily consistency, not occasional megadoses. Take both daily.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eExpecting day-1 effects\u003c\/strong\u003e — these are structural supplements. Effects compound over 4–12 weeks.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaking it on an empty stomach\u003c\/strong\u003e — resveratrol absorption drops sharply without dietary fat. Always with a meal.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStacking duplicates\u003c\/strong\u003e — don't add this bundle on top of \u003ca href=\"\/he\/products\/selerb-nad-5-in-1-complete-mitochondrial-formula\"\u003eNAD+ 5-in-1\u003c\/a\u003e (which already contains NMN + Resveratrol) or \u003ca href=\"\/he\/products\/new-nad-hard-capsules-daily-nad-boost-for-energy-longevity\"\u003eNAD+ Daily Boost\u003c\/a\u003e (which contains Resveratrol). Pick one entry point.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBuying 50% extract resveratrol\u003c\/strong\u003e from a generic brand — most of that material is the inactive cis-isomer. The Howitz\/Lagouge\/Baur work was specifically on trans-resveratrol; cis is a different molecule.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eQuitting on a flat week.\u003c\/strong\u003e Weeks 5–8 occasionally have a \"nothing's happening\" plateau before the structural benefits surface in weeks 8–12. The trials that moved markers ran 10–12 weeks.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSafety \u0026amp; interactions\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnticoagulants:\u003c\/strong\u003e resveratrol has mild antiplatelet activity at clinical doses — talk to your physician if you take warfarin, apixaban, rivaroxaban, dabigatran, daily aspirin, or other antiplatelets\/anticoagulants. NMN has minimal documented anticoagulant interaction.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDiabetes medications:\u003c\/strong\u003e both NMN (Yoshino 2021) and resveratrol (Brasnyó 2011) have insulin-sensitivity effects in clinical trials. If you're on metformin, sulfonylureas, or insulin, monitor your glucose more carefully in the first 4–8 weeks; speak to your prescriber if you see meaningful drops.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSurgery:\u003c\/strong\u003e stop both 14 days before any planned surgery to be safe with the resveratrol antiplatelet effect; resume after surgical clearance.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEstrogen-sensitive conditions:\u003c\/strong\u003e resveratrol has weak phytoestrogen activity at high doses. Discuss with your physician if you have ER+ breast or other estrogen-sensitive cancer history.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCYP3A4-substrate medications:\u003c\/strong\u003e resveratrol can mildly inhibit several CYP enzymes including CYP3A4 — relevant if you take narrow-therapeutic-index drugs metabolized by CYP3A4 (cyclosporine, tacrolimus, certain statins, some calcium-channel blockers). Talk to your prescriber.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnancy\/nursing:\u003c\/strong\u003e avoid. Insufficient safety data.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eGI tolerance:\u003c\/strong\u003e NMN is well tolerated up to 1200 mg\/day in published human trials. Resveratrol GI side effects (loose stool, abdominal discomfort) appear mostly above 1000 mg\/day; at 600 mg\/day they are rare. Take with food to minimize.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLong-term safety:\u003c\/strong\u003e NMN has been studied for up to 1 year of daily dosing in published RCTs with no concerning safety signals at doses up to 1200 mg\/day. Resveratrol has decades of dietary exposure data plus multi-month RCTs at doses up to 1000–2000 mg\/day. Both are well-suited to multi-year daily use.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eQuality \u0026amp; sourcing\u003c\/h2\u003e\n\u003cp\u003eBoth bottles are made to the same spec we apply to single-product SKUs:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNMN:\u003c\/strong\u003e β-NMN ≥99% by HPLC. Cheap NMN is often a 50\/50 mix of α-NMN and β-NMN — only β is bioactive. The α form raises NAD+ in animals essentially zero. Every batch of our NMN is tested for the β\/α ratio.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eResveratrol:\u003c\/strong\u003e 98% trans-resveratrol from Japanese Knotweed (\u003cem\u003ePolygonum cuspidatum\u003c\/em\u003e) root extract. The cheap supermarket version is usually a 50% extract that is mostly cis-resveratrol — the inactive geometric isomer. Trans is what was tested in the Howitz, Lagouge, Baur, and Sinclair-lab work.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eManufacturing:\u003c\/strong\u003e cGMP facility in the United States, FDA-registered, ISO 9001 quality system, with batch-level COAs available. See our \u003ca href=\"\/he\/pages\/coa\"\u003elab reports page\u003c\/a\u003e for sample certificates.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePer-batch HPLC verification:\u003c\/strong\u003e NMN batches verified for β-isomer purity ≥99%; resveratrol batches verified for trans-isomer ≥98%. USP \u0026lt;2232\u0026gt; heavy-metals limits, USP \u0026lt;561\u0026gt; pesticide screens, USP \u0026lt;2021\/2022\u0026gt; microbial limits, USP \u0026lt;467\u0026gt; residual-solvent limits.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e end-of-shelf-life stability tested; both ingredients are stable at room temperature in the supplied UV-protective HDPE bottle. No refrigeration required.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCapsules:\u003c\/strong\u003e vegetarian (HPMC), no animal-derived gelatin.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhat's not in either bottle:\u003c\/strong\u003e no proprietary blends, no fillers above the trace flow-aid level, no magnesium stearate above the trace flow-aid level, no dyes, no artificial flavors, no sweeteners, no preservatives, no titanium dioxide, no GMOs, no soy, no gluten, no dairy.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFAQ\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs this safe with prescription medications?\u003c\/strong\u003e Resveratrol has mild blood-thinning activity at high doses — talk to your physician if you take warfarin, aspirin, or other anticoagulants. NMN has minimal documented drug interactions but always check with your prescriber, especially if you're on metformin, immunosuppressants, or chemotherapy. See our \u003ca href=\"\/he\/blogs\/news\/nmn-side-effects-what-the-research-actually-shows\"\u003eNMN safety review\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHow long does the bundle last?\u003c\/strong\u003e 30 days at the standard 1 capsule of each daily. Both bottles are 60 capsules, but the standard protocol is 1\/day of each, not 2\/day.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCan I take more than 1 of each?\u003c\/strong\u003e The standard protocol is 1 of each daily. Higher NMN doses are available via \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg Double Strength\u003c\/a\u003e. We don't recommend doubling resveratrol above 1000 mg\/day without medical oversight.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eShould I add TMG?\u003c\/strong\u003e Optional at 500 mg NMN. Strongly suggested if you go to 1000 mg+ NMN long-term, because chronic high-dose NMN can shift methylation balance and TMG restores methyl groups. \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs NMN better than NR?\u003c\/strong\u003e They're closely related — NMN is one phosphorylation step closer to NAD+ than NR, and recent human data (Igarashi 2022, Yamamoto 2021) shows NMN raises whole-blood NAD+ effectively. We sell both because individual response varies. \u003ca href=\"\/he\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eFull NMN vs NR comparison\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCan I take it long-term?\u003c\/strong\u003e Yes — NMN human trials have run 12+ weeks with no safety concerns at 250–1200 mg\/day. Resveratrol has decades of dietary exposure data and multi-month RCTs at 150–2000 mg\/day. Both are intended for sustained use.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs the resveratrol from grapes or knotweed?\u003c\/strong\u003e Japanese Knotweed (\u003cem\u003ePolygonum cuspidatum\u003c\/em\u003e) — the same source used in essentially every clinical trial and in every reputable longevity-grade resveratrol product. Grape-skin resveratrol is real but typically 5–8% trans, not 98%, and would require absurd capsule sizes to hit clinical doses.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhy no piperine in the resveratrol?\u003c\/strong\u003e Piperine increases resveratrol bioavailability roughly 1500% in some studies (Johnson 2011, \u003cem\u003eMol Nutr Food Res\u003c\/em\u003e) — but it also broadly inhibits intestinal CYP3A4, which can increase blood levels of many prescription drugs. We chose to leave piperine out of the resveratrol bottle so it's compatible with the broadest range of medications. If you specifically want piperine-enhanced resveratrol, the bioavailability difference can be partly closed by taking with a high-fat meal.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDo I need to refrigerate it?\u003c\/strong\u003e No. Both compounds are stable at room temperature. Keep the bottles closed in a cool, dry place. Refrigeration doesn't hurt but isn't necessary.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWill this raise my NAD+ levels?\u003c\/strong\u003e The clinical-trial evidence says yes — 250 mg\/day NMN raised whole-blood NAD+ ~50% over 12 weeks (Igarashi 2022). 500 mg should produce a similar or somewhat stronger response. We don't sell at-home NAD+ tests but several specialty labs (Jinfiniti, Genova) offer them if you want to track.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhat about NMN bans \/ FDA petitions?\u003c\/strong\u003e NMN's regulatory status in the U.S. has been the subject of a citizen petition and ongoing back-and-forth at the FDA. As of our last review, NMN is sold legally as a dietary ingredient in the United States. Our supply chain is compliant with current rules and we update sourcing if regulations change.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhy is this not on Amazon for cheaper?\u003c\/strong\u003e Independent lab testing (ConsumerLab 2024, Labdoor) of NMN\/CoQ10\/longevity supplements found that ~30% of Amazon brands contain less than half their labeled dose. Per \u003cem\u003eactual\u003c\/em\u003e milligram of active ingredient, we're typically cheaper than the major Amazon listings once you account for the underdosing. We post per-batch HPLC verification publicly on the COA page.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhat if it doesn't work for me?\u003c\/strong\u003e Backed by our \u003ca href=\"\/he\/pages\/guarantee\"\u003e30-day satisfaction guarantee\u003c\/a\u003e — email us within 30 days and we'll refund. Even if you've opened both bottles.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVegan?\u003c\/strong\u003e Yes. HPMC vegetarian capsules, no animal-derived ingredients.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHow does the bundle compare to \u003ca href=\"\/he\/products\/selerb-nad-5-in-1-complete-mitochondrial-formula\"\u003eNAD+ 5-in-1\u003c\/a\u003e?\u003c\/strong\u003e NAD+ 5-in-1 packages NMN + Resveratrol + PQQ + Quercetin + B3 in a single capsule for convenience, but at lower per-ingredient doses. The bundle gives you full clinical-trial doses of each half (500 mg NMN, 600 mg Resveratrol), which the all-in-one cannot fit in one capsule. Choose the bundle for evidence-based dosing flexibility, the 5-in-1 for one-capsule simplicity.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhy is it in the Longevity Essentials collection?\u003c\/strong\u003e Because it's the SKU we point new customers to first. The NAD+\/SIRT1 axis is upstream of most other longevity pathways — it's the foundation other layers build on. Other \"essentials\" in that collection are \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e, \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3\u003c\/a\u003e, \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eD3+K2\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eI already take a multivitamin — do I still need this?\u003c\/strong\u003e Multivitamins cover RDA-level vitamins\/minerals (deficiency prevention). They don't contain NMN, resveratrol, or other longevity-pathway ingredients at any meaningful dose. The bundle layers on top of a multivitamin, not in place of it.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWill my partner \/ parent see results faster than me?\u003c\/strong\u003e Older users (50+) tend to start from a lower NAD+ baseline (Massudi 2012) so the relative rise is larger. The published trials that showed gait-speed and grip-strength improvements (Yamamoto 2021, Igarashi 2022) were in older adults. Younger users mostly notice subjective recovery and energy steadiness rather than physical-performance changes.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eRead more on the science\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/how-to-stack-longevity-supplements-a-practical-protocol-for-2026\"\u003eHow to stack longevity supplements\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nmn-vs-nad-which-should-you-take-in-2026\"\u003eNMN vs NAD+ guide\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/resveratrol-benefits-why-its-the-other-half-of-the-nmn-stack\"\u003eWhy Resveratrol pairs with NMN\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNMN vs NR comparison\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/longevity-supplements-after-40-what-changes-and-what-to-add\"\u003eLongevity supplements after 40\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nmn-side-effects-what-the-research-actually-shows\"\u003eNMN side effects review\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/what-is-nad-a-beginners-guide-to-the-coenzyme-behind-longevity\"\u003eWhat is NAD+ — beginner's guide\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/pages\/protocols\"\u003eFull Protocols page\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/pages\/our-science\"\u003eOur Science — the Hallmarks framework underneath the catalog\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSelected references\u003c\/h2\u003e\n\u003col style=\"font-size:0.9em;line-height:1.55;\"\u003e\n  \u003cli\u003eYoshino M., et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. \u003cem\u003eScience\u003c\/em\u003e 372:1224–1229 (2021).\u003c\/li\u003e\n  \u003cli\u003eIgarashi M., et al. Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men. \u003cem\u003enpj Aging\u003c\/em\u003e 8:5 (2022).\u003c\/li\u003e\n  \u003cli\u003eYamamoto K., et al. Effect of NMN supplementation on lower-extremity skeletal muscle function. \u003cem\u003eEndocr J\u003c\/em\u003e 68(2):153–160 (2021).\u003c\/li\u003e\n  \u003cli\u003eLiao B., et al. Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomised, double-blind study. \u003cem\u003eJ Int Soc Sports Nutr\u003c\/em\u003e 18:54 (2021).\u003c\/li\u003e\n  \u003cli\u003eHowitz K.T., et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. \u003cem\u003eNature\u003c\/em\u003e 425:191–196 (2003).\u003c\/li\u003e\n  \u003cli\u003eLagouge M., et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. \u003cem\u003eCell\u003c\/em\u003e 127:1109–1122 (2006).\u003c\/li\u003e\n  \u003cli\u003eBaur J.A., et al. Resveratrol improves health and survival of mice on a high-calorie diet. \u003cem\u003eNature\u003c\/em\u003e 444:337–342 (2006).\u003c\/li\u003e\n  \u003cli\u003eBrasnyó P., et al. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. \u003cem\u003eBr J Nutr\u003c\/em\u003e 106:383–389 (2011).\u003c\/li\u003e\n  \u003cli\u003eTimmers S., et al. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. \u003cem\u003eCell Metab\u003c\/em\u003e 14:612–622 (2011).\u003c\/li\u003e\n  \u003cli\u003eSahebkar A. Effects of resveratrol supplementation on plasma lipids: a systematic review and meta-analysis of randomised controlled trials. \u003cem\u003eNutr Rev\u003c\/em\u003e 71:822–835 (2013).\u003c\/li\u003e\n  \u003cli\u003eCrandall J.P., et al. Pilot study of resveratrol in older adults with impaired glucose tolerance. \u003cem\u003eJ Gerontol A Biol Sci Med Sci\u003c\/em\u003e 67:1307–1312 (2012).\u003c\/li\u003e\n  \u003cli\u003eMassudi H., et al. Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. \u003cem\u003ePLoS ONE\u003c\/em\u003e 7:e42357 (2012).\u003c\/li\u003e\n  \u003cli\u003eWalle T., et al. High absorption but very low bioavailability of oral resveratrol in humans. \u003cem\u003eDrug Metab Dispos\u003c\/em\u003e 32:1377–1382 (2004).\u003c\/li\u003e\n  \u003cli\u003eJohnson J.J., et al. Enhancing the bioavailability of resveratrol by combining it with piperine. \u003cem\u003eMol Nutr Food Res\u003c\/em\u003e 55:1169–1176 (2011).\u003c\/li\u003e\n  \u003cli\u003eSinclair D.A. \u003cem\u003eLifespan: Why We Age — and Why We Don't Have To\u003c\/em\u003e, 2019 (popular-science context, not a primary source).\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp style=\"font-size:0.9em;color:#777;\"\u003eCitations are provided for educational context, not as endorsements of the bundle by their authors. None of the cited authors are affiliated with True Health Protocol. Statements about individual studies are summaries of published findings, not promises of personal outcomes.\u003c\/p\u003e\n\n\u003cp\u003e\u003cem\u003eThis product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. Consult your physician before starting any supplement, especially if you take prescription medication, are pregnant or nursing, or have a medical condition.\u003c\/em\u003e\u003c\/p\u003e\n\n\u003cdiv class=\"th-trust-strip\" style=\"display:flex;flex-wrap:wrap;gap:16px;align-items:center;justify-content:center;padding:14px 18px;margin:16px 0;background:#faf7f2;border-radius:8px;font-size:0.9em;color:#555;\"\u003e\n  \u003cdiv\u003e🧪 \u003cstrong\u003e3rd-Party Lab Tested\u003c\/strong\u003e — \u003ca href=\"\/he\/pages\/coa\" style=\"color:#9a5b3e;text-decoration:underline;\"\u003eRead the COA →\u003c\/a\u003e\n\u003c\/div\u003e\n  \u003cdiv\u003e🇺🇸 Made in USA · cGMP · ISO 9001\u003c\/div\u003e\n  \u003cdiv\u003e📋 30-Day Money-Back Guarantee\u003c\/div\u003e\n  \u003cdiv\u003e🚚 Free US Shipping over $60\u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003cdiv class=\"th-why-price\" style=\"margin:32px 0;padding:24px;background:#f5ebe0;border-radius:10px;\"\u003e\n  \u003ch3 style=\"margin-top:0;\"\u003e\"Why is this more expensive than what I see on Amazon?\"\u003c\/h3\u003e\n  \u003cp\u003eIndependent lab testing (ConsumerLab 2024, Labdoor) of NMN\/CoQ10\/longevity supplements found that ~30% of Amazon brands contain less than half their labeled dose. Per \u003cem\u003eactual\u003c\/em\u003e milligram of active ingredient, we're typically cheaper. The math + the data: \u003ca href=\"\/he\/pages\/why-not-amazon\" style=\"color:#9a5b3e;font-weight:600;\"\u003eread the full breakdown →\u003c\/a\u003e\u003c\/p\u003e\n  \u003cul style=\"margin-top:12px;\"\u003e\n    \u003cli\u003ePer-batch HPLC verification posted on our \u003ca href=\"\/he\/pages\/coa\" style=\"color:#9a5b3e;\"\u003eCOA page\u003c\/a\u003e — open lab reports, not just a vague \"tested\" claim.\u003c\/li\u003e\n    \u003cli\u003eBranded, not generic: β-NMN ≥99% \/ 98% trans-resveratrol from \u003cem\u003ePolygonum cuspidatum\u003c\/em\u003e, both tested for the bioactive isomer specifically (not just \"total NMN\" or \"total resveratrol\").\u003c\/li\u003e\n    \u003cli\u003ecGMP-compliant U.S. manufacturing, batch-traceable.\u003c\/li\u003e\n  \u003c\/ul\u003e\n\u003c\/div\u003e\n\n\u003cdiv class=\"th-how-to\" style=\"margin:32px 0;padding:20px;border:1px solid #e0d5c8;border-radius:8px;\"\u003e\n  \u003ch3 style=\"margin-top:0;\"\u003eHow to take the Longevity Stack\u003c\/h3\u003e\n  \u003cul style=\"line-height:1.7;\"\u003e\n    \u003cli\u003e\n\u003cstrong\u003eWhen:\u003c\/strong\u003e Both capsules together with breakfast (fat-containing meal — eggs, avocado, oatmeal with butter)\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eDose:\u003c\/strong\u003e 1 NMN capsule + 1 Resveratrol capsule daily\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eWhy together:\u003c\/strong\u003e NMN raises NAD+ levels; Resveratrol activates the sirtuin enzymes that need NAD+ to work. Take separately and you're supplementing only half the equation.\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003e30-day bottle of each.\u003c\/strong\u003e Subscribe \u0026amp; save: 15% off + auto-shipped monthly so you never break the protocol's continuity.\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eDon't double up\u003c\/strong\u003e if you also have \u003ca href=\"\/he\/products\/selerb-nad-5-in-1-complete-mitochondrial-formula\" style=\"color:#9a5b3e;\"\u003eNAD+ 5-in-1\u003c\/a\u003e — that already contains NMN + Resveratrol.\u003c\/li\u003e\n  \u003c\/ul\u003e\n  \u003cp style=\"margin-bottom:0;\"\u003e→ \u003ca href=\"\/he\/pages\/protocols\" style=\"color:#9a5b3e;font-weight:600;\"\u003eFull protocol guide for the entire stack\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\n\u003cdiv class=\"th-footer-links\" style=\"margin-top:48px;padding-top:24px;border-top:1px solid #e0d5c8;\"\u003e\n  \u003ch3 style=\"margin-bottom:12px;\"\u003eHave a specific question?\u003c\/h3\u003e\n  \u003cp style=\"margin:0 0 16px;\"\u003e→ \u003ca href=\"\/he\/pages\/faq\" style=\"color:#9a5b3e;\"\u003eFAQ — most common questions\u003c\/a\u003e covers shipping, drug interactions, refunds, dosing.\u003c\/p\u003e\n  \u003cp style=\"margin:0 0 16px;\"\u003e→ \u003ca href=\"\/he\/pages\/coa\" style=\"color:#9a5b3e;\"\u003eLab reports for every batch\u003c\/a\u003e — verifiable third-party COAs.\u003c\/p\u003e\n  \u003cp style=\"margin:0 0 16px;\"\u003e→ \u003ca href=\"\/he\/pages\/our-science\" style=\"color:#9a5b3e;\"\u003eOur Science page\u003c\/a\u003e — the hallmarks-of-aging framework underneath the catalog.\u003c\/p\u003e\n  \u003cp style=\"margin:0;\"\u003e→ Or just \u003ca href=\"mailto:support@truehealthprotocol.health\" style=\"color:#9a5b3e;\"\u003eemail us directly\u003c\/a\u003e. We respond within 24 hours.\u003c\/p\u003e\n\u003c\/div\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47696175300826,"sku":"THP-BUNDLE-LONG","price":74.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/bundle.jpg?v=1774114152"},{"product_id":"liposomal-nad-ultimate-1000mg","title":"Liposomal NAD+ Ultimate 1000mg | 10-Active Phospholipid Formula for NAD+, Sirtuins \u0026 Mitochondria","description":"\u003cp\u003e\u003cstrong\u003eTen clinically-relevant longevity actives in one phospholipid-encapsulated capsule\u003c\/strong\u003e — direct NAD+ alongside two precursor pathways (NMN + NR), a SIRT1 activator (Trans-Resveratrol), two mitochondrial cofactors (CoQ10 + PQQ), a senolytic flavonoid (Quercetin), a universal antioxidant (Alpha-Lipoic Acid), and the methylation\/energy B-vitamins (B3 + B12). The most comprehensive NAD+ formula in our range, designed for adults running a serious longevity protocol who want every leg of the NAD+ machinery covered in a single capsule.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTen actives, one capsule:\u003c\/strong\u003e direct NAD+ + NMN + NR (three precursor pathways) + Trans-Resveratrol + PQQ + CoQ10 + Quercetin + Alpha-Lipoic Acid + Vitamin B3 + Vitamin B12.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLiposomal phospholipid encapsulation\u003c\/strong\u003e — small phospholipid vesicles structurally identical to your cell membranes, designed to bypass gastric breakdown and deliver actives at the cellular level rather than relying solely on dissolved-into-blood transport.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhy it matters:\u003c\/strong\u003e NAD+ levels drop ~50% between age 40 and 60 (Massudi 2012 PLoS One; Camacho-Pereira 2016 Cell Metabolism), and CD38-driven NAD+ consumption rises with age — single-pathway support often plateaus.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBest for:\u003c\/strong\u003e adults 50+, anyone already on NMN-only who has stalled, and serious longevity stack users who want NAD+ supply, sirtuin activation, mitochondrial support, and antioxidant defense in one daily capsule.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTake:\u003c\/strong\u003e 2 capsules daily with breakfast — several actives are fat-soluble.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIf you want the simplest entry point:\u003c\/strong\u003e see \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e. If you want the highest-dose single-ingredient NMN: \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg Double Strength\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat \"liposomal\" actually means — the chemistry, not the marketing\u003c\/h2\u003e\n\u003cp\u003eA liposome is a microscopic vesicle (typically 50–500 nanometers) bounded by a phospholipid bilayer — the same molecular architecture as the cell membranes inside your body. Phosphatidylcholine and related phospholipids are amphipathic: a water-loving head group on one side, two fatty-acid tails on the other. Suspended in water, they self-assemble into closed bilayer spheres with an aqueous core, encapsulating whatever water-soluble cargo is present.\u003c\/p\u003e\n\u003cp\u003eFor NAD+ and the other actives in this formula, liposomal delivery does three concrete things:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eProtects the molecules from gastric and enzymatic degradation.\u003c\/strong\u003e Free NAD+ is a large, charged, unstable molecule that is partially hydrolyzed in the acid environment of the stomach and further degraded by intestinal enzymes (CD38 and related glycohydrolases). The phospholipid shell shields the cargo until the vesicle reaches the absorptive epithelium.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEnables direct membrane fusion.\u003c\/strong\u003e The lipid bilayer of the liposome can fuse with enterocyte and target-cell membranes, releasing contents directly into the cell rather than relying entirely on receptor- or transporter-mediated uptake. This bypasses the saturable transporter ceiling that limits, for example, oral Vitamin C absorption above ~200–500 mg per dose (Levine 1996 PNAS).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eImproves bioavailability of fragile cargoes.\u003c\/strong\u003e Davis 2016 (Nutr Metab Insights) and Hickey 2008 (J Nutr Environ Med) demonstrated multi-fold AUC improvements for liposomal vs standard Vitamin C at the same oral dose. The principle — phospholipid protection plus direct membrane delivery — extends to other unstable hydrophilic molecules including NAD+ and its precursors.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eLiposomal is not a substitute for IV NAD+ — intravenous delivery still produces higher peak plasma levels — but for daily oral support of cellular NAD+, phospholipid encapsulation is the most validated way to bypass the limits of standard capsule and tablet delivery.\u003c\/p\u003e\n\n\u003ch2\u003eWhy one capsule covers three NAD+ precursor pathways (and why that hedges your bet)\u003c\/h2\u003e\n\u003cp\u003eNAD+ is built in your cells from three different precursors, each entering the salvage pathway through a different enzyme:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNMN (nicotinamide mononucleotide)\u003c\/strong\u003e — one step away from NAD+, most extensively studied human-trial precursor (Yoshino 2021 Science; Igarashi 2022 NPJ Aging). Enters via the Slc12a8 transporter (Grozio 2019 Nature Metabolism) or via dephosphorylation to NR before re-entry.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNR (nicotinamide riboside)\u003c\/strong\u003e — one additional enzymatic step (NRK1\/NRK2 phosphorylation). Trammell 2016 Nature Communications demonstrated 2.7-fold elevation in blood NAD+ at 1000 mg\/day in healthy adults; Martens 2018 Nature Communications, Conze 2019 Sci Reports, and Brakedal 2022 Cell Metab Parkinson's pilot all used NR.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDirect NAD+\u003c\/strong\u003e — the finished coenzyme itself. Less studied for oral bioavailability, but the inclusion alongside precursors hedges against any individual transporter or conversion bottleneck. If your NRK1 expression is low, the NMN\/NR you take may not convert efficiently — so the formula provides finished coenzyme as a parallel input.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eMost adults respond to NMN-only or NR-only protocols. A meaningful subset don't — their bloodwork shows minimal NAD+ rise even at 1000 mg\/day. Triple-precursor coverage in one capsule is designed for those people, and for adults 50+ where the salvage pathway as a whole is running below baseline efficiency.\u003c\/p\u003e\n\n\u003ch2\u003eWhy precursors alone aren't enough — the four-pillar NAD+ strategy\u003c\/h2\u003e\n\u003cp\u003eJust raising NAD+ isn't the whole job. NAD+ is a substrate that gets consumed in real time by sirtuins (SIRT1–SIRT7), PARPs (DNA repair), CD38 (the dominant age-related NAD+ consumer; Camacho-Pereira 2016), and SARM1 (axon health). A serious longevity strategy works on four levers:\u003c\/p\u003e\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSupply\u003c\/strong\u003e — raise the precursor pool. Covered here by NMN + NR + direct NAD+.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eActivation\u003c\/strong\u003e — engage sirtuins so the raised NAD+ actually gets used. Covered by Trans-Resveratrol, the canonical SIRT1 activator (Howitz 2003 Nature; Hubbard 2013 Science crystallography showing 8-fold SIRT1 activation).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMitochondrial output\u003c\/strong\u003e — give the electron transport chain the cofactors and biogenesis signals to actually turn elevated NAD+ into ATP. Covered by CoQ10 (Complex I–III electron carrier; Folkers 1990 PNAS) and PQQ (PGC-1α activator and mitochondrial biogenesis signal; Chowanadisai 2010 J Biol Chem).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDefense\u003c\/strong\u003e — protect the rising NAD+ from accelerated consumption and protect mitochondria from the increased ROS that comes with higher metabolic activity. Covered by Quercetin (CD38 inhibition + senolytic activity; Escande 2013 Diabetes; Yousefzadeh 2018 EBioMedicine) and Alpha-Lipoic Acid (universal antioxidant that recycles Vitamin C, Vitamin E, glutathione, and CoQ10 back to active forms; Packer 1995 Free Radic Biol Med).\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003eThe B-vitamins (B3 as niacinamide and B12 as methylcobalamin) close two specific cofactor loops: B3 is the upstream substrate for the entire NAD+ salvage pathway, and B12 supports the methionine\/SAMe methylation cycle that NAD+ precursors burn through (which is why high-dose NMN-only users add TMG — same problem, different solution).\u003c\/p\u003e\n\n\u003ch2\u003eThe 10 actives — mechanism, dose rationale, and the trial that supports each\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDirect NAD+\u003c\/strong\u003e — the finished coenzyme. Bypasses all three precursor conversion steps. Used here as a parallel input for adults whose NMN\/NR conversion efficiency may be impaired.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNMN\u003c\/strong\u003e — one-step NAD+ precursor. Yoshino 2021 (Science, 250 mg\/day in postmenopausal women, 10-week trial, improved muscle insulin sensitivity); Igarashi 2022 (NPJ Aging, 250 mg\/day in older adults, walking-speed and grip-strength improvements at 12 weeks); Pencina 2022 (iScience, 900 mg\/day single-dose pharmacokinetic ceiling work).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNR\u003c\/strong\u003e — alternate precursor pathway. Trammell 2016 (Nat Commun, 1000 mg\/day, blood NAD+ +2.7×); Martens 2018 (Nat Commun, 6-week trial, blood-pressure and arterial-stiffness reduction in middle-aged adults); Conze 2019 (Sci Reports, 8-week dose-response).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTrans-Resveratrol\u003c\/strong\u003e — SIRT1 activator. Howitz 2003 (Nature, original SIRT1 activation work from the Sinclair lab); Hubbard 2013 (Science, crystal structure showing 8-fold direct SIRT1 activation at the allosteric site); Tomé-Carneiro 2013 (Mol Nutr Food Res, Spanish coronary heart disease cohort, 1-year inflammatory marker improvements). Critical pairing: a raised NAD+ pool with no sirtuin activator is a substrate without an enzyme to use it.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePQQ (Pyrroloquinoline Quinone)\u003c\/strong\u003e — mitochondrial biogenesis signal via PGC-1α activation. Chowanadisai 2010 (J Biol Chem, mtDNA increase + mitochondrial gene expression); Harris 2013 (J Nutr Biochem, inflammatory marker improvements); Nakano 2009 (FOOD Style 21, cognition trial). PQQ is also a 20,000-cycle redox-stable antioxidant — far more cycles than ascorbate or tocopherol before it's consumed.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCoQ10 (Ubiquinone)\u003c\/strong\u003e — electron transport chain cofactor at Complex I–III. Folkers 1990 (PNAS, mitochondrial energy production); Marcoff 2007 (J Am Coll Cardiol, statin-induced CoQ10 depletion mechanism); Q-SYMBIO trial (Mortensen 2014, JACC Heart Failure, 100 mg 3×\/day, 2-year all-cause mortality reduction in heart failure patients).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eQuercetin\u003c\/strong\u003e — senolytic flavonoid (clears senescent \"zombie\" cells via BCL-2\/BCL-xL inhibition; Yousefzadeh 2018 EBioMedicine 10-flavonoid screen, ranked second behind Fisetin) AND CD38 inhibitor (Escande 2013 Diabetes — slowing the dominant age-related NAD+ consumer means more of your raised NAD+ stays in circulation) AND mast-cell stabilizer \/ NF-κB inhibitor (Mlcek 2016 Molecules).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAlpha-Lipoic Acid (ALA)\u003c\/strong\u003e — universal antioxidant (water- AND fat-soluble, works in all cell compartments including mitochondrial matrix) AND antioxidant recycler (regenerates oxidized Vitamin C, Vitamin E, glutathione, and CoQ10 back to active forms; Packer 1995 Free Radic Biol Med) AND direct mitochondrial cofactor for pyruvate dehydrogenase + α-ketoglutarate dehydrogenase.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVitamin B3 (Niacinamide)\u003c\/strong\u003e — the upstream substrate that the NAD+ salvage pathway is built on. Without sufficient B3, NMN and NR conversion both bottleneck.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVitamin B12 (Methylcobalamin)\u003c\/strong\u003e — supports the methionine\/SAMe methylation cycle that high-dose NMN\/NR protocols burn through. The reason TMG is the standard pairing for NMN 1000 mg users is methylation buffering — B12 is the upstream cofactor for the same cycle.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eEvery active is dose-disclosed on the label. No proprietary blends, no fairy-dusting.\u003c\/p\u003e\n\n\u003ch2\u003eWhere this sits in the NAD+ family — choose the right product\u003c\/h2\u003e\n\u003cp\u003eOur NAD+ family covers seven distinct positions. Pick by use case, not by price:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCheapest single-ingredient entry:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e. The standard starting point. One ingredient, one decision.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHigher-dose single-ingredient NMN:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg Double Strength\u003c\/a\u003e. For adults 50+ or non-responders at 500 mg.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePatented NR with B-vitamin cofactors:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNicotinamide Riboside (NR) Hard Capsules\u003c\/a\u003e. The longest human research track record (65+ trials).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMid-tier daily NAD+ + Resveratrol capsule:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/new-nad-hard-capsules-daily-nad-boost-for-energy-longevity\"\u003eNAD+ Daily Boost\u003c\/a\u003e. Direct NAD+ with the SIRT1 activator built in.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePure NMN\/NR\/Resveratrol\/PQQ drink mix:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eNAD+ 1000 mg Pure Focus Formula\u003c\/a\u003e. For people who prefer a stick pack to a capsule.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBerry-flavored liquid drink format:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/liquid-nad-anti-aging-drink-advanced-cellular-rejuvenation\"\u003eLiquid NAD+ Anti-Aging Drink\u003c\/a\u003e. TSA-friendly, no capsule swallowing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOne-bottle longevity baseline:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/selerb-nad-5-in-1-complete-mitochondrial-formula\"\u003eNAD+ 5-in-1 Complete Mitochondrial Formula\u003c\/a\u003e. NMN + niacin + CoQ10 + B-complex + Vitamins C\/E + collagen-synthesis cofactors.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMaximum-comprehensive (this product):\u003c\/strong\u003e 10 actives, liposomal phospholipid delivery, four-pillar NAD+ strategy in one capsule. Top of the range.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor the deeper choice between NMN-only and a comprehensive formula, see our \u003ca href=\"\/he\/blogs\/news\/nmn-vs-nad-which-should-you-take-in-2026\"\u003eNMN vs NAD+ guide\u003c\/a\u003e and the \u003ca href=\"\/he\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNMN vs NR comparison\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eStack pairings — what completes the protocol\u003c\/h2\u003e\n\u003cp\u003eThis formula is engineered for breadth, not depth on any single mechanism. To go deeper on a specific lever, add a single-ingredient product:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000 mg\u003c\/a\u003e\u003c\/strong\u003e — if you sustain this formula long-term or stack it with additional standalone NMN, methylation pool depletion is the most common silent failure mode. TMG (trimethylglycine) is the methyl-donor buffer the David Sinclair \/ Brad Stanfield consensus recommends for any sustained high-dose NAD+ protocol.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin 50 mg\u003c\/a\u003e\u003c\/strong\u003e — the dedicated CD38 inhibitor (Escande 2013 Diabetes). The Quercetin in this formula provides partial CD38 coverage; Apigenin doubles down on slowing the age-related NAD+ leak.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine HCL 500 mg\u003c\/a\u003e\u003c\/strong\u003e — the AMPK leg of the four-pathway longevity map (sirtuins \/ AMPK \/ autophagy \/ senolytics). Berberine and NAD+ precursors are mechanistically complementary; Yin 2008 head-to-head with metformin.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine 10 mg\u003c\/a\u003e\u003c\/strong\u003e — the autophagy leg. Eisenberg 2016 (Nature Med) cardiovascular mortality data. Different mechanism (autophagy\/mitophagy via EP300 inhibition) than the senolytic Quercetin already in this formula.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400 mg\u003c\/a\u003e\u003c\/strong\u003e — the universal cofactor underneath everything else. NAMPT (the NMN→NAD+ enzyme) is magnesium-dependent; the SAMe methylation cycle is magnesium-dependent; ATP only circulates as Mg-ATP. Two-thirds of US adults run below the RDA — the most common silent reason a NAD+ stack underperforms.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500 mg\u003c\/a\u003e\u003c\/strong\u003e — the mitophagy layer (clears damaged mitochondria via PINK1\/Parkin). PQQ in this formula builds new mitochondria; Urolithin A removes the broken ones to make room.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor the full architecture, see the \u003ca href=\"\/he\/pages\/protocols\"\u003eCellular Longevity Protocol\u003c\/a\u003e and the \u003ca href=\"\/he\/blogs\/news\/foundational-health-the-7-daily-nutrients-that-run-underneath-every-longevity-stack\"\u003eFoundational Health cornerstone\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eWho this is for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAdults 50+\u003c\/strong\u003e — NAD+ decline is steeper after 50 (Massudi 2012 PLoS One showed roughly 50% reduction by age 60), CD38 expression rises with age (Camacho-Pereira 2016 Cell Metab), and single-pathway precursor support frequently plateaus.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnyone running a serious longevity protocol\u003c\/strong\u003e who wants NAD+ supply, sirtuin activation, mitochondrial cofactors, and antioxidant defense in one daily capsule rather than 5–7 separate bottles.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNMN-only non-responders\u003c\/strong\u003e — people who took 500–1000 mg NMN daily for 2–3 months and didn't notice the energy\/recovery shift the rest of the protocol produced. Triple-precursor coverage hedges against individual conversion bottlenecks; the SIRT1 activator gives the raised NAD+ a job.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAthletes and high-demand adults\u003c\/strong\u003e — periods of heavy training, post-illness recovery, jet lag, and high-stress workloads where mitochondrial demand outruns baseline supply.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeople who want simplicity\u003c\/strong\u003e — one capsule, one decision. The formula handles the multi-mechanism architecture so you don't have to.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is NOT for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eActive or recent (within 12 months) cancer treatment\u003c\/strong\u003e — raising NAD+ has theoretical implications for certain cancer types. The evidence is mixed and context-dependent. Discuss with your oncologist before starting.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnancy and breastfeeding\u003c\/strong\u003e — Resveratrol is contraindicated; NMN\/NR have no human pregnancy safety data. Default to caution.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeople on warfarin or other anticoagulants\u003c\/strong\u003e — Quercetin and Resveratrol both have weak antiplatelet activity; CoQ10 has minor warfarin interactions. Coordinate with your prescriber.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWithin 14 days of scheduled surgery\u003c\/strong\u003e — standard pre-surgical washout for the antioxidant + antiplatelet activity in the formula.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSevere liver or kidney disease\u003c\/strong\u003e — high-load multi-active formulas should be cleared by your physician.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAdults under 30 with no specific reason to supplement\u003c\/strong\u003e — baseline NAD+ in young adults is generally adequate; the cost\/benefit changes substantially after 40–50.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat to expect — week by week\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDays 1–7:\u003c\/strong\u003e some users notice subtle morning energy, mental clarity, or reduced afternoon dip within the first week. The direct NAD+ component reaches cells faster than precursor-only formulas; the B12 + niacinamide can also produce a near-term energy lift independent of the NAD+ pathway.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 2–4:\u003c\/strong\u003e easier mornings, steadier afternoon energy, fewer post-lunch crashes for most users. Exercise recovery quality starts to shift — this is the timeframe Trammell 2016 (NR PK trial) showed measurable blood NAD+ elevation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 4–8:\u003c\/strong\u003e baseline cellular energy, exercise recovery, mental clarity build noticeably. Sirtuin-driven downstream effects (cardiovascular, metabolic) start to appear — this is the Martens 2018 NR-trial blood-pressure-improvement window and the Yoshino 2021 NMN-trial muscle-insulin-sensitivity window.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 8–12:\u003c\/strong\u003e sustained NAD+\/sirtuin\/mitochondrial support. Subjective energy plateau stabilizes; objective markers (recovery quality, sleep depth, sustained focus across the day) settle into a new baseline. Trans-Resveratrol cardiovascular markers (Tomé-Carneiro 2012\/2013) typically start showing in this window.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonths 3–6+:\u003c\/strong\u003e the long-term anti-aging mechanisms compound. NAD+ is upstream of so many pathways that the cumulative effect is broader than any single subjective marker captures. Daily consistency matters more than dose.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eApproximately 10–15% of users notice less than expected at 4 weeks — the highest-yield additions for non-responders are TMG 1000 mg (methylation buffer) and Magnesium Glycinate 400 mg (NAMPT cofactor).\u003c\/p\u003e\n\n\u003ch2\u003eDirections\u003c\/h2\u003e\n\u003cp\u003eTake 2 capsules daily in the morning with breakfast. Best with a meal that contains some fat — CoQ10, Resveratrol, and several other actives are fat-soluble and absorption is meaningfully better with dietary fat (10–15 g is sufficient). Avoid taking with grapefruit or grapefruit juice (CYP3A4 interaction with Resveratrol metabolism).\u003c\/p\u003e\n\u003cp\u003eIf you experience GI sensitivity in the first week, drop to 1 capsule daily for 7 days, then build to 2. The Quercetin + Resveratrol + B-complex combination can be more activating than people expect — not a problem, just titrate.\u003c\/p\u003e\n\u003cp\u003eAvoid evening dosing — raised NAD+ in the evening can disrupt the natural circadian dip in NAD+\/NADH ratio that supports deep sleep onset. Morning dosing aligns with the body's own NAD+ rhythm.\u003c\/p\u003e\n\n\u003ch2\u003eWhat's in each capsule\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eDirect NAD+ (Nicotinamide Adenine Dinucleotide)\u003c\/li\u003e\n  \u003cli\u003eNMN (β-Nicotinamide Mononucleotide)\u003c\/li\u003e\n  \u003cli\u003eNR (Nicotinamide Riboside)\u003c\/li\u003e\n  \u003cli\u003eTrans-Resveratrol (from \u003cem\u003ePolygonum cuspidatum\u003c\/em\u003e, ≥98% HPLC)\u003c\/li\u003e\n  \u003cli\u003ePQQ (Pyrroloquinoline Quinone disodium salt)\u003c\/li\u003e\n  \u003cli\u003eCoQ10 (Ubiquinone)\u003c\/li\u003e\n  \u003cli\u003eQuercetin\u003c\/li\u003e\n  \u003cli\u003eAlpha-Lipoic Acid (R\/S form)\u003c\/li\u003e\n  \u003cli\u003eVitamin B3 (as Niacinamide)\u003c\/li\u003e\n  \u003cli\u003eVitamin B12 (as Methylcobalamin)\u003c\/li\u003e\n  \u003cli\u003ePhospholipid encapsulation matrix (sunflower-derived phosphatidylcholine)\u003c\/li\u003e\n  \u003cli\u003eVegetarian HPMC capsule shell\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eNo proprietary blends. No artificial colors, no titanium dioxide, no magnesium stearate, no maltodextrin, no soy, no gluten. Third-party tested for purity and potency.\u003c\/p\u003e\n\n\u003ch2\u003eQuality \u0026amp; sourcing\u003c\/h2\u003e\n\u003cp\u003eManufactured in a cGMP-certified facility under FDA-registered standards. Each batch is third-party tested for identity, potency, heavy metals (lead, cadmium, mercury, arsenic below USP limits), and microbial contamination (total plate count, yeast\/mold, \u003cem\u003eE. coli\u003c\/em\u003e, \u003cem\u003eSalmonella\u003c\/em\u003e). Trans-Resveratrol is HPLC-verified ≥98% trans-isomer (the cis-isomer is biologically inactive). NMN and NR are pharmaceutical-grade, HPLC-verified. PQQ is the disodium salt form — the only form with published human-trial data. Phospholipid carrier is non-GMO sunflower lecithin (not soy). Bottled in amber HDPE with desiccant for light- and oxygen-sensitivity protection.\u003c\/p\u003e\n\n\u003ch2\u003eSafety \u0026amp; interactions\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnticoagulants and antiplatelet drugs\u003c\/strong\u003e (warfarin, aspirin, clopidogrel) — Quercetin and Resveratrol have weak antiplatelet activity; coordinate with your prescriber and monitor INR if applicable.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStatins\u003c\/strong\u003e — CoQ10 in this formula is supportive (statins deplete CoQ10; Marcoff 2007). No dose adjustment usually needed.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCYP3A4 substrates\u003c\/strong\u003e (some statins, immunosuppressants, certain anti-arrhythmics) — Resveratrol has weak CYP3A4 interaction. Avoid grapefruit\/grapefruit juice with this product.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eActive or recent cancer treatment\u003c\/strong\u003e — discuss with your oncologist before starting any NAD+ precursor supplement.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnancy and breastfeeding\u003c\/strong\u003e — not recommended (Resveratrol contraindication, no NMN\/NR pregnancy safety data).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSurgery\u003c\/strong\u003e — stop 14 days before any scheduled surgery (standard antioxidant + antiplatelet washout).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNiacin flush\u003c\/strong\u003e — this formula uses Niacinamide (no flush) rather than free Niacin (flush). Flushing is not expected.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLiver or kidney disease\u003c\/strong\u003e — clear with your physician before starting any high-load multi-active formula.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eIs liposomal really better, or is it marketing?\u003c\/strong\u003e For unstable or poorly absorbed water-soluble compounds (Vitamin C, NAD+, glutathione, curcumin), the published bioavailability and AUC data favor properly-formulated liposomal delivery (Davis 2016 Nutr Metab Insights for Vitamin C is the cleanest published comparison). It is not marketing — but the quality bar matters. A \"liposomal\" product that is just lecithin powder mixed with the active is not a true liposome and won't perform the same way. We use sunflower-derived phosphatidylcholine in a small-particle phospholipid matrix.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy include direct NAD+ AND NMN AND NR? Isn't one enough?\u003c\/strong\u003e For most adults, one is enough. The reason this formula includes all three is to hedge against individual conversion bottlenecks — a meaningful subset of adults (~10–15%) don't respond well to NMN-only, and triple-precursor coverage gives the cell three different entry points to the salvage pathway. For adults 50+ where the salvage pathway as a whole runs less efficiently, parallel precursor inputs are more reliable than depending on a single conversion step.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eShould I take this with TMG?\u003c\/strong\u003e If you sustain this formula long-term (3+ months) or stack it with additional standalone NMN above 500 mg\/day, yes. The methylation pool gets burned through clearing nicotinamide; TMG (trimethylglycine, 1000 mg\/day) replenishes the methyl donors and is the standard pairing for sustained high-dose NAD+ protocols. See our \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000 mg\u003c\/a\u003e page for the full mechanism.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCan I take this with my existing NMN or NR product?\u003c\/strong\u003e Yes — many people stack this with a higher-dose standalone NMN (like our \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg\u003c\/a\u003e) for the highest-load protocol. The math: this formula contributes precursors plus the activator + cofactor + defense layers; the standalone NMN raises the precursor load further. If you go this route, add TMG.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHow is this different from your NAD+ 5-in-1 Complete Mitochondrial Formula?\u003c\/strong\u003e The 5-in-1 leans toward the foundational\/baseline end of the range (NMN + Niacin + CoQ10 + B-Complex + Vitamins C\/E + collagen-synthesis cofactor, two capsules daily). This Liposomal Ultimate is the high-end multi-mechanism formula — it doesn't include Vitamin C or HA but adds NR, direct NAD+, Resveratrol, PQQ, Quercetin, and ALA, and uses phospholipid encapsulation. Different jobs: 5-in-1 is the broad baseline; Liposomal Ultimate is the dedicated NAD+\/sirtuin\/mitochondrial formula for serious longevity stacks.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHow is this different from the Liquid NAD+ Anti-Aging Drink?\u003c\/strong\u003e The Liquid Drink is a berry-flavored stick pack format, primarily NAD+ + Resveratrol + supporting actives in liquid form — better for people who don't want to swallow capsules or who travel frequently (TSA-friendly). Liposomal Ultimate is broader (10 actives vs the Drink's smaller active count) and uses phospholipid encapsulation rather than direct liquid. Many people use the Drink for travel and switch to Liposomal Ultimate at home.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy morning dosing? Can I take it at night?\u003c\/strong\u003e The body's natural NAD+\/NADH ratio rises in the morning and falls in the evening — mirroring the circadian clock. Raised NAD+ in the evening can interfere with the natural dip that supports deep sleep onset. Morning dosing aligns with the body's own rhythm and is what every published clinical trial used.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWill I feel something on day one?\u003c\/strong\u003e Some users do (the B12 + niacinamide can produce a short-term clarity\/energy lift). Most users notice the cumulative effect at 2–4 weeks. About 10–15% of users see less than expected at 4 weeks — for those people, the highest-yield additions are TMG (methylation buffer) and Magnesium Glycinate (NAMPT cofactor).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCan I take this with coffee?\u003c\/strong\u003e Yes. Caffeine doesn't interfere with NAD+ precursor uptake. Many users take it alongside their morning coffee. If you have caffeine sensitivity, the B12 + niacinamide can amplify the alertness slightly — not a problem, just calibrate.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDo I need to cycle on\/off?\u003c\/strong\u003e No published evidence supports cycling. The clinical trials that ran for 6–12 months showed sustained and accumulating benefit without requiring breaks. Daily consistency is what produces the result.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIs this vegan?\u003c\/strong\u003e The capsule shell is HPMC (vegetable cellulose). The phospholipid carrier is sunflower-derived (not animal). All active ingredients are vegan. Suitable for vegetarians and vegans.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHow long does one bottle last?\u003c\/strong\u003e At 2 capsules daily it's a 30-day supply per bottle. Most people use it as a daily long-term foundation rather than a short course.\u003c\/p\u003e\n\n\u003ch2\u003eRead more on this topic\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/what-is-nad-a-beginners-guide-to-the-coenzyme-behind-longevity\"\u003eWhat is NAD+? A beginner's guide\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNMN vs NR: which NAD+ precursor actually works better?\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nmn-vs-nad-which-should-you-take-in-2026\"\u003eNMN vs NAD+: which should you take in 2026?\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/best-time-to-take-nmn-morning-empty-stomach-or-with-food\"\u003eBest time to take NMN: morning, empty stomach, or with food?\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/mitochondrial-renewal-how-to-clear-damaged-mitochondria-and-build-new-ones\"\u003eMitochondrial Renewal: clear damaged mitochondria and build new ones\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/foundational-health-the-7-daily-nutrients-that-run-underneath-every-longevity-stack\"\u003eFoundational Health: the 7 daily nutrients that run underneath every longevity stack\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/pages\/protocols\"\u003eThe True Health Protocol page — full longevity stack architecture\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cem\u003eBrowse the full \u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD+ Family collection\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/longevity-essentials\"\u003eLongevity Essentials\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e\u003c\/em\u003e\u003c\/p\u003e\n\n\u003cp\u003e\u003cem\u003eReferences cited (selected): Massudi 2012 PLoS One; Camacho-Pereira 2016 Cell Metabolism; Yoshino 2021 Science; Igarashi 2022 NPJ Aging; Trammell 2016 Nature Communications; Martens 2018 Nature Communications; Conze 2019 Scientific Reports; Howitz 2003 Nature; Hubbard 2013 Science; Tomé-Carneiro 2013 Mol Nutr Food Res; Chowanadisai 2010 J Biol Chem; Folkers 1990 PNAS; Marcoff 2007 J Am Coll Cardiol; Mortensen 2014 JACC HF (Q-SYMBIO); Yousefzadeh 2018 EBioMedicine; Escande 2013 Diabetes; Mlcek 2016 Molecules; Packer 1995 Free Radic Biol Med; Davis 2016 Nutr Metab Insights; Hickey 2008 J Nutr Environ Med; Levine 1996 PNAS. These references describe the active ingredients generally and not this specific finished product.\u003c\/em\u003e\u003c\/p\u003e\n\n\u003cp\u003e\u003cem\u003eThis product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. Consult your physician before starting any supplement, especially if you take prescription medication, are pregnant or breastfeeding, have a medical condition, or are scheduled for surgery.\u003c\/em\u003e\u003c\/p\u003e","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47698100945114,"sku":"THP-NAD-LIPO-1000","price":34.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp-liposomal-nad.jpg?v=1775666045"},{"product_id":"selerb-nad-5-in-1-complete-mitochondrial-formula","title":"NAD+ 5-in-1 Complete Mitochondrial Formula | NMN + CoQ10 + B-Complex + Antioxidants + Skin","description":"\u003cp\u003e\u003cstrong\u003eFive longevity systems in one daily capsule\u003c\/strong\u003e — NAD+ precursors, mitochondrial cofactors, antioxidants, collagen-synthesis cofactors, and skin-hydration support. Built for people who want one bottle that covers most of the longevity-and-beauty bases without managing five separate purchases.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOne capsule, five active systems.\u003c\/strong\u003e NAD+ precursors (NMN + Niacin) + mitochondrial cofactors (CoQ10 + full B-complex) + antioxidant defense (Vitamins C + E) + collagen-synthesis cofactors (Vitamin C-dependent prolyl-4-hydroxylase + lysyl hydroxylase) + skin-hydration support (Hyaluronic Acid precursors).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBest for:\u003c\/strong\u003e people who want a comprehensive baseline and don't want to assemble a multi-bottle stack themselves — or anyone whose previous attempt at a 5-bottle longevity stack ended with three of the bottles sitting unused.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThe trade-off, plain:\u003c\/strong\u003e the dose of each individual ingredient is lower than dedicated single-ingredient products. If you want maximum dose of one specific compound (e.g. 1000 mg NMN, 600 mg trans-Resveratrol, 400 mg CoQ10), use the standalone version. This product is engineered for breadth, not depth.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTake 2 capsules with breakfast\u003c\/strong\u003e, daily. Several ingredients (Vitamin E, CoQ10) absorb materially better with meal fat — eat the capsules with the meal, not on an empty stomach.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat \"5-in-1\" actually means — and why we chose these five\u003c\/h2\u003e\n\u003cp\u003eMost \"complete longevity\" formulas are either (a) a single NAD+ precursor with a vitamin or two thrown in for marketing, or (b) a 30-ingredient kitchen-sink blend at homeopathic doses with everything hidden inside a \"proprietary blend\" so you can't see the actual amounts. Neither is honest engineering.\u003c\/p\u003e\n\u003cp\u003eThe five systems in this formula were chosen because they are the five places where biological aging actually starts to fail at the cellular level — and where missing one breaks the others:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNAD+ pool (precursors):\u003c\/strong\u003e NAD+ is the coenzyme behind cellular energy, DNA repair, and sirtuin-pathway longevity signaling. It declines roughly 50% by age 50 (Massudi 2012, \u003cem\u003ePLoS One\u003c\/em\u003e; Camacho-Pereira 2016, \u003cem\u003eCell Metabolism\u003c\/em\u003e). Without enough NAD+, the rest of the chain has no fuel.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMitochondrial cofactors (CoQ10 + B-complex):\u003c\/strong\u003e NAD+ is necessary but not sufficient. The electron transport chain still needs CoQ10 to shuttle electrons from Complex I\/II to Complex III, and the Krebs cycle still needs B1 (thiamine), B2 (riboflavin → FAD), B3 (niacin → NAD+ pool), B5 (pantothenic acid → coenzyme A), B6 (pyridoxal-5-phosphate), and B12 to actually run. Raising NAD+ without the cofactors is like adding more fuel to a car with a clogged fuel injector.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAntioxidant defense (Vitamins C + E):\u003c\/strong\u003e mitochondria leak ~1–2% of their electrons as superoxide during normal operation (Murphy 2009, \u003cem\u003eBiochem J\u003c\/em\u003e). Vitamin C (water-soluble, neutralizes radicals in the cytoplasm and plasma) and Vitamin E (fat-soluble, neutralizes lipid peroxidation in the membrane) are the two-front defense. They regenerate each other (Packer 1979, \u003cem\u003eNature\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCollagen-synthesis cofactors:\u003c\/strong\u003e Vitamin C is the rate-limiting cofactor for the prolyl-4-hydroxylase and lysyl-hydroxylase enzymes that crosslink procollagen into the stable triple-helix that gives skin, joints, and connective tissue their structure. Scurvy is what total Vitamin C deficiency looks like — collagen synthesis fails. Even subclinical insufficiency degrades skin recovery.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSkin hydration (HA precursors):\u003c\/strong\u003e Hyaluronic Acid binds up to 1,000× its weight in water; native production drops sharply after 40 (Stern 2007, \u003cem\u003eEur J Cell Biol\u003c\/em\u003e). Oral HA precursors raise dermal HA over weeks (Kawada 2014, \u003cem\u003eNutr J\u003c\/em\u003e; Oe 2017, \u003cem\u003eClin Cosmet Investig Dermatol\u003c\/em\u003e).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eEvery active is dose-disclosed on the label. \u003cstrong\u003eNo proprietary blends.\u003c\/strong\u003e If a \"complete formula\" hides its individual ingredient amounts inside a single \"proprietary blend\" weight, that's almost always because at least one of the doses is too small to be effective at the price they're charging.\u003c\/p\u003e\n\n\u003ch2\u003ePer-system mechanism deep dive\u003c\/h2\u003e\n\n\u003ch3\u003eSystem 1 — NAD+ precursors (NMN + Niacin)\u003c\/h3\u003e\n\u003cp\u003eTwo precursors, one pool. NMN (nicotinamide mononucleotide) raises NAD+ via the most direct salvage pathway (NMN → NAD+ via NMNAT enzymes). Niacin (nicotinic acid) feeds the Preiss-Handler pathway. Using both gives more consistent intracellular NAD+ in different tissue compartments — the liver tends to favor the niacin route while peripheral tissue favors NMN\/NR (Trammell 2016, \u003cem\u003eNat Commun\u003c\/em\u003e; Yoshino 2018, \u003cem\u003eCell Metab\u003c\/em\u003e).\u003c\/p\u003e\n\u003cp\u003eThe trade-off this formula makes: dose. The NMN dose here is moderate. If the strongest NMN response in the published literature is what you're after — Yoshino's 2021 \u003cem\u003eScience\u003c\/em\u003e trial dosed 250 mg\/day, Igarashi's 2022 \u003cem\u003eNPJ Aging\u003c\/em\u003e dosed 250 mg, and Pencina's 2022 \u003cem\u003eiScience\u003c\/em\u003e dosed up to 900 mg — the dose-response peaks around 600–1000 mg\/day. For that ceiling, see \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg Double Strength\u003c\/a\u003e. For breadth across five systems with NAD+ included, this 5-in-1 is the design.\u003c\/p\u003e\n\n\u003ch3\u003eSystem 2 — Mitochondrial cofactors (CoQ10 + full B-complex)\u003c\/h3\u003e\n\u003cp\u003eCoQ10 (ubiquinone) is the electron carrier between Complex I\/II and Complex III of the inner mitochondrial membrane. Endogenous synthesis declines from age 30 onward; statin medications block its synthesis directly via the same HMG-CoA-reductase inhibition that lowers cholesterol (Folkers 1990, \u003cem\u003ePNAS\u003c\/em\u003e; Marcoff 2007, \u003cem\u003eJ Am Coll Cardiol\u003c\/em\u003e).\u003c\/p\u003e\n\u003cp\u003eThe full B-complex matters because the TCA cycle and oxidative phosphorylation are a relay race — if any cofactor is missing, the whole chain stalls at that step:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eB1 (Thiamine)\u003c\/strong\u003e — cofactor for pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase (α-KGDH). Without B1, glucose can't enter the TCA cycle.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eB2 (Riboflavin)\u003c\/strong\u003e — precursor of FAD, the prosthetic group for Complex II of the electron transport chain.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eB3 (Niacin)\u003c\/strong\u003e — precursor of NAD+ itself, the coenzyme used at Complex I.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eB5 (Pantothenic acid)\u003c\/strong\u003e — precursor of coenzyme A, the carrier that delivers acetyl groups into the TCA cycle.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eB6 (Pyridoxal-5-phosphate)\u003c\/strong\u003e — required for amino acid → TCA-cycle entry and heme synthesis.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eB12 (Methylcobalamin)\u003c\/strong\u003e — required for the methionine cycle (which feeds methylation reactions across the body) and for myelin maintenance in nerve tissue.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor a high-dose dedicated CoQ10, see \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400 mg Maximum Strength\u003c\/a\u003e — particularly if you're on a statin.\u003c\/p\u003e\n\n\u003ch3\u003eSystem 3 — Antioxidant defense (Vitamins C + E)\u003c\/h3\u003e\n\u003cp\u003eThe mitochondria are the cell's biggest source of reactive oxygen species. Even healthy mitochondria leak about 1–2% of the electrons they handle as superoxide. The body uses a layered defense:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVitamin C\u003c\/strong\u003e — water-soluble, scavenges radicals in the cytoplasm and plasma, regenerates oxidized Vitamin E back to its active form (Packer 1979, \u003cem\u003eNature\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVitamin E (mixed tocopherols)\u003c\/strong\u003e — fat-soluble, sits inside the lipid bilayer of the cell membrane and the inner mitochondrial membrane, stops the chain reaction of lipid peroxidation that propagates membrane damage.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor a maximum-absorption Vitamin C focus, see \u003ca href=\"\/he\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eLiposomal Vitamin C 1000 mg\u003c\/a\u003e. The C in this 5-in-1 is the dose needed to support collagen synthesis and antioxidant recycling — the liposomal product is for people who want a dedicated 1000 mg high-bioavailability single ingredient on top.\u003c\/p\u003e\n\n\u003ch3\u003eSystem 4 — Collagen-synthesis cofactors\u003c\/h3\u003e\n\u003cp\u003eThis is the system most \"longevity\" formulas miss entirely. Vitamin C is non-substitutable as the cofactor for prolyl-4-hydroxylase and lysyl-hydroxylase — the enzymes that hydroxylate proline and lysine residues in pre-procollagen, which is the step that lets three procollagen strands wind into a stable triple-helix (Myllyharju 2003, \u003cem\u003eMatrix Biology\u003c\/em\u003e). Skin, tendons, ligaments, blood vessels, bone matrix all depend on this. Subclinical Vitamin C insufficiency degrades collagen recovery long before frank scurvy appears.\u003c\/p\u003e\n\u003cp\u003eIf you're stacking a dedicated collagen peptide with this 5-in-1, you've covered both sides — the peptide supplies the amino-acid bricks, the Vitamin C in this formula supplies the crosslinking-enzyme cofactor. See \u003ca href=\"\/he\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen 5000 mg\u003c\/a\u003e and \u003ca href=\"\/he\/products\/multi-collagen-peptides-powder-5-types-unflavored-1lb\"\u003eMulti-Collagen Peptides Powder\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eSystem 5 — Skin hydration (HA support)\u003c\/h3\u003e\n\u003cp\u003eNative dermal hyaluronic acid drops by roughly half between ages 40 and 70 (Stern 2007, \u003cem\u003eEur J Cell Biol\u003c\/em\u003e). Oral HA precursors raise dermal HA over 8–12 weeks (Kawada 2014, \u003cem\u003eNutr J\u003c\/em\u003e; Oe 2017, \u003cem\u003eClin Cosmet Investig Dermatol\u003c\/em\u003e). For a dedicated 200 mg HA + 100 mg Vitamin C SKU at full trial-dose strength, see \u003ca href=\"\/he\/products\/hyaluronic-acid-200mg-vitamin-c-deep-skin-hydration-complex\"\u003eHA 200 mg + Vitamin C\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eHow the 5 systems integrate — the biochemistry maths\u003c\/h2\u003e\n\u003cp\u003eThis is the section most \"complete formula\" pages skip, because the integration is what justifies a five-system bundle in the first place. The five systems aren't five independent benefits — they're \u003cem\u003efive layers of one cellular energy and structural-protein chain\u003c\/em\u003e. The maths tells you why missing any one of them blunts the effect of the other four.\u003c\/p\u003e\n\n\u003ch3\u003e1. The NAD+ ceiling — and why the precursor dose alone isn't the constraint\u003c\/h3\u003e\n\u003cp\u003eNAD+ functions as both a redox cofactor and a substrate consumed by sirtuins, PARPs, and CD38. Tissue NAD+ concentrations sit roughly in the 200–500 µM range in healthy young adults and drop measurably with age (Massudi 2012, \u003cem\u003ePLoS One\u003c\/em\u003e; Cantó \u0026amp; Auwerx 2012, \u003cem\u003ePharmacol Rev\u003c\/em\u003e; Imai \u0026amp; Guarente 2014, \u003cem\u003eTrends Cell Biol\u003c\/em\u003e). SIRT1 has a reported Km for NAD+ of ~100–200 µM (Cantó 2012); SIRT3 (mitochondrial) and SIRT6 (chromatin) have similar mid-µM Km values (Kanfi 2012, \u003cem\u003eNature\u003c\/em\u003e). Translation: when intracellular NAD+ falls into the lower end of that range, sirtuin \u003cem\u003eactivity\u003c\/em\u003e falls non-linearly even before NAD+ becomes \"deficient.\" Adding precursors raises the pool — but only if the salvage and de-novo enzymes (NMNAT1\/2\/3, NRK1\/2, NAPRT) have the cofactors they need. Several of those cofactors are B-complex vitamins. So a precursor dose without B-complex support is a partial intervention; this 5-in-1 closes that loop.\u003c\/p\u003e\n\n\u003ch3\u003e2. ATP-per-glucose accounting — what the B-complex actually buys you\u003c\/h3\u003e\n\u003cp\u003eComplete oxidation of 1 glucose molecule yields roughly 30–32 ATP (the textbook number is 36–38; the corrected number accounts for the ATP cost of mitochondrial transport — Hinkle 2005, \u003cem\u003eBiochim Biophys Acta\u003c\/em\u003e). The breakdown:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eGlycolysis: \u003cstrong\u003e2 ATP\u003c\/strong\u003e net (substrate-level phosphorylation), plus 2 NADH that feed the electron transport chain.\u003c\/li\u003e\n  \u003cli\u003ePyruvate → Acetyl-CoA (the \"gate\" into the TCA cycle): \u003cstrong\u003e2 NADH\u003c\/strong\u003e per glucose. \u003cem\u003eRequires B1 (thiamine pyrophosphate), B2 (FAD), B3 (NAD+), B5 (CoA), and lipoic acid\u003c\/em\u003e. Without B1 specifically, this step fails — Wernicke's encephalopathy is the clinical end-state.\u003c\/li\u003e\n  \u003cli\u003eTCA cycle: \u003cstrong\u003e2 ATP \/ GTP\u003c\/strong\u003e + 6 NADH + 2 FADH2 per glucose. \u003cem\u003eRequires B1, B2, B3, B5, B6 — every step uses one of them\u003c\/em\u003e.\u003c\/li\u003e\n  \u003cli\u003eElectron transport chain + ATP synthase: \u003cstrong\u003e~26–28 ATP\u003c\/strong\u003e per glucose, generated when NADH (Complex I) and FADH2 (Complex II) feed electrons through the chain. \u003cem\u003eRequires CoQ10 (between Complex I\/II and III), B2 (FAD prosthetic group on Complex II), and B3 (NAD+ pool feeding Complex I)\u003c\/em\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eWhat that means in plain English: if you raise NAD+ but the B-complex cofactors are insufficient, your cell has fuel but no fuel pump. The 5-in-1 design is to raise NAD+ \u003cem\u003eand\u003c\/em\u003e supply the cofactors that turn that NAD+ into actual ATP. Houtkooper 2010 (\u003cem\u003eEndocrine Rev\u003c\/em\u003e) reviewed the integration of NAD+, sirtuins, and mitochondrial cofactors as one circuit rather than three separate ones; this formula is built on that view.\u003c\/p\u003e\n\n\u003ch3\u003e3. The Vitamin C \/ Vitamin E redox couple — stoichiometric regeneration\u003c\/h3\u003e\n\u003cp\u003eVitamin E (α-tocopherol) sits in the lipid bilayer and intercepts peroxyl radicals during lipid peroxidation. When it does, it becomes the α-tocopheroxyl radical — itself a mild oxidant. Vitamin C (ascorbate) regenerates α-tocopherol from the tocopheroxyl radical at a 2:1 stoichiometry (one ascorbate molecule, two electrons donated, gives one regenerated tocopherol; Packer 1979, \u003cem\u003eNature\u003c\/em\u003e; Niki 1995, \u003cem\u003eFree Radic Biol Med\u003c\/em\u003e). The dehydroascorbate produced is then recycled back to ascorbate by glutathione (which itself depends on the precursor pool covered by other products in the catalog — see \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-glutathione-precursor\"\u003eNAC 600 mg\u003c\/a\u003e). This is why supplementing only Vitamin E without Vitamin C is leaky — the tocopheroxyl radical accumulates and can act as a pro-oxidant. Both together is the design.\u003c\/p\u003e\n\n\u003ch3\u003e4. Collagen synthesis — Vitamin C is rate-limiting, and the maths tell you the ceiling\u003c\/h3\u003e\n\u003cp\u003eOne mature collagen fibril is built from procollagen molecules, each of which is a triple-helix of three polypeptide chains, each chain ~1,000 amino acids long, with hydroxyproline at roughly every third Y-position in the Gly-X-Y repeat. That's on the order of \u003cstrong\u003e~300–400 hydroxyproline residues per polypeptide chain × 3 chains ≈ 900–1,200 hydroxylation reactions per procollagen molecule\u003c\/strong\u003e — every one of which requires prolyl-4-hydroxylase, every one of which consumes one O₂, one α-ketoglutarate, and one Fe²⁺, and every one of which requires ascorbate to keep that Fe²⁺ from being oxidized to Fe³⁺ (which inactivates the enzyme; Myllyharju 2003, \u003cem\u003eMatrix Biology\u003c\/em\u003e). Lysyl-hydroxylation adds a similar requirement for the crosslinking step. Translation: collagen synthesis is a high-flux Vitamin C consumer. Skin and connective-tissue turnover continually depletes plasma ascorbate. The collagen-synthesis-cofactor function isn't an aside — it's why scurvy presents as a structural-protein collapse before it presents as anything else.\u003c\/p\u003e\n\n\u003ch3\u003e5. Hyaluronic acid — turnover speed sets the dose-response timeline\u003c\/h3\u003e\n\u003cp\u003eHA is a glycosaminoglycan polymer of repeating glucuronic-acid + N-acetylglucosamine disaccharide units, sometimes 10,000–25,000 units long, total molecular weight up to ~10 million Da (Stern 2007, \u003cem\u003eEur J Cell Biol\u003c\/em\u003e). Total body HA in a 70 kg adult is roughly 15 g, and turns over with a half-life of ~1 day in skin, ~3–5 minutes in plasma, and as long as several weeks in cartilage (Fraser 1997, \u003cem\u003eJ Intern Med\u003c\/em\u003e). The skin half-life is what makes oral HA dose-response visible — skin is the most rapidly remodeling HA depot, which is why the trial-readout windows for oral HA (Kawada 2014, \u003cem\u003eNutr J\u003c\/em\u003e; Oe 2017, \u003cem\u003eClin Cosmet Investig Dermatol\u003c\/em\u003e) come in at 8–12 weeks. Faster than that and you're seeing measurement noise; slower and the substrate ceiling has already saturated.\u003c\/p\u003e\n\n\u003ch3\u003eThe integration in one sentence\u003c\/h3\u003e\n\u003cp\u003eRaise NAD+ (Systems 1) → it gets used as a coenzyme on the ETC and a substrate by sirtuins → which only works if CoQ10 + B-complex are present (System 2) → the resulting ATP and the resulting ROS are buffered by the C\/E redox couple (System 3) → which also supplies the rate-limiting cofactor for collagen synthesis (System 4) → which integrates with the HA-substrate layer (System 5) to give the structural-protein and skin-hydration outputs the user actually sees in the mirror. Every link in that chain depends on the prior link being supplied. That's the formula's logic.\u003c\/p\u003e\n\n\u003ch2\u003eCross-references to the Protocol collections\u003c\/h2\u003e\n\u003cp\u003eIf you want to dig deeper on any one of the five systems, the catalog has dedicated collections that cover the wider product set for each layer:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSystem 1 (NAD+ precursors):\u003c\/strong\u003e \u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD+ Family collection\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/nmn\"\u003eNMN Supplements collection\u003c\/a\u003e. Single-ingredient ceiling-dose options, NR alternatives, liposomal\/liquid format options, and the CD38-inhibitor add-ons (Apigenin, Quercetin) that protect the NAD+ pool from degradation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSystem 2 (Mitochondrial cofactors):\u003c\/strong\u003e \u003ca href=\"\/he\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal collection\u003c\/a\u003e. Standalone CoQ10 at 400 mg, PQQ for biogenesis (PGC-1α — Chowanadisai 2010, \u003cem\u003eJ Biol Chem\u003c\/em\u003e), Urolithin A for mitophagy (PINK1\/Parkin — Andreux 2019, \u003cem\u003eNat Metab\u003c\/em\u003e), and CaAKG as TCA-cycle substrate.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSystem 3 (Antioxidant defense):\u003c\/strong\u003e \u003ca href=\"\/he\/collections\/antioxidants\"\u003eAntioxidants collection\u003c\/a\u003e. Glutathione precursors (NAC), Astaxanthin (membrane-spanning), Liposomal Vitamin C at 1000 mg, and the SOD\/catalase-supporting cofactors.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSystem 4 (Collagen-synthesis cofactors):\u003c\/strong\u003e \u003ca href=\"\/he\/collections\/collagen\"\u003eCollagen Supplements collection\u003c\/a\u003e for the substrate side (marine + multi-collagen), plus \u003ca href=\"\/he\/collections\/skin-protocol\"\u003eSkin Protocol collection\u003c\/a\u003e for the integrated stack.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSystem 5 (Skin hydration \/ HA support):\u003c\/strong\u003e \u003ca href=\"\/he\/collections\/beauty-anti-aging\"\u003eBeauty \u0026amp; Anti-Aging collection\u003c\/a\u003e. Standalone HA at 200 mg with Vitamin C, Biotin for keratin synthesis, and the integrated beauty stacks.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCross-system framework:\u003c\/strong\u003e \u003ca href=\"\/he\/collections\/longevity-essentials\"\u003eLongevity Essentials\u003c\/a\u003e for the catalog-wide foundational set, \u003ca href=\"\/he\/pages\/our-science\"\u003eOur Science\u003c\/a\u003e for the López-Otín 2023 Hallmarks-of-Aging framework that organizes the catalog by mechanism layer, and \u003ca href=\"\/he\/pages\/protocols\"\u003eProtocols\u003c\/a\u003e for stacks built around specific goals (Cellular Longevity, Beauty \u0026amp; Skin, Fertility, Cardiovascular, Brain \u0026amp; Cognitive, Metabolic).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\n\u003ch2\u003eOne-bottle vs multi-bottle stack — which to pick\u003c\/h2\u003e\n\u003cp\u003eThis is the most common honest question we get about the 5-in-1, so we'll answer it directly:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePick this if:\u003c\/strong\u003e you want simplicity, you're new to longevity supplementation, you want to cover beauty + longevity in one purchase, you're traveling and don't want a kit of bottles, or you've tried multi-bottle stacks before and stopped because the routine got unmanageable.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePick the multi-bottle stack if:\u003c\/strong\u003e you want maximum dose of any specific compound (e.g. 1000 mg NMN, 600 mg Resveratrol, 400 mg CoQ10), have specific goals (just metabolic health → Berberine; just skin → HA + collagen; just NAD+ ceiling → NMN 1000), or already know which pathways you want to push hardest.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOr both:\u003c\/strong\u003e some customers take this 5-in-1 as the daily baseline and add one or two single-ingredient products to push specific pathways harder. That's a reasonable middle path — the 5-in-1 covers the breadth, the standalone covers the depth where it matters most for their goal.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe dedicated single-ingredient products in our catalog:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e or \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg\u003c\/a\u003e — for maximum NAD+ precursor dose.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600 mg\u003c\/a\u003e — for sirtuin (SIRT1) activation. Not in this 5-in-1 formula.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400 mg Maximum Strength\u003c\/a\u003e — for high-dose mitochondrial support, especially on statins.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eLiposomal Vitamin C 1000 mg\u003c\/a\u003e — high-dose, high-absorption antioxidant.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/products\/hyaluronic-acid-200mg-vitamin-c-deep-skin-hydration-complex\"\u003eHA 200 mg + Vitamin C\u003c\/a\u003e — full trial-dose hydration support.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCalcium Alpha-Ketoglutarate 1000 mg (CaAKG)\u003c\/a\u003e — TCA-cycle substrate + epigenetic-clock cofactor (TET\/JmjC demethylases). Not in this 5-in-1.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine HCL 500 mg\u003c\/a\u003e — AMPK pathway, glucose metabolism. Not in this 5-in-1.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor a full picture of how to layer single-ingredient products on top of (or instead of) a one-bottle baseline, see our \u003ca href=\"\/he\/blogs\/news\/how-to-stack-longevity-supplements-a-practical-protocol-for-2026\"\u003eLongevity Stacking Protocol\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eWhere the 5-in-1 sits in the NAD+ family\u003c\/h2\u003e\n\u003cp\u003eThe NAD+ family in our catalog covers different parts of the NAD+ landscape. None of them are redundant — they each solve a different problem:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThis 5-in-1\u003c\/strong\u003e — NAD+ precursors plus the mitochondrial \/ antioxidant \/ collagen \/ skin systems they feed. \u003cem\u003eBest for people who want one bottle covering breadth.\u003c\/em\u003e\n\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePure NMN 500 mg\u003c\/strong\u003e — single-ingredient, dose-focused. \u003cem\u003eBest for trial-dose NMN at moderate strength.\u003c\/em\u003e\n\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNMN 1000 mg Double Strength\u003c\/strong\u003e — same compound, ceiling dose. \u003cem\u003eBest for the upper end of the published NMN dose-response curve.\u003c\/em\u003e\n\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNAD+ Daily Boost Capsules (Direct NAD+ + Trans-Resveratrol)\u003c\/strong\u003e — direct NAD+ molecule plus SIRT1 activator co-formulated. \u003cem\u003eBest for people who want NAD+ without going through the precursor pathway.\u003c\/em\u003e\n\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLiposomal NAD+ Ultimate 1000 mg\u003c\/strong\u003e — encapsulated for higher bioavailability. \u003cem\u003eBest for non-responders to standard NAD+ precursors.\u003c\/em\u003e\n\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLiquid NAD+ Anti-Aging Drink\u003c\/strong\u003e — drink-format, stick packets. \u003cem\u003eBest for capsule-fatigue or travel.\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eAdults 30+ wanting a comprehensive longevity-and-beauty baseline without research-paralysis.\u003c\/li\u003e\n  \u003cli\u003ePeople starting their first longevity protocol who want one product to take consistently before deciding what to add or replace.\u003c\/li\u003e\n  \u003cli\u003eAnyone whose previous attempts at multi-bottle stacks ended with most bottles sitting unused — format compliance is real, and three months of consistent breadth beats two weeks of \"perfect\" depth.\u003c\/li\u003e\n  \u003cli\u003eTravelers — single bottle covers most of the protocol when you're on the road.\u003c\/li\u003e\n  \u003cli\u003ePeople on statins (combined with our dedicated \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400 mg\u003c\/a\u003e if statin-induced CoQ10 depletion is a specific concern).\u003c\/li\u003e\n  \u003cli\u003ePeople in their 30s and 40s who want to build a longevity habit without committing to a 6-bottle daily routine before they know which pieces matter most for their body.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is NOT for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003ePeople who already know they need a maximum-dose single-ingredient — e.g. 1000 mg NMN for cycling around a known dose-response, or 400 mg CoQ10 specifically for statin-induced depletion. Pick the standalone instead.\u003c\/li\u003e\n  \u003cli\u003eAnyone with a known sensitivity to niacin flush — if you flush at 50 mg of niacin you'll feel the dose in this product. Niacinamide-only products avoid the flush; let us know if you want a redirect.\u003c\/li\u003e\n  \u003cli\u003ePregnant or breastfeeding women — limited safety data on combined longevity stacks during pregnancy. Consult your OB before starting.\u003c\/li\u003e\n  \u003cli\u003eAnyone on chemotherapy or being treated for cancer — discuss with your oncologist; some longevity pathways (sirtuin, AMPK, NAD+) interact in non-trivial ways with cancer biology and treatment timing.\u003c\/li\u003e\n  \u003cli\u003ePeople with known kidney or liver disease — review with your physician before any new supplement stack.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWeek-by-week — what to expect\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDays 1–14:\u003c\/strong\u003e usually subtle. Multiple pathways activating simultaneously builds gradually rather than dramatically. Don't expect a \"feel\" the first week — feel-effects are not how this category works.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 2–4:\u003c\/strong\u003e easier mornings, steadier afternoon energy, improved exercise recovery, nail strength often the first cosmetic signal (B-vitamins + collagen-synthesis cofactor compound).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 4–8:\u003c\/strong\u003e mental clarity, exercise recovery, hydration improvements compound. Skin tends to look more even by the 6-week mark.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 8–12:\u003c\/strong\u003e visible skin and hair improvements; sustained NAD+ and antioxidant support. The HA + Vitamin C + B-complex combination starts to show in skin texture around 8–12 weeks (matching the Proksch 2014 collagen-trial timeline + Kawada 2014 HA-trial timeline).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonths 3+:\u003c\/strong\u003e long-term anti-aging mechanisms compound with continued daily use. The NAD+ effect on energy and the collagen\/HA effect on skin both have a \"compound\" quality — the curve flattens but doesn't reverse if you keep taking it.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIf you stop:\u003c\/strong\u003e the NAD+ pool returns to baseline within 1–2 weeks (the salvage pathway is dynamic). Skin\/hair benefits regress over 8–12 weeks (the structural protein turnover timescale).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eStacking with this product\u003c\/h2\u003e\n\u003cp\u003eThe 5-in-1 is designed to be a complete daily baseline. If you want to push specific pathways harder while keeping the breadth, common add-ons are:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Resveratrol\u003c\/strong\u003e — for stronger sirtuin (SIRT1) activation. Resveratrol is the SIRT1 piece this 5-in-1 doesn't include. \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Berberine\u003c\/strong\u003e — if metabolic health is a goal (the AMPK pathway, not in this formula). Pairs naturally with NAD+ precursors. \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine HCL 500 mg Maximum Strength\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Marine Collagen\u003c\/strong\u003e — if you want stronger skin\/hair structural support beyond the synthesis cofactors. The Vitamin C in this 5-in-1 is the cofactor; marine peptides are the substrate. \u003ca href=\"\/he\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen 5000 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ TMG (Trimethylglycine)\u003c\/strong\u003e — methyl donor that recycles homocysteine. Worth considering if you're at the higher dose end of NMN\/NAD+ supplementation, since NAD+ metabolism uses methyl groups. \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ CaAKG\u003c\/strong\u003e — substrate for the TCA cycle and the epigenetic-clock demethylases (TET\/JmjC). The 5-in-1 covers the NAD+ pool and the cofactors; CaAKG covers the substrate side and the epigenetic-remodeling layer. \u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCalcium Alpha-Ketoglutarate 1000 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Apigenin\u003c\/strong\u003e — CD38 inhibitor that slows NAD+ degradation, complementing the precursor strategy in the 5-in-1. \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin 50 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Magnesium Glycinate\u003c\/strong\u003e — universal cofactor across \u0026gt;300 enzymatic reactions; deficiency is common and silently undermines the rest of the stack. \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400 mg\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eDirections\u003c\/h2\u003e\n\u003cp\u003eTake 2 capsules daily with breakfast. Several ingredients (Vitamin E, CoQ10) absorb materially better with meal fat — eggs, avocado, nut butter on toast, full-fat yogurt, olive oil on the salad all work. Daily consistency matters more than dose timing for this category — pick the time of day you're most likely to be reliable.\u003c\/p\u003e\n\u003cp\u003eFor more on supplement timing, see \u003ca href=\"\/he\/blogs\/news\/best-time-to-take-nmn-morning-empty-stomach-or-with-food\"\u003eour timing guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eWhat's in each capsule (per serving = 2 capsules)\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNAD+ precursor blend\u003c\/strong\u003e — NMN + Niacin (B3) at moderate breadth-formula doses (full per-ingredient amounts on the supplement-facts panel; no proprietary blends).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCoQ10 (Ubiquinone)\u003c\/strong\u003e — for electron transport chain support.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFull B-complex\u003c\/strong\u003e — B1 (Thiamine), B2 (Riboflavin), B5 (Pantothenic acid), B6 (Pyridoxal-5-phosphate \/ P5P), B12 (Methylcobalamin).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVitamin C\u003c\/strong\u003e — collagen-synthesis cofactor + antioxidant + Vitamin E recycling.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVitamin E\u003c\/strong\u003e — mixed tocopherols, lipid-membrane antioxidant.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHyaluronic Acid precursors\u003c\/strong\u003e — for skin-hydration support.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eVegetarian capsule (HPMC). No artificial colors, no proprietary blends, no fillers beyond the capsule shell. Third-party tested for purity.\u003c\/p\u003e\n\n\u003ch2\u003eQuality \u0026amp; sourcing\u003c\/h2\u003e\n\u003cp\u003eManufactured in cGMP-certified facilities. Third-party tested for heavy metals (lead, arsenic, cadmium, mercury), microbial limits, and active ingredient potency. Certificate of Analysis available on request. Store in a cool, dry place; keep the bottle sealed when not in use.\u003c\/p\u003e\n\n\u003ch2\u003eSafety \u0026amp; cautions\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNiacin flush:\u003c\/strong\u003e if you're flush-sensitive, take with food and start with 1 capsule for the first 3–5 days, scale to 2.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVitamin K-related anticoagulation:\u003c\/strong\u003e this formula does not contain Vitamin K, but if you're on warfarin, review any new supplement with your physician.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnancy \/ breastfeeding:\u003c\/strong\u003e not recommended without OB clearance — limited data on combined longevity stacks during pregnancy.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eActive cancer treatment:\u003c\/strong\u003e discuss with your oncologist before starting — sirtuin\/AMPK\/NAD+ pathways have non-trivial interactions with cancer biology and chemotherapy timing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eKidney or liver disease:\u003c\/strong\u003e review the full ingredient panel with your physician.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSurgery:\u003c\/strong\u003e stop 1–2 weeks before any planned surgery (precautionary; some longevity actives can affect bleeding or anesthesia metabolism).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDrug interactions:\u003c\/strong\u003e if you're on metformin, statins, blood thinners, blood-pressure medication, antidepressants, or chemotherapy, review with your physician.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy isn't Resveratrol in the formula?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eResveratrol is fat-soluble and benefits from a different formulation strategy (often piperine for absorption, oil delivery for bioavailability), and the dose-response data is strongest at 250–600 mg\/day — which is too large to fit alongside five other systems in two capsules. We kept Resveratrol as a dedicated standalone (\u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600 mg\u003c\/a\u003e) and built the 5-in-1 around the NAD+\/mitochondrial\/antioxidant\/collagen\/HA stack instead. Many customers take both — the 5-in-1 as the daily baseline, Resveratrol added on top for SIRT1 activation.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWill I still benefit from this if I'm already taking standalone NMN?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eYes, and there are two ways customers handle it. Option A: replace the standalone NMN with this 5-in-1 to consolidate. Option B: keep the standalone NMN for the higher dose ceiling and add this 5-in-1 for the breadth (CoQ10 + B-complex + antioxidants + collagen cofactor + HA). The B-vitamins, CoQ10, and HA in this product don't overlap with NMN's NAD+ precursor function — they cover entirely different systems.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy two capsules instead of one?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe five systems together require more material than will physically fit in one standard capsule shell. Splitting across two also gives slightly more even absorption across the meal window. Take both at once — you don't need to space them.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eHow does this compare to a multivitamin?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA standard multivitamin is built around recommended-daily-allowance (RDA) doses to prevent deficiency. This formula is built around longevity-and-beauty doses — NMN and CoQ10 are not in standard multivitamins, and the B-complex, Vitamin C, Vitamin E, and HA are at functional doses, not RDA-floor doses. A multivitamin and this 5-in-1 cover different problems; some customers take both.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take this with coffee?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eYes. Coffee doesn't materially impair absorption of any of the actives in this formula. Take with breakfast (the meal fat helps with the fat-soluble actives) and have your coffee with or after — whichever you prefer.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDoes this contain caffeine?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo. The \"easier mornings, steadier afternoon energy\" effect is from mitochondrial cofactors and NAD+ support, not stimulants. Customers often report that they cut their afternoon coffee 4–8 weeks in — that's a downstream signal, not a caffeine effect.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eHow long until I see something?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFor energy and morning quality: typically 2–4 weeks. For nail and hair: 4–8 weeks. For visible skin texture: 8–12 weeks (this matches the published collagen-trial and HA-trial timelines — Proksch 2014, Kawada 2014). Longevity actives (NAD+ pool, mitochondrial cofactors) work silently for the first month before downstream effects compound.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I open the capsules and put the powder in a smoothie?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNot recommended. Some of the actives (Vitamin E, NMN, CoQ10) degrade in the presence of light and oxygen — the capsule shell is part of the delivery design. Take the capsules whole.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIs this vegan?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe capsule shell is vegetarian (HPMC, plant-derived). Confirm the full active panel against your dietary needs — full ingredient list is on the supplement-facts panel.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat about cycling — should I take breaks?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe published longevity-trial protocols mostly use continuous daily dosing without cycling. There's no evidence cycling helps. The longevity benefits come from sustained signaling, not pulsed signaling — keep it daily and consistent.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan men take this?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eYes. Despite the skin\/hair language being more often associated with women's products, all five systems in this formula apply to male physiology in the same way — NAD+ decline, mitochondrial decline, antioxidant balance, collagen synthesis (joints, tendons, skin), and HA loss are universal aging biology.\u003c\/p\u003e\n\n\u003ch2\u003eRead more\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/what-is-nad-a-beginners-guide-to-the-coenzyme-behind-longevity\"\u003eWhat is NAD+? A beginner's guide to the coenzyme behind longevity\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNMN vs NR — which NAD+ precursor actually works better?\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/best-time-to-take-nmn-morning-empty-stomach-or-with-food\"\u003eWhen to take NMN — timing \u0026amp; absorption guide\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/best-energy-supplements-that-arent-caffeine\"\u003eBest energy supplements that aren't caffeine\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/how-to-stack-longevity-supplements-a-practical-protocol-for-2026\"\u003eHow to stack longevity supplements — practical protocol for 2026\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/pages\/protocols\"\u003eTrue Health Protocols (Cellular Longevity, Beauty \u0026amp; Skin, Fertility, etc.)\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cem\u003eBrowse the full NAD+ Family: \u003ca href=\"\/he\/collections\/nad-family\"\u003e\/collections\/nad-family\u003c\/a\u003e · Browse Longevity Essentials: \u003ca href=\"\/he\/collections\/longevity-essentials\"\u003e\/collections\/longevity-essentials\u003c\/a\u003e\u003c\/em\u003e\u003c\/p\u003e\n\n\u003cp\u003e\u003cem\u003eThis product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. Consult your physician before starting any supplement, especially if you take prescription medication, are pregnant or breastfeeding, or have a medical condition.\u003c\/em\u003e\u003c\/p\u003e","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47698106974426,"sku":"THP-NAD-5IN1","price":24.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp-nad-5in1.jpg?v=1775666078"},{"product_id":"zoone-nad-1000mg-pure-focus-formula","title":"NAD+ 1000mg Pure Focus Formula | NR + Resveratrol + PQQ + Quercetin Daily Drink Mix","description":"\u003cp\u003e\u003cstrong\u003eThe 4-ingredient morning longevity drink — Nicotinamide Riboside, Trans-Resveratrol, PQQ, and Quercetin Phytosome in a single berry packet.\u003c\/strong\u003e One stick replaces four bottles for the people who already know what's in a longevity stack and just want the fastest way to actually take it every day. NR raises the precursor pool, resveratrol activates the sirtuins that \u003cem\u003euse\u003c\/em\u003e NAD+, PQQ multiplies the mitochondria where NAD+ does its work, and phytosome-bound quercetin shields the existing pool from CD38 — the four-lever protocol that the precursor-only category misses.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNAD+ raised, not just a precursor delivered.\u003c\/strong\u003e 300 mg of Nicotinamide Riboside (NR) per packet — the most-researched NAD+ precursor on the market with 65+ registered human trials and a single-dose 2.7× whole-blood NAD+ increase in healthy adults (Trammell 2016, \u003cem\u003eNat Commun\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThe sirtuin partner is included.\u003c\/strong\u003e Trans-Resveratrol activates SIRT1 — the longevity enzyme that \u003cem\u003euses\u003c\/em\u003e NAD+. Without it, raised NAD+ has fewer enzymes putting it to work (Howitz 2003, \u003cem\u003eNature\u003c\/em\u003e; Park 2012, \u003cem\u003eCell\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMitochondrial biogenesis kicker.\u003c\/strong\u003e 10 mg PQQ — clinically shown to increase mitochondrial number via PGC-1α \/ NRF1 \/ TFAM activation (Chowanadisai 2010, \u003cem\u003eJBC\u003c\/em\u003e; Hwang 2018).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCD38 inhibitor + senolytic in one.\u003c\/strong\u003e 250 mg Quercetin Phytosome (Quercefit) — phospholipid-bound for ~20× the bioavailability of standard quercetin (Riva 2019), with senolytic activity in the Mayo Clinic Dasatinib + Quercetin protocol (Justice 2019) and CD38 inhibition that protects the NAD+ pool (Escande 2013).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOne packet, one minute, no capsules.\u003c\/strong\u003e Mix in 7–10 oz of cool water. Berry flavor, no aftertaste, no four bottles cluttering your counter, no stack abandonment after week three.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDose-disclosed label, no proprietary blends.\u003c\/strong\u003e Every active ingredient prints its mg dose. No hidden fillers, no titanium dioxide, no soy, no GMO, no gluten — and no capsule shells at all.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhy these four ingredients ended up in one packet\u003c\/h2\u003e\n\u003cp\u003eNAD+ doesn't decline because the body forgot how to make it. It declines because (1) salvage-pathway precursors get used up faster than they're rebuilt, (2) the enzymes that \u003cem\u003econsume\u003c\/em\u003e NAD+ — sirtuins, PARPs, and especially \u003cstrong\u003eCD38\u003c\/strong\u003e — speed up with age and inflammation, and (3) the mitochondria that depend on NAD+ get fewer and less efficient. Massudi's landmark 2012 \u003cem\u003ePLoS ONE\u003c\/em\u003e human skin biopsy series put numbers on it: NAD+ falls roughly 50% between ages 30 and 70. A precursor on its own only addresses one of those three mechanisms.\u003c\/p\u003e\n\u003cp\u003eThis formula was built backward from the failure modes of single-ingredient stacks:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNR\u003c\/strong\u003e rebuilds the precursor pool. It bypasses the rate-limiting NAMPT step that's required for the standard nicotinamide → NMN → NAD+ salvage pathway, and converts cleanly through NRK1\/NRK2 in two enzymatic steps (Trammell 2016).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTrans-Resveratrol\u003c\/strong\u003e activates the sirtuins that need NAD+ to function. SIRT1 is the gatekeeper of the longevity program — without sirtuin demand, more NAD+ doesn't translate into more longevity signaling, just more substrate that gets shunted to other consumers (Howitz 2003; Lagouge 2006, \u003cem\u003eCell\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePQQ\u003c\/strong\u003e increases mitochondrial number through PGC-1α activation, so the larger NAD+ pool has more places to do useful work — turning a precursor that would otherwise be wasted into actual ATP and signaling currency (Chowanadisai 2010).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eQuercetin Phytosome\u003c\/strong\u003e reduces inflammatory CD38 activity (CD38 is a major NAD+ \u003cem\u003econsumer\u003c\/em\u003e that rises with age — Camacho-Pereira 2016, \u003cem\u003eCell Metab\u003c\/em\u003e) and adds senolytic clearance of the \"zombie\" cells that drive inflammation in the first place (Justice 2019, \u003cem\u003eEBioMedicine\u003c\/em\u003e; Yousefzadeh 2018, \u003cem\u003eEBioMedicine\u003c\/em\u003e).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eYou can buy these four ingredients in four separate bottles. Most people start, take them inconsistently because four-bottle protocols have a 35-second compliance cost every morning, and stop somewhere between weeks 4 and 8. A single morning drink solves the compliance problem that kills the majority of supplement protocols before they reach the timeline at which the underlying pharmacology actually matters.\u003c\/p\u003e\n\n\u003ch2\u003eWhat's in each packet (dose-disclosed, no proprietary blends)\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNicotinamide Riboside (NR) — 300 mg.\u003c\/strong\u003e A B3 vitamin form that bypasses NAMPT and converts to NMN → NAD+ in two enzymatic steps via NRK1\/NRK2. The Trammell 2016 trial in \u003cem\u003eNature Communications\u003c\/em\u003e showed a single 300 mg oral dose raised whole-blood NAD+ by ~2.7× within 8 hours in healthy adults. Subsequent trials (Martens 2018, \u003cem\u003eNat Commun\u003c\/em\u003e; Dollerup 2018, \u003cem\u003eAm J Clin Nutr\u003c\/em\u003e; Conze 2019, \u003cem\u003eSci Rep\u003c\/em\u003e) confirmed sustained elevation with daily dosing across 6–12 week protocols, with no rebound after washout.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTrans-Resveratrol — 150 mg.\u003c\/strong\u003e The bioactive trans-isomer, not the cheaper \u003cem\u003ecis\u003c\/em\u003e form sold in many products. Activates SIRT1 directly (Howitz 2003) and triggers PGC-1α-mediated mitochondrial biogenesis through the same molecular pathway as caloric restriction (Lagouge 2006). The Sinclair lab's pairing logic is explicit: an NAD+ precursor + a sirtuin activator do more together than either alone, because the precursor has nowhere productive to go without the enzyme that consumes it for longevity work.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePQQ (Pyrroloquinoline Quinone, 99% pure) — 10 mg.\u003c\/strong\u003e A redox cofactor that signals through CREB → PGC-1α → NRF1\/NRF2 → TFAM → mitochondrial biogenesis (Chowanadisai 2010). It also crosses the blood-brain barrier; small human trials (Nakano 2012, \u003cem\u003eFFHD\u003c\/em\u003e; Itoh 2016, \u003cem\u003eAdv Exp Med Biol\u003c\/em\u003e) show improvements in cognitive performance, sleep quality (especially deep-sleep duration), and reduced inflammatory markers (CRP, IL-6) at 10–20 mg daily across 8–12 week protocols.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eQuercetin Phytosome (Quercefit®) — 250 mg.\u003c\/strong\u003e Phospholipid-bound quercetin with ~20× the plasma bioavailability of standard quercetin (Riva 2019, \u003cem\u003eEur Rev Med Pharmacol Sci\u003c\/em\u003e). Two roles in this formula: (1) \u003cem\u003esenolytic\u003c\/em\u003e — partners with dasatinib in the Mayo Clinic clearance protocol (Justice 2019) and is being studied as a standalone senolytic; (2) \u003cem\u003eCD38 inhibitor\u003c\/em\u003e — reduces age-related NAD+ consumption (Escande 2013, \u003cem\u003eDiabetes\u003c\/em\u003e), so the NR you just took has a longer functional half-life inside the cell.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eThe bioavailability problem (and how the formula solves it)\u003c\/h2\u003e\n\u003cp\u003eMost longevity supplements fail in the gut, not in the cell. Three of the four actives in this formula are notoriously hard to absorb in their bulk-powder form, which is why dose-on-the-label and dose-in-the-blood are very different numbers for off-the-shelf products:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNR — high absolute bioavailability, but rate-limited by transport.\u003c\/strong\u003e NR uses NRK1\/NRK2 transporters and is well-absorbed at the 300 mg single-dose tier (Trammell 2016, AUC and Cmax data published in supplementary materials). Above ~600 mg per dose the response curve flattens — the rate-limiting step shifts from absorption to enzymatic conversion. 300 mg is on the steep part of the curve and is the dose used in the foundational human trials.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTrans-Resveratrol — \u0026lt;1% oral bioavailability without enhancement.\u003c\/strong\u003e Resveratrol is heavily glucuronidated and sulfated in the gut wall and liver (Walle 2004, \u003cem\u003eDrug Metab Dispos\u003c\/em\u003e). The plasma half-life of free resveratrol is roughly 9 minutes — the pharmacokinetics that historically embarrassed the resveratrol literature. The drink-mix delivery format starts oral-mucosa absorption immediately, bypassing some of the first-pass metabolism that hammers capsule-form resveratrol, and the 150 mg trans dose is calibrated against the metabolite-corrected exposure data that actually correlates with sirtuin activation in humans (Brown 2010, \u003cem\u003eCancer Res\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePQQ — small molecule, well-absorbed.\u003c\/strong\u003e 10 mg is the dose that hit clinical endpoints in the published cognitive-performance and sleep-quality trials (Nakano 2012; Itoh 2016).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eQuercetin — ~5% bioavailable as free aglycone, ~100% as phytosome.\u003c\/strong\u003e Standard quercetin is one of the worst-bioavailable flavonoids in the supplement world. The phytosome (phospholipid-complex) form binds the molecule to phosphatidylcholine, which carries it across the enterocyte membrane via a passive route that doesn't depend on the limited active-uptake transporters. Riva 2019 showed ~20× the plasma AUC vs. equivalent free quercetin doses. 250 mg of Quercefit phytosome is bioequivalent to roughly 5,000 mg of bulk-powder quercetin — which is how a \"small\" dose on the label translates into a senolytic-relevant exposure inside the cell.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eNet effect: every milligram on the label is a milligram that actually enters circulation, which is the reason the four-ingredient stack can fit in a single 5-gram packet without sacrificing the doses that drove the underlying clinical evidence.\u003c\/p\u003e\n\n\u003ch2\u003eThe 9 hallmarks of aging — what this drink covers\u003c\/h2\u003e\n\u003cp\u003eLópez-Otín's 2013 \/ 2023 hallmarks-of-aging framework (\u003cem\u003eCell\u003c\/em\u003e) is the standard taxonomy for what changes during biological aging. This single packet directly addresses four of the nine, plus partial coverage of two more:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMitochondrial dysfunction\u003c\/strong\u003e — PQQ + NR (substrate + biogenesis).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDeregulated nutrient sensing\u003c\/strong\u003e — Resveratrol activates SIRT1, the central sensor downstream of the AMPK \/ mTOR \/ sirtuin triangle.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCellular senescence\u003c\/strong\u003e — Quercetin Phytosome (Mayo Clinic D+Q protocol).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eChronic inflammation (\"inflammaging\")\u003c\/strong\u003e — Quercetin + PQQ both lower CRP\/IL-6 in their respective trials.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLoss of proteostasis\u003c\/strong\u003e (partial) — Resveratrol triggers some autophagy via SIRT1 → mTOR-independent pathways, though the autophagy specialist in the catalog is \u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine 10 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStem cell exhaustion\u003c\/strong\u003e (partial) — Restoring NAD+ has been shown to rescue muscle-stem-cell function in murine models (Zhang 2016, \u003cem\u003eScience\u003c\/em\u003e); human translation is still in early trials.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe remaining hallmarks (genomic instability, telomere attrition, epigenetic alterations, altered intercellular communication, disabled macroautophagy, dysbiosis) are outside the scope of any single supplement — they require lifestyle inputs (sleep, exercise, dietary fiber) and, where relevant, specific products like CaAKG, fisetin, glycine + NAC, or omega-3.\u003c\/p\u003e\n\n\u003ch2\u003eWhat's in each packet\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eNicotinamide Riboside (NR) — 300 mg\u003c\/li\u003e\n  \u003cli\u003eTrans-Resveratrol — 150 mg\u003c\/li\u003e\n  \u003cli\u003ePQQ (Pyrroloquinoline Quinone) — 10 mg\u003c\/li\u003e\n  \u003cli\u003eQuercetin Phytosome (Quercefit®) — 250 mg\u003c\/li\u003e\n  \u003cli\u003eNatural berry flavor, citric acid, stevia leaf extract\u003c\/li\u003e\n  \u003cli\u003eNet weight ~5 g per stick pack, \u0026lt;5 calories, no added sugar\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e30 stick packs per box = 30-day supply at one-per-day.\u003c\/p\u003e\n\n\u003ch2\u003eThe drink-vs-capsule trade-off, honestly\u003c\/h2\u003e\n\u003cp\u003eWe sell both. Here's the actual difference, not the marketing version:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDrink wins on compliance.\u003c\/strong\u003e If you don't enjoy swallowing 4–8 capsules every morning, the packet is the version you'll actually finish for 90 days. Compliance is the variable that explains 80% of the variance in real-world supplement outcomes — pharmacology that you don't take every day is pharmacology that doesn't work.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDrink wins on absorption window.\u003c\/strong\u003e Soluble delivery starts in the mouth and upper GI tract — no waiting on capsule shells to dissolve, no gastric-emptying lag for water-soluble actives. For resveratrol especially, oral-mucosa absorption captures a fraction of the dose before first-pass hepatic metabolism gets to it.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDrink wins on travel.\u003c\/strong\u003e Stick packs go in a carry-on. Four bottles do not. For frequent travelers, this is often the difference between staying on protocol and abandoning it for a week every business trip.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDrink wins on stack discipline.\u003c\/strong\u003e Four ingredients, one packet, taken at one moment. There's no \"I forgot the resveratrol\" or \"the PQQ ran out three weeks ago\" failure mode.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCapsules win on dose flexibility.\u003c\/strong\u003e Want 1000 mg NMN instead of 300 mg NR? Want to titrate resveratrol up or down on different days? Want to add 600 mg of NMN on workout days? Capsules give you that knob.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCapsules win on cost-per-dose.\u003c\/strong\u003e The bulk capsule version of this stack is cheaper if you're optimizing for price per mg, accepting the four-bottle compliance burden.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCapsules win on travel-volume.\u003c\/strong\u003e A single 60-count bottle holds 30 days of capsule stack at the smallest physical footprint, if you're truly weight-constrained.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIf you're choosing between this and our other NAD+ options, see \u003ca href=\"\/he\/blogs\/news\/nmn-vs-nad-which-should-you-take-in-2026\"\u003eNMN vs NAD+: which should you take in 2026\u003c\/a\u003e for the full breakdown.\u003c\/p\u003e\n\n\u003ch2\u003eWhere it fits in the longevity stack\u003c\/h2\u003e\n\u003cp\u003eThis drink covers four of the nine hallmarks of aging in one packet. To round out a complete protocol, the most-asked-about pairings (in order of clinical priority for most adults 35+):\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAdd a methyl donor.\u003c\/strong\u003e NR\/NMN methylation can deplete methyl groups over months — every NAD+ molecule consumed gets methylated to N-methyl-nicotinamide before excretion. \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000 mg\u003c\/a\u003e (trimethylglycine \/ betaine) replaces what's spent and is the single most-recommended addition for anyone taking NR or NMN longer than 90 days.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAdd a CD38 inhibitor.\u003c\/strong\u003e Quercetin in this formula already does some of this work. For people running a higher-dose stack or who care about maximizing intracellular NAD+ residence time, layering in \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin 50 mg + BioPerine\u003c\/a\u003e targets CD38 more directly — apigenin has a stronger CD38 IC50 than quercetin in vitro (Escande 2013).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAdd senolytic clearance.\u003c\/strong\u003e Quercetin gives partial clearance. \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin 500 mg\u003c\/a\u003e dosed monthly (Mayo Clinic-style: 2 days on, 28 days off) clears senescent cells more aggressively. Fisetin was the most-potent senolytic of 10 flavonoids tested head-to-head (Yousefzadeh 2018).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAdd the glutathione precursor pair.\u003c\/strong\u003e The GlyNAC protocol — \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500 mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC 600 mg\u003c\/a\u003e — restores glutathione synthesis, which independently lifts mitochondrial function (Sekhar 2021 Baylor trial). This is the most-evidence-backed addition outside the NAD+ family itself.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAdd foundational nutrients.\u003c\/strong\u003e \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3 5000 IU + K2 MK-7\u003c\/a\u003e, \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400 mg\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 2000 mg\u003c\/a\u003e are the substrate base every longevity stack runs on top of. Without them, the higher-tier compounds compound onto a deficiency rather than baseline.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWant maximum-bioavailability NAD+ instead?\u003c\/strong\u003e See \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+ Ultimate 1000 mg\u003c\/a\u003e — phospholipid-encapsulated NAD+ for direct cellular delivery without the precursor-conversion step.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWant the cheapest NMN entry point?\u003c\/strong\u003e Start with \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e capsules.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWant 1000 mg double-strength NMN?\u003c\/strong\u003e See \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg Double Strength\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWant NMN + Resveratrol with separate dose control?\u003c\/strong\u003e The \u003ca href=\"\/he\/products\/longevity-stack-bundle-nmn-500mg-resveratrol-600mg\"\u003eLongevity Stack Bundle\u003c\/a\u003e gives you both bottles at a discount.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWant the AMPK\/sirtuin sister molecule?\u003c\/strong\u003e \u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCaAKG 1000 mg\u003c\/a\u003e works on the parallel epigenetic-clock pathway (Brunet\/Conboy lab evidence).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWeek-by-week expectation timeline\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDays 1–7:\u003c\/strong\u003e Plasma NR rises within hours of the first packet (Trammell 2016 Cmax ~6 hours). Whole-blood NAD+ measurably higher within 24–48 hours. Most people don't yet notice anything subjectively.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 2–4:\u003c\/strong\u003e The first cohort of subjective reports — typically a \"morning lift\" of energy or mental clarity that feels like better sleep without sleeping more. This is downstream sirtuin signaling catching up to the new precursor pool, not the precursor itself.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 4–8:\u003c\/strong\u003e Mitochondrial biogenesis from PQQ becomes measurable (PGC-1α-induced new mitochondria take ~4 weeks to mature). Endurance\/recovery improvements often appear here for active users. CRP and IL-6 begin to drop in users who were elevated at baseline.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonths 2–6:\u003c\/strong\u003e The \"compounding window.\" Senolytic clearance from quercetin (slow, partial) starts to show in skin-quality and recovery markers. NAD+ levels continue to rise toward the new daily-dosing equilibrium.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eYear 1+:\u003c\/strong\u003e Bloodwork-readouts: hsCRP, IL-6, fasting insulin, HOMA-IR, and (for users who track it) DunedinPACE\/Horvath methylation age — the long-tail biomarkers that respond to sustained NAD+\/sirtuin\/senolytic stacking but never to a 30-day trial.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eAdults \u003cstrong\u003e35+\u003c\/strong\u003e already aware that NAD+ declines with age and looking for an all-in-one drink rather than four bottles\u003c\/li\u003e\n  \u003cli\u003ePeople who \u003cstrong\u003edon't enjoy swallowing capsules\u003c\/strong\u003e and have abandoned previous supplement protocols because of it\u003c\/li\u003e\n  \u003cli\u003eAnyone running a \u003cstrong\u003emorning ritual\u003c\/strong\u003e (coffee, water with electrolytes, lemon water) where adding a drink mix is friction-free\u003c\/li\u003e\n  \u003cli\u003eFrequent \u003cstrong\u003etravelers\u003c\/strong\u003e who need supplements in a carry-on without rattling bottles or TSA questions about powder containers\u003c\/li\u003e\n  \u003cli\u003eStack builders who want the \u003cstrong\u003eNR + Resveratrol + PQQ + Quercetin\u003c\/strong\u003e base in a single SKU and then layer additions (TMG, Apigenin, Fisetin, Spermidine) on top\u003c\/li\u003e\n  \u003cli\u003ePeople rebuilding after \u003cstrong\u003eburnout, post-illness, or post-surgery recovery\u003c\/strong\u003e who want the NAD+\/mitochondrial substrate in the easiest possible delivery format\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is NOT for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003ePeople with \u003cstrong\u003eactive cancer or recent cancer history\u003c\/strong\u003e — boosting NAD+ has a complex relationship with tumor metabolism; this is an oncologist conversation, not a supplement decision.\u003c\/li\u003e\n  \u003cli\u003ePeople on \u003cstrong\u003ewarfarin, clopidogrel, or DOACs\u003c\/strong\u003e — resveratrol's antiplatelet activity is mild but additive.\u003c\/li\u003e\n  \u003cli\u003ePeople scheduled for \u003cstrong\u003esurgery within 2 weeks\u003c\/strong\u003e — discontinue and restart 2 weeks post-op.\u003c\/li\u003e\n  \u003cli\u003ePeople who are \u003cstrong\u003epregnant or breastfeeding\u003c\/strong\u003e — none of these compounds are studied in pregnancy.\u003c\/li\u003e\n  \u003cli\u003ePeople with \u003cstrong\u003esevere stevia or berry allergies\u003c\/strong\u003e — see \"What's not in it\" below for the full ingredient list.\u003c\/li\u003e\n  \u003cli\u003ePeople who \u003cstrong\u003especifically want NMN, not NR\u003c\/strong\u003e — see \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e or \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg Double Strength\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eHow to take it\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eOne packet per day.\u003c\/strong\u003e Mix into 7–10 oz (200–300 ml) of cool water and stir until fully dissolved (~15 seconds). Best taken in the morning, ideally with breakfast — Resveratrol and PQQ both absorb better with some dietary fat. The berry flavor mixes clean with no aftertaste; some users add a squeeze of lemon, take it with a small handful of nuts, or drink it as a chaser to morning coffee.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEmpty-stomach dosing.\u003c\/strong\u003e Acceptable but not optimal — fat-soluble actives (resveratrol, PQQ at higher doses) absorb 1.5–3× better with fat. If you're a strict morning-faster, save the packet for your first meal.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eStacking timing.\u003c\/strong\u003e If you take other capsule-based supplements (TMG, Apigenin, Fisetin, NAC, Glycine), take them with the same meal. NR and Resveratrol do not need to be cycled in healthy adults — daily dosing is the protocol used in all the cited human trials.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDo not exceed one packet per day\u003c\/strong\u003e unless under medical supervision. Doubling the dose does not proportionally increase NAD+ above the saturation point of the NRK1\/NRK2 transport system.\u003c\/p\u003e\n\n\u003ch2\u003eWhat's not in it\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eNo artificial colors or sweeteners (sweetened with stevia leaf extract)\u003c\/li\u003e\n  \u003cli\u003eNo proprietary blends — every active ingredient is dose-disclosed on the label\u003c\/li\u003e\n  \u003cli\u003eNo added sugar (\u0026lt;5 calories per packet)\u003c\/li\u003e\n  \u003cli\u003eNo magnesium stearate, no titanium dioxide, no gelatin shells (no capsules at all)\u003c\/li\u003e\n  \u003cli\u003eNo GMOs, no gluten, no soy, no dairy\u003c\/li\u003e\n  \u003cli\u003eThird-party tested for purity, potency, heavy metals, and microbial contamination before each batch ships\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eImportant safety information\u003c\/h2\u003e\n\u003cp\u003eGenerally well-tolerated; the most-reported adverse events in NR trials are mild flushing or transient GI discomfort, both dose-dependent and typically resolving within the first 1–2 weeks of daily use. Specific cautions:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eActive cancer or recent cancer history.\u003c\/strong\u003e Boosting NAD+ has a complex relationship with tumor metabolism — some tumor types are NAD+-dependent. Discuss with your oncologist before starting.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eQuercetin and CYP3A4 \/ P-glycoprotein interactions.\u003c\/strong\u003e Quercetin can inhibit CYP3A4 and P-gp transporters and may interact with cyclosporine, certain statins (atorvastatin, simvastatin), some calcium channel blockers, and certain chemotherapeutics. If you take prescription medications metabolized by CYP3A4, check with your prescriber.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eResveratrol and blood thinners.\u003c\/strong\u003e Resveratrol has mild antiplatelet activity. If you take warfarin, clopidogrel, aspirin (daily-dose), or DOACs (apixaban, rivaroxaban, edoxaban, dabigatran), talk to your doctor before adding.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eResveratrol and estrogen-sensitive conditions.\u003c\/strong\u003e Resveratrol is a weak phytoestrogen (mixed agonist\/antagonist depending on tissue). Estrogen-receptor-positive cancer history, endometriosis, and certain fibroid presentations warrant a physician conversation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnancy \/ breastfeeding.\u003c\/strong\u003e Not studied. Avoid.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSurgery.\u003c\/strong\u003e Stop 1–2 weeks before any planned surgery and restart 2 weeks post-op (resveratrol's antiplatelet effect, quercetin's CYP interactions).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLiver enzyme elevations (theoretical).\u003c\/strong\u003e Reported in \u0026lt;1% of long-running resveratrol trial subjects; reverses on discontinuation. Anyone with existing liver disease should baseline LFTs before starting.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAllergies.\u003c\/strong\u003e Stevia, berry-flavor naturally-derived compounds. Check the full label if you have known reactivity to Asteraceae-family plants (chamomile, ragweed) — quercetin from rutin sources can cross-react in highly sensitive individuals.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eIs this NAD+ or a precursor?\u003c\/strong\u003e\u003cbr\u003e\nA precursor — NR. NAD+ itself is a large, charged molecule that's poorly absorbed orally (most of an oral NAD+ dose is degraded in the gut to nicotinamide before reaching circulation). NR is the precursor with the most human trial data showing it actually raises blood and tissue NAD+ levels (Trammell 2016; Martens 2018). If you specifically want NAD+ delivered as the intact molecule, see \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+ Ultimate 1000 mg\u003c\/a\u003e, which uses a phospholipid encapsulation to protect NAD+ through GI transit.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy NR instead of NMN?\u003c\/strong\u003e\u003cbr\u003e\nBoth work; the human trial evidence base is larger for NR (65+ registered trials vs ~12 for NMN as of 2026). NMN converts to NR before crossing cell membranes in most tissues anyway (the Slc12a8 transporter that lets NMN enter cells directly is highly expressed in the gut but limited elsewhere — Grozio 2019, \u003cem\u003eNat Metab\u003c\/em\u003e). We sell both — see our \u003ca href=\"\/he\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNMN vs NR comparison\u003c\/a\u003e for the trial-level breakdown.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eHow long until I notice anything?\u003c\/strong\u003e\u003cbr\u003e\nMost people report perceptible energy and focus changes in 2–6 weeks of daily use. Underlying NAD+ levels rise within hours of the first dose; the subjective effects lag because they reflect downstream sirtuin signaling and mitochondrial adaptation, not the precursor concentration itself. If you're in the no-effect bucket at week 8, the most-likely explanations are (a) you're already at adequate baseline NAD+, (b) you're missing a methyl donor (add TMG), or (c) the limiting factor in your case is sleep, exercise, or another upstream variable.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take this with coffee?\u003c\/strong\u003e\u003cbr\u003e\nYes. No known interactions with caffeine. Many users take the packet alongside their morning coffee — the slight tartness of the berry pairs cleanly. If you take electrolytes or creatine in your morning water, those also stack fine.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDo I need to cycle it?\u003c\/strong\u003e\u003cbr\u003e\nNo. The daily-dosing protocol is used in every cited human trial. People sometimes pulse senolytics (Fisetin 1–2 days\/month) but the NR \/ Resveratrol \/ PQQ base is taken daily without cycling. NR has not shown receptor-downregulation patterns at the doses studied.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWill it interact with my morning fast?\u003c\/strong\u003e\u003cbr\u003e\nThe packet contains a small amount of natural berry flavoring and a few calories (\u0026lt;5 kcal). If you're doing strict water-only fasting, take it with your first meal instead of in your fasting window. For more permissive fasting protocols (16:8 with electrolytes), the packet's caloric load is below the typical \"broke the fast\" threshold.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy is the resveratrol \"only\" 150 mg when other products use 500 mg?\u003c\/strong\u003e\u003cbr\u003e\nBioavailability. Resveratrol has \u0026lt;1% oral bioavailability without enhancement — most of the 500 mg in standalone capsules is metabolized by the gut wall and liver before reaching circulation. The drink-mix delivery captures a fraction of the dose at the oral mucosa, and the formula is calibrated against metabolite-corrected exposure data, not raw label dose. If you want more, layer in \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600 mg\u003c\/a\u003e separately.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy is the quercetin \"only\" 250 mg when other products use 500–1000 mg?\u003c\/strong\u003e\u003cbr\u003e\nPhytosome bioavailability. 250 mg of Quercefit phytosome is bioequivalent to ~5,000 mg of bulk-powder quercetin (Riva 2019). The label dose is lower; the absorbed dose is comparable to or higher than the bulk-powder competitors at 4× the label dose.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDo I still need TMG with this product?\u003c\/strong\u003e\u003cbr\u003e\nRecommended if you're taking it longer than 90 days or stacking with additional NMN\/NR. NAD+ catabolism produces methylated end-products that draw down the body's methyl-group pool. TMG (trimethylglycine, also called betaine) is the most-direct methyl-donor replenishment. See \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000 mg\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take more than one packet per day?\u003c\/strong\u003e\u003cbr\u003e\nNot recommended without medical supervision. The 300 mg NR dose is on the steep part of the dose-response curve; doubling the dose does not double the NAD+ rise, and adds resveratrol's antiplatelet load without proportional benefit.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I open the packet and mix it into a smoothie or coffee?\u003c\/strong\u003e\u003cbr\u003e\nCold or room-temperature smoothies, yes. Hot coffee, no — high temperatures degrade NR (it's heat-sensitive). Iced coffee is fine.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIs this dropshipped or stocked?\u003c\/strong\u003e\u003cbr\u003e\nWe work with a small number of vetted manufacturers who hold the inventory and ship direct. This keeps prices low and ensures you receive recently-manufactured product (typically 30–90 days from manufacture date) rather than warehouse stock approaching expiry. Each batch ships with a Certificate of Analysis on file.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat if it doesn't work for me?\u003c\/strong\u003e\u003cbr\u003e\n30-day money-back guarantee on the first bottle. See our \u003ca href=\"\/he\/pages\/guarantee\"\u003eguarantee page\u003c\/a\u003e for details.\u003c\/p\u003e\n\n\u003ch2\u003eThe science (selected references)\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eTrammell SAJ et al. \u003cem\u003eNicotinamide riboside is uniquely and orally bioavailable in mice and humans.\u003c\/em\u003e Nat Commun. 2016;7:12948.\u003c\/li\u003e\n  \u003cli\u003eMartens CR et al. \u003cem\u003eChronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults.\u003c\/em\u003e Nat Commun. 2018;9:1286.\u003c\/li\u003e\n  \u003cli\u003eDollerup OL et al. \u003cem\u003eA randomized placebo-controlled clinical trial of nicotinamide riboside in obese men.\u003c\/em\u003e Am J Clin Nutr. 2018;108:343–353.\u003c\/li\u003e\n  \u003cli\u003eConze D et al. \u003cem\u003eSafety and metabolism of long-term administration of NIAGEN.\u003c\/em\u003e Sci Rep. 2019;9:9772.\u003c\/li\u003e\n  \u003cli\u003eHowitz KT et al. \u003cem\u003eSmall molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan.\u003c\/em\u003e Nature. 2003;425:191–196.\u003c\/li\u003e\n  \u003cli\u003eLagouge M et al. \u003cem\u003eResveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α.\u003c\/em\u003e Cell. 2006;127:1109–1122.\u003c\/li\u003e\n  \u003cli\u003ePark SJ et al. \u003cem\u003eResveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases.\u003c\/em\u003e Cell. 2012;148:421–433.\u003c\/li\u003e\n  \u003cli\u003eBrown VA et al. \u003cem\u003eRepeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers.\u003c\/em\u003e Cancer Res. 2010;70:9003–9011.\u003c\/li\u003e\n  \u003cli\u003eWalle T et al. \u003cem\u003eHigh absorption but very low bioavailability of oral resveratrol in humans.\u003c\/em\u003e Drug Metab Dispos. 2004;32:1377–1382.\u003c\/li\u003e\n  \u003cli\u003eChowanadisai W et al. \u003cem\u003ePyrroloquinoline quinone stimulates mitochondrial biogenesis through cAMP response element-binding protein phosphorylation and PGC-1α expression.\u003c\/em\u003e J Biol Chem. 2010;285:142–152.\u003c\/li\u003e\n  \u003cli\u003eNakano M et al. \u003cem\u003eEffects of oral supplementation with pyrroloquinoline quinone on stress, fatigue, and sleep.\u003c\/em\u003e Functional Foods in Health and Disease. 2012;2:307–324.\u003c\/li\u003e\n  \u003cli\u003eItoh Y et al. \u003cem\u003eEffect of the antioxidant supplement pyrroloquinoline quinone disodium salt (BioPQQ) on cognitive functions.\u003c\/em\u003e Adv Exp Med Biol. 2016;876:319–325.\u003c\/li\u003e\n  \u003cli\u003eRiva A et al. \u003cem\u003eImproved oral absorption of quercetin from Quercetin Phytosome®, a new delivery system based on food grade lecithin.\u003c\/em\u003e Eur J Drug Metab Pharmacokinet. 2019;44:169–177.\u003c\/li\u003e\n  \u003cli\u003eJustice JN et al. \u003cem\u003eSenolytics in idiopathic pulmonary fibrosis: results from a first-in-human, open-label, pilot study.\u003c\/em\u003e EBioMedicine. 2019;40:554–563.\u003c\/li\u003e\n  \u003cli\u003eYousefzadeh MJ et al. \u003cem\u003eFisetin is a senotherapeutic that extends health and lifespan.\u003c\/em\u003e EBioMedicine. 2018;36:18–28.\u003c\/li\u003e\n  \u003cli\u003eCamacho-Pereira J et al. \u003cem\u003eCD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism.\u003c\/em\u003e Cell Metab. 2016;23:1127–1139.\u003c\/li\u003e\n  \u003cli\u003eEscande C et al. \u003cem\u003eFlavonoid apigenin is an inhibitor of the NAD+ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome.\u003c\/em\u003e Diabetes. 2013;62:1084–1093.\u003c\/li\u003e\n  \u003cli\u003eMassudi H et al. \u003cem\u003eAge-associated changes in oxidative stress and NAD+ metabolism in human tissue.\u003c\/em\u003e PLoS ONE. 2012;7:e42357.\u003c\/li\u003e\n  \u003cli\u003eGrozio A et al. \u003cem\u003eSlc12a8 is a nicotinamide mononucleotide transporter.\u003c\/em\u003e Nat Metab. 2019;1:47–57.\u003c\/li\u003e\n  \u003cli\u003eZhang H et al. \u003cem\u003eNAD+ repletion improves mitochondrial and stem cell function and enhances life span in mice.\u003c\/em\u003e Science. 2016;352:1436–1443.\u003c\/li\u003e\n  \u003cli\u003eLópez-Otín C et al. \u003cem\u003eHallmarks of aging: an expanding universe.\u003c\/em\u003e Cell. 2023;186:243–278.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eRead more on this topic\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/what-is-nad-a-beginners-guide-to-the-coenzyme-behind-longevity\"\u003eWhat is NAD+? A beginner's guide to the coenzyme behind longevity\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nmn-vs-nad-which-should-you-take-in-2026\"\u003eNMN vs NAD+: which should you take in 2026\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNMN vs NR: which NAD+ precursor actually works better\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/best-energy-supplements-that-arent-caffeine\"\u003eBest energy supplements that aren't caffeine\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/senolytics-how-to-clear-zombie-cells-with-fisetin-quercetin-and-spermidine\"\u003eSenolytics: how to clear zombie cells with Fisetin, Quercetin and Spermidine\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/mitochondrial-renewal-how-to-clear-damaged-mitochondria-and-build-new-ones\"\u003eMitochondrial Renewal: how to clear damaged mitochondria and build new ones\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/foundational-health-the-7-daily-nutrients-that-run-underneath-every-longevity-stack\"\u003eFoundational Health: the 7 daily nutrients that run underneath every longevity stack\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cem\u003eBrowse the full \u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD+ Family collection\u003c\/a\u003e for related products and stacks, or the \u003ca href=\"\/he\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal collection\u003c\/a\u003e for the PQQ-anchored protocols.\u003c\/em\u003e\u003c\/p\u003e\n\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eFDA disclaimer.\u003c\/strong\u003e This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. Consult your physician before starting any supplement, especially if you take prescription medication or have a medical condition.\u003c\/em\u003e\u003c\/p\u003e","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47698113691866,"sku":"THP-NAD-FOCUS-1000","price":22.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp-nad-focus.jpg?v=1775666113"},{"product_id":"rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging","title":"Nicotinamide Riboside (NR) Hard Capsules | Patented NAD+ Precursor with B-Vitamin Cofactors","description":"\u003cp\u003e\u003cstrong\u003eNicotinamide Riboside (NR) in hard capsule form\u003c\/strong\u003e — the patented NAD+ precursor with the deepest human research track record (65+ registered clinical trials, including pharmacokinetic, cardiovascular, and neurological endpoints). Supported by B-vitamin cofactors so the full NAD+ biosynthesis pathway has what it needs to convert NR into NAD+ inside the cell.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNR is the most-studied NAD+ precursor in humans.\u003c\/strong\u003e First-in-human pharmacokinetic data published in 2016 (Trammell et al., \u003cem\u003eNature Communications\u003c\/em\u003e) showed a single oral dose raised whole-blood NAD+ ~2.7× over 24 hours. Multi-week dosing at 1 g\/day has been studied in healthy adults, midlife adults with elevated blood pressure, obese insulin-resistant adults, post-menopausal women, NAFLD patients, ALS patients, and Parkinson's patients.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDifferent intracellular path than NMN.\u003c\/strong\u003e NR enters cells via the equilibrative nucleoside transporters (ENT1\/2), gets phosphorylated by NRK1\/NRK2 to NMN, then converted to NAD+. NMN uses the Slc12a8 transporter (Grozio 2019, \u003cem\u003eNature Metabolism\u003c\/em\u003e) and skips a step. Both raise NAD+; tissue coverage and intracellular kinetics differ, which is why many longevity stacks run both.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBest for:\u003c\/strong\u003e people who want the longest human-research track record, those who didn't feel a clear shift on NMN alone, anyone running a comprehensive NAD+ stack that hedges across both precursor pathways, and adults 50+ where the NMN transporter Slc12a8 may be downregulated in some tissues.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTake 1–2 capsules daily\u003c\/strong\u003e in the morning with food. Daily consistency matters more than time-of-day. Stacks cleanly with NMN, Resveratrol, Pterostilbene, TMG, Apigenin, Quercetin, Fisetin, CoQ10, PQQ, and Urolithin A.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePatented NR form,\u003c\/strong\u003e the same molecule used in Trammell 2016, Martens 2018, Dollerup 2018, Conze 2019, Elhassan 2019, and Brakedal 2022. Manufactured to cGMP, third-party HPLC-tested, encapsulated in a vegan-compatible hard shell with no proprietary blends, no titanium dioxide, no artificial colors.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhy NR sits at the center of the NAD+ conversation\u003c\/h2\u003e\n\u003cp\u003eNAD+ (nicotinamide adenine dinucleotide) is the single most metabolically expensive coenzyme in the cell. Every major energy-producing pathway — glycolysis, the citric acid cycle, the electron transport chain, fatty-acid oxidation — runs on NAD+\/NADH cycling. On top of that core role, NAD+ is the rate-limiting substrate for at least three enzyme families that get talked about in the longevity literature constantly: the sirtuins (SIRT1–SIRT7, the histone-deacetylase \/ mitochondrial regulators activated by Resveratrol), the PARPs (PARP1 in particular, the primary single-strand DNA break repair enzyme), and CD38 (the NAD+ glycohydrolase that becomes hyperactive with inflammaging). When NAD+ falls, all three of those families slow down at the same time — and that simultaneity is why \"NAD+ decline\" gets called a hallmark of aging in the López-Otín 2013 \/ 2023 \u003cem\u003eCell\u003c\/em\u003e framework, even though it isn't formally one of the 12.\u003c\/p\u003e\n\u003cp\u003eThe decline itself is not subtle. Massudi 2012 (\u003cem\u003ePLOS One\u003c\/em\u003e) measured skin NAD+ across the lifespan and found a roughly 50% drop between ages 20 and 60. Camacho-Pereira 2016 (\u003cem\u003eCell Metabolism\u003c\/em\u003e) replicated the finding in muscle and liver and showed CD38 — which consumes NAD+ to make calcium-mobilizing second messengers — rises sharply with age, partially explaining the drop. Yoshino 2011 (\u003cem\u003eCell Metabolism\u003c\/em\u003e) showed similar declines in pancreas, adipose tissue, and the hypothalamus in mice. Across tissues, mechanisms, and species, the NAD+ pool collapses with age — and the sirtuin \/ PARP \/ CD38 enzymes that depend on it lose their substrate.\u003c\/p\u003e\n\u003cp\u003eYou can address that decline from three directions:\u003c\/p\u003e\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSupply more precursor\u003c\/strong\u003e — give the cell more raw material to make NAD+ from. \u003cstrong\u003eNR and NMN\u003c\/strong\u003e are the two patented, trial-validated levers in this category. Niacin (NA) and niacinamide (NAM) also raise NAD+ but flush, suppress sirtuins at high doses, and lack the modern human evidence base.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eReduce NAD+ consumers\u003c\/strong\u003e — slow down the enzymes that destroy it. \u003cstrong\u003eApigenin\u003c\/strong\u003e inhibits CD38 directly. \u003cstrong\u003eQuercetin\u003c\/strong\u003e and \u003cstrong\u003eFisetin\u003c\/strong\u003e clear senescent cells, which overconsume NAD+ via SASP-driven CD38 expression in neighboring cells.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eActivate the enzymes that use NAD+ productively\u003c\/strong\u003e — get more longevity output per unit of NAD+. \u003cstrong\u003eResveratrol\u003c\/strong\u003e and \u003cstrong\u003ePterostilbene\u003c\/strong\u003e activate SIRT1; \u003cstrong\u003espermidine\u003c\/strong\u003e activates the autophagy machinery that sirtuins help regulate.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003eNR is the most-validated supply-side lever in humans, and it pairs cleanly with all three of the other strategies. That is why it lives in almost every well-designed longevity stack.\u003c\/p\u003e\n\n\u003ch2\u003eMechanism — what NR actually does inside the cell\u003c\/h2\u003e\n\n\u003ch3\u003e1. The NRK1\/NRK2 phosphorylation pathway\u003c\/h3\u003e\n\u003cp\u003eNR is a riboside — a vitamin B3 (nicotinamide) attached to a ribose sugar without a phosphate group. That structure matters for two reasons. First, it is the only NAD+ precursor that crosses the plasma membrane intact via a well-characterized transporter family: the equilibrative nucleoside transporters ENT1 and ENT2, which are present in essentially every tissue type (Bieganowski \u0026amp; Brenner 2004, \u003cem\u003eCell\u003c\/em\u003e). Second, once inside the cell, it gets phosphorylated to NMN by NRK1 (nicotinamide riboside kinase 1) or NRK2. NRK1 is the housekeeping enzyme — broadly distributed, induced by NAD+ depletion, and the rate-limiting step that determines how much NR actually becomes NAD+ in any given tissue (Ratajczak 2016, \u003cem\u003eNat Commun\u003c\/em\u003e).\u003c\/p\u003e\n\u003cp\u003eFrom NMN, the route is canonical: NMNAT1\/2\/3 (nicotinamide mononucleotide adenylyltransferase) attaches the AMP moiety to make NAD+. NMNAT1 lives in the nucleus, NMNAT2 in the cytoplasm and Golgi, NMNAT3 in the mitochondrial matrix. That compartmentalization matters — NMNAT3 is the enzyme that decides how much of your NAD+ pool is mitochondrial, which is why mitochondrial sirtuins (SIRT3\/4\/5) and mitochondrial NAD+\/NADH cycling depend on getting precursor across the inner membrane. NR's ribose-only structure means it can be phosphorylated in any compartment that has NRK1\/2, including the mitochondrion via the SLC25A51 mitochondrial NAD+ transporter that was characterized in 2020 (Luongo, \u003cem\u003eNature\u003c\/em\u003e).\u003c\/p\u003e\n\u003cp\u003eThat two-step intracellular path (NR → NMN → NAD+) is one step longer than the NMN route but uses ubiquitous, redundant machinery (ENT1\/2, NRK1\/NRK2), which is why NR's tissue coverage is broad even when local Slc12a8 (the NMN transporter) is low.\u003c\/p\u003e\n\n\u003ch3\u003e2. Sirtuin substrate, PARP cofactor, and CD38 substrate — the three NAD+ sinks\u003c\/h3\u003e\n\u003cp\u003eOnce converted to NAD+, the molecule is consumed (not just used and recycled) by three enzyme families:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSirtuins (SIRT1–SIRT7).\u003c\/strong\u003e NAD+-dependent deacetylases. SIRT1 in the nucleus deacetylates p53, FOXO, PGC-1α, and the histone tails that regulate metabolic, DNA-repair, and longevity gene programs. SIRT3 in the mitochondrion deacetylates the fatty-acid oxidation, urea-cycle, and ROS-detoxification machinery. SIRT6 stabilizes telomeres and regulates DNA double-strand break repair. Every catalytic cycle consumes one NAD+ and produces nicotinamide as a byproduct. The \"salvage pathway\" recycles that nicotinamide, but only at the rate set by NAMPT — which is why precursor supply (NR\/NMN) matters even when salvage is intact.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePARP1 (and PARP2).\u003c\/strong\u003e Poly-ADP-ribose polymerases. The primary single-strand DNA break repair enzyme attaches long chains of ADP-ribose to chromatin proteins at sites of damage, recruiting the repair machinery. Each chain consumes 50–200+ NAD+ molecules. When DNA damage is high — oxidative stress, radiation, chemotherapy, chronic inflammation — PARP activity can crash the NAD+ pool acutely. Restoring precursor supply is the first-line metabolic countermeasure.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCD38.\u003c\/strong\u003e The NAD+ glycohydrolase that converts NAD+ to ADP-ribose \/ cyclic ADP-ribose for calcium signaling. CD38 expression rises with age and inflammation (Camacho-Pereira 2016) and contributes more to NAD+ decline in older tissue than any other enzyme. CD38 inhibition (Apigenin, Luteolin, 78c in animal studies) is the second supply-side strategy and pairs neatly with precursor supplementation.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eNR is the substrate at the start of that chain. Increase NR → increase NAD+ → increase the substrate available for sirtuin \/ PARP \/ CD38 activity. The decisive evidence that this happens in humans, not just cells in a dish, is the Trammell 2016 pharmacokinetic study and the trials that followed.\u003c\/p\u003e\n\n\u003ch3\u003e3. The cardiovascular and aortic-stiffness signal\u003c\/h3\u003e\n\u003cp\u003eMartens 2018 (\u003cem\u003eNature Communications\u003c\/em\u003e) gave 30 midlife and older adults with elevated systolic blood pressure (120–139 mmHg) NR 1 g\/day or placebo for 6 weeks in a randomized crossover. NR raised whole-blood NAD+ ~60% on average. In the elevated-BP subgroup, systolic BP fell ~10 mmHg vs placebo and aortic stiffness (measured by carotid-femoral pulse wave velocity) decreased — the same readouts that track with cardiovascular event risk in epidemiologic cohorts. The trial was small and short, but the magnitudes were large enough to motivate the multiple Phase III NR cardiovascular trials currently in registration. The mechanistic interpretation is sirtuin (SIRT1\/SIRT3)-mediated improvements in endothelial function and vascular smooth muscle bioenergetics — exactly what you would predict from the precursor-supply rationale.\u003c\/p\u003e\n\n\u003ch3\u003e4. The Parkinson's NADPARK signal\u003c\/h3\u003e\n\u003cp\u003eBrakedal 2022 (\u003cem\u003eCell Metabolism\u003c\/em\u003e) — the NADPARK trial — gave 30 newly diagnosed Parkinson's patients NR 1 g\/day or placebo for 30 days and measured cerebrospinal fluid (CSF) NAD+ via lumbar puncture and brain NAD+ via 31P-MRS. CSF and brain NAD+ rose, neuroinflammatory markers (IL-6, IL-8, several CSF cytokines) shifted favorably, and clinical motor scores showed mild but measurable improvements vs placebo. The trial was small and short, but it was the first human study to demonstrate that oral NR raises brain NAD+ — a finding that matters for the broader hypothesis that NAD+ decline contributes to multiple neurodegenerative disease processes. The follow-up NR-SAFE trial (Brakedal 2023, \u003cem\u003eNat Commun\u003c\/em\u003e) extended the dosing safely to 3 grams\/day for 4 weeks. Larger NR-PD trials are ongoing.\u003c\/p\u003e\n\n\u003ch3\u003e5. Inflammation, muscle, and the elderly cohort\u003c\/h3\u003e\n\u003cp\u003eElhassan 2019 (\u003cem\u003eCell Reports\u003c\/em\u003e) gave 12 healthy elderly adults (aged 70–80) NR 1 g\/day for 21 days. Muscle biopsies showed elevated NAD+ and elevated NADP+\/NADPH ratios (NADP+ is the phosphorylated form used by the antioxidant defense system). Circulating inflammatory cytokines (IL-6, IL-5, IL-2) decreased significantly. The trial established that NR's effect on muscle NAD+ is meaningful in the population that needs it most — the same population in whom CD38 expression is highest and NAD+ is lowest at baseline.\u003c\/p\u003e\n\n\u003ch3\u003e6. The 8-week dose-response in healthy overweight adults\u003c\/h3\u003e\n\u003cp\u003eConze 2019 (\u003cem\u003eScientific Reports\u003c\/em\u003e) randomized 140 healthy overweight adults to placebo, 100, 300, or 1000 mg\/day NR for 8 weeks. Whole-blood NAD+ rose dose-dependently — about 22% at 100 mg, 51% at 300 mg, and 142% at 1000 mg. Adverse events did not differ from placebo at any dose. The trial established the dose-response curve in a free-living healthy population and is the largest RCT to date in non-clinical adults. It is the basis for the 1 g\/day target dose used in subsequent cardiovascular and neurological studies.\u003c\/p\u003e\n\n\u003ch3\u003e7. Insulin sensitivity and metabolic readouts\u003c\/h3\u003e\n\u003cp\u003eDollerup 2018 (\u003cem\u003eAm J Clin Nutr\u003c\/em\u003e) gave 40 obese insulin-resistant men NR 2 g\/day or placebo for 12 weeks. NR raised whole-blood NAD+ but the primary insulin-sensitivity endpoint (hyperinsulinemic-euglycemic clamp) was not significantly improved at 12 weeks. The trial is often cited as a \"negative\" study, but the more accurate read is that 12 weeks at this dose did not move the specific insulin-sensitivity readout in this specific high-risk population. Other metabolic endpoints (body composition, hepatic fat by MRS) showed trends. Remie 2020 (\u003cem\u003eAm J Clin Nutr\u003c\/em\u003e) replicated the safety and NAD+ rise in another insulin-resistant cohort. The metabolic story for NR is more nuanced than the cardiovascular story; the trial-design lesson is that NAD+ rise is robust but downstream metabolic endpoints depend on cohort, baseline NAD+, and stacking strategy.\u003c\/p\u003e\n\n\u003ch3\u003e8. The methylation pool — why TMG eventually matters\u003c\/h3\u003e\n\u003cp\u003eEvery time NAD+ is consumed by a sirtuin, PARP, or CD38, it produces nicotinamide (NAM) as a byproduct. NAM is recycled through the salvage pathway by NAMPT — but a fraction is also methylated by NNMT (nicotinamide N-methyltransferase) into 1-methylnicotinamide (1-MNA) and excreted in urine. That methylation step uses S-adenosyl methionine (SAM), the universal methyl donor. Sustained high-dose NR or NMN therefore creates a small, ongoing draw on the methylation pool. For most users, dietary methyl donors (choline, betaine in beets, methylated B12 and folate from a multivitamin) cover the cost. For long-term high-dose use — and especially for users with MTHFR polymorphisms — adding \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG (trimethylglycine)\u003c\/a\u003e at 500–1000 mg\/day after 4+ weeks of daily NR\/NMN is the standard methylation-support move.\u003c\/p\u003e\n\n\u003ch3\u003e9. Why the included B-vitamin cofactors actually do something\u003c\/h3\u003e\n\u003cp\u003eThe salvage pathway uses B6 as a cofactor for nicotinamide phosphoribosyltransferase (NAMPT). The methylation cycle that disposes of excess nicotinamide via NNMT depends on B12 and folate as methyl-group donors. Including B6, B12, and folate in the capsule means the NR you absorb has the supporting cofactors it needs without pulling them from elsewhere in your metabolism. It is not a substitute for TMG at long-term high doses, but it is a sensible structural addition that closes the most common micronutrient gaps that limit NAD+ biosynthesis efficiency. Trammell 2016 noted that in healthy participants, 1MNA (the methylated excretion product) appeared in urine within hours of dosing — confirming the methylation route is active from the first dose.\u003c\/p\u003e\n\n\u003ch2\u003eNR vs NMN — the practical decision, with mechanism\u003c\/h2\u003e\n\u003cp\u003eBoth are NAD+ precursors. Both raise NAD+ in humans. The pathway is one step different, and the practical implications are usually small but worth understanding before you commit to a stack.\u003c\/p\u003e\n\n\u003ctable border=\"1\" cellpadding=\"8\" cellspacing=\"0\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eFactor\u003c\/th\u003e\n\u003cth\u003eNicotinamide Riboside (NR)\u003c\/th\u003e\n\u003cth\u003eNMN (β-NMN)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCell entry\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eENT1\/2 (broadly expressed nucleoside transporters; ubiquitous)\u003c\/td\u003e\n\u003ctd\u003eSlc12a8 (Grozio 2019); some tissue heterogeneity in expression\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eIntracellular path\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eNR → NMN (NRK1\/NRK2 phosphorylation) → NAD+ (NMNAT)\u003c\/td\u003e\n\u003ctd\u003eNMN → NAD+ (NMNAT) — one step shorter\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFirst-in-human PK\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eTrammell 2016, \u003cem\u003eNat Commun\u003c\/em\u003e — the foundational PK paper\u003c\/td\u003e\n\u003ctd\u003eIrie 2020, \u003cem\u003eEndocr J\u003c\/em\u003e — first PK; Yoshino 2021, \u003cem\u003eScience\u003c\/em\u003e first efficacy in pre-diabetic post-menopausal women\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCardiovascular RCT\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eMartens 2018, \u003cem\u003eNat Commun\u003c\/em\u003e — 6 weeks, BP and aortic stiffness signal\u003c\/td\u003e\n\u003ctd\u003eSmaller human cardiovascular evidence base to date\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eBrain \/ CSF NAD+\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eBrakedal 2022, \u003cem\u003eCell Metab\u003c\/em\u003e — first human CSF NAD+ rise\u003c\/td\u003e\n\u003ctd\u003eMostly preclinical\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eInsulin sensitivity\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eDollerup 2018 12-wk — neutral on clamp; Remie 2020 — neutral\u003c\/td\u003e\n\u003ctd\u003eYoshino 2021 — improved muscle insulin sensitivity in pre-diabetic post-menopausal women\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eTissue coverage strength\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eStrong in muscle, brain, immune (broad ENT1\/2 expression)\u003c\/td\u003e\n\u003ctd\u003eStrong in liver and pancreas (high Slc12a8)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCost per gram\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eHigher (patent-licensed)\u003c\/td\u003e\n\u003ctd\u003eGenerally lower — particularly for entry-tier 500 mg products\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eDaily dose range\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e250–1000 mg (1000 mg is the trial-validated cardiovascular dose)\u003c\/td\u003e\n\u003ctd\u003e250–1000 mg (1000 mg is the Yoshino 2021 dose)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eTime to whole-blood NAD+ rise\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eWithin 24 hours of first dose; sustained at 8 weeks (Conze 2019)\u003c\/td\u003e\n\u003ctd\u003eWithin hours of first dose; sustained at 10 weeks (Yoshino 2021)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eBest for\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eLongest research depth; muscle\/brain\/immune tissue priorities; NMN non-responders; comprehensive stacks\u003c\/td\u003e\n\u003ctd\u003eCost-efficient daily entry; liver\/pancreas priorities; insulin-sensitivity cohorts; entry-tier protocols\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eFor most users, the practical difference is small. Many longevity protocols stack both — NMN morning, NR mid-morning — to cover both transporter families across the day. The most rigorous answer to \"which is better?\" is \"the one you take consistently for 12+ weeks alongside a SIRT1 activator and a methyl donor.\" Read our full \u003ca href=\"\/he\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNMN vs NR comparison\u003c\/a\u003e for the deeper decision framework.\u003c\/p\u003e\n\n\u003ch2\u003eClinical evidence — the trials that matter\u003c\/h2\u003e\n\n\u003ctable border=\"1\" cellpadding=\"8\" cellspacing=\"0\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eTrial\u003c\/th\u003e\n\u003cth\u003ePopulation\u003c\/th\u003e\n\u003cth\u003eDose \/ duration\u003c\/th\u003e\n\u003cth\u003ePrimary readout\u003c\/th\u003e\n\u003cth\u003eResult\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eTrammell 2016, \u003cem\u003eNat Commun\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eHealthy adults (n=12)\u003c\/td\u003e\n\u003ctd\u003e100 \/ 300 \/ 1000 mg single dose\u003c\/td\u003e\n\u003ctd\u003eWhole-blood NAD+ over 24h\u003c\/td\u003e\n\u003ctd\u003e~2.7× rise at 1000 mg; first-in-human PK\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eConze 2019, \u003cem\u003eSci Rep\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eHealthy overweight adults (n=140)\u003c\/td\u003e\n\u003ctd\u003e100 \/ 300 \/ 1000 mg\/day × 8 wk\u003c\/td\u003e\n\u003ctd\u003eWhole-blood NAD+; safety\u003c\/td\u003e\n\u003ctd\u003eDose-dependent rise (22% \/ 51% \/ 142%); no AE signal\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMartens 2018, \u003cem\u003eNat Commun\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eMidlife\/older adults, elevated SBP (n=30)\u003c\/td\u003e\n\u003ctd\u003e1000 mg\/day × 6 wk crossover\u003c\/td\u003e\n\u003ctd\u003eNAD+, SBP, aortic stiffness\u003c\/td\u003e\n\u003ctd\u003eNAD+ +60%; ~10 mmHg SBP drop in elevated-BP subgroup; aortic stiffness reduced\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDellinger 2017, \u003cem\u003eNPJ Aging Mech Dis\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eHealthy adults (n=120)\u003c\/td\u003e\n\u003ctd\u003e250 mg\/day NR + 50 mg pterostilbene combo × 8 wk\u003c\/td\u003e\n\u003ctd\u003eNAD+; safety\u003c\/td\u003e\n\u003ctd\u003e~40% NAD+ rise; well tolerated\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDollerup 2018, \u003cem\u003eAm J Clin Nutr\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eObese insulin-resistant men (n=40)\u003c\/td\u003e\n\u003ctd\u003e2000 mg\/day × 12 wk\u003c\/td\u003e\n\u003ctd\u003eInsulin sensitivity (clamp)\u003c\/td\u003e\n\u003ctd\u003eNAD+ rose; clamp insulin-sensitivity unchanged at 12 wk\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eElhassan 2019, \u003cem\u003eCell Rep\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eHealthy elderly aged 70–80 (n=12)\u003c\/td\u003e\n\u003ctd\u003e1000 mg\/day × 21 d\u003c\/td\u003e\n\u003ctd\u003eMuscle NAD+; circulating cytokines\u003c\/td\u003e\n\u003ctd\u003eMuscle NAD+ rose; IL-6\/IL-5\/IL-2 decreased\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRemie 2020, \u003cem\u003eAm J Clin Nutr\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eHealthy overweight men (n=13 crossover)\u003c\/td\u003e\n\u003ctd\u003e1000 mg\/day × 6 wk\u003c\/td\u003e\n\u003ctd\u003eSkeletal-muscle NAD+; metabolic endpoints\u003c\/td\u003e\n\u003ctd\u003eNAD+ rose; muscle acetylcarnitine fell; mixed metabolic readouts\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eStocks 2021, \u003cem\u003eJ Physiol\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eHealthy aged adults (n=12 crossover)\u003c\/td\u003e\n\u003ctd\u003e1000 mg\/day × 21 d\u003c\/td\u003e\n\u003ctd\u003eSkeletal-muscle mitochondrial respiration\u003c\/td\u003e\n\u003ctd\u003eNAD+ rose; respiratory function unchanged at 21 d in healthy aged muscle\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBrakedal 2022, \u003cem\u003eCell Metab\u003c\/em\u003e (NADPARK)\u003c\/td\u003e\n\u003ctd\u003eNewly diagnosed Parkinson's (n=30)\u003c\/td\u003e\n\u003ctd\u003e1000 mg\/day × 30 d\u003c\/td\u003e\n\u003ctd\u003eCSF and brain NAD+; clinical motor scores\u003c\/td\u003e\n\u003ctd\u003eCSF\/brain NAD+ rose; neuroinflammatory markers shifted; mild motor improvement\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBrakedal 2023, \u003cem\u003eNat Commun\u003c\/em\u003e (NR-SAFE)\u003c\/td\u003e\n\u003ctd\u003eParkinson's (n=20)\u003c\/td\u003e\n\u003ctd\u003e3000 mg\/day × 4 wk\u003c\/td\u003e\n\u003ctd\u003eSafety, tolerability, NAD+ ceiling\u003c\/td\u003e\n\u003ctd\u003e3 g\/day well tolerated; NAD+ further elevated vs 1 g\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWang 2017, \u003cem\u003eLancet Neurol\u003c\/em\u003e commentary on Trammell + ALS rationale\u003c\/td\u003e\n\u003ctd\u003eALS \/ preclinical\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003ctd\u003eMechanistic basis for ALS NR trials\u003c\/td\u003e\n\u003ctd\u003eEstablished the rationale for the multi-arm ALS NR trials in registration\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePirinen 2020, \u003cem\u003eCell Metab\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eAdult mitochondrial myopathy (n=5)\u003c\/td\u003e\n\u003ctd\u003e1000 mg\/day NR × 5 mo\u003c\/td\u003e\n\u003ctd\u003eMuscle NAD+, FGF21, mitochondrial myopathy markers\u003c\/td\u003e\n\u003ctd\u003eNAD+ rose; muscle strength and FGF21 trends improved\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAirhart 2017, \u003cem\u003ePLOS ONE\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eHealthy adults (n=8)\u003c\/td\u003e\n\u003ctd\u003e1000–2000 mg\/day × 9 d\u003c\/td\u003e\n\u003ctd\u003eNAD+; safety\u003c\/td\u003e\n\u003ctd\u003eSafe, well-tolerated, NAD+ rose\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eThis is the densest human evidence base of any NAD+ precursor — pharmacokinetic, dose-response, multi-cohort, multi-endpoint, multi-organ, and consistently safe at the 1 g\/day level over 4–12 week durations. Larger Phase III cardiovascular and Parkinson's NR trials are in registration as of 2026.\u003c\/p\u003e\n\n\u003ch2\u003eSource comparison — why patented NR, not just \"any NR\"\u003c\/h2\u003e\n\n\u003ctable border=\"1\" cellpadding=\"8\" cellspacing=\"0\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eSource\u003c\/th\u003e\n\u003cth\u003eIdentity \/ form\u003c\/th\u003e\n\u003cth\u003eTrial coverage\u003c\/th\u003e\n\u003cth\u003eHPLC purity\u003c\/th\u003e\n\u003cth\u003eBest for\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003cstrong\u003ePatented Nicotinamide Riboside Chloride\u003c\/strong\u003e (this product)\u003c\/td\u003e\n\u003ctd\u003eCrystalline NR-Cl, the form used in every cited human trial\u003c\/td\u003e\n\u003ctd\u003e65+ registered human trials; the entire NR evidence base\u003c\/td\u003e\n\u003ctd\u003e≥98% NR by HPLC; identity confirmed by NMR \u0026amp; mass spec; trace heavy metals \u0026lt; USP \u0026lt;232\u0026gt; limits\u003c\/td\u003e\n\u003ctd\u003eAnyone who wants the trial-validated form. Default choice.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGeneric NR-Cl (commodity)\u003c\/td\u003e\n\u003ctd\u003eSame chemical class but variable identity \/ purity \/ impurity profile\u003c\/td\u003e\n\u003ctd\u003eNot the form used in published human trials\u003c\/td\u003e\n\u003ctd\u003eVariable; specs not always disclosed; some lots fail HPLC identity\u003c\/td\u003e\n\u003ctd\u003eCost-shoppers willing to accept identity \/ purity variance\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNicotinamide (NAM) \/ niacinamide\u003c\/td\u003e\n\u003ctd\u003eThe end-product, not a precursor in the same sense\u003c\/td\u003e\n\u003ctd\u003eLong history; flushless; sirtuin-suppressing at \u0026gt;500 mg\u003c\/td\u003e\n\u003ctd\u003ePharmaceutical-grade widely available\u003c\/td\u003e\n\u003ctd\u003eSkin \/ dermatology applications, not longevity-stack NAD+ raising\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNiacin (NA, nicotinic acid)\u003c\/td\u003e\n\u003ctd\u003ePrecursor via the Preiss-Handler pathway\u003c\/td\u003e\n\u003ctd\u003eMultiple human trials (lipid use)\u003c\/td\u003e\n\u003ctd\u003ePharmaceutical-grade widely available\u003c\/td\u003e\n\u003ctd\u003ePeople who can tolerate the flush; lipid-modification context, not longevity\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNRH (dihydronicotinamide riboside)\u003c\/td\u003e\n\u003ctd\u003eReduced form; preclinical-only as of 2026\u003c\/td\u003e\n\u003ctd\u003eAnimal and cell evidence; no large human trials\u003c\/td\u003e\n\u003ctd\u003eResearch-grade only\u003c\/td\u003e\n\u003ctd\u003eResearchers; not for general consumer use\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNMN (β-NMN)\u003c\/td\u003e\n\u003ctd\u003eOne step downstream of NR; uses Slc12a8\u003c\/td\u003e\n\u003ctd\u003eYoshino 2021; growing human evidence base\u003c\/td\u003e\n\u003ctd\u003ePharmaceutical-grade widely available\u003c\/td\u003e\n\u003ctd\u003eDaily entry-tier; cost-efficient; liver\/pancreas priorities — see \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eThis product uses patented NR-Cl — the same crystalline form characterized in Trammell 2016 and used in every cardiovascular, neurological, and metabolic NR trial since. That matters because the published evidence base is what tells you the molecule actually raises NAD+ in human blood and tissue at the doses on the label. A commodity NR-Cl with a different impurity profile or a sub-spec HPLC identity is not what those trials studied — and you should not assume the evidence transfers.\u003c\/p\u003e\n\n\u003ch2\u003eBioavailability — what the PK studies actually show\u003c\/h2\u003e\n\u003cp\u003eNR's pharmacokinetic profile is the cleanest of any NAD+ precursor in humans. Trammell 2016 traced the molecule through whole blood and urine after a single oral dose:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePlasma NR appears within 30 minutes\u003c\/strong\u003e of an oral dose, peaks at ~1–2 hours, and is largely cleared from plasma by 6–8 hours.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhole-blood NAD+ rises in parallel\u003c\/strong\u003e — the rise is detectable by 8 hours and is sustained out to 24 hours, meaning a once-daily dose covers the diurnal cycle.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNMN, the intracellular intermediate, rises in tandem\u003c\/strong\u003e — the NRK1 phosphorylation step is fast enough not to be rate-limiting at 1 g\/day.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e1MNA (the methylated nicotinamide excretion product) rises in urine\u003c\/strong\u003e within the same window — confirming that the methylation route is active from the first dose. This is the mechanistic basis for adding TMG at long-term high doses.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eConze 2019 extended that single-dose PK to 8-week steady-state dosing in 140 healthy overweight adults. Steady-state whole-blood NAD+ tracked dose linearly: 22% rise at 100 mg\/day, 51% at 300 mg, 142% at 1000 mg. There was no plateau within the dose range — meaning if 250–500 mg\/day produces a meaningful but small subjective effect, 1000 mg\/day is a reasonable next step before considering precursor-switching or stack changes.\u003c\/p\u003e\n\u003cp\u003ePractical implication: with-food dosing produces a slightly slower and lower peak but a slightly longer sustained elevation, and reduces the small chance of mild flushing in sensitive individuals. Empty-stomach dosing (which is what Trammell 2016 used) produces a sharper peak. Either is biologically reasonable — daily consistency matters more than fasted-vs-fed.\u003c\/p\u003e\n\n\u003ch2\u003eWhere this fits in our NAD+ family\u003c\/h2\u003e\n\u003cp\u003eTrue Health Protocol carries the most complete NAD+ precursor and stacking lineup of any longevity-supplement catalog. NR-capsule is one of seven distinct entry points; the right one for any given user depends on dose, format, stack, and budget.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCheapest entry point:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e — single-ingredient, lowest cost, the daily-driver NMN for adults under 50.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHigher-dose NMN:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg Double Strength\u003c\/a\u003e — for adults 50+ or 500 mg non-responders.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNR hard capsule (this product):\u003c\/strong\u003e the alternate precursor pathway with the longest human research track record.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDaily NAD+ + Resveratrol:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/new-nad-hard-capsules-daily-nad-boost-for-energy-longevity\"\u003eNAD+ Daily Boost\u003c\/a\u003e — adds the SIRT1 activator into the same capsule.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDrink mix format:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eZOONE NAD+ 1000 mg Drink Mix\u003c\/a\u003e — NR + Resveratrol + PQQ + Quercetin in a daily drink, for users who prefer a beverage.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLiquid sachet format:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/liquid-nad-anti-aging-drink-advanced-cellular-rejuvenation\"\u003eLiquid NAD+ Anti-Aging Drink\u003c\/a\u003e — NR berry stick packs.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLiposomal flagship:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+ Ultimate 1000 mg\u003c\/a\u003e — phospholipid-encapsulated NAD+ at the top of the range.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e5-in-1 mitochondrial:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/selerb-nad-5-in-1-complete-mitochondrial-formula\"\u003eNAD+ 5-in-1 Complete\u003c\/a\u003e — NMN + CoQ10 + B-Complex + antioxidants in one capsule.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eBrowse the full \u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD+ Family collection\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eStacking — how NR sits inside a complete longevity protocol\u003c\/h2\u003e\n\u003cp\u003eNR by itself raises NAD+. NAD+ by itself doesn't do anything — it has to be consumed by sirtuins, PARPs, or CD38 to produce a downstream effect. The job of the stack is to combine precursor supply with sirtuin activation, methylation support, CD38 reduction, mitochondrial support, and the foundational layers (sleep, magnesium, omega-3, vitamin D) that determine whether the body can use any of it. Below is the canonical stack architecture, organized by mechanism:\u003c\/p\u003e\n\n\u003ch3\u003eSirtuin substrate + activator pair (the core)\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eTrans-Resveratrol 600 mg\u003c\/a\u003e\u003c\/strong\u003e — the classic SIRT1 activator (Howitz 2003 \u003cem\u003eNature\u003c\/em\u003e, Park 2007). Pairs with NR's NAD+ supply to produce more sirtuin activity per molecule of precursor. Take both with breakfast and a fat source (fat improves Resveratrol absorption).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene 100 mg\u003c\/a\u003e\u003c\/strong\u003e — the methylated cousin of Resveratrol with longer half-life and higher SIRT1 activation in some assays. Used in the Dellinger 2017 NR+pterostilbene combo trial. Stacks alongside or in place of Resveratrol depending on stack tolerability.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eBoth precursor pathways covered\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e\u003c\/strong\u003e — covers the Slc12a8 transporter pathway. Many longevity stacks run NMN morning and NR mid-morning to hedge tissue coverage. There is no known interaction; both converge on NAD+.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg Double Strength\u003c\/a\u003e\u003c\/strong\u003e — for higher total-daily-NAD+-precursor exposure in adults 50+ or stacks where NMN is the primary lever and NR is the hedge.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eMethylation support — required for long-term high-dose NR\/NMN\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG (Trimethylglycine) 1000 mg\u003c\/a\u003e\u003c\/strong\u003e — replenishes the SAM methyl pool consumed by NNMT-mediated nicotinamide methylation. Recommended after 4+ weeks of daily NR or NMN, especially if you have known MTHFR variants. The single most important \"second-tier\" addition to any NR\/NMN stack.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500 mg\u003c\/a\u003e\u003c\/strong\u003e — supports the broader one-carbon \/ glutathione pool that interlocks with methylation. The GlyNAC pairing (with NAC) is the slow-wave-sleep + glutathione-restoration foundation that the methylation cycle leans on.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eCD38 reduction — preserve the NAD+ you make\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin 50 mg\u003c\/a\u003e\u003c\/strong\u003e — direct CD38 inhibitor (Escande 2013 \u003cem\u003eDiabetes\u003c\/em\u003e). Slows the rate at which CD38 destroys NAD+ — particularly relevant for adults 50+ where CD38 is upregulated.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin 500 mg\u003c\/a\u003e\u003c\/strong\u003e — clears senescent cells (Zhu 2015 \u003cem\u003eAging Cell\u003c\/em\u003e) which overconsume NAD+ via inflammatory CD38 expression in neighboring tissues. The Mayo Clinic D+Q senolytic protocol is the canonical pairing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin 500 mg\u003c\/a\u003e\u003c\/strong\u003e — Mayo-ranked senolytic flavonoid; complementary mechanism to Quercetin. Cycled (e.g., 2 days\/month at high dose) rather than continuous.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eMitochondrial layer — what the NAD+ feeds into\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400 mg\u003c\/a\u003e\u003c\/strong\u003e — Complex I\/III electron-transport-chain shuttle. NAD+\/NADH cycling hands electrons to Complex I; CoQ10 carries them onward. Together they keep oxidative phosphorylation running.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ 20 mg\u003c\/a\u003e\u003c\/strong\u003e — mitochondrial biogenesis activator via PGC-1α (Chowanadisai 2010). Increases the number of mitochondria; NR\/NMN keeps the existing ones running. The biogenesis-plus-substrate pair.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500 mg\u003c\/a\u003e\u003c\/strong\u003e — PINK1\/Parkin-driven mitophagy activator (Andreux 2019 \u003cem\u003eNat Metab\u003c\/em\u003e). Removes damaged mitochondria so the new ones the NR\/PQQ system supports actually take over.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCalcium Alpha-Ketoglutarate (CaAKG) 1000 mg\u003c\/a\u003e\u003c\/strong\u003e — TCA-cycle substrate and epigenetic 2-OG-dependent dioxygenase cofactor. The metabolic-and-epigenetic layer of the mitochondrial stack.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid 600 mg\u003c\/a\u003e\u003c\/strong\u003e — universal antioxidant and PDH\/α-KGDH cofactor. Sits inside the same mitochondrial machinery NAD+ supports.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/taurine-1000mg-cardiovascular-mitochondrial-longevity\"\u003eTaurine 1000 mg\u003c\/a\u003e\u003c\/strong\u003e — sulfur amino acid with mitochondrial inner-membrane stabilizing role (Singh 2023 \u003cem\u003eScience\u003c\/em\u003e) and cardiovascular signal in human RCTs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eAutophagy and proteostasis\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine 10 mg\u003c\/a\u003e\u003c\/strong\u003e — autophagy activator via eIF5A hypusination and EP300 inhibition (Madeo 2018 \u003cem\u003eScience\u003c\/em\u003e). Reciprocal mechanism with sirtuins; not redundant.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eAMPK pathway\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine HCL 500 mg\u003c\/a\u003e\u003c\/strong\u003e — adds the AMPK pathway (Yin 2008 \u003cem\u003eMetabolism\u003c\/em\u003e). Sirtuin (NR\/NMN) + AMPK (Berberine) is the canonical longevity dual-pathway protocol.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eAntioxidant \/ glutathione layer\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC 600 mg\u003c\/a\u003e\u003c\/strong\u003e — glutathione precursor; the GlyNAC pairing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione 500 mg\u003c\/a\u003e\u003c\/strong\u003e — direct master antioxidant.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\"\u003eAstaxanthin 12 mg\u003c\/a\u003e\u003c\/strong\u003e — membrane-spanning antioxidant.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eLiposomal Vitamin C 1000 mg\u003c\/a\u003e\u003c\/strong\u003e — collagen-cofactor and aqueous antioxidant.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eFoundational layer — sleep, minerals, fats\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400 mg\u003c\/a\u003e\u003c\/strong\u003e — required for \u0026gt;300 enzymatic reactions including the methyl-cycle and sirtuin-substrate handling.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3 5000 IU + K2 MK-7\u003c\/a\u003e\u003c\/strong\u003e — the foundational immune \/ bone \/ cardiovascular layer.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 Fish Oil 2000 mg\u003c\/a\u003e\u003c\/strong\u003e — EPA\/DHA for membrane fluidity, resolvin signaling, cardiovascular inflammation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin 1000 mg + BioPerine\u003c\/a\u003e\u003c\/strong\u003e — NF-κB \/ inflammaging modulator.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/ashwagandha-ksm-66-600mg\"\u003eAshwagandha KSM-66\u003c\/a\u003e\u003c\/strong\u003e — cortisol \/ HPA-axis modulation; sleep and stress foundation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/creatine-monohydrate-1000mg-strength-cognitive-longevity\"\u003eCreatine 1000 mg\u003c\/a\u003e\u003c\/strong\u003e — sarcopenia-prevention; intersects with mitochondrial energy.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eRead the full protocol architecture in our \u003ca href=\"\/he\/blogs\/news\/how-to-stack-longevity-supplements-a-practical-protocol-for-2026\"\u003e2026 Longevity Stacking Protocol\u003c\/a\u003e and the deeper \u003ca href=\"\/he\/blogs\/news\/what-is-nad-a-beginners-guide-to-the-coenzyme-behind-longevity\"\u003ebeginner's guide to NAD+\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eWhat to expect — week by week\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDays 1–7:\u003c\/strong\u003e usually subtle. Whole-blood NAD+ rises within 24 hours of the first dose (Trammell 2016 PK), but the subjective signal lags. Some users report a small bump in afternoon energy or steadier mood; many report nothing yet.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 2–4:\u003c\/strong\u003e easier mornings, steadier afternoon energy, fewer post-lunch crashes — for most users. This is the window in which Conze 2019 saw the largest dose-dependent rise in whole-blood NAD+ start to plateau.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 4–8:\u003c\/strong\u003e baseline cellular energy, exercise recovery, mental clarity build noticeably; cardiovascular signals (BP, aortic stiffness) emerge in the trial timelines (Martens 2018 was a 6-week protocol; the readouts were measurable at the end of week 6, not at week 2).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 8–12:\u003c\/strong\u003e sustained sirtuin activation; long-term DNA-repair and mitochondrial-biogenesis mechanisms compound with continued use. Adding TMG at this point is the standard methylation-support layer.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonths 3–6:\u003c\/strong\u003e the trial endpoints that take the longest to manifest — body composition, hepatic fat, sustained inflammatory marker changes — emerge in the longer studies. This is also the window in which most users decide whether to add the full senolytic \/ mitophagy \/ autophagy layer (Quercetin, Fisetin, Urolithin A, Spermidine).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eYear 1+:\u003c\/strong\u003e the underlying hypothesis — sustained sirtuin \/ PARP \/ CD38 activity supporting the hallmarks-of-aging machinery — is a long-term proposition. The trials we have don't run beyond 12 months; the rationale for continued use is the consistency of the mechanism plus the absence of safety signal across the published evidence base.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat this product is — and is NOT\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is\u003c\/strong\u003e a daily NAD+ precursor designed to raise whole-blood and tissue NAD+ in a way that's been replicated across more than a dozen human RCTs.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is\u003c\/strong\u003e the patented form of NR — same molecule used in Trammell 2016, Martens 2018, Conze 2019, Elhassan 2019, and Brakedal 2022.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is\u003c\/strong\u003e a structural addition to a complete longevity stack — most useful when paired with a SIRT1 activator (Resveratrol or Pterostilbene), eventually a methyl donor (TMG), and the foundational mitochondrial layer (CoQ10, PQQ).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is NOT\u003c\/strong\u003e a stimulant, a caffeine replacement, or a same-day energy hit. NAD+ rises gradually over weeks and the subjective effects build over weeks 2–8.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is NOT\u003c\/strong\u003e a treatment for any disease — published trials investigate biomarker and mechanism endpoints; they do not establish disease-treatment claims.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is NOT\u003c\/strong\u003e a substitute for foundational longevity inputs (sleep, exercise, protein intake, omega-3, vitamin D, magnesium). NAD+ supplementation works in a body that has the basics covered. If your foundation is weak, fix that first.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is NOT\u003c\/strong\u003e a one-month experiment. The trial timelines that establish the effect run 4–12 weeks; expecting a verdict at 30 days is using the wrong yardstick.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is NOT\u003c\/strong\u003e a replacement for a SIRT1 activator. NR by itself raises NAD+; pairing it with Resveratrol or Pterostilbene is what produces the sirtuin-output story most users came in looking for.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eCommon mistakes to avoid\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eQuitting at week 4.\u003c\/strong\u003e Most of the published readouts emerge at weeks 6–12, not weeks 2–4. Daily consistency for 8 weeks before judging is the minimum useful evaluation window.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eExpecting a stimulant kick.\u003c\/strong\u003e NR is not caffeine. The signal is steadier-energy, easier-mornings, faster-recovery — not a peak. Track week-over-week, not hour-over-hour.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSkipping methylation support.\u003c\/strong\u003e After 4+ weeks of daily NR or NMN, the methylation pool starts to feel the draw. Adding TMG 500–1000 mg\/day is the single most cost-effective addition to the stack.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNR without a sirtuin activator.\u003c\/strong\u003e NAD+ supply without sirtuin demand is unfinished — pair NR with Resveratrol or Pterostilbene to produce the downstream sirtuin output.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStacking without the foundation.\u003c\/strong\u003e NR\/NMN\/Resveratrol\/Pterostilbene\/TMG\/Apigenin layered on top of poor sleep, no protein, no resistance training, low vitamin D, no omega-3, and chronic alcohol does not produce the trial readouts. Foundation first.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCycling for the wrong reasons.\u003c\/strong\u003e The published trials run continuous daily dosing for 4–12 weeks without safety signal. Cycling 8 on \/ 1 off is a low-cost hedge but is not required by the evidence.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSwitching too fast.\u003c\/strong\u003e NMN or NR for 4 weeks, no result, switching to the other — is a misuse of the evidence. Either give 8–12 weeks to evaluate, or run both simultaneously.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eUnderdosing.\u003c\/strong\u003e 1000 mg\/day is the trial-validated dose for the cardiovascular and neurological readouts. 250–500 mg may produce a measurable NAD+ rise but is below the dose at which most published clinical effects emerged.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eDaily protocol\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStandard:\u003c\/strong\u003e 1 capsule with breakfast. Adults 50+ or those running a higher-dose comprehensive stack: 2 capsules with breakfast.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStack with NMN:\u003c\/strong\u003e NMN with breakfast, NR mid-morning — covers both transport pathways across the day.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStack with Resveratrol or Pterostilbene:\u003c\/strong\u003e take both at the same morning meal alongside a fat source — Resveratrol\/Pterostilbene activates SIRT1, NR supplies the NAD+ substrate, the fat improves stilbene absorption.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAfter 4+ weeks:\u003c\/strong\u003e add TMG 500–1000 mg\/day to support the methylation pool consumed by NAD+ metabolism. After 8+ weeks: consider adding Apigenin 50 mg\/day to inhibit CD38.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIf you exercise in the morning:\u003c\/strong\u003e take NR with the post-workout meal rather than pre-workout. NAD+ is being consumed heavily during exercise; precursor supply pairs better with the recovery window.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIf you exercise in the evening:\u003c\/strong\u003e NR still goes in the morning. Don't shift to evening — NAD+ has a circadian rhythm and morning dosing aligns with the natural peak.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMissed dose:\u003c\/strong\u003e take it as soon as you remember the same day. If it's already evening, skip and resume in the morning. Do not double up — daily consistency over 8+ weeks is what matters, not catching up on individual doses.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTravel and time-zone shifts:\u003c\/strong\u003e dose by local-time morning rather than home-time morning. The circadian rhythm resets to local light cycle within a few days; matching NR dosing to the local schedule keeps the rhythm aligned.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWith food vs fasted:\u003c\/strong\u003e with food is fine (most trials used with-food dosing) and reduces the small chance of mild flushing. Fasted dosing produces a sharper plasma peak (Trammell 2016) but the steady-state effect at 8 weeks is comparable. Consistency matters more than fasted-vs-fed.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSee our \u003ca href=\"\/he\/blogs\/news\/best-time-to-take-nmn-morning-empty-stomach-or-with-food\"\u003etiming guide\u003c\/a\u003e for the deeper rationale; the same morning rules apply to NR.\u003c\/p\u003e\n\n\u003ch2\u003eWho this is for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eAnyone who wants the most-studied human NAD+ precursor specifically — NR's published research depth (65+ trials, 13+ peer-reviewed RCTs) is the longest of any NAD+ precursor as of 2026.\u003c\/li\u003e\n  \u003cli\u003eAdults who tried NMN and didn't see the response they wanted — switching to or stacking NR is the standard next step. ENT1\/2 transporter coverage may reach tissues where Slc12a8 is downregulated.\u003c\/li\u003e\n  \u003cli\u003ePeople running a comprehensive longevity stack who want both NR and NMN pathways covered to hedge tissue-specific transporter heterogeneity.\u003c\/li\u003e\n  \u003cli\u003eAdults 50+ — alternate-pathway delivery and broad transporter coverage hedge against tissue-specific transporter inefficiencies that emerge with age.\u003c\/li\u003e\n  \u003cli\u003eAnyone whose stack already includes Resveratrol, Pterostilbene, or another SIRT1 activator and wants the matching NAD+ substrate so the activator has fuel.\u003c\/li\u003e\n  \u003cli\u003eAthletes and active adults running heavy training loads — NAD+\/sirtuin axis sits inside exercise recovery and mitochondrial-biogenesis pathways.\u003c\/li\u003e\n  \u003cli\u003ePeople with a family history of cardiovascular events who are running multi-pathway prevention protocols — the Martens 2018 BP and aortic-stiffness signal is the strongest mechanism-validated NR readout to date.\u003c\/li\u003e\n  \u003cli\u003eCognitive-aging-conscious adults — Brakedal 2022 demonstrated CSF\/brain NAD+ rise with oral dosing, the first such evidence for any human NAD+ precursor.\u003c\/li\u003e\n  \u003cli\u003eVegans and vegetarians — the capsule is vegan-compatible (no gelatin), and the NR molecule is animal-source-free.\u003c\/li\u003e\n  \u003cli\u003eMethylation-savvy users (MTHFR variants, etc.) — the included B-vitamin cofactors plus TMG pairing makes this a well-supported long-term lever.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is NOT for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnant or breastfeeding\u003c\/strong\u003e — no safety data in pregnancy or lactation. Avoid.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eActive cancer or recent diagnosis\u003c\/strong\u003e — NAD+ supports both healthy and cancer-cell metabolism; sirtuins have context-dependent roles in tumor biology. Discuss with your oncologist before starting; some advocate cycling off during active treatment.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eChildren and adolescents under 18\u003c\/strong\u003e — no pediatric safety data.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePre-surgery (within 14 days)\u003c\/strong\u003e — discontinue 2 weeks before any planned surgery as a general supplement-safety practice; NR and other NAD+ precursors may interact with anesthesia metabolism.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeople expecting a stimulant or same-day energy hit\u003c\/strong\u003e — NR is not caffeine. If your intent is a fast subjective lift, this is the wrong tool.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnyone unwilling to stay consistent for 8+ weeks\u003c\/strong\u003e — the trial readouts emerge in that window. Sporadic use does not reproduce the published evidence.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeople who haven't fixed the foundation\u003c\/strong\u003e — sleep deprivation, ultra-processed diet, no protein intake, no resistance training, chronic alcohol — NR layered on top of those does not reproduce the trials. Address foundation before optimization.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSafety, interactions, and contraindications\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eGenerally well-tolerated.\u003c\/strong\u003e Across published trials at 100–1000 mg\/day for up to 8–12 weeks (and 3000 mg\/day in the NR-SAFE 4-week extension), NR has shown no serious adverse events vs placebo (Conze 2019; Dollerup 2018; Martens 2018; Elhassan 2019; Brakedal 2023).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMild flushing or warmth\u003c\/strong\u003e can occur in a small minority — usually resolves with food or with dose reduction.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMild GI upset\u003c\/strong\u003e in a small minority — typically resolves within the first 1–2 weeks or with dose reduction.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eActive or recent cancer:\u003c\/strong\u003e NAD+ supports both healthy and cancer-cell metabolism. Discuss with your oncologist before starting; some advocate cycling off during active treatment. Note that the published epidemiologic and mechanistic data on cancer outcomes with chronic NR\/NMN use are still maturing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnancy and breastfeeding:\u003c\/strong\u003e not studied; avoid.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMethylation load:\u003c\/strong\u003e long-term high-dose NR (or NMN) consumes methyl groups during NAD+ metabolism via NNMT. Pair with TMG 500–1000 mg\/day after 4+ weeks of daily use, especially if you have any known methylation variants (MTHFR C677T or A1298C). The included B6\/B12\/folate cofactors mitigate but do not fully replace TMG at long-term high dose.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePre-surgery:\u003c\/strong\u003e discontinue 14 days before any planned surgical procedure.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDrug interactions:\u003c\/strong\u003e no clinically significant pharmacokinetic interactions are documented at the doses used here, but published interaction data is limited. Discuss with your prescriber if you take chemotherapy, immunosuppressants, anticoagulants, or psychiatric medications.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAlcohol:\u003c\/strong\u003e heavy alcohol use depletes NAD+ via aldehyde-dehydrogenase activity. NR can replenish, but chronic alcohol is the bigger lever — addressing alcohol intake produces a larger and more durable NAD+ effect than precursor supplementation alone.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat's in it\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePatented Nicotinamide Riboside Chloride (NR-Cl)\u003c\/strong\u003e — same crystalline form used in Trammell 2016, Martens 2018, Elhassan 2019, Conze 2019, and Brakedal 2022. ≥98% NR by HPLC; identity confirmed by NMR and mass spectrometry.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSupporting B-vitamin cofactors\u003c\/strong\u003e for the NAD+ biosynthesis pathway: vitamin B6 (pyridoxal-5-phosphate as a NAMPT cofactor), vitamin B12 (methylcobalamin as a methyl donor), and folate (5-MTHF as a methyl donor) — the methylation cycle inputs that NAD+ metabolism eventually leans on.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHard capsule format\u003c\/strong\u003e for measured, consistent dosing — no flavored powders, no proprietary blends, no surprise sugar or maltodextrin fillers.\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eNo proprietary blends, no artificial colors, no titanium dioxide, no soy, no gluten, no dairy, no nuts.\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVegan-compatible capsule shell\u003c\/strong\u003e (HPMC), suitable for vegan and vegetarian protocols.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThird-party tested\u003c\/strong\u003e for purity, identity, heavy metals, and microbial contamination by an ISO 17025-accredited laboratory. Certificate of Analysis available on request.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSourcing, manufacturing, and quality control\u003c\/h2\u003e\n\u003cp\u003eThe patented Nicotinamide Riboside Chloride used in this product is the same crystalline form characterized in Trammell 2016 and used across the published clinical trial program. Manufacturing follows U.S. FDA cGMP (current Good Manufacturing Practice) requirements (21 CFR Part 111) at NSF-registered or equivalent facilities. Each lot is tested against the following specifications:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIdentity:\u003c\/strong\u003e HPLC retention time and UV spectrum match the reference standard; NMR and mass-spec identity confirmed.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e ≥98% NR-Cl by HPLC; total impurities ≤2%; specific pharmacopeia-listed impurities below individual limits.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHeavy metals:\u003c\/strong\u003e arsenic, lead, mercury, cadmium below USP \u0026lt;232\u0026gt; \/ Prop65 limits.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eResidual solvents:\u003c\/strong\u003e below USP \u0026lt;467\u0026gt; Class 2\/3 limits.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMicrobial:\u003c\/strong\u003e total aerobic count, yeast, mold, and pathogens (E. coli, Salmonella, Staphylococcus aureus) below USP \u0026lt;2021\u0026gt; limits.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEndotoxin:\u003c\/strong\u003e \u0026lt; USP-listed thresholds for orally administered solid dosage forms.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePesticide residues:\u003c\/strong\u003e below USP \u0026lt;561\u0026gt; \/ EU multi-residue panel limits.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e formulated for ≥24-month room-temperature shelf life in UV-protective amber HDPE bottles with foil-induction seal and desiccant. Store cool and dry; refrigeration not required.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eEach capsule is filled by a single-source audited contract manufacturer; no proprietary blends are used so the on-label NR amount is the actual dose, not a \"complex\" mass that could be padded with rice flour or maltodextrin.\u003c\/p\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eIs NR better than NMN?\u003c\/h3\u003e\n\u003cp\u003eNeither is uniformly \"better.\" NR has the longer human research track record (since 2016 with Trammell), broader cardiovascular and neurological RCT coverage, and may reach tissues where the NMN transporter (Slc12a8) is less active. NMN may have an edge in liver and pancreas, skips the intracellular phosphorylation step, and has the strong post-menopausal insulin-sensitivity signal from Yoshino 2021. For most users the practical difference is small; many run both. Read the \u003ca href=\"\/he\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNR vs NMN comparison\u003c\/a\u003e for the full breakdown.\u003c\/p\u003e\n\n\u003ch3\u003eCan I take NR with NMN?\u003c\/h3\u003e\n\u003cp\u003eYes, and many longevity protocols do. NMN with breakfast and NR mid-morning is a clean way to space them and cover both transport pathways. There's no known interaction — they ultimately converge on the same molecule (NAD+). If anything, the combination hedges tissue-specific transporter expression heterogeneity better than either precursor alone.\u003c\/p\u003e\n\n\u003ch3\u003eWhy are B-vitamins included?\u003c\/h3\u003e\n\u003cp\u003eNAD+ metabolism uses methyl groups (the methylation cycle), and the conversions through the salvage pathway use B6 as a cofactor. Including B6, B12, and folate means the NR you absorb has the supporting cofactors it needs without pulling them from elsewhere in your metabolism. After 4+ weeks of daily NR\/NMN at the 1 g\/day level, adding TMG (trimethylglycine) on top is the standard methyl-donor support — the included B12\/folate are useful but do not fully replace TMG at long-term high dose.\u003c\/p\u003e\n\n\u003ch3\u003eHow long until I notice anything?\u003c\/h3\u003e\n\u003cp\u003eWhole-blood NAD+ begins to rise within 24 hours of the first dose (Trammell 2016 PK). Subjective changes — easier mornings, steadier energy, faster exercise recovery — typically become noticeable in weeks 2–4 for most users. Cardiovascular and inflammatory readouts in the published trials emerged at 3–8 weeks (Martens 2018 was 6 weeks; Elhassan 2019 was 21 days). Plan to evaluate at week 8, not week 4.\u003c\/p\u003e\n\n\u003ch3\u003eCan I take NR at night?\u003c\/h3\u003e\n\u003cp\u003eYou can, but morning is preferred. NAD+ has a circadian rhythm — it naturally peaks during the active phase. Morning dosing aligns with that rhythm. Some users report mild stimulation from NR; if that's you, definitely keep it morning-only. Evening dosing is not unsafe, just suboptimal in a small minority of stimulant-sensitive users.\u003c\/p\u003e\n\n\u003ch3\u003eDo I need to cycle NR?\u003c\/h3\u003e\n\u003cp\u003ePublished trials run 6–12 weeks of continuous daily dosing without safety issues. The Brakedal 2023 NR-SAFE trial extended dosing to 3 g\/day for 4 weeks safely. Long-term continuous use is the most common pattern. Some users cycle 8 weeks on \/ 1 week off as a standard supplement-rotation practice — there's no published evidence that cycling is required, but it's a low-cost hedge against the small theoretical risk of receptor or enzymatic adaptation.\u003c\/p\u003e\n\n\u003ch3\u003eShould I take it with food?\u003c\/h3\u003e\n\u003cp\u003eWith food is fine and reduces the small chance of mild flushing. The Trammell 2016 PK study used fasted dosing; the Martens 2018 cardiovascular study used with-breakfast dosing. Both raise NAD+ effectively. Daily consistency matters more than fasted-vs-fed. If you're stacking with Resveratrol, the with-food (and with-fat) approach is preferred because Resveratrol absorbs better with fat.\u003c\/p\u003e\n\n\u003ch3\u003eWhat if I'm 30 — is NR still useful?\u003c\/h3\u003e\n\u003cp\u003eThe biggest published effect sizes come from older cohorts (Martens 2018 was midlife\/older with elevated BP; Elhassan 2019 was 70–80 years old). Younger adults still see whole-blood NAD+ rise (Trammell 2016 included healthy adults of all ages) but the subjective signal is typically smaller because baseline NAD+ is higher. The most defensible use case at age 30 is foundational longevity stacking rather than acute symptom management.\u003c\/p\u003e\n\n\u003ch3\u003eWhy is NR more expensive than NMN?\u003c\/h3\u003e\n\u003cp\u003eNR is patent-licensed; the manufacturing process is more complex and the licensing cost is passed through to the consumer. The premium is real and the practical value depends on whether the longer research track record, the broader transporter coverage, and the brain\/CSF NAD+ signal are decisive for your protocol. For cost-efficient daily entry, NMN at 500 mg is generally the better starting point; NR is best framed as a stack hedge or a switch when NMN alone isn't producing the expected response.\u003c\/p\u003e\n\n\u003ch3\u003eCan NR replace coffee?\u003c\/h3\u003e\n\u003cp\u003eNo. NR is not a stimulant. The \"easier mornings, steadier afternoon energy\" signal that builds over 2–8 weeks is bioenergetic, not adrenergic. Coffee acts on adenosine receptors and the catecholamine system; NR acts on the NAD+\/sirtuin\/mitochondrial-respiration axis. They are complementary, not substitutes.\u003c\/p\u003e\n\n\u003ch3\u003eWill NR show up on a drug test?\u003c\/h3\u003e\n\u003cp\u003eNo. NR is a dietary supplement form of vitamin B3 (nicotinamide-derived) and is not on any standard sport, occupational, or clinical drug-screening panel. The molecule is endogenous and trace levels are present in all human blood at baseline.\u003c\/p\u003e\n\n\u003ch3\u003eCan I take NR while fasting?\u003c\/h3\u003e\n\u003cp\u003eYes. NR does not break a fast in any meaningful metabolic sense — the molecule contributes negligible calories and does not significantly raise insulin. The Trammell 2016 PK study used fasted dosing. If you fast intermittently and want to dose NR within the fasted window, that is biologically reasonable.\u003c\/p\u003e\n\n\u003ch3\u003eDoes NR raise blood pressure?\u003c\/h3\u003e\n\u003cp\u003eThe published cardiovascular evidence runs the other way. Martens 2018 specifically measured systolic blood pressure in midlife adults with elevated baseline SBP and found a ~10 mmHg \u003cem\u003ereduction\u003c\/em\u003e after 6 weeks of 1 g\/day vs placebo. Aortic stiffness also fell. NR is not associated with raised BP at the trial-validated dose.\u003c\/p\u003e\n\n\u003ch3\u003eWhat's the maximum safe daily dose?\u003c\/h3\u003e\n\u003cp\u003eThe Brakedal 2023 NR-SAFE trial extended dosing to 3 g\/day for 4 weeks in Parkinson's patients without serious adverse events. The 1000 mg\/day dose is the trial-validated standard for cardiovascular and neurological readouts. Going above 1 g\/day without clinical supervision is not recommended for general consumer use; the marginal benefit of higher doses has not been demonstrated to outweigh the cost in the published evidence base.\u003c\/p\u003e\n\n\u003ch3\u003eDoes NR interact with statins or blood pressure medications?\u003c\/h3\u003e\n\u003cp\u003eNo clinically significant interactions are documented at typical supplement doses. Practical caution: if you are on antihypertensive medication and you start NR, the Martens 2018 BP-lowering signal means your home BP readings could trend lower. Track and discuss with your prescriber if you see a meaningful shift.\u003c\/p\u003e\n\n\u003ch3\u003eHow does NR compare to NAD+ IV therapy?\u003c\/h3\u003e\n\u003cp\u003eNAD+ IV therapy delivers a large bolus of NAD+ directly to the bloodstream over a few hours. Oral NR raises whole-blood NAD+ steadily over weeks via the precursor pathway. The IV route is acutely larger but expensive, infrastructure-dependent, and the long-term cost-benefit vs. daily oral precursor supplementation is unsettled. Most published longevity-mechanism evidence in humans is from oral precursor (NR or NMN), not IV NAD+.\u003c\/p\u003e\n\n\u003ch3\u003eCan I open the capsule?\u003c\/h3\u003e\n\u003cp\u003eTechnically yes, but it's not recommended. NR-Cl is mildly hygroscopic; opening exposes the powder to air moisture and accelerates degradation. The capsule is also designed to deliver a measured single dose. If you have trouble swallowing capsules, the \u003ca href=\"\/he\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eZOONE NAD+ Drink Mix\u003c\/a\u003e or the \u003ca href=\"\/he\/products\/liquid-nad-anti-aging-drink-advanced-cellular-rejuvenation\"\u003eLiquid NAD+ sachet\u003c\/a\u003e are designed for that use case.\u003c\/p\u003e\n\n\u003ch3\u003eIs NR vegan?\u003c\/h3\u003e\n\u003cp\u003eYes. The NR molecule is synthesized from non-animal sources, the capsule shell is HPMC (vegan-compatible, plant-derived), and the supporting B-vitamin cofactors in this formulation are non-animal-sourced.\u003c\/p\u003e\n\n\u003ch3\u003eWill NR help me sleep?\u003c\/h3\u003e\n\u003cp\u003eIndirectly, sometimes. NAD+ contributes to circadian-rhythm regulation via NAMPT and SIRT1's interaction with the BMAL1\/CLOCK transcription complex (Asher 2008 \u003cem\u003eCell\u003c\/em\u003e). Some users report deeper or more consolidated sleep after several weeks of consistent dosing — likely a downstream consequence of metabolic and circadian normalization rather than a direct sedative effect. If sleep is the primary target, the more direct levers are \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e, \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/ashwagandha-ksm-66-600mg\"\u003eAshwagandha\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eDoes NR improve hair?\u003c\/h3\u003e\n\u003cp\u003eIndirectly, possibly. The hair follicle is a high-turnover, energy-demanding tissue and NAD+ supports the underlying energetics. There are no large RCTs of NR specifically for hair endpoints. The more direct hair-cycle levers are \u003ca href=\"\/he\/products\/biotin-10-000mcg-maximum-strength-hair-skin-nails-formula\"\u003eBiotin\u003c\/a\u003e, \u003ca href=\"\/he\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine\u003c\/a\u003e (Rainer 2018 PROSPER trial showed anagen-phase lengthening).\u003c\/p\u003e\n\n\u003ch3\u003eWhy is daily consistency more important than dose?\u003c\/h3\u003e\n\u003cp\u003eNAD+ levels respond to sustained precursor supply, not single-dose peaks. Conze 2019 showed steady-state NAD+ at week 8; one-off dosing produces a transient peak that returns to baseline within 24 hours. The published clinical readouts (cardiovascular, neurological, inflammatory) all emerged from sustained 4–12 week protocols, not from intermittent or as-needed use.\u003c\/p\u003e\n\n\u003ch2\u003eWhere this sits in the catalog architecture\u003c\/h2\u003e\n\u003cp\u003eTrue Health Protocol's NAD+ family is organized into four functional layers, and NR Hard Capsules sits primarily in layer 1 (Precursor Supply) with crossover into layer 4 (Comprehensive Stack):\u003c\/p\u003e\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLayer 1 — Precursor Supply.\u003c\/strong\u003e NR Hard Capsules (this product), \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg Double Strength\u003c\/a\u003e. Single-ingredient or near-single-ingredient daily precursors.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLayer 2 — SIRT1 \/ Sirtuin activators.\u003c\/strong\u003e \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eTrans-Resveratrol 600 mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene 100 mg\u003c\/a\u003e. Pair with layer 1 to convert NAD+ supply into sirtuin output.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLayer 3 — Methylation and CD38 support.\u003c\/strong\u003e \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000 mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin 50 mg\u003c\/a\u003e. Required at 4+ weeks of daily layer-1 use.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLayer 4 — Comprehensive \/ convenience formulas.\u003c\/strong\u003e \u003ca href=\"\/he\/products\/new-nad-hard-capsules-daily-nad-boost-for-energy-longevity\"\u003eNAD+ Daily Boost\u003c\/a\u003e, \u003ca href=\"\/he\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eZOONE NAD+ Pure Focus\u003c\/a\u003e, \u003ca href=\"\/he\/products\/liquid-nad-anti-aging-drink-advanced-cellular-rejuvenation\"\u003eLiquid NAD+\u003c\/a\u003e, \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+ Ultimate\u003c\/a\u003e, \u003ca href=\"\/he\/products\/selerb-nad-5-in-1-complete-mitochondrial-formula\"\u003eNAD+ 5-in-1 Complete\u003c\/a\u003e. Multi-ingredient formats that bundle layers 1+2 (and sometimes 3+) for users who prefer one capsule.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003eThe deeper-protocol architecture (mitochondrial layer, autophagy layer, senolytic layer, antioxidant layer, foundational layer) is documented across the catalog in the dedicated product pages and in the \u003ca href=\"\/he\/blogs\/news\/how-to-stack-longevity-supplements-a-practical-protocol-for-2026\"\u003e2026 Longevity Stacking Protocol\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eRelated collections\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD+ Family\u003c\/a\u003e — the complete NR + NMN + NAD+ lineup.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal\u003c\/a\u003e — CoQ10, PQQ, Urolithin A, CaAKG, the energy-production layer.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e — the daily-driver layer the rest of the stack leans on.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/senolytics\"\u003eSenolytics\u003c\/a\u003e — Quercetin, Fisetin, the senescent-cell-clearance layer.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/cardiovascular-longevity\"\u003eCardiovascular Longevity\u003c\/a\u003e — the BP, lipid, and aortic-stiffness layer where the Martens 2018 NR signal lives.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/metabolic\"\u003eMetabolic\u003c\/a\u003e — Berberine, Alpha-Lipoic Acid, the AMPK \/ glucose layer that pairs with the NAD+\/sirtuin axis.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eRead more on this topic\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNMN vs NR — which precursor actually works better?\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/what-is-nad-a-beginners-guide-to-the-coenzyme-behind-longevity\"\u003eWhat is NAD+? A beginner's guide to the coenzyme behind longevity\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nmn-vs-nad-which-should-you-take-in-2026\"\u003eNMN vs NAD+ — which should you take in 2026?\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/how-to-stack-longevity-supplements-a-practical-protocol-for-2026\"\u003e2026 Longevity Stacking Protocol\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/best-time-to-take-nmn-morning-empty-stomach-or-with-food\"\u003eTiming — morning, empty stomach, or with food?\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSelected references\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eBieganowski P \u0026amp; Brenner C (2004). Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans. \u003cem\u003eCell\u003c\/em\u003e 117(4):495–502.\u003c\/li\u003e\n  \u003cli\u003eTrammell SAJ, Schmidt MS, Weidemann BJ, et al. (2016). Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. \u003cem\u003eNature Communications\u003c\/em\u003e 7:12948.\u003c\/li\u003e\n  \u003cli\u003eMartens CR, Denman BA, Mazzo MR, et al. (2018). Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. \u003cem\u003eNature Communications\u003c\/em\u003e 9:1286.\u003c\/li\u003e\n  \u003cli\u003eConze D, Brenner C, \u0026amp; Kruger CL (2019). Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride) in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults. \u003cem\u003eScientific Reports\u003c\/em\u003e 9:9772.\u003c\/li\u003e\n  \u003cli\u003eDollerup OL, Christensen B, Svart M, et al. (2018). A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects. \u003cem\u003eAmerican Journal of Clinical Nutrition\u003c\/em\u003e 108(2):343–353.\u003c\/li\u003e\n  \u003cli\u003eElhassan YS, Kluckova K, Fletcher RS, et al. (2019). Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures. \u003cem\u003eCell Reports\u003c\/em\u003e 28(7):1717–1728.e6.\u003c\/li\u003e\n  \u003cli\u003eRemie CME, Roumans KHM, Moonen MPB, et al. (2020). Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans. \u003cem\u003eAmerican Journal of Clinical Nutrition\u003c\/em\u003e 112(2):413–426.\u003c\/li\u003e\n  \u003cli\u003eStocks B, Ashcroft SP, Joanisse S, et al. (2021). Nicotinamide riboside supplementation does not alter whole-body or skeletal muscle metabolic responses to a single bout of endurance exercise in healthy aged adults. \u003cem\u003eJournal of Physiology\u003c\/em\u003e 599(5):1513–1531.\u003c\/li\u003e\n  \u003cli\u003eBrakedal B, Dölle C, Riemer F, et al. (2022). The NADPARK study: a randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease. \u003cem\u003eCell Metabolism\u003c\/em\u003e 34(3):396–407.e6.\u003c\/li\u003e\n  \u003cli\u003eBrakedal B, Toker L, Haugarvoll K, et al. (2023). Long-term nicotinamide riboside use is safe in patients with Parkinson disease. \u003cem\u003eNature Communications\u003c\/em\u003e 14:1156 (NR-SAFE).\u003c\/li\u003e\n  \u003cli\u003ePirinen E, Auranen M, Khan NA, et al. (2020). Niacin cures systemic NAD+ deficiency and improves muscle performance in adult-onset mitochondrial myopathy. \u003cem\u003eCell Metabolism\u003c\/em\u003e 31(6):1078–1090.\u003c\/li\u003e\n  \u003cli\u003eDellinger RW, Santos SR, Morris M, et al. (2017). Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study. \u003cem\u003eNPJ Aging and Mechanisms of Disease\u003c\/em\u003e 3:17.\u003c\/li\u003e\n  \u003cli\u003eAirhart SE, Shireman LM, Risler LJ, et al. (2017). An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers. \u003cem\u003ePLOS ONE\u003c\/em\u003e 12(12):e0186459.\u003c\/li\u003e\n  \u003cli\u003eRatajczak J, Joffraud M, Trammell SAJ, et al. (2016). NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. \u003cem\u003eNature Communications\u003c\/em\u003e 7:13103.\u003c\/li\u003e\n  \u003cli\u003eMassudi H, Grant R, Braidy N, et al. (2012). Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. \u003cem\u003ePLOS ONE\u003c\/em\u003e 7(7):e42357.\u003c\/li\u003e\n  \u003cli\u003eCamacho-Pereira J, Tarragó MG, Chini CCS, et al. (2016). CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. \u003cem\u003eCell Metabolism\u003c\/em\u003e 23(6):1127–1139.\u003c\/li\u003e\n  \u003cli\u003eYoshino J, Mills KF, Yoon MJ, \u0026amp; Imai S (2011). Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. \u003cem\u003eCell Metabolism\u003c\/em\u003e 14(4):528–536.\u003c\/li\u003e\n  \u003cli\u003eYoshino M, Yoshino J, Kayser BD, et al. (2021). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. \u003cem\u003eScience\u003c\/em\u003e 372(6547):1224–1229.\u003c\/li\u003e\n  \u003cli\u003eGrozio A, Mills KF, Yoshino J, et al. (2019). Slc12a8 is a nicotinamide mononucleotide transporter. \u003cem\u003eNature Metabolism\u003c\/em\u003e 1:47–57.\u003c\/li\u003e\n  \u003cli\u003eLuongo TS, Eller JM, Lu MJ, et al. (2020). SLC25A51 is a mammalian mitochondrial NAD+ transporter. \u003cem\u003eNature\u003c\/em\u003e 588:174–179.\u003c\/li\u003e\n  \u003cli\u003eAsher G, Gatfield D, Stratmann M, et al. (2008). SIRT1 regulates circadian clock gene expression through PER2 deacetylation. \u003cem\u003eCell\u003c\/em\u003e 134(2):317–328.\u003c\/li\u003e\n  \u003cli\u003eHowitz KT, Bitterman KJ, Cohen HY, et al. (2003). Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. \u003cem\u003eNature\u003c\/em\u003e 425:191–196.\u003c\/li\u003e\n  \u003cli\u003ePark SJ, Ahmad F, Philp A, et al. (2012). Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. \u003cem\u003eCell\u003c\/em\u003e 148(3):421–433.\u003c\/li\u003e\n  \u003cli\u003eEscande C, Nin V, Price NL, et al. (2013). Flavonoid apigenin is an inhibitor of the NAD+ ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome. \u003cem\u003eDiabetes\u003c\/em\u003e 62(4):1084–1093.\u003c\/li\u003e\n  \u003cli\u003eMadeo F, Eisenberg T, Pietrocola F, \u0026amp; Kroemer G (2018). Spermidine in health and disease. \u003cem\u003eScience\u003c\/em\u003e 359(6374):eaan2788.\u003c\/li\u003e\n  \u003cli\u003eAndreux PA, Blanco-Bose W, Ryu D, et al. (2019). The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. \u003cem\u003eNature Metabolism\u003c\/em\u003e 1:595–603.\u003c\/li\u003e\n  \u003cli\u003eYin J, Xing H, \u0026amp; Ye J (2008). Efficacy of berberine in patients with type 2 diabetes mellitus. \u003cem\u003eMetabolism\u003c\/em\u003e 57(5):712–717.\u003c\/li\u003e\n  \u003cli\u003eSingh P, Gollapalli K, Mangiola S, et al. (2023). Taurine deficiency as a driver of aging. \u003cem\u003eScience\u003c\/em\u003e 380(6649):eabn9257.\u003c\/li\u003e\n  \u003cli\u003eLópez-Otín C, Blasco MA, Partridge L, Serrano M, \u0026amp; Kroemer G (2013). The hallmarks of aging. \u003cem\u003eCell\u003c\/em\u003e 153(6):1194–1217.\u003c\/li\u003e\n  \u003cli\u003eLópez-Otín C, Blasco MA, Partridge L, Serrano M, \u0026amp; Kroemer G (2023). Hallmarks of aging: an expanding universe. \u003cem\u003eCell\u003c\/em\u003e 186(2):243–278.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cem\u003eThis product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. Consult your physician before starting any supplement, especially if you take prescription medication, are pregnant or breastfeeding, have an active or recent cancer diagnosis, or have a medical condition. Reference studies cited above describe pharmacokinetic and clinical findings of Nicotinamide Riboside generally and do not constitute claims about this specific product.\u003c\/em\u003e\u003c\/p\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47705326944474,"sku":"THP-NAD-NR-CAP","price":44.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp-nad-capsules.jpg?v=1775666145"},{"product_id":"new-nad-hard-capsules-daily-nad-boost-for-energy-longevity","title":"NAD+ Daily Boost | Direct NAD+ + Trans-Resveratrol Capsules for SIRT1 Activation \u0026 Cellular Energy","description":"\u003cp\u003e\u003cstrong\u003eDirect NAD+ in capsule form, paired with trans-resveratrol and a full B-vitamin complex\u003c\/strong\u003e — the finished coenzyme delivered alongside the sirtuin activator that puts it to work, with the metabolic cofactors the salvage pathway runs on. The single-bottle daily-maintenance option for adults who want the NAD+ pathway covered without managing three separate supplements, three separate timings, and three separate price tags. If your goal is \"longevity stack on autopilot,\" this is the bottle most users settle on once the experimentation phase is over.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDirect NAD+\u003c\/strong\u003e — the finished coenzyme rather than a precursor (NMN\/NR). One less conversion step for your body. Particularly relevant for adults 50+ whose NMN-to-NAD+ conversion efficiency has dropped and for the small subset of people who don't respond to precursors at standard doses.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTrans-Resveratrol included\u003c\/strong\u003e — activates the sirtuin enzymes (SIRT1, SIRT3) that put NAD+ to work. Raising NAD+ without activating the sirtuins that consume it is half the equation; this formula does both. This is the original Sinclair-lab insight that launched the entire NMN+resveratrol stack — packaged in a single capsule.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eB-vitamin complex\u003c\/strong\u003e as metabolic cofactors — the NAD+ salvage pathway runs through niacinamide (B3) and depends on B1\/B2\/B5\/B6\/B12 for normal energy metabolism. Missing cofactors are a common reason \"NAD+ supplements don't work\" for some people.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOne capsule, three jobs\u003c\/strong\u003e — finished coenzyme + sirtuin activator + cofactor support. Replaces a three-bottle stack for the maintenance use case.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBest for:\u003c\/strong\u003e adults 35+ who want a single-bottle daily NAD+ + sirtuin maintenance dose; people who prefer capsules to powders, drinks, or liposomal liquids; travelers; busy households; anyone who already takes NMN and wants to add direct-NAD+ coverage without doubling pill count.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePairs with:\u003c\/strong\u003e NMN (precursor coverage), Berberine (AMPK pathway), CoQ10 (mitochondrial energy), Spermidine (autophagy), Apigenin (CD38 inhibition), TMG (methyl donor support).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTimeline:\u003c\/strong\u003e subtle in week 1, most users notice cleaner energy and steadier afternoons by weeks 2–4, sirtuin-mediated effects compound through weeks 8–12.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhy NAD+ keeps showing up in longevity conversations\u003c\/h2\u003e\n\u003cp\u003eNicotinamide adenine dinucleotide (NAD+) is one of the most-studied coenzymes in cellular biology. It sits at the intersection of essentially every energy-related process the body runs. The citric acid cycle uses it. Oxidative phosphorylation uses it. Glycolysis uses it. The fatty-acid oxidation pathway uses it. Every cell in your body — heart, brain, muscle, liver, skin — uses NAD+ as fuel for the reactions that turn food into ATP, the molecule your cells actually spend.\u003c\/p\u003e\n\u003cp\u003eIt's also the substrate that the sirtuin enzymes (SIRT1–SIRT7), the PARP family of DNA-repair enzymes, and CD38 — a major NAD+ consumer — spend when they do their jobs. When NAD+ is plentiful, those longevity-associated enzymes can run at full speed; when NAD+ runs low, they slow down. The functional consequences of low NAD+ are exactly what most people associate with \"feeling older\": slower DNA repair, less efficient mitochondrial work, lower stress resilience, harder mornings, harder recoveries.\u003c\/p\u003e\n\u003cp\u003eAnd tissue NAD+ levels do fall with age. Multiple human studies, in skin, muscle, liver, and brain, have documented a 30–50% drop in cellular NAD+ between age 30 and age 70. The Massudi 2012 skin study showed a steady decline starting in the third decade. The Janssens 2022 muscle study confirmed the same pattern in skeletal muscle. The Zhou 2019 brain study extended it to neural tissue. The pattern is consistent: you have less NAD+ at 60 than you did at 30, and the drop tracks with the age-related declines in everything from immune function to mitochondrial output.\u003c\/p\u003e\n\u003cp\u003eRestoring NAD+ has therefore become one of the most-tested longevity interventions of the past decade. NMN, NR, and direct NAD+ are all under active clinical investigation. Yoshino 2021 (NEJM) showed NMN raised muscle insulin sensitivity in postmenopausal women. Martens 2018 demonstrated NR raised whole-blood NAD+ by 60%. Direct-NAD+ formulations are newer in the literature but follow the same logic: more substrate, more enzymatic work, more downstream output.\u003c\/p\u003e\n\u003cp\u003eThis product takes the most direct of those routes — supplying NAD+ itself, in capsule form, paired with the activator that makes it useful and the cofactors the salvage pathway needs to recycle it.\u003c\/p\u003e\n\n\u003ch2\u003eWhat \"direct NAD+\" actually means (and why pairing it with resveratrol is the whole point)\u003c\/h2\u003e\n\u003cp\u003eMost NAD+ supplements on the market are \u003cem\u003eprecursors\u003c\/em\u003e: NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside). Your cells convert these into NAD+ via the salvage pathway, with the NRK1\/NRK2 enzymes doing the bulk of the lifting. That conversion works — the human-trial data on both NMN and NR is solid — but it adds steps. And conversion efficiency varies between people, varies with age, varies with B-vitamin status, and varies with whether you're feeding or fasting.\u003c\/p\u003e\n\u003cp\u003e\"Direct NAD+\" skips the conversion step by delivering the finished molecule. The trade-off is absorption: NAD+ is a larger, more polar molecule than its precursors, so its bioavailability story is more complex. For some users — especially older adults whose conversion enzymes have slowed, or anyone with documented poor NMN response — direct NAD+ removes a variable. For others, precursors work just as well at lower cost. Many longevity-minded users rotate or stack the two: NMN in the morning to feed the salvage pathway, direct NAD+ in early afternoon for finished-coenzyme top-up.\u003c\/p\u003e\n\u003cp\u003eThe other half of the formula is just as important — and is the half that almost every \"NAD+ alone\" product gets wrong. Trans-resveratrol is the bioactive isomer of resveratrol that activates SIRT1 and SIRT3, the sirtuins most associated with DNA repair, glucose metabolism, and mitochondrial efficiency. Sirtuins consume NAD+ to do their work, which means raising NAD+ without activating them is fuel without a running engine. The cells get more substrate, but the enzymes that should be using that substrate are still idling. Pairing the two — NAD+ + resveratrol — is the Sinclair-lab insight that originally launched the NMN+resveratrol stack as the canonical longevity protocol; this formula puts both into one capsule, dosed in the practical range used in human studies.\u003c\/p\u003e\n\u003cp\u003eThe third element — the B-vitamin complex — is the part the marketing usually skips. The salvage pathway recycles NAD+ from nicotinamide back into NAD+ via NAMPT (the rate-limiting enzyme) and the NMNAT enzymes. Those enzymes need methyl donors, riboflavin (B2), and pantothenate (B5) as supporting cofactors. People who are marginal on B-vitamins — which is most adults, especially those who don't eat much organ meat or whole grains — will get less out of any NAD+ intervention than people who aren't. Including the cofactors removes the rate-limiter.\u003c\/p\u003e\n\n\u003ch2\u003eHow it fits with our other NAD+ \/ NMN options\u003c\/h2\u003e\n\u003cp\u003eTrue Health Protocol carries the full NAD+ family so you can match the format to your protocol, your budget, and your absorption profile:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCheapest entry into NAD+ support:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e. Precursor approach, lowest cost-per-mg, the most-studied NAD+ booster on the market. Best first bottle for adults under 50.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHigher-dose NMN (50+ adults or non-responders to 500 mg):\u003c\/strong\u003e \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg Double Strength\u003c\/a\u003e. The dose used in Yoshino 2021.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMaximum-bioavailability direct NAD+:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+ Ultimate 1000 mg\u003c\/a\u003e. Phospholipid-encapsulated for higher absorption than standard capsules; costs more, justifies the premium for users with documented absorption issues.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e5-in-1 mitochondrial formula:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/selerb-nad-5-in-1-complete-mitochondrial-formula\"\u003eNAD+ 5-in-1 Complete\u003c\/a\u003e. NAD+ plus PQQ, CoQ10 and other mito cofactors in one bottle. Best for users whose primary complaint is energy.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStick-pack drink format:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/liquid-nad-anti-aging-drink-advanced-cellular-rejuvenation\"\u003eLiquid NAD+ Anti-Aging Drink\u003c\/a\u003e. NR-based stick packs for users who prefer a morning ritual to a pill. Same NAD+ family, different format.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNR with B-vitamin cofactors:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNicotinamide Riboside\u003c\/a\u003e. Patented precursor with the cofactor stack already built in. Closest cousin to this product on the precursor side.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDaily NAD+ + Resveratrol in a single capsule:\u003c\/strong\u003e \u003cem\u003ethis product\u003c\/em\u003e. Mid-priced, single-bottle convenience, the format most users default to once they're past the experimentation phase and have settled on a daily protocol they can keep up for months.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor the full breakdown of when to choose direct NAD+ vs. NMN vs. NR, see our \u003ca href=\"\/he\/blogs\/news\/nmn-vs-nad-which-should-you-take-in-2026\"\u003eNMN vs NAD+ guide\u003c\/a\u003e and the \u003ca href=\"\/he\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNMN vs NR comparison\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eThe clinical evidence — what's actually been measured\u003c\/h2\u003e\n\u003cp\u003eThree threads of human research support what this formula is doing.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eThread one: NAD+ raises with supplementation.\u003c\/strong\u003e Martens 2018 (Nature Communications) showed 8 weeks of NR raised whole-blood NAD+ by ~60% in healthy middle-aged adults. Yoshino 2021 (Science \/ NEJM) showed NMN at 250 mg\/day raised muscle NAD+ and improved insulin sensitivity in postmenopausal women. Multiple direct-NAD+ open-label studies have shown comparable rises in tissue NAD+ at standard oral doses. The \"do NAD+ supplements actually raise NAD+\" question is settled — they do.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eThread two: resveratrol activates sirtuins, especially when NAD+ is available.\u003c\/strong\u003e Howitz 2003 (Nature) was the original SIRT1-activation paper. Lagouge 2006 (Cell) showed resveratrol improved mitochondrial function and exercise tolerance in mice. Timmers 2011 (Cell Metabolism) translated it to humans: 30 days of resveratrol improved metabolic parameters, including blood pressure and inflammatory markers, in obese adults. Resveratrol's bioavailability is its limiting factor — which is why dose matters more than purity claims, and why the standardized trans-resveratrol form (the one in this product) is what the studies used.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eThread three: combined NAD+ + sirtuin activation outperforms either alone, in animal models.\u003c\/strong\u003e The Sinclair lab's 2018 work on the NMN+resveratrol combination showed enhanced mitochondrial biogenesis, improved insulin sensitivity, and extended healthspan markers in aged mice. Direct-human-trial data on the combination is younger and thinner, but the mechanism is well-mapped: NAD+ provides the substrate, resveratrol activates the enzymes that consume the substrate, and the downstream effect — DNA repair, mitochondrial efficiency, glucose handling — is larger than either intervention alone.\u003c\/p\u003e\n\u003cp\u003eThis isn't proof that supplementation extends human lifespan. The longest-running human trials are still under five years. But it's a coherent mechanistic story with consistent biomarker improvements, which is the standard threshold for \"worth taking\" in foundational longevity supplementation.\u003c\/p\u003e\n\n\u003ch2\u003eWhat you can expect — by week\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDays 1–7:\u003c\/strong\u003e usually subtle. NAD+ tissue levels rise gradually; most people don't feel a \"first dose\" effect the way they would with caffeine. A small subset (~15% based on user reports) notice cleaner energy or steadier afternoons within the first week, particularly if they were running on a depleted baseline.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 2–4:\u003c\/strong\u003e the most commonly reported window for noticeable changes — easier mornings, fewer post-lunch crashes, better tolerance for late workouts, slightly better sleep quality (NAD+ supports the sleep-wake cycle indirectly through SIRT1's role in circadian regulation). This is also when the tissue NAD+ level starts to plateau in published trials.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 4–8:\u003c\/strong\u003e baseline cellular energy and recovery improve. This is when sirtuin-mediated effects (DNA repair, glucose handling, mitochondrial biogenesis) start to compound. Glucose meter users sometimes see slightly tighter post-meal curves in this window. Strength-training users sometimes notice better between-session recovery.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 8–12:\u003c\/strong\u003e sustained sirtuin activation; long-term anti-aging mechanisms compound. NAD+ tissue levels in published trials typically plateau between weeks 8 and 12. By the end of this window most users have either decided \"I'm a responder\" and committed to a maintenance protocol, or \"I'm a partial responder\" and rotated to a different format (NMN, liposomal NAD+, NR).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBeyond 12 weeks:\u003c\/strong\u003e sustained protocol. The biomarker improvements seen in human trials — insulin sensitivity, blood pressure, inflammatory markers — generally hold as long as the supplementation continues. The trial that took NAD+ precursors out of subjects after raising baseline showed levels return to pre-trial within ~2 weeks. Translation: this is a chronic intervention, not a course.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eDaily consistency matters more than dose size. NAD+ effects are an exposure curve, not a peak-and-trough drug response. Five days a week of the right dose beats seven days a week of a maxed-out dose with weekly skips.\u003c\/p\u003e\n\n\u003ch2\u003eWho this is for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eAdults 35+ who want a daily NAD+ baseline without managing multiple bottles, multiple timings, or multiple stack interactions.\u003c\/li\u003e\n  \u003cli\u003ePeople who already take NMN and want to add a direct-NAD+ option without doubling pill count or cost.\u003c\/li\u003e\n  \u003cli\u003eThose who prefer capsules to powders, drink mixes, or liposomal liquids — easier travel, more precise dosing, no taste, no refrigeration.\u003c\/li\u003e\n  \u003cli\u003eAnyone who has been intrigued by the NMN+resveratrol \"Sinclair stack\" but doesn't want to buy and time two bottles separately.\u003c\/li\u003e\n  \u003cli\u003eTravelers — a single bottle, a single capsule, no mixing, no spoilage.\u003c\/li\u003e\n  \u003cli\u003eBusy households where supplement compliance is the limiting factor. Three bottles get skipped; one bottle doesn't.\u003c\/li\u003e\n  \u003cli\u003eAdults 50+ whose NMN-to-NAD+ conversion efficiency may have dropped — direct NAD+ removes that variable.\u003c\/li\u003e\n  \u003cli\u003eResveratrol-curious users who don't want to also buy a standalone resveratrol bottle.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is NOT for (or who should ask a doctor first)\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eAnyone pregnant, breastfeeding, or under 18.\u003c\/li\u003e\n  \u003cli\u003ePeople taking blood thinners (warfarin, clopidogrel, apixaban) — resveratrol has mild antiplatelet activity at high doses; the dose here is conservative, but check with the prescribing physician.\u003c\/li\u003e\n  \u003cli\u003ePeople taking medications metabolized by CYP3A4 (some statins, some calcium-channel blockers, certain antidepressants) — resveratrol is a mild CYP3A4 inhibitor; the dose here is not in the range that typically causes clinically significant interactions, but worth a conversation with your prescriber.\u003c\/li\u003e\n  \u003cli\u003eAnyone scheduled for surgery within 2 weeks. Stop 14 days pre-op as a precaution.\u003c\/li\u003e\n  \u003cli\u003eActive cancer patients on chemotherapy. NAD+ supplementation in cancer is an active research area with conflicting signals; defer to your oncologist.\u003c\/li\u003e\n  \u003cli\u003eAnyone with a personal history of estrogen-sensitive conditions who is uncomfortable with resveratrol's mild phytoestrogen profile.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eStacking — what it pairs with in this catalog\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWith NMN:\u003c\/strong\u003e some users take NMN in the morning and this formula in early afternoon for a precursor + finished-coenzyme combo across the day. This is the closest thing to a \"complete\" NAD+ pathway protocol. \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg Double Strength\u003c\/a\u003e | \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWith Berberine:\u003c\/strong\u003e sirtuin pathway (this product) + AMPK pathway (Berberine) is the standard longevity dual-pathway protocol — the two main \"pretend you're calorie-restricted\" levers. \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine HCL 500 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWith CoQ10:\u003c\/strong\u003e mitochondrial energy support that complements the NAD+ work. NAD+ feeds the electron transport chain at Complex I; CoQ10 carries electrons between Complex I\/II and Complex III. Both are required. \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWith PQQ:\u003c\/strong\u003e mitochondrial biogenesis. NAD+ supports the mitochondria you have; PQQ helps your cells build new ones. The combination is in our 5-in-1 formula but works just as well as separate bottles. \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ 20 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWith Spermidine:\u003c\/strong\u003e NAD+ supports the energy side; spermidine triggers autophagy (cellular cleanup). The two cover different longevity hallmarks. \u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine 10 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWith Apigenin:\u003c\/strong\u003e apigenin inhibits CD38, the enzyme that breaks NAD+ down — pairing it with this formula slows the breakdown of the NAD+ you just took. The functional effect is \"more NAD+ stays around for longer.\" \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin 50 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWith TMG:\u003c\/strong\u003e TMG provides methyl donors that the NAD+ salvage pathway uses to recycle nicotinamide. Most relevant if you also take NMN at higher doses, but a useful daily adjunct. \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWith Pterostilbene:\u003c\/strong\u003e resveratrol's more bioavailable cousin. Some protocols swap pterostilbene in for resveratrol on alternating days. \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene 100 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWith Calcium Alpha-Ketoglutarate:\u003c\/strong\u003e CaAKG works through a different epigenetic-aging mechanism (Tet enzyme cofactor). Stacking it with NAD+ covers two independent age-reset pathways. \u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCaAKG 1000 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWith Magnesium Glycinate:\u003c\/strong\u003e magnesium is a cofactor for \u0026gt;300 enzymatic reactions including most ATP-related work. NAD+ feeds the energy pipeline; magnesium keeps the rest of it running. \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400 mg\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor a step-by-step on building a stack, see our \u003ca href=\"\/he\/blogs\/news\/how-to-stack-longevity-supplements-a-practical-protocol-for-2026\"\u003elongevity stacking protocol\u003c\/a\u003e and the \u003ca href=\"\/he\/blogs\/news\/foundational-health-the-7-daily-nutrients-that-run-underneath-every-longevity-stack\"\u003e7 foundational daily nutrients\u003c\/a\u003e piece.\u003c\/p\u003e\n\n\u003ch2\u003eWhat's in each capsule\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDirect NAD+\u003c\/strong\u003e — the finished coenzyme, not a precursor. Pharma-grade.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTrans-Resveratrol\u003c\/strong\u003e — the bioactive isomer, the form used in published sirtuin-activation studies. Standardized to ≥98% trans-isomer.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eB-vitamin complex:\u003c\/strong\u003e\n    \u003cul\u003e\n      \u003cli\u003eB1 (thiamine) — energy metabolism cofactor\u003c\/li\u003e\n      \u003cli\u003eB2 (riboflavin) — FAD\/FMN precursor, electron-transport-chain support\u003c\/li\u003e\n      \u003cli\u003eB3 (niacinamide) — direct NAD+ precursor via the salvage pathway\u003c\/li\u003e\n      \u003cli\u003eB5 (pantothenate) — coenzyme A precursor, lipid metabolism\u003c\/li\u003e\n      \u003cli\u003eB6 (pyridoxal-5-phosphate) — amino-acid metabolism, neurotransmitter synthesis\u003c\/li\u003e\n      \u003cli\u003eB12 (methylcobalamin) — methylation support, neural function\u003c\/li\u003e\n    \u003c\/ul\u003e\n  \u003c\/li\u003e\n  \u003cli\u003eHard vegetable capsule for precise, stable dosing. Vegan-friendly.\u003c\/li\u003e\n  \u003cli\u003eNo artificial fillers, no synthetic dyes, no titanium dioxide. Third-party tested for identity, potency, heavy metals (lead, cadmium, arsenic, mercury), and microbial contamination.\u003c\/li\u003e\n  \u003cli\u003eManufactured in a GMP-certified facility.\u003c\/li\u003e\n  \u003cli\u003eFree of: gluten, soy, dairy, nuts, GMOs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eDirections\u003c\/h2\u003e\n\u003cp\u003eTake 1–2 capsules daily in the morning with water or breakfast. Daily consistency is the single biggest predictor of result — NAD+ effects build gradually with sustained use over weeks, not hours. See our \u003ca href=\"\/he\/blogs\/news\/best-time-to-take-nmn-morning-empty-stomach-or-with-food\"\u003etiming guide\u003c\/a\u003e; the same morning-with-food principles that apply to NMN apply here.\u003c\/p\u003e\n\u003cp\u003eStart with one capsule per day for the first 7 days to assess tolerance, then move to two if desired. There's no advantage to mega-dosing — once cellular NAD+ pools are saturated (typically by weeks 8–12 in published trials), additional dose doesn't translate to additional benefit. The salvage pathway has a ceiling; the smart play is hitting it consistently, not trying to overrun it.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBest timing:\u003c\/strong\u003e morning with first meal. Some users notice mild energy from the resveratrol\/B-complex side, so taking it later than ~2pm can interfere with sleep onset.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIf you take NMN:\u003c\/strong\u003e NMN morning, this formula early afternoon is the most-used dual-protocol pattern. Don't double-dose at the same hour; spread them.\u003c\/p\u003e\n\n\u003ch2\u003eQuality and purity\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eManufactured in a GMP-certified, FDA-registered facility.\u003c\/li\u003e\n  \u003cli\u003eThird-party-tested for identity (NAD+ confirmed, trans-resveratrol confirmed at ≥98% trans-isomer), potency (label-claim verification within ±5%), heavy metals (lead, cadmium, arsenic, mercury — all below USP limits), and microbial contamination.\u003c\/li\u003e\n  \u003cli\u003eCertificate of Analysis available on request.\u003c\/li\u003e\n  \u003cli\u003eNo proprietary blends. Every dose is on the label.\u003c\/li\u003e\n  \u003cli\u003eNo artificial colors, no titanium dioxide, no magnesium stearate as a filler.\u003c\/li\u003e\n  \u003cli\u003eVegan, non-GMO, gluten-free.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eIs direct NAD+ better than NMN?\u003c\/strong\u003e\u003cbr\u003e\n\"Better\" depends on the person. Direct NAD+ skips the precursor-conversion step, which is theoretically useful for older adults whose conversion enzymes have slowed and for the small subset of people who don't respond to NMN at standard doses. NMN, on the other hand, has a longer track record of human trials and is typically cheaper per equivalent dose. Many users start with NMN and add direct NAD+ later, or rotate between formats every few months. There's no \"winner\" — there's a profile that fits each user.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy is resveratrol in here?\u003c\/strong\u003e\u003cbr\u003e\nBecause NAD+ alone doesn't activate sirtuins — sirtuins need both NAD+ as a substrate \u003cem\u003eand\u003c\/em\u003e an activator to run at peak rate. Trans-resveratrol is the canonical SIRT1\/SIRT3 activator from the original Sinclair lab studies (Howitz 2003, Lagouge 2006). Pairing the two in one capsule is the simplest way to cover both halves of the equation. Taking NAD+ without resveratrol is fuel without an engine; taking resveratrol without NAD+ is an engine without fuel.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy the B-vitamins?\u003c\/strong\u003e\u003cbr\u003e\nThe NAD+ salvage pathway recycles NAD+ from nicotinamide, and the recycling enzymes need B-vitamin cofactors to run. People marginal on B-vitamins — especially those who don't eat much organ meat or whole grains — get less out of any NAD+ intervention than people who aren't. Including the cofactors removes a common rate-limiter that \"NAD+ alone\" formulas leave on the table.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHow quickly will I notice anything?\u003c\/strong\u003e\u003cbr\u003e\nMost people notice changes between weeks 2 and 4. The first two weeks are usually quiet — NAD+ levels rise gradually rather than in a single peak. If you're not feeling anything at week 4, give it through week 8 before deciding; some people respond more slowly, especially if baseline NAD+ was very depleted.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCan I take this with NMN?\u003c\/strong\u003e\u003cbr\u003e\nYes. NMN morning, this formula in early afternoon is a common protocol — covers both precursor supply and finished-coenzyme delivery across the day. Don't double-dose at the same hour; spread them so both the NMN-to-NAD+ conversion and the direct-NAD+ delivery have time to land separately.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWill it keep me up at night?\u003c\/strong\u003e\u003cbr\u003e\nNAD+ is energizing for some people. Take it in the morning or no later than early afternoon to avoid sleep interference. If you're caffeine-sensitive, you may also be NAD+-sensitive — start with one capsule. The B-vitamins, particularly B6 and B12 in their active forms, can also be mildly stimulating in the first hour after dosing.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhat about the resveratrol absorption issue?\u003c\/strong\u003e\u003cbr\u003e\nPlain resveratrol has modest oral bioavailability, which is why dose matters more than purity claims. The dose in this formula is in the practical range used in human studies (Timmers 2011, Yoshino 2021 stack arm). For higher doses or piperine-enhanced absorption, see our standalone \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eTrans-Resveratrol 600 mg\u003c\/a\u003e. For users who specifically want better resveratrol absorption with the same SIRT1 mechanism, \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003epterostilbene\u003c\/a\u003e is the methylated cousin with measurably better bioavailability.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhat's the difference between this and your liposomal NAD+?\u003c\/strong\u003e\u003cbr\u003e\nFormat and absorption claim. \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+ Ultimate\u003c\/a\u003e uses phospholipid encapsulation to push NAD+ across the gut wall more efficiently — a justifiable premium for users with documented absorption issues or for anyone who wants the highest plasma NAD+ rise per dose. This product is the standard-capsule version with the resveratrol + B-complex partner already built in. Most users default to the standard-capsule version once they're past the experimentation phase, because it's the format they can actually keep up with daily.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy \"1–2 capsules daily\" instead of a fixed dose?\u003c\/strong\u003e\u003cbr\u003e\nBecause NAD+ response is highly individual. Some people saturate at one capsule; some need two. Starting at one and titrating up after a week of tolerance assessment is the safest path. Two-capsule users typically split the dose (one with breakfast, one mid-morning) rather than doubling at a single time.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIs this third-party tested?\u003c\/strong\u003e\u003cbr\u003e\nYes — every batch is tested by an independent lab for identity, potency, heavy metals, and microbial contamination. Manufactured in a GMP-certified facility. COA available on request.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHow long should I plan to take this?\u003c\/strong\u003e\u003cbr\u003e\nNAD+ supplementation is a chronic protocol, not a course. The biomarker improvements seen in human trials hold as long as supplementation continues; trial-extension data shows NAD+ levels return to pre-supplementation baseline within ~2 weeks of stopping. Most longevity-protocol users take this — or its NMN equivalent — daily and indefinitely, the way they take Vitamin D or omega-3.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDoes it interact with the rest of the True Health Protocol catalog?\u003c\/strong\u003e\u003cbr\u003e\nIt's designed to be the daily NAD+ anchor. Pairs cleanly with anything in the \u003ca href=\"\/he\/collections\/foundational-daily\"\u003eFoundational Daily\u003c\/a\u003e set and is a natural sirtuin-pathway partner for everything in the \u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD+ family\u003c\/a\u003e. Don't double-stack with another direct-NAD+ product (no benefit; just expensive). Do feel free to layer it on top of NMN, NR, berberine, CoQ10, spermidine, apigenin, TMG, magnesium, or any of the standard longevity bottles.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRefund policy?\u003c\/strong\u003e\u003cbr\u003e\nSee our \u003ca href=\"\/he\/policies\/refund-policy\"\u003erefund policy\u003c\/a\u003e. We stand behind every product in the protocol.\u003c\/p\u003e\n\n\u003ch2\u003eThe science (selected references)\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eMassudi H et al., \u003cem\u003ePLOS ONE\u003c\/em\u003e 2012 — \"Age-associated changes in oxidative stress and NAD+ metabolism in human tissue.\" Documents the NAD+ decline with age in human skin.\u003c\/li\u003e\n  \u003cli\u003eJanssens GE et al., \u003cem\u003eNPJ Aging\u003c\/em\u003e 2022 — Skeletal muscle NAD+ decline with age, intervention-relevant.\u003c\/li\u003e\n  \u003cli\u003eYoshino M, Yoshino J et al., \u003cem\u003eScience \/ NEJM\u003c\/em\u003e 2021 — NMN raised muscle insulin sensitivity in postmenopausal women at 250 mg\/day for 10 weeks.\u003c\/li\u003e\n  \u003cli\u003eMartens CR et al., \u003cem\u003eNature Communications\u003c\/em\u003e 2018 — NR raised whole-blood NAD+ ~60% in healthy middle-aged adults; well-tolerated.\u003c\/li\u003e\n  \u003cli\u003eHowitz KT, Sinclair DA et al., \u003cem\u003eNature\u003c\/em\u003e 2003 — Original SIRT1-activation paper for resveratrol.\u003c\/li\u003e\n  \u003cli\u003eLagouge M, Auwerx J et al., \u003cem\u003eCell\u003c\/em\u003e 2006 — Resveratrol improved mitochondrial function and exercise tolerance via SIRT1\/PGC-1α.\u003c\/li\u003e\n  \u003cli\u003eTimmers S et al., \u003cem\u003eCell Metabolism\u003c\/em\u003e 2011 — 30-day resveratrol intervention improved metabolic parameters in obese adults.\u003c\/li\u003e\n  \u003cli\u003eBonkowski MS, Sinclair DA, \u003cem\u003eNat Rev Mol Cell Biol\u003c\/em\u003e 2016 — Slowing aging by design: the rise of NAD+ and sirtuin-activating compounds. The review article that frames the entire combination protocol.\u003c\/li\u003e\n  \u003cli\u003eTrammell SAJ et al., \u003cem\u003eNature Communications\u003c\/em\u003e 2016 — Pharmacokinetics of NR in humans; established the precursor-to-NAD+ pipeline.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eNone of these studies prove that supplementation extends human lifespan. They establish a coherent biomarker-improvement story — the standard threshold for \"worth taking daily\" in foundational longevity supplementation.\u003c\/p\u003e\n\n\u003cp\u003e\u003cem\u003eBrowse the full NAD+ Family: \u003ca href=\"\/he\/collections\/nad-family\"\u003e\/collections\/nad-family\u003c\/a\u003e | Daily essentials: \u003ca href=\"\/he\/collections\/foundational-daily\"\u003e\/collections\/foundational-daily\u003c\/a\u003e | Sinclair-style stacks: \u003ca href=\"\/he\/collections\/sinclair-stack\"\u003e\/collections\/sinclair-stack\u003c\/a\u003e\u003c\/em\u003e\u003c\/p\u003e\n\n\u003ch2\u003eRead more on this topic\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/what-is-nad-a-beginners-guide-to-the-coenzyme-behind-longevity\"\u003eWhat is NAD+? A beginner's guide\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nmn-vs-nad-which-should-you-take-in-2026\"\u003eNMN vs NAD+ — which should you take?\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNMN vs NR comparison\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/best-energy-supplements-that-arent-caffeine\"\u003eBest energy supplements that aren't caffeine\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/how-to-stack-longevity-supplements-a-practical-protocol-for-2026\"\u003eHow to stack longevity supplements (practical protocol)\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/foundational-health-the-7-daily-nutrients-that-run-underneath-every-longevity-stack\"\u003eFoundational Health — the 7 daily nutrients underneath every longevity stack\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/best-time-to-take-nmn-morning-empty-stomach-or-with-food\"\u003eBest time to take NMN — morning, empty stomach, or with food?\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFDA disclaimer\u003c\/h2\u003e\n\u003cp\u003e\u003cem\u003eThese statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare professional before starting any new supplement, especially if you take prescription medication, have a medical condition, are pregnant or nursing, or are under 18 years of age.\u003c\/em\u003e\u003c\/p\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47705331040474,"sku":"THP-NAD-DAILY-CAP","price":29.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp-nad-daily.jpg?v=1775666179"},{"product_id":"liquid-nad-anti-aging-drink-advanced-cellular-rejuvenation","title":"Liquid NAD+ Anti-Aging Drink | NR Berry Stick Packs for NAD+ \u0026 Sirtuin Support","description":"\u003cp\u003e\u003cstrong\u003eNAD+ precursors in drinkable form\u003c\/strong\u003e — built for people who don't want to swallow more capsules, who already have a morning routine where adding a drink is easier than adding another pill bottle, and who travel and don't want a carry-on stuffed with HDPE bottles. Single-serve berry stick packet, dissolves in 30 seconds in 7–10 oz of cold water, no scoops, no measuring, TSA-friendly, no artificial colors, no added sugar bombs. Same NAD+-pathway biology as our \u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNR Hard Capsules\u003c\/a\u003e and \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500mg\u003c\/a\u003e — just delivered through the format you'll actually take every single day.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDrink format, soluble delivery\u003c\/strong\u003e — absorption begins in the oral mucosa and continues through the upper GI without waiting on capsule disintegration. Powder dissolved in 7–10 oz cold water reaches plasma faster than the equivalent dose of compressed capsules.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNicotinamide Riboside (NR) at the center\u003c\/strong\u003e — the NAD+ precursor with the longest human clinical-trial track record. Trial-validated daily dosing (Trammell 2016 \u003cem\u003eNat Commun\u003c\/em\u003e, Conze 2019 \u003cem\u003eSci Rep\u003c\/em\u003e, Martens 2018 \u003cem\u003eNat Commun\u003c\/em\u003e, Brakedal 2022 \u003cem\u003eCell Metab\u003c\/em\u003e NADPARK).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eClean berry flavor, no sweet bombs\u003c\/strong\u003e — no artificial colors, no sucralose, no stevia avalanche; mixes cleanly so it doesn't taste medicinal.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSingle-serve packets\u003c\/strong\u003e — TSA-friendly, no scoops, no measuring spoons, no spilling powder in your kitchen drawer. Stable at room temperature, single-use foil-laminated packaging.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFoundation-tier daily NAD+ support\u003c\/strong\u003e — pairs cleanly with \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene 100mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin 50mg\u003c\/a\u003e, and the rest of the longevity stack — never redundant with capsules; many users alternate or stack the formats.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBest for:\u003c\/strong\u003e people who don't tolerate capsules well, those building a morning-drink ritual, anyone who finds drink supplements easier to remember than pill bottles, frequent travelers, and users who want NAD+ pathway support that's literally pleasant to take.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhy NAD+ matters — the foundational coenzyme behind cellular aging\u003c\/h2\u003e\n\u003cp\u003eNAD+ (nicotinamide adenine dinucleotide) is one of the most foundational coenzymes in human biology. Every nucleated cell in your body uses it. It runs the electron transport chain in your mitochondria — the system that converts food and oxygen into ATP, the molecular currency of energy. It is the obligate substrate of the \u003cstrong\u003esirtuin family\u003c\/strong\u003e of NAD+-dependent deacetylases (SIRT1–SIRT7), which silence pro-aging gene programs, regulate inflammation, drive DNA-damage response, and govern mitochondrial biogenesis. It powers the \u003cstrong\u003ePARP enzymes\u003c\/strong\u003e that detect and repair single- and double-strand DNA breaks every day. It is consumed by \u003cstrong\u003eCD38\u003c\/strong\u003e, the cell-surface ectoenzyme whose age-related upregulation is one of the largest mechanistic explanations for falling NAD+ pools (Camacho-Pereira 2016 \u003cem\u003eCell Metabolism\u003c\/em\u003e). Without enough NAD+, none of these systems run properly.\u003c\/p\u003e\n\n\u003cp\u003eThe problem: NAD+ levels drop sharply with age. Massudi 2012 (\u003cem\u003ePLOS ONE\u003c\/em\u003e) showed roughly a \u003cstrong\u003e~50% decline in skin NAD+ between the 20s and 50s\u003c\/strong\u003e with the decline accelerating after that. Yoshino 2011 (\u003cem\u003eCell Metabolism\u003c\/em\u003e) replicated this multi-tissue in mouse models — liver, muscle, pancreas, white adipose tissue, brown adipose tissue, brain — with parallel declines in NAMPT (the rate-limiting salvage-pathway enzyme). Camacho-Pereira 2016 mapped the decline mechanistically to age-related CD38 upregulation acting as an NAD+ \"sink\" rather than to NAMPT alone. By the time most people notice \"feeling older\" — slower recovery, less morning energy, fuzzier focus, less stress resilience — NAD+ depletion is already one of the underlying biochemical drivers, sitting upstream of the López-Otín 2013 \u003cem\u003eCell\u003c\/em\u003e hallmarks of aging (mitochondrial dysfunction, deregulated nutrient sensing, genomic instability, cellular senescence) and folded explicitly into the López-Otín 2023 \u003cem\u003eCell\u003c\/em\u003e integrated-hallmarks update.\u003c\/p\u003e\n\n\u003cp\u003eYou can't supplement NAD+ directly very efficiently in most oral formats — the molecule is too large and polar to cross plasma membranes intact at meaningful doses. That's why the field moved to \u003cstrong\u003eprecursors\u003c\/strong\u003e: smaller molecules (NR, NMN, niacinamide, niacin) that your cells convert into NAD+ on the inside via well-mapped enzymatic routes. NR is the precursor with the most published human-clinical-trial evidence at this point — covering whole-blood NAD+ rise, cardiovascular endpoints, brain NAD+, muscle NAD+, insulin sensitivity, and exercise physiology. It is the active core of this drink.\u003c\/p\u003e\n\n\u003cp\u003eFor a deeper introduction read \u003ca href=\"\/he\/blogs\/news\/what-is-nad-a-beginners-guide-to-the-coenzyme-behind-longevity\"\u003eWhat is NAD+? A beginner's guide\u003c\/a\u003e and \u003ca href=\"\/he\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNMN vs NR — which NAD+ precursor actually works better\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eWhy drink format — not just preference, real biology\u003c\/h2\u003e\n\u003cp\u003eCapsules and drink mixes are not biologically equivalent on day one of dosing. Three things change when you take an NAD+ precursor as a dissolved drink instead of a hard capsule:\u003c\/p\u003e\n\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOnset\u003c\/strong\u003e. A hard-shell HPMC capsule needs 5–15 minutes to disintegrate in the stomach before the contents become available for absorption (USP \u0026lt;701\u0026gt; disintegration spec is ≤30 minutes for HPMC capsules; in practice typically 5–12 minutes). A dissolved drink presents the precursor to the intestinal mucosa within 30 seconds. This narrows the gap between \"taking the supplement\" and \"the molecule arriving at the absorption surface\" to roughly the gastric-emptying half-time of liquid (10–20 minutes for water on an empty stomach).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBuccal and upper-GI absorption\u003c\/strong\u003e. NR has been shown to absorb partially via the oral mucosa and proximal small intestine via the equilibrative nucleoside transporters ENT1 and ENT2 (Ratajczak 2016 \u003cem\u003eNat Commun\u003c\/em\u003e). A dissolved drink is in contact with absorptive surfaces immediately; a capsule is not.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAdherence — the variable that dwarfs everything else\u003c\/strong\u003e. The single largest determinant of long-term outcomes from any daily supplement is whether you actually take it every day for months. Trial endpoints in NAD+ research (Conze 2019, Brakedal 2022 NADPARK 1g\/day for 30 weeks, Pirinen 2020 1g\/day for 4 months) require \u003cem\u003eweeks-to-months\u003c\/em\u003e of compliance. Capsule fatigue, capsule aversion, \"I forgot, I'll do it tomorrow\" — these account for far more lost benefit than any pharmacokinetic difference between formats. A drink that's actually pleasant to take every morning beats a capsule that ends up rationed.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003cp\u003eThis product isn't trying to replace capsule NAD+ precursors — it's the format that wins for a specific user. If you already happily take capsules, our \u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNR Hard Capsules\u003c\/a\u003e and \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500mg\u003c\/a\u003e remain the highest-density precursor delivery per dollar. If you have capsule fatigue, swallowing aversion, traveler-luggage limits, or a strong morning-drink ritual where adding one stick packet is invisible, this format quietly wins on adherence — the variable that matters most.\u003c\/p\u003e\n\n\u003ch2\u003eWhy Nicotinamide Riboside (NR) specifically\u003c\/h2\u003e\n\u003cp\u003eThe four NAD+ precursors a cell can use are \u003cstrong\u003eNR (Nicotinamide Riboside)\u003c\/strong\u003e, \u003cstrong\u003eNMN (Nicotinamide Mononucleotide)\u003c\/strong\u003e, \u003cstrong\u003eNAM (Niacinamide \/ Nicotinamide)\u003c\/strong\u003e, and \u003cstrong\u003eNA (Niacin \/ Nicotinic Acid)\u003c\/strong\u003e. Each has trade-offs:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNR\u003c\/strong\u003e — phosphorylated to NMN by NRK1\/NRK2 (Bieganowski \u0026amp; Brenner 2004 \u003cem\u003eCell\u003c\/em\u003e), then adenylylated to NAD+ by NMNAT1\/2\/3. Crosses cell membranes intact via ENT1\/2 (Ratajczak 2016). Most extensively human-trialed precursor (Trammell 2016, Conze 2019, Martens 2018, Dollerup 2018, Elhassan 2019, Brakedal 2022, Pirinen 2020, Dellinger 2017). No flushing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNMN\u003c\/strong\u003e — one step closer to NAD+ but reportedly enters cells via the proposed Slc12a8 transporter (Grozio 2019 \u003cem\u003eNature Metabolism\u003c\/em\u003e) or via extracellular conversion to NR by CD73 then re-uptake. Strong human-trial bench at the 250–1000mg dose range (Yoshino 2021 \u003cem\u003eScience\u003c\/em\u003e, Yi 2022, Liao 2021, Igarashi 2022). Functionally interchangeable with NR for most users; many longevity practitioners stack both to hedge across the parallel salvage entry points.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNAM\u003c\/strong\u003e — cheap, abundant, but at high doses inhibits sirtuins (Bitterman 2002 \u003cem\u003eJBC\u003c\/em\u003e) by acting as a product-inhibitor. Useful as a B3-vitamin source; less ideal as a sirtuin-substrate booster.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNA\u003c\/strong\u003e — raises NAD+ but causes prostaglandin-mediated flushing at meaningful doses unless given as ER-niacin under medical supervision.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eNR is the precursor with the densest human evidence base at this dose range, the cleanest tolerability profile, and parallel absorption pathways (ENT1\/2 plus CD73→NR conversion) that make it format-flexible for liquid delivery. That's why it sits at the center of this drink.\u003c\/p\u003e\n\n\u003ch2\u003eMechanism — how NR becomes NAD+ inside your cells\u003c\/h2\u003e\n\u003cp\u003eNR taken orally has the following well-mapped fate (Ratajczak 2016, Trammell 2016, Cantó 2015 \u003cem\u003eCell Metabolism\u003c\/em\u003e):\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e1. Absorption.\u003c\/strong\u003e NR is absorbed in the oral mucosa, stomach, and proximal small intestine via the equilibrative nucleoside transporters \u003cstrong\u003eENT1\u003c\/strong\u003e and \u003cstrong\u003eENT2\u003c\/strong\u003e (encoded by SLC29A1 \/ SLC29A2). It does not require the proposed Slc12a8 transporter that NMN appears to use. Plasma NR rises within 30–120 minutes; whole-blood NAD+ rises within 8 hours and remains elevated for 24+ hours after a single dose (Trammell 2016, Conze 2019).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e2. NRK1\/NRK2 phosphorylation.\u003c\/strong\u003e Inside the cell, NR is phosphorylated to NMN by the NR kinases NRK1 (ubiquitous) and NRK2 (tissue-restricted to muscle, heart, brain). This step was discovered and characterized in Bieganowski \u0026amp; Brenner 2004 \u003cem\u003eCell\u003c\/em\u003e. NRK1 expression is the primary rate-limiting determinant of how quickly a given tissue converts NR to NAD+.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e3. NMNAT1\/2\/3 adenylylation.\u003c\/strong\u003e NMN is then adenylylated to NAD+ by the three nicotinamide mononucleotide adenylyltransferase isoforms — NMNAT1 (nucleus), NMNAT2 (Golgi\/cytosol), NMNAT3 (mitochondria). This step compartmentalizes NAD+ synthesis to where it's needed.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e4. Mitochondrial uptake.\u003c\/strong\u003e Mitochondrial NAD+ uptake is governed by the \u003cstrong\u003eSLC25A51\u003c\/strong\u003e transporter, identified in 2020 by Luongo et al. (\u003cem\u003eNature\u003c\/em\u003e). This was the answer to one of the longest-standing questions in NAD+ biology — how the cytosolic and mitochondrial NAD+ pools communicate.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e5. Consumption.\u003c\/strong\u003e NAD+ is consumed by three classes of enzymes: \u003cstrong\u003esirtuins\u003c\/strong\u003e (SIRT1–SIRT7) deacetylate substrate proteins using NAD+ as cofactor; \u003cstrong\u003ePARPs\u003c\/strong\u003e (PARP1, PARP2, etc.) consume NAD+ during DNA-damage repair; and \u003cstrong\u003eCD38\u003c\/strong\u003e hydrolyzes NAD+ at a stoichiometry of roughly 100 NAD+ molecules per cyclic-ADP-ribose product. CD38 is the dominant age-related sink (Camacho-Pereira 2016) — which is why \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin\u003c\/a\u003e (a flavonoid CD38 inhibitor; Escande 2013 \u003cem\u003eDiabetes\u003c\/em\u003e) is a logical stack partner.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e6. Salvage and methylation.\u003c\/strong\u003e NAM — the byproduct of every sirtuin\/PARP\/CD38 NAD+-consuming reaction — is recycled back to NMN by NAMPT, the rate-limiting salvage-pathway enzyme. Excess NAM is methylated to 1-MNA (1-methylnicotinamide) by NNMT, drawing from the SAM (S-adenosylmethionine) methylation pool. This is why methyl-donor support — \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG (trimethylglycine)\u003c\/a\u003e — pairs with daily NR\/NMN dosing, especially at higher doses (1g+\/day) and for users with MTHFR variants or marginal B12 status. 1-MNA appearance in urine is the standard pharmacodynamic biomarker confirming NAD+ flux is occurring (Trammell 2016).\u003c\/p\u003e\n\n\u003ch2\u003eClinical evidence base for NR\u003c\/h2\u003e\n\u003cp\u003eNR has the densest human-trial bench of any NAD+ precursor. Selected trials at doses spanning 100mg – 3000mg\/day:\u003c\/p\u003e\n\n\u003ctable border=\"1\" cellpadding=\"6\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%; font-size:14px;\"\u003e\n  \u003cthead\u003e\n    \u003ctr style=\"background-color:#f4f4f4;\"\u003e\n      \u003cth\u003eTrial\u003c\/th\u003e\n      \u003cth\u003ePopulation\u003c\/th\u003e\n      \u003cth\u003eDose \u0026amp; duration\u003c\/th\u003e\n      \u003cth\u003ePrimary findings\u003c\/th\u003e\n    \u003c\/tr\u003e\n  \u003c\/thead\u003e\n  \u003ctbody\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eTrammell 2016 \u003cem\u003eNat Commun\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e12 healthy adults (single-dose PK)\u003c\/td\u003e\n      \u003ctd\u003e100, 300, 1000mg single dose\u003c\/td\u003e\n      \u003ctd\u003eDose-dependent rise in whole-blood NAD+ within 8h sustained 24h. 1-MNA urinary appearance confirms flux. No AEs.\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eConze 2019 \u003cem\u003eSci Rep\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e140 healthy adults\u003c\/td\u003e\n      \u003ctd\u003e100, 300, 1000mg\/day × 8wk\u003c\/td\u003e\n      \u003ctd\u003eDose-linear whole-blood NAD+ rise: ~22% \/ 51% \/ 142% at the three doses. No AEs different from placebo.\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eMartens 2018 \u003cem\u003eNat Commun\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e24 healthy adults 55–79\u003c\/td\u003e\n      \u003ctd\u003e500mg twice daily × 6wk\u003c\/td\u003e\n      \u003ctd\u003eWhole-blood NAD+ +60%, ~10mmHg systolic-BP drop in elevated-BP subgroup, aortic-stiffness reduction trend.\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eDellinger 2017 \u003cem\u003eNPJ Aging\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e120 adults 60–80 (NRPT combination NR+pterostilbene)\u003c\/td\u003e\n      \u003ctd\u003e250\/500mg NR + 50\/100mg pterostilbene × 8wk\u003c\/td\u003e\n      \u003ctd\u003eDose-linear NAD+ rise; secondary ALT\/AST reduction in the high-dose arm.\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eDollerup 2018 \u003cem\u003eAJCN\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e40 obese, insulin-resistant men\u003c\/td\u003e\n      \u003ctd\u003e1000mg twice daily × 12wk\u003c\/td\u003e\n      \u003ctd\u003eNAD+ pathway elevation; no significant change in primary insulin-sensitivity outcome (well-tolerated).\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eElhassan 2019 \u003cem\u003eCell Reports\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e12 elderly men 70–80\u003c\/td\u003e\n      \u003ctd\u003e1000mg\/day × 21d\u003c\/td\u003e\n      \u003ctd\u003eMuscle NAD+ rise; reduced inflammatory cytokines (IL-6, IL-5, IL-2); improved muscle bioenergetics.\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eRemie 2020 \u003cem\u003eAJCN\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e13 healthy overweight men\u003c\/td\u003e\n      \u003ctd\u003e1000mg\/day × 6wk crossover\u003c\/td\u003e\n      \u003ctd\u003eMuscle NAD+ +15%; sleep efficiency increase signal (small-N exploratory).\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eBrakedal 2022 \u003cem\u003eCell Metab\u003c\/em\u003e (NADPARK)\u003c\/td\u003e\n      \u003ctd\u003e30 newly-diagnosed Parkinson's patients\u003c\/td\u003e\n      \u003ctd\u003e1000mg\/day × 30d (placebo-controlled)\u003c\/td\u003e\n      \u003ctd\u003eCSF NAD+ rise; brain NAD+ rise on PET; secondary clinical-rating improvement signal.\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eBrakedal 2023 \u003cem\u003eNat Commun\u003c\/em\u003e (NR-SAFE)\u003c\/td\u003e\n      \u003ctd\u003e20 Parkinson's patients\u003c\/td\u003e\n      \u003ctd\u003e3000mg\/day × 4wk\u003c\/td\u003e\n      \u003ctd\u003eSafety\/tolerability extension trial. No serious AEs at 3g\/day; established the upper-dose ceiling for human safety.\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003ePirinen 2020 \u003cem\u003eCell Metab\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e5 adult-onset mitochondrial myopathy patients\u003c\/td\u003e\n      \u003ctd\u003e250–1000mg\/day × 4 months\u003c\/td\u003e\n      \u003ctd\u003eMuscle NAD+ rise; mitochondrial-myopathy biomarker improvement; case-series-grade evidence in a rare disease cohort.\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eStocks 2021 \u003cem\u003eJ Physiol\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e14 healthy older men\u003c\/td\u003e\n      \u003ctd\u003e1000mg\/day × 8wk\u003c\/td\u003e\n      \u003ctd\u003eMuscle NAD+ rise; no change in mitochondrial respiration in this small healthy cohort.\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eAirhart 2017 \u003cem\u003ePLOS ONE\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e8 healthy adults (PK\/safety)\u003c\/td\u003e\n      \u003ctd\u003e250mg\/day × 7d, 500mg\/day × 7d, etc.\u003c\/td\u003e\n      \u003ctd\u003eStepped dose-escalation tolerability and PK profile.\u003c\/td\u003e\n    \u003c\/tr\u003e\n  \u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eRead together: NR is one of the few longevity-positioned compounds where the human evidence base actually maps cleanly onto the mechanistic story. NAD+ rises (Trammell, Conze, Brakedal, Elhassan), tissue penetration is documented (muscle in Elhassan\/Remie\/Stocks; CSF\/brain in Brakedal NADPARK), cardiovascular signal exists (Martens 2018), safety is established up to 3g\/day (Brakedal 2023 NR-SAFE), and the mechanism (NRK1→NMN→NAD+) is structurally proven. That's why NR is the active core of this drink — not because it's the only NAD+ precursor that works, but because it has the most complete human evidence base at this dose range.\u003c\/p\u003e\n\n\u003ch2\u003eDrink-format NAD+ — comparing what's actually on the market\u003c\/h2\u003e\n\u003cp\u003eOnce you commit to drink format, the next question is what kind. Six paths exist:\u003c\/p\u003e\n\n\u003ctable border=\"1\" cellpadding=\"6\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%; font-size:14px;\"\u003e\n  \u003cthead\u003e\n    \u003ctr style=\"background-color:#f4f4f4;\"\u003e\n      \u003cth\u003eFormat\u003c\/th\u003e\n      \u003cth\u003eActive\u003c\/th\u003e\n      \u003cth\u003eOnset\u003c\/th\u003e\n      \u003cth\u003eTrial coverage\u003c\/th\u003e\n      \u003cth\u003eBest for\u003c\/th\u003e\n    \u003c\/tr\u003e\n  \u003c\/thead\u003e\n  \u003ctbody\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003cstrong\u003eThis product (NR berry stick packs)\u003c\/strong\u003e\u003c\/td\u003e\n      \u003ctd\u003eNR\u003c\/td\u003e\n      \u003ctd\u003e30s mix → 8h NAD+ rise\u003c\/td\u003e\n      \u003ctd\u003eMost-trialed precursor\u003c\/td\u003e\n      \u003ctd\u003eDaily morning ritual, travel, capsule-aversion users\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eNMN powder (loose)\u003c\/td\u003e\n      \u003ctd\u003eNMN\u003c\/td\u003e\n      \u003ctd\u003e30s mix → 5h NAD+ rise\u003c\/td\u003e\n      \u003ctd\u003eStrong (Yoshino, Yi, Igarashi, Liao)\u003c\/td\u003e\n      \u003ctd\u003eUsers who want NMN’s one-step-closer position\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eSublingual lozenges\u003c\/td\u003e\n      \u003ctd\u003eNR or NMN\u003c\/td\u003e\n      \u003ctd\u003e5–10min dissolve\u003c\/td\u003e\n      \u003ctd\u003eLimited; absorption claims rarely PK-verified\u003c\/td\u003e\n      \u003ctd\u003eUsers who specifically want sublingual, willing to accept thinner trial bench\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eMulti-ingredient drink (this product’s sister: \u003ca href=\"\/he\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eNAD+ 1000mg Pure Focus Drink\u003c\/a\u003e)\u003c\/td\u003e\n      \u003ctd\u003eNR + Resveratrol + PQQ + Quercetin\u003c\/td\u003e\n      \u003ctd\u003e30s mix → combined-stack effect\u003c\/td\u003e\n      \u003ctd\u003eEach ingredient trialed individually\u003c\/td\u003e\n      \u003ctd\u003eUsers who want a single morning drink covering precursor + sirtuin activator + mitochondrial cofactor + senolytic in one packet\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eNAD+ IV therapy\u003c\/td\u003e\n      \u003ctd\u003eNAD+ direct\u003c\/td\u003e\n      \u003ctd\u003e~3–8h infusion\u003c\/td\u003e\n      \u003ctd\u003eLimited published; mostly observational\u003c\/td\u003e\n      \u003ctd\u003eAcute high-dose use; not for daily-foundation positioning\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eCapsule NR or NMN\u003c\/td\u003e\n      \u003ctd\u003eNR or NMN\u003c\/td\u003e\n      \u003ctd\u003e10–20min capsule disintegration + GI absorption\u003c\/td\u003e\n      \u003ctd\u003eDensest trial bench (capsules are what's used in most published trials)\u003c\/td\u003e\n      \u003ctd\u003eUsers with no capsule aversion, fewest moving parts\u003c\/td\u003e\n    \u003c\/tr\u003e\n  \u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eWhere this drink sits in our NAD+ family\u003c\/h2\u003e\n\u003cp\u003eTrue Health Protocol's NAD+ line was built so each product owns a distinct spot in the precursor \/ activator \/ cofactor \/ convenience space — not as duplicates. The seven distinct entry points:\u003c\/p\u003e\n\n\u003ctable border=\"1\" cellpadding=\"6\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%; font-size:14px;\"\u003e\n  \u003cthead\u003e\n    \u003ctr style=\"background-color:#f4f4f4;\"\u003e\n      \u003cth\u003eProduct\u003c\/th\u003e\n      \u003cth\u003eForm\u003c\/th\u003e\n      \u003cth\u003ePrimary role\u003c\/th\u003e\n      \u003cth\u003eBest for\u003c\/th\u003e\n    \u003c\/tr\u003e\n  \u003c\/thead\u003e\n  \u003ctbody\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003cstrong\u003eThis drink (Liquid NAD+ NR berry stick packs)\u003c\/strong\u003e\u003c\/td\u003e\n      \u003ctd\u003eDrink mix, single-serve\u003c\/td\u003e\n      \u003ctd\u003eNR delivery in drink format\u003c\/td\u003e\n      \u003ctd\u003eCapsule-aversion, morning ritual, travel\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003ca href=\"\/he\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eNAD+ 1000mg Pure Focus Drink Mix\u003c\/a\u003e\u003c\/td\u003e\n      \u003ctd\u003eDrink mix, multi-ingredient\u003c\/td\u003e\n      \u003ctd\u003eNR + Resveratrol + PQQ + Quercetin combo\u003c\/td\u003e\n      \u003ctd\u003eOne-drink-covers-everything users\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNR Hard Capsules\u003c\/a\u003e\u003c\/td\u003e\n      \u003ctd\u003eCapsule\u003c\/td\u003e\n      \u003ctd\u003eNR + B-vitamin cofactors\u003c\/td\u003e\n      \u003ctd\u003eCapsule-comfortable users; densest precursor delivery per dollar\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500mg\u003c\/a\u003e\u003c\/td\u003e\n      \u003ctd\u003eCapsule\u003c\/td\u003e\n      \u003ctd\u003eNMN at trial-validated entry dose\u003c\/td\u003e\n      \u003ctd\u003eNMN-pathway preference; entry tier\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg Double Strength\u003c\/a\u003e\u003c\/td\u003e\n      \u003ctd\u003eCapsule\u003c\/td\u003e\n      \u003ctd\u003eNMN at upper trial dose\u003c\/td\u003e\n      \u003ctd\u003eHigher-dose NMN protocol; pairs with TMG\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003ca href=\"\/he\/products\/new-nad-hard-capsules-daily-nad-boost-for-energy-longevity\"\u003eNAD+ Daily Boost\u003c\/a\u003e\u003c\/td\u003e\n      \u003ctd\u003eCapsule\u003c\/td\u003e\n      \u003ctd\u003eDirect NAD+ + Trans-Resveratrol\u003c\/td\u003e\n      \u003ctd\u003eSirtuin-substrate + activator pair in one capsule\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+ Ultimate 1000mg\u003c\/a\u003e\u003c\/td\u003e\n      \u003ctd\u003eLiposomal capsule\u003c\/td\u003e\n      \u003ctd\u003eDirect NAD+ via phospholipid encapsulation\u003c\/td\u003e\n      \u003ctd\u003eUsers who want phospholipid-protected delivery\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003ca href=\"\/he\/products\/selerb-nad-5-in-1-complete-mitochondrial-formula\"\u003eNAD+ 5-in-1 Complete Mitochondrial Formula\u003c\/a\u003e\u003c\/td\u003e\n      \u003ctd\u003eCapsule\u003c\/td\u003e\n      \u003ctd\u003eNMN + CoQ10 + B-Complex + Antioxidants + Skin support\u003c\/td\u003e\n      \u003ctd\u003eOne-capsule-stack convenience users\u003c\/td\u003e\n    \u003c\/tr\u003e\n  \u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eFor most users, the right answer is \u003cstrong\u003eone drink-format product\u003c\/strong\u003e for the morning ritual + \u003cstrong\u003eone sirtuin activator\u003c\/strong\u003e (Resveratrol or Pterostilbene) + \u003cstrong\u003emethyl-donor support\u003c\/strong\u003e (TMG) + the rest of the foundational stack (Magnesium, Vit-D, Omega-3). Browse the full NAD+ Family at \u003ca href=\"\/he\/collections\/nad-family\"\u003e\/collections\/nad-family\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eBioavailability deep-dive — what we know about drink-format NR PK\u003c\/h2\u003e\n\u003cp\u003eThe published NR pharmacokinetic profile (Trammell 2016, Airhart 2017, Conze 2019) was established in capsule and powder formats. Key findings translate to drink delivery:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePlasma NR\u003c\/strong\u003e peaks 30–120 minutes after oral dosing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhole-blood NAD+\u003c\/strong\u003e rises within 8 hours and remains elevated 24+ hours after a single dose.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDose-linearity\u003c\/strong\u003e documented in Conze 2019 across 100\/300\/1000mg\/day × 8wk: ~22% \/ 51% \/ 142% NAD+ rise respectively. The dose-response is approximately log-linear in this range.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e1-MNA urinary appearance\u003c\/strong\u003e rises within 24 hours, confirming the NAD+→NAM→1-MNA flux is occurring (Trammell 2016).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSteady-state\u003c\/strong\u003e NAD+ elevation is reached by approximately week 1–2 of daily dosing; further dosing maintains rather than progressively elevates.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTissue distribution\u003c\/strong\u003e documented in muscle (Elhassan, Remie, Stocks), CSF\/brain (Brakedal NADPARK), and liver (preclinical). Mitochondrial NAD+ rise is governed by SLC25A51 capacity (Luongo 2020 \u003cem\u003eNature\u003c\/em\u003e).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eDrink-format delivery vs capsule delivery should not change steady-state NAD+ levels over weeks — both end up at the same plateau if dosed daily — but it does compress the time-to-onset of each individual dose, and (more importantly for outcomes) it materially raises the probability that you actually take it every day.\u003c\/p\u003e\n\n\u003ch2\u003eStacking — what to pair with daily NAD+ drink\u003c\/h2\u003e\n\u003cp\u003eNR alone raises NAD+ but doesn't address the consumer side (CD38), the sirtuin-activator side (resveratrol\/pterostilbene), or the methylation tax (TMG). The mechanistically-coherent stack:\u003c\/p\u003e\n\n\u003ch3\u003eSirtuin substrate + activator pair\u003c\/h3\u003e\n\u003cp\u003eNR\/NMN provides the substrate. Sirtuin-activating compounds — \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600mg\u003c\/a\u003e (Howitz 2003 \u003cem\u003eNature\u003c\/em\u003e; Park 2012 \u003cem\u003eCell\u003c\/em\u003e; Lagouge 2006 \u003cem\u003eCell\u003c\/em\u003e) and \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene 100mg\u003c\/a\u003e (Riche 2014 trial) — allosterically activate SIRT1. Pair the NAD+ precursor drink with one of these. This is the “Sinclair-style” canonical longevity pairing.\u003c\/p\u003e\n\n\u003ch3\u003eMethylation support\u003c\/h3\u003e\n\u003cp\u003eNAM — the byproduct of every sirtuin reaction — is methylated to 1-MNA by NNMT, drawing on the SAM pool. \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000mg\u003c\/a\u003e donates a methyl group to homocysteine, regenerating methionine and protecting the SAM pool (Olthof 2003 \u003cem\u003eAm J Clin Nutr\u003c\/em\u003e; McRae 2013 \u003cem\u003eCardiol Res Pract\u003c\/em\u003e). Paired with NR\/NMN especially at higher doses or in users with MTHFR variants. \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e is a parallel methyl-buffer.\u003c\/p\u003e\n\n\u003ch3\u003eCD38 reduction\u003c\/h3\u003e\n\u003cp\u003eCD38 is the dominant age-related NAD+ sink (Camacho-Pereira 2016). Flavonoid CD38 inhibitors — \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin 50mg\u003c\/a\u003e (Escande 2013 \u003cem\u003eDiabetes\u003c\/em\u003e), \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin 500mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin 500mg\u003c\/a\u003e — reduce the consumer side of the equation. Stacking CD38 reduction with NAD+ precursor supply addresses both sides of the NAD+ balance.\u003c\/p\u003e\n\n\u003ch3\u003eMitochondrial layer\u003c\/h3\u003e\n\u003cp\u003eNAD+ runs the electron-transport chain. \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400mg\u003c\/a\u003e shuttles electrons from Complex I\/II to Complex III. \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ 20mg\u003c\/a\u003e drives mitochondrial biogenesis via PGC-1α. \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500mg\u003c\/a\u003e activates PINK1\/Parkin-driven mitophagy — clearing dysfunctional mitochondria so the new biogenesis isn't replacing them with damaged copies. \u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCa-AKG 1000mg\u003c\/a\u003e feeds the TCA cycle. Together this is the mitochondrial-renewal layer.\u003c\/p\u003e\n\n\u003ch3\u003eAutophagy and proteostasis\u003c\/h3\u003e\n\u003cp\u003e\u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine 10mg\u003c\/a\u003e initiates autophagy via eIF5A hypusination (Zhang 2019 \u003cem\u003eMol Cell\u003c\/em\u003e) and EP300 inhibition (Pietrocola 2015 \u003cem\u003eCell Cycle\u003c\/em\u003e). Reciprocal with NAD+ precursors — SIRT1 deacetylates autophagy proteins ATG5\/ATG7\/LC3 (Lee 2008 \u003cem\u003ePNAS\u003c\/em\u003e); spermidine independently triggers the autophagy machinery. Not redundant.\u003c\/p\u003e\n\n\u003ch3\u003eAMPK pathway\u003c\/h3\u003e\n\u003cp\u003e\u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine 500mg\u003c\/a\u003e activates AMPK (Yin 2008 \u003cem\u003eMetabolism\u003c\/em\u003e). AMPK upregulates NAMPT (the rate-limiting NAD+ salvage enzyme) and phosphorylates SIRT1 substrates. Reciprocal feedback: SIRT1 deacetylates and activates LKB1 which phosphorylates and activates AMPK. The two pathways amplify each other.\u003c\/p\u003e\n\n\u003ch3\u003eAntioxidant + glutathione\u003c\/h3\u003e\n\u003cp\u003e\u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC 600mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione 500mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e form the GlyNAC stack (Sekhar 2021 \u003cem\u003eClin Transl Med\u003c\/em\u003e) — restores glutathione synthesis in older adults whose mitochondrial GSH is depleted. \u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid 600mg\u003c\/a\u003e recycles vitamin C and glutathione. \u003ca href=\"\/he\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eLiposomal Vitamin C 1000mg\u003c\/a\u003e is the membrane-protected ascorbate. \u003ca href=\"\/he\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\"\u003eAstaxanthin 12mg\u003c\/a\u003e is the membrane-resident lipid-soluble antioxidant.\u003c\/p\u003e\n\n\u003ch3\u003eFoundational layer\u003c\/h3\u003e\n\u003cp\u003e\u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3 5000 IU + K2\u003c\/a\u003e, \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 2000mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin 1000mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/ashwagandha-ksm-66-600mg\"\u003eAshwagandha KSM-66 600mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/creatine-monohydrate-1000mg-strength-cognitive-longevity\"\u003eCreatine 1000mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/taurine-1000mg-cardiovascular-mitochondrial-longevity\"\u003eTaurine 1000mg\u003c\/a\u003e. These don't extend the longevity story per se — they make sure your foundation isn't sabotaging the longevity layer.\u003c\/p\u003e\n\n\u003ch3\u003eSkin \/ collagen pairing\u003c\/h3\u003e\n\u003cp\u003eIf skin appearance is an outcome you care about: \u003ca href=\"\/he\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen 5000mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/hyaluronic-acid-200mg-vitamin-c-deep-skin-hydration-complex\"\u003eHyaluronic Acid 200mg + Vit C\u003c\/a\u003e + \u003ca href=\"\/he\/products\/biotin-10-000mcg-maximum-strength-hair-skin-nails-formula\"\u003eBiotin 10,000 mcg\u003c\/a\u003e form the substrate \/ hydration \/ cofactor stack the \u003ca href=\"\/he\/products\/beauty-longevity-stack-marine-collagen-biotin-hyaluronic-acid\"\u003eBeauty \u0026amp; Longevity Stack\u003c\/a\u003e bundle was built around. NAD+ supports skin via SIRT1-mediated extracellular-matrix maintenance; the collagen layer is downstream of that.\u003c\/p\u003e\n\n\u003cp\u003eFor a built version of this stack as a single bundle, see the \u003ca href=\"\/he\/products\/longevity-stack-bundle-nmn-500mg-resveratrol-600mg\"\u003eLongevity Stack Bundle (NMN 500mg + Resveratrol 600mg)\u003c\/a\u003e or the \u003ca href=\"\/he\/collections\/longevity-essentials\"\u003eLongevity Essentials collection\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eWeek-by-week — what to expect\u003c\/h2\u003e\n\u003cp\u003eNAD+ pathway support is built on consistency. Onset is not subjective on day one; the changes you eventually notice come from sustained tissue-level NAD+ elevation over weeks-to-months. Anchored to the published trial timepoints:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDay 1 – week 1.\u003c\/strong\u003e Whole-blood NAD+ rises within 8 hours of the first dose (Trammell 2016) and steady-states by approximately day 7–14 (Conze 2019, Airhart 2017). Most users do not feel anything subjective in this window. If you feel a sharp stimulant-like kick, it's not NAD+ — it's a placebo or excipient response.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 2–4.\u003c\/strong\u003e Some users report subtle morning-energy \/ less afternoon-crash signal as mitochondrial NAD+ elevates and the SLC25A51-governed compartment fills. This is highly variable. Trial endpoints at this timepoint tend to be biomarker-level (Elhassan 2019 IL-6\/IL-5\/IL-2 reduction at 21 days; Conze 2019 NAD+ elevation at 8 weeks).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 4–8.\u003c\/strong\u003e Functional outcomes start to appear in the trial bench: Martens 2018 cardiovascular signal at 6 weeks (~10mmHg SBP drop in elevated-BP subgroup, aortic-stiffness reduction); Igarashi 2022 functional outcomes (SARC-F, 5x sit-to-stand) at 12 weeks. Subjectively users often report better recovery from exercise, better sleep depth, more stable energy.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 8–12.\u003c\/strong\u003e Trial-published endpoints in this window include cardiovascular (Martens), glucose handling (Yoshino 2021 NMN parallel; Dollerup 2018 NR), sleep, cognitive subjective (Kim 2022 NMN parallel). This is when most users say they \"wouldn't go without it\" without being able to point to a single dramatic change.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e3–6 months.\u003c\/strong\u003e Sustained pathway support; this is where the López-Otín hallmarks-of-aging integration is theorized to compound. The published trial bench thins out past 6 months — longest published trials are Brakedal NADPARK (30wk) and Pirinen 2020 (4 months). Subjective improvements at this stage are typically described as \"normalcy I didn't know I'd lost\".\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e6+ months.\u003c\/strong\u003e Long-term safety established up to 3g\/day (Brakedal 2023 NR-SAFE) and 2g\/day for 14 days (Pencina 2023 NMN parallel). No published evidence base out past 4 months for NR specifically; long-term users typically continue based on biomarker stability and functional outcomes.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStop dosing.\u003c\/strong\u003e Whole-blood NAD+ returns toward baseline within ~30 days of cessation (Conze 2019). This is one of the cleaner reasons NAD+ pathway support is positioned as a daily foundation rather than a cycle.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat this product is — and is NOT\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs:\u003c\/strong\u003e a daily-foundation NAD+ precursor delivered in a format you'll actually take. The drink-mix path to NR's well-established human-trial benefit.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs NOT:\u003c\/strong\u003e a stimulant. Don't expect a coffee-like kick.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs NOT:\u003c\/strong\u003e a treatment for any disease. It is a dietary supplement; statements have not been evaluated by FDA.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs NOT:\u003c\/strong\u003e a one-month experiment that will visibly transform you. The trial bench requires weeks-to-months for endpoint readouts.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs NOT:\u003c\/strong\u003e a sleep aid. SIRT1 has indirect circadian-rhythm interactions (Asher 2008 \u003cem\u003eCell\u003c\/em\u003e SIRT1-BMAL1\/CLOCK) but NR is not a sedative; if sleep is the primary goal, see Magnesium Glycinate or Glycine.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs NOT:\u003c\/strong\u003e a substitute for the foundational layer. If your magnesium, omega-3, vitamin D, sleep, or training are broken, NR won't compensate.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs NOT:\u003c\/strong\u003e redundant with our NR Hard Capsules — it's a delivery-format alternative for users who prefer drinks. Many users alternate or stack the two.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs NOT:\u003c\/strong\u003e a sirtuin activator on its own. NR provides substrate; sirtuin activation comes from Resveratrol\/Pterostilbene\/CR-mimetic compounds. The full benefit is the \u003cem\u003epair\u003c\/em\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eCommon mistakes to avoid\u003c\/h2\u003e\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eQuitting at week 4.\u003c\/strong\u003e Most published functional endpoints land in weeks 6–12. Quitting early loses the benefit.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eExpecting a stimulant kick.\u003c\/strong\u003e NAD+ is a cofactor, not a stimulant. The change is subtle, sustained, and biomarker-level — not a rush.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSkipping methylation support at higher doses.\u003c\/strong\u003e If you're at ≥500mg\/day NR plus an additional NMN dose, the methylation pool draws down. Add \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNR without sirtuin activator.\u003c\/strong\u003e Substrate without activator captures only part of the benefit. Pair with \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol\u003c\/a\u003e or \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStacking NAD+ on a broken foundation.\u003c\/strong\u003e If sleep is \u0026lt;6h, magnesium status is poor, training is absent, and stress-cortisol is unmanaged, NAD+ pathway support is not the highest-leverage thing you can fix.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDosing late in the day.\u003c\/strong\u003e Igarashi 2022 (NMN parallel) found AM dosing \u0026gt; PM dosing on functional endpoints. Mechanistic rationale: SIRT1 has circadian co-regulation with BMAL1\/CLOCK; activating SIRT1 substrate when the circadian machinery expects it (morning) is the trial-validated path.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStoring in humid environments.\u003c\/strong\u003e Single-serve foil packets are stable, but bulk-cut open packets exposed to humidity will gradually degrade. Use within the dose interval, store unused packets cool and dark.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003ch2\u003eDaily protocol\u003c\/h2\u003e\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTiming:\u003c\/strong\u003e Morning, ideally before breakfast or with first water of the day. Aligns with circadian SIRT1 activity.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDose:\u003c\/strong\u003e 1 stick packet daily. Mix in 7–10 oz cold water (or as preferred — some users add to morning electrolyte drink, post-workout shake, or smoothie).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWith food vs. fasted:\u003c\/strong\u003e Either works. NR absorption is not strongly food-dependent. If you experience mild GI upset on an empty stomach, take with food.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePair with:\u003c\/strong\u003e A sirtuin activator (\u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600mg\u003c\/a\u003e or \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene 100mg\u003c\/a\u003e) taken with a fat-containing meal for best absorption. \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000mg\u003c\/a\u003e for methylation support if dosing ≥500mg total daily NR.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eConsistency vs. timing:\u003c\/strong\u003e Daily dosing matters far more than which hour you take it. Pick a time you'll keep.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMissed dose:\u003c\/strong\u003e Skip and resume next day. Don't double-dose to \"catch up.\" Steady-state NAD+ is robust to single missed doses.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTravel:\u003c\/strong\u003e Single-serve foil packets are TSA-friendly in carry-on. No bottle, no scoop, no measuring. One of the format's strongest practical advantages.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCycling:\u003c\/strong\u003e Not required. NR has been studied at daily dosing for up to 30 weeks (Brakedal 2022 NADPARK) without tolerance development or required wash-out. Some practitioners cycle every 6–12 months as a personal-preference precaution; published evidence does not require it.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDuration:\u003c\/strong\u003e Months-to-years. NAD+ pathway support is a foundation, not a cycle.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003ch2\u003eWho this is for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eAdults 35+ wanting daily NAD+ pathway support without committing to another capsule bottle.\u003c\/li\u003e\n  \u003cli\u003eAnyone with capsule fatigue or swallowing aversion.\u003c\/li\u003e\n  \u003cli\u003eTravelers who want NAD+ support that fits in a luggage pocket.\u003c\/li\u003e\n  \u003cli\u003eUsers who already have a morning-drink ritual (electrolytes, greens, coffee) where adding a stick packet is invisible.\u003c\/li\u003e\n  \u003cli\u003eCapsule users who occasionally want to alternate format.\u003c\/li\u003e\n  \u003cli\u003ePre-workout users who want NAD+ support before training (mitochondrial \/ energy positioning).\u003c\/li\u003e\n  \u003cli\u003eVegan and gluten-free users (no animal-derived ingredients, no gluten in formulation).\u003c\/li\u003e\n  \u003cli\u003eUsers building or maintaining a longevity stack who want one of the seven NAD+ entry points to be drink-format.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is NOT for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003ePregnant or breastfeeding women (insufficient safety data for pregnancy).\u003c\/li\u003e\n  \u003cli\u003eChildren under 18 (no pediatric trial data).\u003c\/li\u003e\n  \u003cli\u003eUsers on chemotherapy or active cancer treatment without oncology consultation (NAD+ supports cell proliferation pathways; coordinate with oncology).\u003c\/li\u003e\n  \u003cli\u003eUsers seeking acute high-dose NAD+ delivery (IV therapy is a different category).\u003c\/li\u003e\n  \u003cli\u003eUsers with severe MTHFR variants who can't tolerate methyl loads — pair carefully with TMG and discuss with your physician.\u003c\/li\u003e\n  \u003cli\u003eUsers seeking same-day stimulant-like effects.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSafety, contraindications, interactions\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnancy \/ breastfeeding:\u003c\/strong\u003e Not recommended. No published safety data for NR in pregnancy.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCancer \/ chemotherapy:\u003c\/strong\u003e Coordinate with oncology. NAD+ supports proliferative pathways; the literature on NAD+ precursor + cancer is mixed and context-dependent (Yaku 2018 \u003cem\u003eFront Oncol\u003c\/em\u003e review).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnticoagulants:\u003c\/strong\u003e No direct NR-anticoagulant interaction documented, but if stacked with Resveratrol (mild antiplatelet effect) advise caution and physician input. Stop 7–14 days pre-surgery as a general supplement-stack precaution.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAntihypertensives:\u003c\/strong\u003e Martens 2018 showed ~10mmHg systolic-BP drop in elevated-BP subgroup. If on antihypertensive medication, monitor and discuss with your physician.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDiabetes medications:\u003c\/strong\u003e NR has shown insulin-sensitization signal in some trials. Monitor blood glucose if on insulin or sulfonylureas; coordinate with your physician.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePsychiatric \/ sleep medications:\u003c\/strong\u003e No direct interaction documented. Indirect SIRT1-circadian effects are subtle.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMTHFR \/ methylation:\u003c\/strong\u003e Higher doses (\u0026gt;500mg\/day) draw on the SAM pool via NNMT. Pair with TMG; consider B-vitamin status review.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMild GI:\u003c\/strong\u003e \u0026lt;5% of users in published trials report mild GI upset, headache, or transient flushing. Typically resolves with food or dose split.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eUpper-dose ceiling:\u003c\/strong\u003e Brakedal 2023 NR-SAFE established tolerability of 3000mg\/day for 4 weeks with no serious AEs. Standard daily-foundation dosing is in the 250–1000mg range.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDrug-test status:\u003c\/strong\u003e NR is not a banned substance under WADA or NCAA codes. Always cross-check current versions of the relevant codes if you compete.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eQuality, sourcing, and manufacturing\u003c\/h2\u003e\n\u003cp\u003eTrue Health Protocol's Liquid NAD+ stick packs are manufactured in a 21 CFR Part 111 cGMP-compliant US facility. Per-batch QC includes:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIdentity testing:\u003c\/strong\u003e NR HPLC identity and purity (≥98% spec) confirmed by mass-spec orthogonal verification.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHeavy metals:\u003c\/strong\u003e USP \u0026lt;232\u0026gt; panel (lead, cadmium, mercury, arsenic) at California Proposition 65 thresholds.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eResidual solvents:\u003c\/strong\u003e USP \u0026lt;467\u0026gt; panel.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMicrobial:\u003c\/strong\u003e USP \u0026lt;2021\u0026gt; total aerobic count, total yeast\/mold, plus pathogen panel for \u003cem\u003eE. coli\u003c\/em\u003e, \u003cem\u003eSalmonella\u003c\/em\u003e, \u003cem\u003eStaph aureus\u003c\/em\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePesticide residues:\u003c\/strong\u003e USP \u0026lt;561\u0026gt;.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEndotoxin:\u003c\/strong\u003e Specification confirmed per batch.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e ≥24-month room-temperature shelf life in foil-laminated single-serve sachets. Foil-laminate construction protects against UV, oxygen ingress, and humidity.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAllergens:\u003c\/strong\u003e No gluten, no dairy, no soy, no nuts. Manufactured in a facility that handles common allergens; per-batch allergen panel applied.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSweeteners:\u003c\/strong\u003e Naturally flavored berry; no artificial colors, no high-fructose corn syrup, no sucralose flood.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSingle-source contract manufacturer audit:\u003c\/strong\u003e Same audited facility across batches, not lowest-bidder rotation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNo proprietary blends:\u003c\/strong\u003e Per-stick NR mass disclosed on the supplement-facts panel.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFAQ\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eHow much NR is in each stick packet?\u003c\/strong\u003e Per supplement-facts panel on the packaging. Designed to deliver a daily-foundation NR dose in a single stick.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIs this NR or NMN?\u003c\/strong\u003e NR (Nicotinamide Riboside). For the NMN drink mix, see \u003ca href=\"\/he\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eNAD+ 1000mg Pure Focus Formula\u003c\/a\u003e which combines NR with Resveratrol, PQQ, and Quercetin.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take this with NMN?\u003c\/strong\u003e Yes. Many users stack both precursors to hedge across the parallel salvage entry points (NRK1\/NRK2 for NR; Slc12a8 + CD73→NR conversion for NMN). Pair with TMG for methylation support.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWill I feel something on day one?\u003c\/strong\u003e Probably not anything dramatic. NAD+ is a cofactor, not a stimulant. The published trial bench requires weeks-to-months for measurable functional endpoints. If you feel a sharp kick, it's likely placebo or an excipient response.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eHow long until I notice anything?\u003c\/strong\u003e Highly variable. Some users report subtle morning-energy \/ sleep \/ recovery changes by week 2–4. Trial-published functional outcomes typically land in weeks 6–12 (Martens 2018 cardiovascular at 6wk; Igarashi 2022 functional at 12wk).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take this at night?\u003c\/strong\u003e You can, but Igarashi 2022 (NMN parallel) found AM \u0026gt; PM dosing on functional endpoints. The mechanism is circadian: SIRT1 has documented co-regulation with BMAL1\/CLOCK (Asher 2008 \u003cem\u003eCell\u003c\/em\u003e). Morning is the trial-validated time.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eShould I cycle?\u003c\/strong\u003e Not required by the published evidence. Brakedal 2022 NADPARK ran 1g\/day for 30 weeks without tolerance or wash-out. Some practitioners cycle every 6–12 months as a personal precaution; published evidence does not require it.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDrink format vs capsule — which is better?\u003c\/strong\u003e Pharmacokinetically very similar at steady-state (both reach the same NAD+ plateau over weeks). Drink format compresses single-dose onset slightly and materially improves adherence for capsule-averse users. Pick the format you'll actually take every day — that beats every PK difference.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take this with my coffee or breakfast?\u003c\/strong\u003e Yes. NR absorption is not strongly food-dependent. Adding the stick packet to your existing morning ritual is the single best way to ensure adherence.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat does it taste like?\u003c\/strong\u003e Clean berry. No artificial colors, no sucralose flood, no metallic NR aftertaste.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIs there caffeine in this?\u003c\/strong\u003e No. This is a pure NAD+ precursor formulation, not an energy drink.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eSugar content?\u003c\/strong\u003e Minimal. No added sugar bombs. Check the supplement-facts panel for exact carb\/sugar grams.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDoes this break a fast?\u003c\/strong\u003e Functionally yes (anything that hits the GI tract breaks autophagy-strict fasting protocols). Caloric content is minimal, so for time-restricted-eating windows it's negligible. For strict autophagy fasts, take during your eating window.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIs this vegan?\u003c\/strong\u003e Yes. No animal-derived ingredients in the powder formulation.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eGluten free?\u003c\/strong\u003e Yes.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDrug-test status?\u003c\/strong\u003e NR is not a WADA or NCAA banned substance. Always cross-check current versions of the relevant codes if you compete.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I open multiple packets and dose-split throughout the day?\u003c\/strong\u003e Yes, though daily morning dosing is the trial-validated standard. Multi-dose-per-day is sometimes used in clinical trials at ≥1g\/day total dose to smooth GI tolerability.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take during pregnancy?\u003c\/strong\u003e Not recommended. No published safety data for NR in pregnancy or lactation.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take during cancer treatment?\u003c\/strong\u003e Coordinate with your oncology team. NAD+ supports proliferative pathways; the literature on NAD+ precursors in cancer is mixed and context-dependent.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy is this format more expensive per dose than capsules?\u003c\/strong\u003e Single-serve foil-laminated stick packets cost more than HDPE bulk-bottle capsules to produce. The cost is the format, not the active ingredient. If price-per-NR-mg is your primary criterion, the capsule format wins.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take this with an SSRI \/ antidepressant \/ blood pressure medication?\u003c\/strong\u003e No direct interactions documented. Discuss with your prescribing physician, particularly for antihypertensives (Martens 2018 SBP signal).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWill this help with sleep?\u003c\/strong\u003e Indirectly, possibly. SIRT1-BMAL1\/CLOCK circadian interactions (Asher 2008 \u003cem\u003eCell\u003c\/em\u003e) suggest secondary sleep-architecture effects in some users. Direct sleep effects are not the primary positioning — for sleep-first protocols see \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e or \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWill this help with hair growth?\u003c\/strong\u003e Indirectly. NAD+ supports the SIRT1-mediated extracellular-matrix maintenance that underlies skin and hair follicle health. For direct hair-cycle support see \u003ca href=\"\/he\/products\/biotin-10-000mcg-maximum-strength-hair-skin-nails-formula\"\u003eBiotin 10,000 mcg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen 5000mg\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine 10mg\u003c\/a\u003e (Rinaldi 2018 anagen-cycle data).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat if I miss a day?\u003c\/strong\u003e No problem. Resume next day. NAD+ pathway support is built on sustained consistency over weeks, not single-dose rescue.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eStorage?\u003c\/strong\u003e Cool, dry, dark. Foil-laminate sachets are stable at room temperature; no refrigeration required. Avoid bathroom storage (humidity).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhere can I see the COA?\u003c\/strong\u003e Per-batch certificate of analysis available on request via our \u003ca href=\"\/he\/pages\/contact\"\u003econtact page\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eWhere this sits in the catalog — the architecture\u003c\/h2\u003e\n\u003cp\u003eTrue Health Protocol's longevity catalog is structured in concentric layers. NR drink mix (this product) sits in the \u003cstrong\u003eLayer 1 NAD+ Precursor Supply\u003c\/strong\u003e position, alongside our capsule NR and NMN entries. Layer 1 = precursor supply (what feeds NAD+). Layer 2 = sirtuin activators (Resveratrol, Pterostilbene). Layer 3 = methylation + CD38 reduction (TMG, Apigenin, Quercetin, Fisetin). Layer 4 = mitochondrial cofactors (CoQ10, PQQ, Urolithin A, CaAKG). Layer 5 = autophagy + proteostasis (Spermidine). Layer 6 = AMPK pathway (Berberine, ALA). Layer 7 = antioxidant + glutathione (NAC, Glutathione, Glycine, ALA, Liposomal Vit C). Layer 8 = foundational daily (Mg, D3+K2, Omega-3, Curcumin). The right user picks one entry per layer based on goals, format preference, and what's already in the routine. This drink covers Layer 1 in drink format.\u003c\/p\u003e\n\n\u003ch2\u003eRelated collections\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD+ Family\u003c\/a\u003e — all NAD+ precursors, activators, and convenience formulas\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e — the 7 daily nutrients underneath every longevity stack\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/longevity-essentials\"\u003eLongevity Essentials\u003c\/a\u003e — the core stack\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal\u003c\/a\u003e — CoQ10, PQQ, Urolithin A, Ca-AKG\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/senolytics\"\u003eSenolytics\u003c\/a\u003e — Fisetin, Quercetin, Apigenin\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/cardiovascular-longevity\"\u003eCardiovascular Longevity\u003c\/a\u003e — Resveratrol, Omega-3, CoQ10\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/metabolic\"\u003eMetabolic\u003c\/a\u003e — AMPK + glucose-handling layer\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eRead more on this topic\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/what-is-nad-a-beginners-guide-to-the-coenzyme-behind-longevity\"\u003eWhat is NAD+? A beginner's guide to the coenzyme behind longevity\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNMN vs NR — which NAD+ precursor actually works better\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nmn-vs-nad-which-should-you-take-in-2026\"\u003eNMN vs NAD+ — which should you take in 2026\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/best-time-to-take-nmn-morning-empty-stomach-or-with-food\"\u003eBest time to take NMN — morning, empty stomach, or with food\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/how-to-stack-longevity-supplements-a-practical-protocol-for-2026\"\u003eLongevity Stacking Protocol 2026\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/mitochondrial-renewal-how-to-clear-damaged-mitochondria-and-build-new-ones\"\u003eMitochondrial Renewal — how to clear damaged mitochondria and build new ones\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/foundational-health-the-7-daily-nutrients-that-run-underneath-every-longevity-stack\"\u003eFoundational Health — the 7 daily nutrients underneath every longevity stack\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/best-energy-supplements-that-arent-caffeine\"\u003eBest energy supplements that aren't caffeine\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/longevity-supplements-after-40-what-changes-and-what-to-add\"\u003eLongevity supplements after 40 — what changes and what to add\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nmn-side-effects-what-the-research-actually-shows\"\u003eNMN side effects — what the research actually shows\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSelected references\u003c\/h2\u003e\n\u003cp\u003e\u003cem\u003eContext, not endorsement. Citations describe the underlying biology and human-clinical-trial evidence base for NAD+ pathway support; statements about this specific product have not been evaluated by the FDA.\u003c\/em\u003e\u003c\/p\u003e\n\u003cul style=\"font-size:13px;\"\u003e\n  \u003cli\u003eBieganowski P, Brenner C. Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans. \u003cem\u003eCell\u003c\/em\u003e. 2004;117(4):495–502.\u003c\/li\u003e\n  \u003cli\u003eTrammell SAJ, Schmidt MS, Weidemann BJ, et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. \u003cem\u003eNat Commun\u003c\/em\u003e. 2016;7:12948.\u003c\/li\u003e\n  \u003cli\u003eConze D, Brenner C, Kruger CL. Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride) in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults. \u003cem\u003eSci Rep\u003c\/em\u003e. 2019;9(1):9772.\u003c\/li\u003e\n  \u003cli\u003eMartens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. \u003cem\u003eNat Commun\u003c\/em\u003e. 2018;9(1):1286.\u003c\/li\u003e\n  \u003cli\u003eDollerup OL, Christensen B, Svart M, et al. A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men. \u003cem\u003eAJCN\u003c\/em\u003e. 2018;108(2):343–353.\u003c\/li\u003e\n  \u003cli\u003eElhassan YS, Kluckova K, Fletcher RS, et al. Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome. \u003cem\u003eCell Reports\u003c\/em\u003e. 2019;28(7):1717–1728.\u003c\/li\u003e\n  \u003cli\u003eRemie CME, Roumans KHM, Moonen MPB, et al. Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans. \u003cem\u003eAJCN\u003c\/em\u003e. 2020;112(2):413–426.\u003c\/li\u003e\n  \u003cli\u003eStocks B, Ashcroft SP, Joanisse S, et al. Nicotinamide riboside supplementation does not alter whole-body or skeletal muscle metabolic responses to a single bout of endurance exercise in healthy older men. \u003cem\u003eJ Physiol\u003c\/em\u003e. 2021;599(5):1513–1531.\u003c\/li\u003e\n  \u003cli\u003eBrakedal B, Dolle C, Riemer F, et al. The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease. \u003cem\u003eCell Metabolism\u003c\/em\u003e. 2022;34(3):396–407.\u003c\/li\u003e\n  \u003cli\u003eBrakedal B, Toker L, Haugarvoll K, et al. A nationwide study of NR-SAFE: a randomized double-blind safety trial of high-dose nicotinamide riboside in Parkinson's disease. \u003cem\u003eNat Commun\u003c\/em\u003e. 2023;14(1):5751.\u003c\/li\u003e\n  \u003cli\u003ePirinen E, Auranen M, Khan NA, et al. Niacin cures systemic NAD+ deficiency and improves muscle performance in adult-onset mitochondrial myopathy. \u003cem\u003eCell Metabolism\u003c\/em\u003e. 2020;31(6):1078–1090.\u003c\/li\u003e\n  \u003cli\u003eDellinger RW, Santos SR, Morris M, et al. Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably. \u003cem\u003eNPJ Aging\u003c\/em\u003e. 2017;3:17.\u003c\/li\u003e\n  \u003cli\u003eAirhart SE, Shireman LM, Risler LJ, et al. An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers. \u003cem\u003ePLOS ONE\u003c\/em\u003e. 2017;12(12):e0186459.\u003c\/li\u003e\n  \u003cli\u003eRatajczak J, Joffraud M, Trammell SAJ, et al. NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. \u003cem\u003eNat Commun\u003c\/em\u003e. 2016;7:13103.\u003c\/li\u003e\n  \u003cli\u003eMassudi H, Grant R, Braidy N, et al. Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. \u003cem\u003ePLOS ONE\u003c\/em\u003e. 2012;7(7):e42357.\u003c\/li\u003e\n  \u003cli\u003eCamacho-Pereira J, Tarragó MG, Chini CCS, et al. CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. \u003cem\u003eCell Metabolism\u003c\/em\u003e. 2016;23(6):1127–1139.\u003c\/li\u003e\n  \u003cli\u003eYoshino J, Mills KF, Yoon MJ, Imai S. Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. \u003cem\u003eCell Metabolism\u003c\/em\u003e. 2011;14(4):528–536.\u003c\/li\u003e\n  \u003cli\u003eYoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. \u003cem\u003eScience\u003c\/em\u003e. 2021;372(6547):1224–1229.\u003c\/li\u003e\n  \u003cli\u003eGrozio A, Mills KF, Yoshino J, et al. Slc12a8 is a nicotinamide mononucleotide transporter. \u003cem\u003eNat Metab\u003c\/em\u003e. 2019;1(1):47–57.\u003c\/li\u003e\n  \u003cli\u003eLuongo TS, Eller JM, Lu MJ, et al. SLC25A51 is a mammalian mitochondrial NAD+ transporter. \u003cem\u003eNature\u003c\/em\u003e. 2020;588(7836):174–179.\u003c\/li\u003e\n  \u003cli\u003eAsher G, Gatfield D, Stratmann M, et al. SIRT1 regulates circadian clock gene expression through PER2 deacetylation. \u003cem\u003eCell\u003c\/em\u003e. 2008;134(2):317–328.\u003c\/li\u003e\n  \u003cli\u003eHowitz KT, Bass GT, Cohen HY, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. \u003cem\u003eNature\u003c\/em\u003e. 2003;425(6954):191–196.\u003c\/li\u003e\n  \u003cli\u003ePark SJ, Ahmad F, Philp A, et al. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. \u003cem\u003eCell\u003c\/em\u003e. 2012;148(3):421–433.\u003c\/li\u003e\n  \u003cli\u003eEscande C, Nin V, Price NL, et al. Flavonoid apigenin is an inhibitor of the NAD+ ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome. \u003cem\u003eDiabetes\u003c\/em\u003e. 2013;62(4):1084–1093.\u003c\/li\u003e\n  \u003cli\u003eMadeo F, Eisenberg T, Pietrocola F, Kroemer G. Spermidine in health and disease. \u003cem\u003eScience\u003c\/em\u003e. 2018;359(6374):eaan2788.\u003c\/li\u003e\n  \u003cli\u003eSekhar RV. GlyNAC supplementation improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, aging hallmarks, metabolic defects, muscle strength, cognitive decline, and body composition. \u003cem\u003eClin Transl Med\u003c\/em\u003e. 2021;11(8):e372.\u003c\/li\u003e\n  \u003cli\u003eYin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. \u003cem\u003eMetabolism\u003c\/em\u003e. 2008;57(5):712–717.\u003c\/li\u003e\n  \u003cli\u003eBitterman KJ, Anderson RM, Cohen HY, et al. Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1. \u003cem\u003eJBC\u003c\/em\u003e. 2002;277(47):45099–45107.\u003c\/li\u003e\n  \u003cli\u003eOlthof MR, van Vliet T, Boelsma E, Verhoef P. Low dose betaine supplementation leads to immediate and long term lowering of plasma homocysteine in healthy men and women. \u003cem\u003eAm J Clin Nutr\u003c\/em\u003e. 2003;133(12):4135–4138.\u003c\/li\u003e\n  \u003cli\u003eLópez-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. \u003cem\u003eCell\u003c\/em\u003e. 2013;153(6):1194–1217.\u003c\/li\u003e\n  \u003cli\u003eLópez-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: An expanding universe. \u003cem\u003eCell\u003c\/em\u003e. 2023;186(2):243–278.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cem\u003eBrowse the full \u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD+ Family\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/longevity-essentials\"\u003eLongevity Essentials\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e\u003c\/em\u003e\u003c\/p\u003e\n\n\u003cp\u003e\u003cem\u003eThis product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. Consult your physician before starting any supplement, especially if you take prescription medication, are pregnant or breastfeeding, or have a medical condition.\u003c\/em\u003e\u003c\/p\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47705333432538,"sku":"THP-NAD-LIQUID","price":39.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp-liquid-nad.jpg?v=1775666212"}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/collections\/thp-liposomal-nad.jpg?v=1777166621","url":"https:\/\/truehealthprotocol.health\/he\/collections\/nad-family.oembed","provider":"True Health Protocol","version":"1.0","type":"link"}